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ABSTRACT 
This study investigated the antioxidant, antidiabetic and toxicity properties of antidiabetic 
medicinal plants comprising of Vernonia amygdalina, Cola nitida, Raffia palm (Raphia hookeri) 
wine, Phaseolus lunatus, Dacryodes edulis, and Clerodendrum volubile using in vitro, ex vivo, in 
silico and in vivo models. The leaves of V. amygdalina and D. edulis, as well as C. volubile flower 
were sequentially extracted with solvents of increasing polarity to yield ethyl acetate, ethanol and 
aqueous extracts. Cola nitida and V. amygdalina were infused in hot water to yield infusion 
extracts. Phaseolus lunatus was subjected to aqueous extraction to yield aqueous extract, while 
Raffia palm wine was concentrated to yield the concentrate. The extracts and concentrate were 
screened for their in vitro and ex vivo antioxidant activities, as well as their inhibitory effect on α-
glucosidase, α-amylase and pancreatic lipase activities, and their ability to stimulate muscle 
glucose uptake and inhibit intestinal glucose absorption in vitro. The ethanol extracts of D. edulis, 
C. volubile and V. amygdalina were subjected to GC-MS analysis, while the aqueous extract of P. 
lunatus, palm wine concentrate and the infusions were analyzed with LC-MS to elucidate the 
active compounds that may be responsible for their bioactivities. The ethanol extracts of C. 
volubile and D. edulis were further subjected to liquid-liquid fractionation to yield the hexane, 
dichloromethane, ethyl acetate, butanol and aqueous fractions. These fractions were also assayed 
for their antioxidant and antidiabetic properties in vitro and ex vivo. The dichloromethane, ethyl 
acetate and butanol fractions were subjected to GC-MS analysis to elucidate their active 
compounds. The identified compounds were molecularly docked with the test enzymes in silico to 
further validate their bioactivities. The antidiabetic properties of palm wine concentrate, C. nitida 
infusion, and D. edulis butanol fraction were investigated in a type 2 diabetes rat model. The in 
vivo study revealed a potent hypoglycemic activity, with concomitant amelioration of oxidative 
stress in the serum, pancreas, testes and brain. This was further substantiated by the 
downregulation of Nrf2 expressions in the pancreas and brain. These results further validate the 
use and safety of these plants in diabetes management. 
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CHAPTER 1 
INTRODUCTION AND LITERATURE REVIEW 
1.0 Introduction 
Diabetes mellitus (DM) is the fastest growing global epidemic scourge affecting over 425 million 
people in 2017 (IDF 2018), which depicts a 2.4% rise in prevalence from 415 million in 2015 (IDF 
2016). This is expected to rise by 48% to 629 million in 2045, with Africa predicted to have a 
156% upsurge (Figure 1.1) (IDF 2018). This predicted upsurge in Africa is a major concern, owing 
to her poor health infrastructures, economic burden and rising incidences of other diseases like 
HIV/AIDS, malaria and tuberculosis. Increased urbanization owing to rural – urban drift, sedentary 
life styles with less physical exercise, and ageing population have been linked to the upsurge (Bos 
and Agyemang 2013; Erukainure et al. 2017a). The number of people living with diabetes in Africa 
was estimated to be 16 million in 2017 (IDF 2018), depicting as the lowest. However, difficulty in 
data collection coupled with lack of high quality data suggests that the number may be much 
higher.  
 
Figure 1. 1: Global epidemic picture of DM in 2017 and 2045. (adapted without permission from IDF 
Diabetes Atlas, 8th edition (I.D.F. 2018)). 
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Diabetes is ranked among the top 10 contributors to global mortality (Figure 1.2) (I.D.F. 2018), a 
major factor being 30-80% of diabetics are undiagnosed. Multiple complications arising from 
prolonged DM has also been implicated in diabetic mortality (Motala 2002).  
 
Figure 1.2: Estimated global mortality (20 – 75 years) due DM in 2017 (adapted without 
permission from IDF Diabetes Atlas, 8th edition (I.D.F. 2018)). *values are in millions 
This has led to continuous increase in global healthcare expenditure. The global healthcare 
expenditure for DM was USD727 billion in 2017, which portrays an 8% rise from the 2015 cost 
(Figure 1.3) (I.D.F. 2018). This increase has been attributed to increased population growth, 
urbanization and lifestyle changes particularly in Sub-Saharan Africa and other developing 
countries (I.D.F. 2016). 
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Figure 1.3: Global healthcare expenditure (in USD billions) on DM in 2017 (adapted without 
permission from IDF Diabetes Atlas, 8th edition (I.D.F. 2018)) 
Due to the cost associated with DM and the economic burden in developing, there have been 
increased search for novel and affordable alternative treatment with little or no side effects. This 
has led to increase paradigm shift to natural products, particularly from plant source (Erukainure 
et al. 2018). However, the safety and toxicity of these alternative treatments remains a huge 
concern. Hence this project, not only aims at studying the efficacies of selected antidiabetic 
medicinal plant but also the toxicity associated with their use for the treatment of diabetes, 
particularly type 2 diabetes (T2D). 
1.1 Diabetes mellitus 
Diabetes mellitus (DM) is a metabolic disorder which affects carbohydrate, fat, and protein 
metabolism owing to defects in insulin secretion and/or action (Erukainure et al. 2013; Vinayagam 
et al. 2016), which leads to chronic hyperglycemia (high blood glucose level) with multiple 
etiologies and pathogenesis (Association 2010; Vinayagam et al. 2016). It is often accompanied 
with glucotoxicity, lipotoxicity, increased inflammation/oxidative stress, and endoplasmic 
reticulum-induced stress leading to apoptotic and necrotic cell death of the pancreatic β-cells 
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(Jadhav et al. 2013; Ndisang et al. 2014). These also lead to the pathogenesis of related 
complications such as hepatopathy, retinopathy, nephropathy, neuropathy, and cardiovascular 
diseases (CVD) (Lin and Sun 2010; Papatheodorou et al. 2016; Tripathi and Srivastava 2006). 
These complications have been implicated in the morbidity and mortality of DM, affecting over 
50% of diabetic patients (Islam 2011; Pari and Saravanan 2004).  
Insulin is regarded as the main anabolic hormone in the body as it regulates the metabolism of 
carbohydrate, fatty acids, and protein (Voet and Voet 2011). It is a polypeptide hormone 
synthesized by the pancreatic β-cells of the islets of Langerhans, and involved mainly in the 
regulation of blood glucose level (Qaid and Abdelrahman 2016; Wilcox 2005). It lowers blood 
glucose level by facilitating its uptake from the blood into cells and skeletal muscles, thereby 
stimulating glycogenesis with concomitant inhibition of glycogenolysis. It decreases plasma fatty 
acid level by stimulating fatty acids uptake into the adipose and muscle tissues; decreasing the rate 
of lipolysis in adipose tissues as well as fatty acid oxidation in muscle and liver (Delarue and 
Magnan 2007; Dimitriadis et al. 2011). It also promotes cell division and growth via its mitogenic 
activities, thus also regarded as a growth hormone (Wilcox 2005). Therefore, its deficiency, 
reduced secretion and/or underutilization have tremendous metabolic fate which has been 
implicated in the pathogenesis of DM (Delarue and Magnan 2007; Dimitriadis et al. 2011; Lin and 
Sun 2010; Wilcox 2005).  
1.2 Types of Diabetes 
There have been much discussions, deliberations and revisions over the years on the classifications 
of DM owing to its etiologies (Baynest 2015; I.D.F. 2018; Ize-Ludlow and Sperling 2005). It is 
commonly classified into 2 types namely: type 1 diabetes (T1D) formerly known as Insulin 
Dependent Diabetes Mellitus (IDDM), and type 2 diabetes (T2D) formerly known as Non-Insulin 
Dependent Diabetes Mellitus (NIDDM). A third type of diabetes has been proposed as type 3 
diabetes (T3D) or brain diabetes, which has been linked to Alzheimer disease (AD) (de la Monte 
and Wands 2008; Leszek et al. 2017; Shaw 2017; Suzanne 2014). Gestational diabetes mellitus 
(GDM) is also another common type of diabetes which occurs during pregnancy. A rare type of 
diabetes is diabetes insipidus, which impairs the synthesis, transportation and/or release of 
vasopressin (an anti-diuretic hormone) (Perkins et al. 2006; Saborio et al. 2000). Others include 
specific types due to other inducements such as monogenic diabetes syndromes, exocrine pancreas 
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diseases, endocrinopathies, and drug/chemical – induced diabetes (Association 2015; Kerner and 
Brückel 2014).  
1.2.1 Type 1 Diabetes (T1D) 
T1D accounts for 10% of global diabetic cases (Association (2001); Ozougwu et al. 2013). It is 
regarded as an autoimmune disease which selectively destroys the pancreatic β-cell, leading to 
insulin deficiency and ensuing hyperglycemia (Atkinson et al. 2014; Gregory et al. 2013; Ozougwu 
et al. 2013). It was initially thought to be a childhood and adolescent metabolic disorder but has 
been discovered to affect adults too. The classic trio or symptoms consisting of polydipsia, 
polyphagia, and polyuria are the most common form of its diagnosis (Atkinson 2012; Atkinson et 
al. 2014; Gregory et al. 2013).  
Factors such as genetics, immunology, and environment have been implicated in the autoimmune 
destruction of the pancreatic β – cells (Figure 1.4). The autoimmune destruction of the pancreatic 
β-cell is considered an inflammatory process as it is mediated by inflammatory cytokines 
particularly β-cell autoantigens, macrophages, dendritic cells, B-lymphocytes, and T-lymphocytes 
(Pugliese 2016; Yoon and Jun 2005). Genetic predispositions have also been reported to induce 
autoimmune destruction of the pancreatic β-cells (Pirot et al. 2008). Several chromosomal loci 
have been identified in the development of T1D, with the human leukocyte antigen (HLA) locus 
reported as the most predisposing (Jahromi and Eisenbarth 2007; Pirot et al. 2008; Todd et al. 
2007). Others include the cytotoxic T-lymphocyte antigen 4 (CTLA4), insulin, and phosphatase 
non-receptor type 22 (PTPN22) loci (Jahromi and Eisenbarth 2007; Kim and Polychronakos 2005; 
Pirot et al. 2008). These loci and others identified are located within the MHC-HLA class II region 
(Cucca et al. 2001; Hakonarson et al. 2007). The predisposing roles of MHC haplotypes and non-
HLA loci in have also been reported (Atkinson and Eisenbarth 2001; Barrett et al. 2009; Fernando 
et al. 2008). These genes cause an aggravated inflammatory and immune response to stimuli, 
thereby increasing the risk of autoimmunity which may affect the β-cell function and presentation 
of antigens in individuals (Åkerblom et al. 2002; Pirot et al. 2008). Environmental factors have 
also been reported to play major roles in the pathogenesis of T1D (Åkerblom et al. 2002; Atkinson 
and Eisenbarth 2001; Pirot et al. 2008). These include the diet types particularly infant and 
adolescent diets, vitamin D deficiency, climate influences, viral infections, growth, toxins, ante- 
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and perinatal risk factors, vaccinations, and stress (Åkerblom et al. 2002; Atkinson and Eisenbarth 
2001; Pirot et al. 2008). These environmental factors act as modifiers of genetic predisposition, 
which in turn induces the activation of cytokines involved in autoimmune destruction of the 
pancreatic β-cell (Jahromi and Eisenbarth 2007).  
 
Figure 1.4: Pathophysiology of type 1 diabetes. 
1.2.2 Type 2 Diabetes (T2D) 
T2D for approximately 90% of all types of diabetes (I.D.F. 2016; I.D.F. 2018), making it the most 
prevalent and a major contributor to diabetic mortality and morbidity. It is a complex heterogenous 
metabolic disorder characterized by impaired insulin secretion and/or action leading to 
hyperglycemia (DeFronzo et al. 2015; Mohammed et al. 2015). This has been attributed to β-cell 
dysfunction, insulin resistance and chronic inflammation of the pancreatic tissues. 
Interactions involving both genetic and environmental factors have been implicated in the 
pathogenesis of T2D (DeFronzo et al. 2015). The genetic factors are pancreatic β-cell dysfunction 
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and insulin resistance, while sedentary lifestyle, lack of physical activities, weight gain, oxidative 
stress and consumption of high calorie diets constitutes environmental factors (DeFronzo et al. 
2015; Kahn et al. 2014). Decreased physical activity and obesity leads to decreased insulin 
sensitivity which when coupled to the genetic burden of insulin resistance, causes the pancreatic 
β-cells to enhance insulin secretion to offset the insulin inaction (Defronzo 1997; DeFronzo 2009). 
This activity helps in maintaining normal glucose tolerance. However, prolonged augmentation of 
insulin secretion will cause the pancreatic β-cell function to begin to decline (DeFronzo 2004; 
DeFronzo 2009). This is followed by increased fasting plasma glucose concentration, leading to 
insulin insensitivity and subsequently diabetes (DeFronzo 2009).  
Hepatic glucose production, reduced insulin secretion, and impaired insulin sensitivity (the 
triumvirate) have been reported as the main defects in the onset of T2D – induced hyperglycemia, 
with pancreatic β-cell failure occurring much earlier (Figure 1.5) (DeFronzo et al. 2015; Lin and 
Sun 2010; Stumvoll et al. 2005).  
 
Figure 1.5: The triumvirate pathophysiology of T2D 
A maximal and/or near-maximal insulin resistance have been documented for individuals at the 
upper tertile of impaired glucose tolerance, with over 80% of their pancreatic β-cell function being 
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lost (DeFronzo 2009).  However, an “ominous octet” has been proposed to replace the triumvirate. 
They are the adipocytes (increased lipolysis), gastrointestinal tract (incretin deficiency/resistance), 
α-cell (hyperglucagonemia), kidney (accelerated glucose reabsorption), and brain (insulin 
resistance/neuro-dysfunction) in addition to the liver, muscle and pancreatic β-cell (Figure 1.6) 
(DeFronzo 2009; DeFronzo et al. 2015). Increased glucagon level and heightened hepatic glucagon 
sensitivity cause the liver to produce excess glucose (DeFronzo et al. 2015). There is an increased 
rate of lipolysis with concomitant increased plasma free fatty acid (FFA) levels owing to insulin 
resistance in the adipocytes, which further exacerbate insulin resistance in the liver and muscle, 
and contributing to pancreatic β-cell failure (DeFronzo et al. 2015; Gustafson et al. 2015). 
Hyperglycemia is being maintained by accelerated glucose reabsorption in the renal tissues by the 
sodium/glucose co-transporter 2 (SGLT2) as well as increased glucose spillage in the urine 
(DeFronzo 2009; DeFronzo et al. 2015; Meyer et al. 1998). Insulin resistance is also aggravated 
by the resistance to leptin, glucagon-like peptide 1 (GLP1), and amylin which are appetite-
suppressive (Cummings and Overduin 2007; DeFronzo et al. 2015; Williams et al. 2006). This is 
further aggravated by low dopamine and serotonin levels in the brain (DeFronzo et al. 2015; 
Mooradian 1988).  
 
Figure 1.6: The ominous octet pathophysiology of T2D. (Adapted without permission from 
DeFrenzo et al. (2015)) 
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1.3 Complications of T2D 
T2D is often described as a multifactorial disease owing to the complications associated with it. 
Chronic hyperglycemia in T2D has been linked to the production of reactive oxygen species 
(ROS), which overwhelms the body’s endogenous antioxidant system resulting to oxidative stress 
(Erukainure et al. 2017a). Oxidative stress has been implicated in the pathogenesis of T2D 
complications such as retinopathy, neuropathy, nephropathy, cardiovascular diseases (CVD), and 
reproductive toxicity. 
Hyperglycemia has also been recognized to mediate the pathogenesis of T2D complications via 
activation of inflammatory cytokines which promotes inflammation (Aronson 2008; Guha et al. 
2000). Thus, making hypoglycemia a major player in T2D complications (Aronson 2008). 
1.3.1 Oxidative stress and T2D 
High concentrations of ROS are generated in most tissues under chronic hyperglycemic condition 
in T2D, with the pancreatic β-cells being the most susceptible compared to any other organs 
(Brownlee 2001; Kajimoto and Kaneto 2004). This have been attributed to its high efficiency for 
glucose uptake on exposure to excess glucose because of high expression of GLUT2 (Kajimoto 
and Kaneto 2004). The expression levels of the antioxidant enzymes glutathione peroxidase (GPx) 
and catalase (CAT) have also been reported to be extremely low in pancreatic β-cells, thus making 
the cells highly susceptible to oxidative damage (Pi et al. 2010).  
Glucose oxidation has been recognized as the main trigger of free radical productions in T2D. 
Glucose is oxidized in its enediol form to an enediol radical in the presence of transition metal, 
which leads to the production of reactive ketoaldehydes and superoxide anion (O2.
-) radicals 
(Maritim et al. 2003). Superoxide dismutase then converts the generated O2.
- to hydrogen peroxide 
(H2O2). The continuous oxidation of glucose owing to hyperglycemia will lead to high 
concentration of O2.
- and accumulation of H2O2 which overwhelms the cells’ GPx and catalase 
activities, thereby leading to production of hydroxyl radicals (OH.). Myeloperoxidase can also 
convert H2O2 to hypochlorous acid (HOCl) in the presence of hydrochloric acid (HCl). Nitric oxide 
can also react with O2.
- to give peroxynitrate (ONOO–).  
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Enhanced glycolysis leading to the non-oxidative catabolism of glucose to lactate have also been 
implicated in hyperglycemia induced generation of free radicals in T2D (Chikezie et al. 2015). 
The continuous generation of lactate from pyruvate causes an increase in free cytosolic 
NADH/NAD+ ratio, which impairs the oxidation of NADH to NAD+ (Chikezie et al. 2015). Thus, 
increasing the cell levels of the electron donor NADH. 
Additionally, acceleration of the tricarboxylic acid (TCA) cycle in hyperglycemia have been 
reported as another mechanism of glucose generation of free radicals (Araki and Nishikawa 2010; 
Brownlee 2001). Pyruvate from the glycolytic pathway is oxidized via the TCA cycle to generate 
NADH and FADH2 (Brownlee 2001). The increased production of these electron donors in 
hyperglycemia leads to the generation of a high mitochondrial membrane potential, which inhibits 
electron transport at complex II with concomitant reduction of oxygen to (O2) to O2.
- (Brownlee 
2001; Du et al. 2001).  
Hyperglycemia have also been shown to induce oxidative stress via activation of the polyol 
pathway; advanced glycation end-product (AGE) formation; the hexosamine pathway; and protein 
kinase C (PKC) isoforms (Aronson 2008; Brownlee 2001; Wiernsperger 2003)  
a) Activation of the Polyol Pathway 
This pathway involves the oxidation of sorbitol to fructose by sorbitol dehydrogenase, with 
concomitant reduction of NAD+ to NADH (Figure 1.7) (Bonnefont-Rousselot 2002; Brownlee 
2001). In non-diabetics, this metabolic pathway for glucose oxidation is very minimal but 
increased in hyperglycemic state. This has been attributed to the high exposure of the cells to 
glucose which saturates the hexokinase, thereby channeling the excess glucose to the polyol 
pathway (Brownlee 2001; Kanwar et al. 2011). The channeled glucose is first reduced by aldose 
reductase to sorbitol, which is then oxidized by sorbitol dehydrogenase to fructose. The continuous 
channeling of glucose to this pathway in hyperglycemia leads to accumulation of sorbitol in the 
cells and consequent production of fructose. The former causes osmotic stress, while the latter 
have been reported for its high glycating activity (Obrosova 2005). Furthermore, aldose reductase 
oxidizes NADH to NAD+ which decreases the cells ability to regenerate reduced glutathione 
(GSH). The continuous generation of the electron donor (NADH), production of fructose, and 
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concomitant depleted GSH levels indicates a potential of redox imbalance in the cells (Brownlee 
2005). 
 
Figure 1.7: The polyol pathway (adapted without permission from Brownlee (2001)) 
b) Increased Formation of Advanced Glycation End-Product (AGE) 
Increased formation of advanced glycation end products (AGEs) has been recognized as one of 
the pathological mechanism of hyperglycemia – induced oxidative injury (Aronson 2008; Vistoli 
et al. 2013). It is a non-enzymatic glycosylation of proteins and/or lipids owing to prolonged 
exposure to glucose as seen in hyperglycemic states (Goldin et al. 2006). The presence of AGEs 
alters enzymatic activities, cellular functions, disrupts molecular conformation, as well as affect 
receptor recognition (Aronson 2008; Goldin et al. 2006). Receptor for advanced glycation end 
products (RAGE) has been reported to be present in most cells (Goldin et al. 2006). The binding 
of AGEs with these receptors are responsible for AGEs pathological contribution to diabetic 
complications. This binding activates RAGE, leading to a series of pathological events 
particularly: 1) upregulation of nuclear factor kappa B (NF-κB) and its target genes leading to 
inflammation; 2) activation of monocytes, and inhibition monocyte migration across the 
membrane; 3) increased transportation of macromolecule across the endothelial membrane; and 4) 
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blockage of endothelial NO activity, leading to the production of ROS (oxidative stress) (Aronson 
2008; Brownlee 2001; Brownlee 2005; Goldin et al. 2006; Vistoli et al. 2013) 
c) Activation of the Hexosamine Pathway 
In hyperglycemic state, excess glucose can be channeled into the hexosamine pathway using 
fructose-6-phospahte as the substrate. It involves the conversion of fructose-6-phosphate to 
glucosamine-6-phosphate by glutamine:fructose-6 phosphate amidotransferase (GFAT), and then 
the final product uridine diphosphate (UDP) N-acetyl glucosamine (Aronson 2008; Brownlee 
2005). UDP N-acetyl glucosamines are involved in O-glycosylation by adding N-
acetylglucosamine (GlcNAc) to a protein’s serine and threonine residues (Aronson 2008). 
Phosphorylation of these residues are critical steps in the regulation of most enzymes, thus 
implying that O-glycosylation could alter normal enzyme activities leading to detrimental 
consequences (Vistoli et al. 2013). Modification of transcription factors and other nuclear and 
cytoplasmic proteins by O-linked GlcNAc have been reported, leading to complications such as 
cardiomyocyte dysfunction, increased carotid artery plaques and abnormal express of the 
glomerular cell gene (Aronson 2008; Brownlee 2001; Brownlee 2005; Goldin et al. 2006). 
d) Activation of Protein Kinase C (PKC) Isoforms 
Hyperglycemia have also been reported to mediate the pathogenesis of T2D via activation of 
protein kinase C (PKC) and its isoforms (Aronson 2008; Brownlee 2001; Brownlee 2005). Protein 
kinase Cs are enzymes involved in the regulation of protein functions by phosphorylation of their 
serine and threonine amino acid residues (Aronson 2008; Brownlee 2005). Hyperglycemia 
influences PKC activities by increasing the synthesis of diacylglycerol from glyceraldehyde-3-
phosphate and dihydroxy-acetone phosphate (Aronson 2008). Diacylglycerol has been shown to 
be an important co-factor for the activation of PKC isoforms: α, β, and γ which are widely 
distributed in cells (Brownlee 2001; Brownlee 2005). Activation of PKC leads to the activation of 
NADPH oxidase which has been implicated in the generation of ROS in blood vessels (Inoguchi 
et al. 2000). PKC has been shown to be involved in the activation of NF-kB by O2.
- (Ogata et al. 
2000). Yakubu et al. (Yakubu et al. 2004) also reported that vasculopathy in hyperglycemia is due 
to the suppression of NO production and NO-dependent relaxation by PKC-coupled generated 
ROS. 
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These factors are considered the potential unifying mechanisms (Figure 1.8) by which 
hyperglycemia mediates oxidative cellular dysfunction which have are implicated in the 
pathogenesis of in T2D complications. These complications are broadly divided into two namely: 
microvascular and macrovascular complications. 
 
Figure 1.8: Potential unified mechanism of hypoglycemia induced oxidative cellular dysfunction 
in T2D (adapted without permission (Luo et al. 2016; Rolo and Palmeira 2006)) 
1.3.2 Microvascular complications 
Microvascular complications are diseases associated with small blood vessels often developed in 
diabetes. The most notables of this complications are retinopathy, nephropathy and neuropathy. 
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a) Diabetic retinopathy 
Diabetic retinopathy is one of the microvascular complications and main cause of blindness in 
prolonged diabetics. It is characterized by vascular lesions in the retinal blood vessels, leading to 
the formation of microaneurysms, haemorrhages and amplified leakage (Ahmed et al. 2010; 
Tripathi and Srivastava 2006). Thereby, resulting to retinal edema and severe exudation of lipid 
(Ahmed et al. 2010). In proliferative retinopathy, there is development of abnormal blood vessels 
and fibrous tissues in the retina with subsequent retinal detachment and visual impairment (Ahmed 
et al. 2010; Forrester and Knott 1997). Hyperglycemia activation of the polyol pathway causes 
accumulation of sorbitol in the lens, thereby leading to cataract (Ahmed et al. 2010; Fong et al. 
2004). 
b) Diabetic nephropathy 
Diabetic nephropathy has been recognized as the leading cause of end-stage renal failure in 
diabetics, affecting type 2 diabetics more susceptible (Fowler 2008). It is characterized by 
glomerular hemodynamic abnormalities which causes glomerular hyper-filtration, leading to 
glomerular damage (microalbuminuria) (Ighodaro and Adeosun 2017). Prolong and untreated 
microalbuminuria often progress to overt proteinuria and end-stage renal failure (Fowler 2008; 
Ighodaro and Adeosun 2017). Increased thickening of the glomerular basement owing to synthesis 
and catabolism of the glomerular basement membrane macromolecules has been implicated in the 
pathogenesis of microalbuminuria (Tripathi and Srivastava 2006). Increased levels of VEGF have 
also been recognized as a causative factor in increasing glomerulus permeability (Ritz and Orth 
1999). 
c) Diabetic neuropathy 
Diabetic neuropathy is a group of diseases that involves the somatic and autonomic nervous system 
due to prolonged hyperglycemia. It is often grouped into polyneuropathy, mono-neuropathy, 
and/or autonomic neuropathy, with polyneuropathy being the most common (Ahmed et al. 2010; 
Ighodaro and Adeosun 2017). Polyneuropathy is characterized by loss of peripheral sensations, 
leading to non-healing ulcers (wounds) and subsequently, non-traumatic amputation (Tripathi and 
Srivastava 2006). This has been attributed to decreased microfilaments, thickened axons, 
monocytes adhesion, and narrow capillary (Tripathi and Srivastava 2006), which may result from 
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hyperglycemia-mediated injury of the nerve parenchyma and/or neuronal ischemia (Chen and 
Reaven 1997).  
1.3.3 Macrovascular complications 
These are complications mostly in T2D associated with large blood vessels. Atherosclerosis 
leading to the narrowing of arterial walls have been recognized as the underlying factor for the 
pathogenesis of macrovascular diseases (Fowler 2008; Ighodaro and Adeosun 2017). Thus, 
making CVDs a major causative factor of mortality in T2D, and account for the highest healthcare 
expenditures (Fowler 2008). This include congestive heart failure, peripheral vascular disease, 
myocardial infarction, and coronary artery disease (Tripathi and Srivastava 2006). The occurrence 
of T2D in metabolic syndrome settings, also makes individuals with T2D susceptible to CVD 
(Fowler 2008). 
Chronic inflammation and oxidative injury to the peripheral arterial wall or coronary vascular 
system have been implicated in the triggering of atherosclerosis (Fowler 2008; Ighodaro and 
Adeosun 2017). This is due to the accumulation of oxidized lipids in the endothelial walls of the 
arteries, causing the narrowing down of the arteries lumen. This is followed by infiltration of 
monocytes across the arterial wall, differentiating into macrophages which form foam cells on 
accumulation with oxidized lipids (Fowler 2008). The formed foam cells further stimulate the 
proliferation of macrophages, attracting T-lymphocytes. T-lymphocytes then induce proliferation 
of the arterial walls’ smooth muscle, attracting collagen accumulation which leads to acute 
vascular infarction.  
1.4 Management of T2D 
Individuals with T2D are commonly recommended to modify their diets and lifestyle, particularly 
for long term management. However, pharmacological/therapeutic interventions are often 
introduced together with these modification for cases of chronic hyperglycemia and/or later stages 
of T2D. These interventions often involve the use of therapeutic drugs in regulating the high blood 
glucose level in chronic hyperglycemic state. These drugs are sub-divided into six major classes 
namely: α-glucosidase inhibitors, biguanides, sulfonylureas, thiazolidinediones, sodium glucose 
co-transporters (SGLT2) inhibitors, and dipeptidyl peptidase (DPP) IV inhibitors. Figure 1.9 
shows the different classes and their target organ of action. 
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Figure 1.9: Classes of antidiabetic drugs, their mechanism and action sites (adapted without 
permission (Hui et al. 2009)) 
1.4.1 α-glucosidase inhibitors 
This class constitutes drugs that control blood glucose level by the competitive inhibition of 
intestinal α-glucosidases activities. Alpha-glucosidases are enzymes involved in the breakdown of 
dietary oligosaccharide to monosaccharides in the small intestine, leading to postprandial rise in 
blood glucose level. Their inhibition will therefore delay the digestion of dietary carbohydrate, 
thus reducing the level of glucose released into the blood stream.  
Examples of commonly used α – glucosidase inhibitors are acarbose, miglitol, and voglibose, with 
α – glucosidase being the most popular drug. However, side effects such as gastrointestinal 
disturbances, bloating, and flatulence have been associated with acarbose (Yee and Fong 1996). 
1.4.2 Biguanides 
This class of therapeutic drugs lowers blood glucose level by reducing hepatic glucose output, 
while enhancing insulin-stimulated glucose uptake and utilization in skeletal muscles and 
peripheral tissues (Campbell 2007; Tripathi and Srivastava 2006). The most common drug in this 
class is metformin. Its ability to increase insulin mediated phosphorylation of insulin-receptor and 
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tyrosine-kinase A, improves insulin actions in tissues that are less sensitive to insulin (Tripathi and 
Srivastava 2006). Metformin has been shown to upregulate GLUT-4 and GLUT-1 transporters in 
skeletal muscles and adipocytes (Klip and Leiter 1990). It increases glucose metabolism in the 
splanchnic bed (Bösenberg and van Zyl 2008). It has also been reported to suppress fatty acid 
oxidation, while reducing triglyceride levels (Bailey and Turner 1996). It is readily absorbed and 
eliminated in the urine (Bösenberg and van Zyl 2008). However, metformin medication has been 
associated with diarrhea, nausea, abdominal spasm, lactic acidosis, and metallic aftertaste 
(Bösenberg and van Zyl 2008). 
1.4.3 Sulfonylureas 
This class of antidiabetic drugs lowers blood glucose level by increasing pancreatic β-cell secretion 
of insulin. They bind directly to the β-cells via the transmembrane sulphonylurea receptor (SUR-
1), leading to the closure of ATP-sensitive K+ channels (Bösenberg and van Zyl 2008; Tripathi 
and Srivastava 2006). This reduces potassium efflux, triggering depolarization of the membrane 
and opening of the voltage-dependent Ca2+-channels which causes an influx of calcium 
(Bösenberg and van Zyl 2008). This in turn stimulates insulin release from pancreatic secretory 
granules. Glibenclamide is the most popular drug in this class, others are gliclazide, glipizide, and 
glimepiride. However, the use of these drugs can lead to hypoglycemia owing to their ability to 
directly induce insulin secretion (Chiniwala and Jabbour 2011). 
1.4.4  Thiazolidinediones 
Also known as insulin sensitizer, this class of diabetic drugs improves insulin sensitivity via 
binding to the PPAR-γ receptor which is abundantly expressed in adipocytes (Bösenberg and van 
Zyl 2008). peroxisome proliferator-activated receptor gamma is a transcription factor which when 
activated insulin-dependent suppression of hepatic glucose output, and regulations lipid 
metabolism (Tripathi and Srivastava 2006). It is activated when bound to thiazolidinediones 
(TZDs). 
Common drugs in this class are troglitazone, pioglitazone, and rosiglitazone. Their sides effects 
include oedema, weight gain, and hypoglycemia. Pioglitazone and rosiglitazone are restricted in 
Canada owing to increased risks of bladder cancer and non-fatal heart attack respectively 
(Bösenberg and van Zyl 2008).  
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1.4.5 SGLT2 inhibitors 
This class of antidiabetic drugs reduce blood glucose level by inhibiting SGLT2, leading to the 
blockage of glucose reabsorption in the proximal renal tissues (Chaudhury et al. 2017). These 
drugs are often considered safe for chronic T2D owing to their ability to reduce blood glucose 
level independent of insulin, thus reducing the work pressure on the pancreatic β-cells. They also 
cause mild weight loss and reduce blood pressure. However, they have been associated with genital 
and urinary infections which could lead to urosepsis, pyelonephritis, and genital mycosis 
(Chaudhury et al. 2017). 
Dapagliflozin and canagliflozin are presently the only commercial available SGLT2-inhibitors. 
However, the former is only marketed in Europe and unapproved by the FDA (Osadebe et al. 
2015). 
1.4.6 Dipeptidyl peptidase (DPP) IV inhibitors 
This class consists of antidiabetic drugs that lower blood glucose level by inhibiting dipeptidyl 
peptidase IV (DPP-4), which is an antagonist of incretin hormones particularly the glucagon-like 
peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) (Osadebe et al. 2015; 
Pratley and Salsali 2007). These hormones are gastrointestinal and are released in response to 
meal. They increase β-cell secretion of insulin, while suppressing the release of glucagon (Osadebe 
et al. 2015). By preventing the inactivation of these hormones, DDP IV inhibitors thus reduces 
postprandial blood glucose rise. 
Examples of antidiabetic drugs in this class are sitagliptin, vidagliptin, saxagliptin, alogliptin, and 
linagliptin (Osadebe et al. 2015). Their side effects include pharyngitis, headache and acute 
pancreatitis  
1.5 Medicinal plants in the treatment and management of T2D 
Over the years, medicinal plants have been part of the world’s healthcare system, where they are 
employed in the folkloric treatment, management and prevention of human diseases. It is being 
estimated that 80% of the third world population rely on the use of herbs in traditional medicine 
as their primary source of healthcare (Ekor 2014), which is an indication of the importance of these 
plants even in modern times. There has also been an increased surge in the patronage and usage of 
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complementary and alternative medicines (CAMs) in developed countries (Anquez-Traxler 2011; 
Ekor 2014), with herbs being a major part. Studies on the medicinal efficacies of these plants have 
led to the development of novel drugs.  
Several studies have documented the use of medicinal plants in the management of T2D and 
treatment of its complications (Erukainure et al. 2018; Ezuruike and Prieto 2014). This has been 
in practice from time immemorial, with the choice of plants and method of administration often 
influenced by both trado-and geo-cultural factors. Their accessibility and affordability have made 
the folkloric use of these plants an important form of healthcare in most developing countries with 
the burden of poor health infrastructures and political instability (W.H.O. 2013). There has also 
been an increased paradigm shift from the use of synthesized drugs to medicinal plants (Erukainure 
et al. 2017b), with some diabetics often relying on combined therapies of herbs and prescription 
drugs (Ezuruike and Prieto 2016). The antidiabetic efficacies of some of these plants have been 
attributed to a lot of factors, particularly the phytochemical constituents. These phytochemicals 
have been documented for their antidiabetic and antioxidative activities (Sabu and Kuttan 2002), 
with the polyphenols playing a major role (Bahadoran et al. 2013). 
1.5.1 Toxicity of medicinal plants in the treatment of T2D 
Despite the efficacy, health benefits, and wide acceptance of medicinal plants, there are however 
concerns about their safety and toxicity. These plants consist of a cocktail of phytochemicals of 
which a few may be therapeutically effective (Angelova et al. 2008). These phytochemicals may 
also elicit herbal – drug, herbal – food or herbal – herbal interactions with detrimental 
consequences (Ezuruike and Prieto 2014; Shan et al. 2007; Yüce et al. 2006). There are also 
concerns on their standardization, characterization, dosing and preparation (Shan et al. 2007), 
thereby making self-medication of herbal preparations a major issue to health practitioners. The 
method of extraction from different plant parts are also issues of concerns as they elicit different 
biological activities, some of which could be toxic due to the type of phytochemicals extracted 
(Ezuruike and Prieto 2014; Liu 2004).  
Studies on some antidiabetic plants showed specific organ toxicity, particularly nephrotoxic and 
hepatotoxic, with concomitant effects on some liver and kidney function enzymes activities (Yüce 
et al. 2006). Some of these plants have been reported for their cytotoxic activities (Hilmi et al. 
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2014; Kadan et al. 2013). In vitro studies have also revealed that some of these plants can modulate 
P-glycoprotein and some cytochrome P450 enzymes, while some can alter the activities of phase 
2 metabolic enzymes (Ezuruike and Prieto 2014). Thereby leading to potential alteration of the 
pharmacokinetics of co-administered drugs, such as glibenclamide which is a substrate of P-
glycoprotein (Ezuruike and Prieto 2014).  
Therefore, it is important to study the efficacies of medicinal plants used in the treatment of T2D 
and its complications, as well as the toxicity associated with their use. 
1.6 Aims and objectives  
The aim of this study was to investigate the antidiabetic and toxicological effects of selected anti-
diabetic African medicinal plants namely: Cola nitida, Clerodendrum volubile, Dacryodes edulis, 
Phaseolus lunatus, Vernonia amygdalina, and Raffia palm (Raphia hookeri) wine using different 
in vitro, ex vivo, and in vivo models. The research objectives included the following: 
1. Chemical properties 
 Investigating the chemical properties of the selected medicinal plants using GC-
MS, LC-MS, HPLC, FTIR, and NMR. 
2. In vitro study 
 Investigating the antioxidant, and enzyme inhibitory effects of the selected 
medicinal plants 
 Investigating the cytotoxic effect and mechanism of toxicity of the selected 
medicinal plants on human embryonic kidney cells (HEK 293) and 3T3-L1 
adipocytes. 
3. Ex vivo study 
 Investigating the antioxidative effect of the selected medicinal plants in oxidative 
pancreatic and hepatic tissues 
 Investigating the inhibitory effect of the selected medicinal plants on glucose 
absorption in isolated small intestines of rats 
 Investigating the effect of the medicinal plants on glucose uptake in rats’ muscle 
and brain 
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 Investigating the effect of the medicinal plants on oxidative dysfunctional 
metabolic pathways using combined metabolomics 
4. In silico studies 
 Predicting the ADME properties of identified compounds of the most active 
medicinal plants 
 Predicting the toxicity class of identified compounds of the most active medicinal 
plants 
 Molecular docking of identified compounds of the most active medicinal plants 
with relevant target protein 
5. In vivo studies 
Three of the plants with the best in vitro and ex vivo activities were selected for this part of 
the study and were investigated for: 
 antidiabetic, antioxidative, and antilipidemic effects in type 2 diabetic rats  
 modulatory effects on cholinergic purinergic enzymes in type 2 diabetic rats 
 modulatory effects on neuronal, testicular, hepatic and pancreatic microarchitecture 
of type 2 diabetic rats 
 modulatory effects on dysfunctional metabolic pathways in type 2 diabetic rats 
 molecular mechanism behind glucose uptake in muscle and brain of type 2 diabetic 
rats 
 molecular mechanism of toxicity in type 2 diabetic rats 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 Plant Materials 
2.1.1 Collection of Plant Materials 
The seeds of Cola nitida, and the leaves and flowers of Clerodendrum volubile were collected 
from Ifon, Ondo State Nigeria. Raffia palm (Raphia hookeri) wine, and the leaves of Dacryodes 
edulis and Vernonia amygdalina were collected from Benin city, Edo State, Nigeria. The seeds of 
Phaseolus lunatus were collected from Irrua, Edo State, Nigeria. All samples, except Dacryodes 
edulis were identified, authenticated and deposited at the herbarium of the department of Botany, 
University of Benin, Benin city, Edo State, Nigeria. They were assigned the voucher numbers:  
UBHC284 (C. volubile), UBHC323 (C. nitida), UBHP284 (P. lunatus) and UBHV342 (V. amygdalina). 
Dacryodes edulis were identified, authenticated and deposited at the herbarium of the department 
of Botany, University of Lagos, Lagos, Nigeria. It was assigned voucher numbers, LUH: 6964.  
All samples except raffia palm wine were air dried, blended, and stored in airtight bags for 
subsequent analysis. 
2.1.2 Preparation of Crude Extracts 
One hundred gram each of the blended samples of D. edulis, V. amygdalina, and C. volubile 
(flowers) were defatted using n-hexane, and then sequentially extracted with solvents of increasing 
polarity to yield ethyl acetate, ethanol and aqueous extracts (Erukainure et al. 2017b). All extracts 
except aqueous were concentrated in vacou using a rotatory evaporator (Buchi RII; Flawil, 
Switzerland) and stored in glass vials at 4oC until further analysis. The aqueous extracts were 
concentrated with a water bath at 50°C, and subsequently stores in glass vials at 4oC until further 
analysis. 
One hundred gram of the blended sample of C. volubile leaves was subjected to methanol (MeOH) 
extraction. The resulting extract was concentrated in vacou using a rotatory evaporator (Buchi RII; 
Flawil, Switzerland) and stored in glass vials at 4oC until further analysis. 
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One hundred gram of the blended seeds of P. lunatus were defatted with n-hexane, and then 
subjected to aqueous extraction with distilled water. The extract was concentrated with a water 
bath at 50°C and stored in glass vials at 4oC until further analysis.  
Fresh raffia palm wine tapped from Raphia hookeri was first filtered with prewashed cotton to 
remove any debris present. It was subsequently divided into 3 batches of 300 mL each. The first 
batch was concentrated at 50°C and labeled as unfermented. The other batches were subjected to 
open air fermentation for 24 and 48 h, respectively. They were concentrated at 50°C with a water 
bath and stored in glass vials at 4°C until further analysis. 
2.1.3 Preparation of hot infusions 
Ten grams each of the blended samples of C. volubile (leaves), C. nitida, and P. americana were 
infused in boiling distilled water and allowed stand overnight (Erukainure et al. 2017c). The 
extracts were filtered and concentrated in a water bath at 50oC, then stored in glass vials at 4°C 
until further analysis. 
2.1.4 Fractionation of crude extracts 
The ethanolic crude extracts of D. edulis, and C. volubile (flowers) as well as the MeOH extract 
of C. volubile leaves were further subjected to liquid – liquid fractionation using a separating 
funnel. Ten grams of each extract was dissolved in distilled water and then fractionated with 
solvents of gradient polarity in the order of hexane, dichloromethane (DCM), ethyl acetate, and 
butanol (BuOH). The aqueous residue was considered as aqueous fraction and was concentrated 
at 50°C with a water bath and stored in glass vials at 4°C until further analysis. The other fractions 
were concentrated in vacou using a rotatory evaporator (Buchi RII) (Erukainure et al. 2018; 
Erukainure et al. 2017a) 
2.1.5 Preparation of stock solution 
A 1 mg/mL stock solution was prepared from each extract and fraction in distilled water. Different 
concentrations consisting of 15, 30, 60, 120 and 240 mg/mL were prepared from the stock solution 
for subsequent in vitro and ex vivo activities (Erukainure et al. 2017c). 
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2.2 Total phenolic content 
The Folin–Ciocalteu reagent assay was used in determining the total phenolic content of each 
extract and fraction (Liu and Yao 2007). 
Twenty microliters of each extract and fraction (240 μg/mL) was incubated with 100 µL of 10% 
diluted Folin ciocalteau reagent and 80 μL of 0.7 M Na2CO3 for 30 minutes at room temperature. 
Absorbance was measured at 765 nm and results expressed as milligrams of gallic acid equivalents 
(GAE) per gram of dry weight. 
2.3 In vitro antioxidant assays 
The 2,2'-diphenyl-1-picrylhydrazyl (DPPH) scavenging (Braca et al. 2002) and ferric reducing 
antioxidant power (FRAP) assays (Benzie and Strain 1996) were used in the determination of the 
in vitro antioxidant activities of the plant extracts and fractions. Ascorbic acid was used as standard 
for both activities. 
2.3.1 DPPH scavenging activity 
One hundred µL of each sample and standard concentrations (15 – 240 mg/mL) was incubated 
with 50 µL of 0.3 mM DPPH solution (in methanol) in the dark for 30 mins at room temperature. 
The absorbance was then read at 517 nm against blank without sample or standard.  
2.3.2 FRAP activity 
One hundred µL of each sample and standard concentrations was mixed with 100 μL sodium 
phosphate buffer (0.2 M, pH 6.6) and 100 μL of 1% potassium ferricyanide and then incubated at 
50°C for 30 mins. The mixture was acidified with 100 μL of 10% trichloroacetic acid (TCA), 100 
μL of distilled water and 200 µL of 0.1% iron (III) chloride (FeCl3) were then added. Absorbance 
was read at 700 nm. Results were expressed as a percentage of the absorbance of the samples to 
that of gallic acid as shown below: 
Ferric reducing antioxidant power (%) =
Absorbance of sample
Absorbance of gallic acid
x 100 
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2.4 Enzyme inhibitory activities 
The antidiabetic and anti-obesogenic potentials of the extracts and fractions were ascertained via 
their ability to inhibit key enzymes linked to type 2 diabetes (α-glucosidase and α-amylase) and 
obesity (pancreatic lipase) in vitro (Kim et al. 2010; Oboh and Ademosun 2011; Shai et al. 2010) 
2.4.1 α-glucosidase Inhibition 
The ability of the extracts and fractions to inhibit α-glucosidase in vitro was carried out according 
to the method described by Oboh and Ademosun (2011), with slight modifications. Fifty microliter 
of each sample concentrations were incubated with equal volume of α-glucosidase (1.0 U/mL) in 
phosphate buffer (100 mM, pH 6.8) at 37°C for 15 mins. Thereafter, 100 µL of 5 mM p-
nitrophenyl-α-D-glucopyranoside (pNPG) solution in phosphate buffer (100 mM, pH 6.8) was 
added to the reaction mixture, which was further incubated for 20 minutes at 37°C. The absorbance 
of the liberated p-nitrophenol was measured at 405 nm and the inhibitory activity expressed as a 
percentage of the control lacking inhibitors as shown in the formula below: 
% inhibition =
Absorbance of control − Absorbance of sample
Absorbance of control
x 100 
Acarbose was used as the standard drug. 
2.4.2 α-amylase inhibition 
The ability of the extract to inhibit α-amylase was investigated in vitro according to the method 
described by Shai et al. (2010), with slight modification. Fifty microliter of each sample 
concentrations or Acarbose was incubated with equal volumes of porcine pancreatic amylase (2 
U/mL) in phosphate buffer (100 mM, pH 6.8) for 10 minutes at 37°C. A 50 µL of 1% starch 
solution in phosphate buffer (100 mM, pH 6.8) was added to the reaction mixture and incubated 
at 37°C for 10 mins. 100 µL of the dinitrosalicylate (DNS) color reagent was then added to the 
mixture and boiled for 10 minutes. Absorbance was then read at 540 nm and the inhibitory activity 
was expressed as percentage of the control without inhibitors as shown below: 
% inhibition =
Absorbance of control − Absorbance of sample
Absorbance of control
x 100 
34 
 
2.4.3  Pancreatic lipase inhibition 
The ability of the extracts and fractions to inhibit pancreatic lipase activity in vitro was determined 
by the method of Kim et al. (2010), with slight modifications. Fifty microliters of each sample or 
orlistat (standard drug) concentrations was added to 84.5 μL of Tris buffer (100 mM Tris–HC1 
and 5 mM CaCl2, pH 7.0), 20 μL of porcine pancreatic lipase (2.5 mg/mL in 10 mM MOPS 
(morpholine propane sulphonic acid) and 1 mM EDTA, pH 6.8) was then added and incubated at 
37°C for 15 mins. 5 μL of 10mM p-NPB (p-nitrophenyl butyrate in dimethyl formamide) was 
added to the reaction mixture and further incubated 30 min at 37°C. Absorbance was then read at 
405 nm and the inhibitory activity was expressed as percentage of the control without inhibitors 
as shown below: 
% inhibition =
Absorbance of control − Absorbance of sample
Absorbance of control
x 100 
2.5 In vitro glucose uptake, absorption and diffusion 
2.5.1 Glucose uptake/ transport by yeast cells 
The effect of the extracts and fractions on glucose uptake/ transport by yeast cells were carried out 
according to previous established protocol (Cirillo 1962; Nirupama et al. 2014). Different 
concentration of the extracts and fractions were dissolved in 1 mL of distilled water containing 25 
mM glucose. The resulting solution was incubated for 10 mins at 37°C. Thereafter, 100μL of 1% 
yeast suspension was added, vortexed and incubated for 60 mins at 37°C. Glucose concentration 
of the solution was determined with dinitro salicylic acid method (DNS), and calculated by the 
formula:  
% 𝑈𝑝𝑡𝑎𝑘𝑒 =  
𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 (𝑐𝑜𝑛𝑡𝑟𝑜𝑙) − 𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 (𝑠𝑎𝑚𝑝𝑙𝑒)
𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 (𝑐𝑜𝑛𝑡𝑟𝑜𝑙)
 
2.5.3 Glucose diffusion  
The ability of the extracts and fractions to inhibit glucose diffusion was carried out using a previous 
established method which monitors the movement of glucose across a dialysis bag (Gallagher et 
al. 2003; Nirupama et al. 2014). One milliliter of 50 µg/mL of the extracts in phosphate buffer 
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(100 mM, pH 6.8) was mixed with 0.22 M glucose and 0.15 M sodium chloride (NaCl) in a dialysis 
bag. The bag was sealed at both ends and placed in 45 mL of NaCl on an orbital shaker at 37°C. 
Glucose movement across the bag was monitored by estimating its concentration in the external 
solution at regular time intervals using the formula: 
% inhibition =
Absorbance of control − Absorbance of sample
Absorbance of control
x 100 
2.6 Ex vivo antioxidative and anti-proinflammatory activities 
Tissues of liver and pancreas harvested from normal male albino rats (180 g) were homogenized 
with phosphate buffer (10 mM, pH6.8) on ice, then centrifuged at 15000 rpm for 15 min at 4°C. 
The supernatant was collected and stored at −20°C.  
2.6.1 Induction and treatment of oxidative stress ex vivo 
Equal volumes of each sample concentration and tissues (pancreatic or hepatic) homogenates were 
incubated with 30% volume of pro-oxidant (0.1 mM FeSO4) at 37°C in 5% CO2 for 30 mins. A 
reaction containing no extract or fraction (untreated) served as negative control. (Erukainure et al. 
2017b; Erukainure et al. 2017c). The incubated samples were analyzed for oxidative and 
proinflammatory biomarkers as described below. 
2.6.2 Oxidative stress biomarkers 
1. Determination of reduced glutathione (GSH) levels  
Reduced glutathione (GSH) levels were determined by the Ellman’s method (Ellman 1959), which 
is based on the oxidation of GSH by 5,5′-dithio-bis(2-nitrobenzoic acid) (DTNB) to form the 
yellow derivative 5′-thio-2-nitrobenzoic acid (TNB).   
The standards were prepared from GSH stock in increasing concentrations: 0.025, 0.05, 0.1, 0.2 
and 0.4 mM. Their absorbance was read at 415 nm and plotted against the concentration to get the 
standard curve (Figure 2.1) 
The samples were deproteinize with an equal volume of 10% TCA and then centrifuged at 3500 
rpm for 5 mins at 25oC. Thereafter, 200 µL of the supernatant was pipetted into a 96 well plate. A 
50 µL of Ellman reagent was then added and allowed to stand for 5 mins. Absorbance was read at 
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415 nm. The GSH level was then extrapolated from the standard curve of plotted GSH 
concentrations. 
2. Determination of superoxide dismutase (SOD) activities 
Superoxide dismutase activity was determined using previously established method based on the 
principle that H2O2 from SOD catalyzed dismutation of O2.
- oxidizes 6-hydroxydopamine (6-HD) 
to produce a coloured product (Gee and Davison 1989). 
A 170 μL of 0.1 mM diethylenetriaminepentaacetic acid (DETAPAC) was added to and 15 μL of 
the samples in a 96-well plate. Thereafter, 15 μL of 1.6 mM 6-HD was added and mixed by gently 
tapping all four sides of plates. Absorbance of the resulting mixture was measured at 492 nm for 
5 mins at 1 min interval. The enzyme activity was calculated by the formula: 
Activity = 1000 x [(A1-Ab)/ε490 ] x 0.5 nmol/min/µg protein  
ε490 = Molar absorptivity at 490nm = 1.742/mM/cm  
A1 and Ab = Reaction rate for sample and blank respectively 
3. Determination of catalase activities 
The catalase activity of the sample was determined using previously established protocol which is 
based on the measurement of decreased absorbance of test samples owing to H2O2 decomposition 
(Aebi 1984). A 340 μL of 50 mM sodium phosphate buffer (pH 7.0) was mixed with 10 μL of the 
samples, then 150 μL of 2 M H2O2 was added to the mixture. Absorbance was read at 240 nm for 
3 min at 1 min interval. 
4.  Determination of lipid peroxidation levels 
Lipid peroxidation levels of the samples were determined by measuring thiobarbituric acid reactive 
substances (TBARS), expressed as malondialdehyde (MDA) equivalent (Chowdhury and Soulsby 
2002; Janero 1990). One hundred microliters of the samples were mixed with an equal volume of 
8.1% SDS solution, 375 μL of 20% acetic acid, 1 mL of 0.25% thiobarbituric acid (TBA), and 425 
μL of distilled water. The reaction mixture was heated at 95°C for 1 h in a water bath. Thereafter, 
200 μL of the heated mixture was pipetted into 96-well plate and absorbance read at 532 nm. A 
standard curve was generated from the absorbance of standard MDA, from which the TBARS 
concentration was extrapolated. 
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5. Determination of non- protein thiol group (NPSH) levels 
The NPSH levels of the samples were determined using Ellman’s reagent according to previous 
established protocol (Adefegha et al. 2017; Habig et al. 1974). Two hundred microliters of the 
samples were deproteinized with 10% triton, then vortexed and allowed to stand for 10 mins. 
Thereafter, 200 μL of 20% TCA was added, vortexed and centrifuged for 10 mins at 4000 rpm at 
4°C. 50 μL of Ellman’s reagent was then added to 100 μL of the supernatant and incubated for 1 
h at room temperature. Absorbance was read at 412 nm. The thiol groups (SH) levels was 
extrapolated from a standard curve of cysteine. 
2.6.3 Anti-proinflammatory activity 
1. Determination of NO levels 
The NO levels of the samples were determined using the Griess method (Sun et al. 2003). One 
hundred microliters of the samples or distilled water (blank) and was incubated with an equal 
volume of Griess reagent for 30 mins at 25°C in the dark. Absorbance was read at 548 nm and the 
result was calculated using the formula: 
𝐍𝐢𝐭𝐫𝐢𝐜 𝐨𝐱𝐢𝐝𝐞 𝐜𝐨𝐧𝐜. = (Absorbance of sample − Absorbance of blank) x 0.1305 
2. Determination of myeloperoxidase activities 
The myeloperoxidase (MPO) activities of the tissue samples were determined using previous 
established method with slight modifications (Ajayi et al. 2015; Granell et al. 2003). One hundred 
microliters of the samples or distilled water (blank) were incubated with 100 µL of 5 mM KCl and 
25 µL of 2 M H2O2 for 10 mins. Thereafter, 50 µL of 1.25% ammonium molybdate was added to 
reaction mixture and allowed to stand for 5 mins. Absorbance was read at 405. 
2.6.4 Purinergic enzymes inhibitory activities 
1. Determination of ATPase activities 
The ATPase activities of the tissue samples were determined according to previous established 
protocol (Adewoye et al. 2000; Erukainure et al. 2017b). Two hundred microliters of the samples 
were incubated with 200 µL of 5 mM KCl, 1300 µL of 0.1 M Tris-HCl buffer, and 40 µL of 50 
38 
 
mM ATP at 37°C in a shaker for 30 mins. Thereafter, 1 mL of distilled water and 1.25% 
ammonium molybdate were added respectively to stop the reaction. 1 mL of freshly prepared 9% 
ascorbic acid was then added to the reaction mixture and allowed to stand for 30 mins. Absorbance 
was read at 660 nm and ATPase activity was calculated as the amount of inorganic phosphate (Pi) 
released/min/mg protein. 
2. Determination of E-NTPDase activities 
The E-NTPDase activities of the tissue samples were determined according to a previously 
established protocol with slight modifications (Ademiluyi et al. 2016; Schetinger et al. 2007). 
Twenty microliters of the samples were incubated with 200 µL of the reaction buffer (1.5 mM 
CaCl2, 5 mM KCl, 0.1 mM EDTA, 10 mM glucose, 225 mM sucrose and 45 mM Tris-HCl) for 10 
mins at 37°C. Thereafter, 20 µL of 50 mM ATP was added to the reaction mixture and further 
incubated for 20 mins at 37°C in a shaker. The reaction was stopped with 200 µL of 10% TCA 
and incubated with 200 µL 1.25% ammonium molybdate and freshly prepared 9% ascorbic acid 
for 10 mins in ice. Absorbance was read at 600 nm and E-NTPDase activity was calculated as the 
amount of inorganic phosphate (Pi) released/min/mg protein. 
2.6.5 Determination of glucose-6-phosphatase activities 
The glucose-6-phosphatase activities of the tissue samples were determined according to 
previously established protocol (Mahato et al. 2011), with slight modification (Erukainure et al. 
2017b). Two hundred microliters of tissues were incubated with 100 µL of 0.25 M glucose, 200 
µL of 5 mM KCl, 1300 µL of 0.1 M Tris-HCl buffer, and 40 µL of 50 mM ATP at 37°C in a shaker 
for 30 mins. Thereafter, 1 mL of distilled water and 1.25% ammonium molybdate were added 
respectively to stop the reaction. 1 mL of freshly prepared 9% ascorbic acid was then added to the 
reaction mixture and allowed to stand for 30 mins. Absorbance was read at 660 nm and ATPase 
activity was calculated as the amount of inorganic phosphate (Pi) released/min/mg protein. 
2.6.6 Quantitation of DNA fragmentation 
Induction and treatment of tissues ex vivo were carried out as described in section 2.5.1 except for 
4 h incubation. The percentage DNA fragmentation of the tissue samples were quantitated with 
diphenylamine (DPA) according to previous established protocol (Erukainure et al. 2017b; 
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Erukainure et al. 2017c; Muhammad et al. 2016; Sellins and Cohen 1987). The samples were 
centrifuged at 200g for 10 mins at 4°C. The supernatant was collected in new tubes and labelled 
S, while the tubes with the substrates (pellets) were labelled B. Thereafter, 100 µL of TTE solution 
was added to tube B, vigorously vortexed for 1 min and centrifuged at 20,000g at 4°C for 10 mins. 
The supernatant was collected into new tubes and labelled T. 100 µL of TTE solution was added 
again to the pellets in tube B. 100μl of 25% TCA was added to all tubes and vigorously vortexed 
for 1 min. They were incubated overnight at 4°C to allow precipitation of the DNA. The 
precipitated DNA was then recovered by pelleting for 10 min at 20,000g at 4°C. The supernatants 
were carefully discarded by aspiration. To hydrolyze the DNA, 160 µL of 5% TCA was added to 
tubes B and T, then heated at 90°C for 15 mins in a water bath. Subsequently, 320μl of freshly 
prepared DPA solution was added to all tubes, vortexed and incubated at 4°C for 4 h. 200 µL of 
the reaction solutions were pipetted into 96 well plate and absorbance read at 600 nm. Quantitation 
was calculated via the formula: 
% Fragmented DNA =  
Absorbance (T) 
Absorbance (T) +  Absorbance (B)
 x 100 
2.7 Ex vivo glucose absorption and uptake  
Intestines, psoas muscles and brain were harvested from normal male albino rats (180 – 200 g). 
They were placed in ice and used immediately for the experiments. All animals used were 
maintained under the guidelines and approval of the animal ethics committee of the University of 
KwaZulu-Natal, Durban, South Africa (protocol approval number: AREC/020/017D). 
2.7.1 Determination of glucose absorption in isolated rat jejunum 
The effect of the extracts and fractions on intestinal glucose absorption was determined according 
to previously established protocol which measures the glucose level in a reaction solution 
containing the extracts and 5 cm isolated rat jejunum (Chukwuma and Islam 2015). The jejunal 
segments of the freshly harvested intestines were removed, flushed with Krebs buffer (118 mM 
NaCl, 5 mM KCl, 1.328 mM CaCl2·2H2O, 1.2 mM KH2PO4, 1.2 mM MgSO4 and 25 mM 
NaHCO3) and subsequently divided into 5 cm segments. The villi of each segments were exposed 
and incubated with different concentrations of the extracts and fractions in 8 mL of Kreb’s buffer 
containing 11.1 mM glucose under a 5% CO2, 95% oxygen and 37°C conditions for 2 h. Tissues 
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incubated in Krebs buffer without the extract served as the normal control. Glucose with Krebs 
buffer without tissue or extracts served as the blank. Glucose concentration were measured before 
and after incubation with an Automated Chemistry Analyzer (Labmax Plenno, Labtest Inc., Costa 
Brava, Brazil). Intestinal glucose absorption was calculated with the formula: 
Glucose absorption / cm of rat jejunum =
GC2 − GC1
Length of jejunum used in cm
 
Where GC1 and GC2 are glucose concentrations (mg/dL) before and after incubation respectively. 
2.7.2 Determination of glucose uptake in isolated rat psoas muscles 
The effect of the extracts and fractions in isolated rat psoas muscles were determined according to 
the method of Chukwuma and Islam (2015). Different concentrations of the extracts and fractions 
were each incubated with 0.5 g of the isolated muscle in 8 mL of Krebs buffer containing 11.1 mM 
glucose under a 5%CO2, 95% oxygen and 37°C conditions for 2 h in a CO2 incubator (Lasec, South 
Africa). Tissues incubated in Krebs buffer without the extract served as the normal control. 
Glucose with Krebs buffer without tissue or extracts served as the blank. Metformin was used as 
the standard drug. Glucose concentration were measured before and after incubation with an 
Automated Chemistry Analyzer (Labmax Plenno, Labtest Inc., Costa Brava, Brazil). Muscle 
glucose absorption was calculated with the formula: 
𝐺𝑙𝑢𝑐𝑜𝑠𝑒 𝑢𝑝𝑡𝑎𝑘𝑒 𝑝𝑒𝑟 𝑔𝑚 𝑜𝑓 𝑟𝑎𝑡 𝑝𝑠𝑜𝑎𝑠 𝑚𝑢𝑠𝑐𝑙𝑒 =
𝐺𝐶1 − 𝐺𝐶2 
𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑚𝑢𝑠𝑐𝑙𝑒 𝑡𝑖𝑠𝑠𝑢𝑒 (𝑔)
 
Where GC1 and GC2 are glucose concentrations (mg/dL) before and after incubation, respectively.  
2.7.3 Determination of glucose uptake in rat brain 
The effect of the extracts and fractions in rat brain were determined according to the method of 
Chukwuma and Islam (2015). Different concentrations of the extracts and fractions were each 
incubated with 0.6 g of the harvested brain in 8 mL of Krebs buffer containing 11.1 mM glucose 
under a 5%CO2, 95% oxygen and 37°C conditions for 2 h in a CO2 incubator (Lasec, South Africa). 
Tissues incubated in Krebs buffer without the extract served as the normal control. Glucose with 
Krebs buffer without tissue or extracts served as the blank. Metformin was used as the standard 
drug. Glucose concentration were measured before and after incubation with an Automated 
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Chemistry Analyzer (Labmax Plenno, Labtest Inc., Costa Brava, Brazil). Brain glucose uptake was 
calculated with the formula: 
𝐺𝑙𝑢𝑐𝑜𝑠𝑒 𝑢𝑝𝑡𝑎𝑘𝑒 𝑝𝑒𝑟 𝑔𝑚 𝑜𝑓 𝑟𝑎𝑡 𝑝𝑠𝑜𝑎𝑠 𝑚𝑢𝑠𝑐𝑙𝑒 =
𝐺𝐶1 − 𝐺𝐶2 
𝑊𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑚𝑢𝑠𝑐𝑙𝑒 𝑡𝑖𝑠𝑠𝑢𝑒 (𝑔)
 
Where GC1 and GC2 are glucose concentrations (mg/dL) before and after incubation, respectively 
2.7.3 Determination of antioxidative, anti-proinflammatory and purinergic enzymes 
activities in brain 
After incubation, the muscle and the brain were homogenized in sodium phosphate buffer (10 mM, 
pH 6.8) on ice, then centrifuged at 15000 rpm for 15 min at 4°C. The supernatant was collected 
and stored at −20°C. They were subsequently analyzed for antioxidative stress, anti-
proinflammatory, and purinergic enzymes activities as described in sections 2.6.2 – 2.6.4. 
2.8 Metabolite profiling and pathway analysis 
Equal volumes of 240 µg/mL of active extracts or fractions and tissue homogenates were incubated 
with 15% pro-oxidant (0.1 mM FeSO4) overnight in 5% CO2 at 37
oC.  
2.8.1 Metabolic Profiling 
The target metabolites were extracted from the incubated samples using a previously described 
method (Chan et al. 2013) with slight modifications (Erukainure et al. 2017c). A 200 μL of the 
treated samples were first deproteinized with 800 μL of 20% methanol/ethanol, before incubating 
in ice for 20 mins. Thereafter, they were centrifuged at 20,000g at 4oC for 10 mins. The supernatant 
containing the metabolites was lyophilized overnight at 45°C. 
The lyophilized samples were scanned at a spectral range of 300 – 4000 cm–1 on a FT infrared 
spectrophotometer. The chemical functional groups were determined by comparing the peak 
heights to an IR spectroscopy correlation table (Erukainure et al. 2017c). 
A 200 μL of 0.1% formic acid was used in reconstituting the samples, which was then subjected 
to mass spectrometry via LC-MS (Shimadzu LCMS-2020 Single Quadrupole) (Erukainure et al. 
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2017c). Identification of the metabolites was done by direct search of mass spectral data against 
the Human Metabolome Database (Wishart et al. 2012). 
2.8.2 Pathway Analysis 
The MetaboAnalyst 3.0 (http://www.metaboanalyst.ca/) and FunRich (www.funrich.org) servers 
were used in analyzing pathways of significantly altered metabolites (Pathan et al. 2015; Xia and 
Wishart 2016).  
2.9 Cytotoxic activity 
The cytotoxicity of the most active fractions was investigated in human embryonic kidney cells 
(HEK293) and 3T3-L1 adipocytes by the 3-(4, 5-dimethyl thiazole-2-yl)-2, 5-diphenyltetrazolium 
bromide (MTT) colormetric assay.  
2.9.1 Cell culture 
The cells were grown in Eagles Minimum Essential Medium (EMEM) supplemented with 10% 
(v/v) fetal bovine serum (FBS), 1% (v/v) L-glutamine, 100 U penicillin and 100 μg/mL 
streptomycin at 37oC in a humidified atmosphere with 5% CO2. 
2.9.2 MTT assay 
The cytotoxic effect of the fractions on HEK293 and 3T3-L1 adipocytes cells was evaluated using 
the standard MTT colorimetric assay (Mosmann 1983). One hundred microliters of different 
concentrations of the fractions were incubated with equal volume of HEK293 cells (1 x 104 
cells/mL) for 48 h at 37C in a humidified atmosphere of 5% CO2. The medium was replaced with 
a fresh one and incubated with 200 µL of MTT  (5 mg/mL in PBS) for 4 h at 37°C. The medium 
and MTT were removed from the wells and replaced with 200 µL of DMSO to dissolve the 
formazan salt. Absorbance was read at 570 nm and the percentage inhibition was calculated using 
the formula: 
% inhibition = (mean of absorbance of sample/mean of absorbance of control) x 100 
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2.9.3 Determination of antioxidative, anti-proinflammation, and purinergic enzymes 
activities 
HEK293 cells were seeded into a 24-well plate at a density of 3.5 - 4.5 x 105 cells/well and 
incubated for 24 h. The cells were then incubated with the fractions for 48 h in a humidified 
atmosphere with 5% CO2 at 37C. A sample-free cells served as the positive control. The medium 
was removed and attached cells were detached gently scraping after rinsing with PBS. Detached 
cells were stored with PBS in 2 mL Eppendorf tubes at -20C until further analysis. The cells were 
assayed for antioxidative, anti-proinflammatory and purinergic enzymes activities as described in 
Sections 2.6 
2.9.4 Apoptosis Assay 
The apoptotic effect of the fractions on the cells was determined by the acridine orange and 
ethidium bromide (AO/EB) dual staining method (Maiyoa et al. 2016). Cells were seeded and 
treated as described in Section 2.9.3. After incubation and rinsing with PBS, a 10 μL dual stain 
(AO: 100 μg/mL, EB: 100 μg/mL in PBS) was added and allowed to stand for 5 min at 25C. 
Thereafter, they were viewed for morphological changes under an Olympus inverted fluorescent 
microscope fitted with a CC12 fluorescent camera, at X200 magnification. Apoptotic index was 
calculated by the formula:   
Apoptotic index =
number of apoptotic cells
number of total cells counted
 
2.10 Determination of chemical profiles of active extracts and fractions 
The active extracts and fractions were subjected to chemical profiling to identify the 
phytochemical constituents that may be responsible for the observed biological activities. 
2.10.1 Gas Chromatography-Mass Spectroscopy (GC-MS) profiling 
The extracts and fractions were analyzed with GC-MS using an Agilent technologies 6890 series 
GC coupled with (an Agilent) 5973 Mass Selective Detector and driven by Agilent Chemstation 
software. The operating parameters were: 
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Column: HP-5MS capillary column (30 m × 0.25 mm ID, 0.25 μm film thickness, 5% 
phenylmethylsiloxane); Carrier gas: ultra-pure helium; Flow rate: 1.0 mL min-1 and a linear 
velocity of 37 cm sec-1; Injector temperature:  was set at 250°C. Initial oven temperature: 60°C, 
programmed to 280°C at the rate of 10°C min-1. Injection: 1 μL made in split mode at a split ratio 
of 20:1; Electron ionization mode:  70 eV; Electron multiplier voltage: at 1859 V; Ion source 
temperature: 230°C; Quadrupole temperature: 150°C; Solvent delay: 4 min; Scan range: 50-
70 amu. 
Compounds were identified by directly comparing the retention times and mass spectral data with 
those in the NIST library.   
2.10.2 Liquid Chromatography-Mass Spectroscopy (LC-MS) profiling  
The aqueous extract, hot water infusions, and fractions were subjected to LC-MS analysis 
(Shimadzu LCMS-2020 Single Quadrupole) by direct injection into the machine via a loop, with 
the stop time set at 4 mins. The operating parameters were:  
Photodiode Array (PDA) sampling frequency: 1.5625 Hz; Operating mode: low pressure 
gradient; Pump A: LC-2030 Pump; Mobile Phase A and B: water and methanol respectively; 
Flow rate: 0.200 ml/min; Start and End wavelengths: 190 and 800 nm respectively; Cell Temp.: 
40 °C; Start and End time: 0.00 and 4.00 mins respectively; Acquisition mode: Scan; Scan 
Speed: 1667 u/s; Polarity: Positive; Event Time: 1.00 s; Detector Voltage: +1.00 kV; 
Threshold: 0; Start and End m/z: 50.00 and 1700.00 respectively. 
Compounds were identified by direct comparing mass spectral data with those in the NIST library 
online and Food Database [FooDB Version 1.0] (FoodDB, 2017). 
2.10.3 High Pressure Liquid Chromatography (HPLC) analysis 
The reverse phase HPLC with an Agilent 1100 Series HPLC-diode-array detector (DAD) was used 
in the profiling of the extracts and fractions. A C18 column (4.6 ×150 mm) packed with 5-μm 
diameter particles was utilized for this method. The operating parameters were:  
Mobile phase A and B: methanol and 100% water respectively; Initial and final temperature 
of left and right columns: 27.3 °C and 28.5 °C respectively; Left and right columns pressure: 
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112.9 and 121.3 bar respectively; Detector Lamp Burn Times setups:  DAD 1, UV Lamp: 
(Current On-Time) 3.89 h, (Accumulated On-Time) 4041.3 h; DAD 1, Visible Lamp: 3.53 3781.6 
h.  
Identification and quantification of compounds were done by comparing the retention time and 
UV absorption spectra with those of the studied standards. 
2.10.4 Fourier Transform Infrared Spectroscopy (FTIR) Analysis 
The chemical functional groups of the extracts and fractions were determined by directly scanning 
at a spectral range of 380 – 4000 cm–1 on a FT infrared spectrophotometer. The functional groups 
were determined by comparing the peak frequencies to an IR spectroscopy correlation table. 
2.10.5 Proton NMR spectroscopy analysis 
Thirteen mg each of the C. nitida infusion, unfermented and fermented Raffia palm wine samples 
were first dissolved in 0.8 mL D2O, then filtered through prewashed cotton before subjecting to 
1H-NMR spectroscopy (400 MHz). Chemical shifts were reported in δ (ppm) values. Compounds 
were identified by direct search and comparison of chemical shift data against the Food Database 
[FooDB Version 1.0] (FoodDB, 2017). 
2.10.6 Amino acid profiling of P. lunatus 
The amino acid profile of the aqueous extract of P. lunatus was determined according to previous 
established protocol by loading the extract into a Technicon sequential Multi-Sample Amino Acid 
Analyzer (TSM) and operated according to the manufacturer’s manual (Benitez 1989). 
2.11 In silico predictions 
2.11.1 In silico prediction of ADME and oral toxicity of identified compounds 
The ADME (absorption, distribution, metabolism, and excretion) properties and oral toxicity of 
the identified compounds of the extracts and fractions were predicted in silico using the 
SwissADME (Daina et al. 2017) and ProTOX (Drwal et al. 2014) online servers. 
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2.11.2 Molecular docking 
Molecular docking was carried out to determine the binding affinities of D-glucose and identified 
compounds with to ATPase, cholinesterase, catalase, myeloperoxidase, glucose transporter 4 
(GLUT4), and α-glucosidase. Their 3D crystal structures were retrieved from protein data bank, 
with PDB access codes- ATPase: 4HYT (Laursen et al. 2013), cholinesterase: 1TBU (Yang et al. 
2013), catalase: 1EVE (Kryger et al. 1999),  myeloperoxidase: 1DNW(Blair-Johnson et al. 2001), 
GLUT4, and α-glucosidase: 3TON (Ren et al. 2011). The protein resolutions were 3.4 Å, 2.2 Å, 
2.5 Å and 1.9 Å for to ATPase, cholinesterase, catalase, and myeloperoxidase respectively. The 
structure of D-glucose and compounds were retrieved from PUBMED and optimized using 
Gaussian 09 (Frisch et al. 2009). The grid box size was determined with AutoDock tools (Sanner 
1999) 1.5.4 for the potential binding sites for all the proteins except α-glucosidase. The optimum 
binding sites of the ligands were determined by the Lamarckian genetic algorithm method (Yang 
et al. 2013). While AutoDock Tools graphical user interface was used in computing the Gasteiger 
charges (Morris et al. 2009). 
For α-glucosidase, the active site was identified using the CASTp server (Liang et al. 1998). The 
Genetic Optimization of Ligand Docking (GOLD) software was used in docking the compounds 
with the active sites of the protein. The docking parameters were set as described in previous 
studies (Erukainure et al. 2017b). 
2.12 In vivo antidiabetic activity in a type 2 diabetic model of rats 
Based on the results from the in vitro and ex vivo studies, 3 plants were selected for the in vivo 
studies in type 2 model diabetic rats. The selected plants were: C. nitida infusion, BuOH fraction 
of D. edulis ethanol extract, and the aqueous extract of P. lunatus. The extracts and fractions were 
prepared as described in section 2.1 but in kilograms to get larger yields. 
 2.12.1 Experimental animals 
Male albino rats of Sprague-Dawley strain weighing about 180–200 g were obtained from the 
Biomedical Research Unit (BRU), University of KwaZulu-Natal, Durban, South Africa. They 
were acclimatized for 1 week on pelletized chows, with water given ad libitum. Standard 
laboratory conditions of natural photo period of 12-h light-dark cycle were maintained. All animals 
used were maintained under the guidelines and approval of the animal ethics committee of the 
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University of KwaZulu-Natal, Durban, South Africa (protocol approval number: 
AREC/020/017D). 
2.12.2 Animal grouping and induction of type 2 diabetes 
The rats were divided into 6 groups consisting of 5 in each normal and 7 in each diabetic group as 
follows: 
Normal Control (NC): Normal rats (non-diabetic and not treated) 
Diabetic Control (DC): Diabetic and untreated control  
Diabetic + low dose (DLD): Diabetic rats administered low dose (150 mg/kg bw) of extract or 
fraction  
Diabetic + high dose (DHD): Diabetic rats administered high dose (300 mg/kg bw) of extract or 
fraction 
Diabetic + standard drug metformin (DSM): Diabetic rats administered 200 mg/kg bw 
metformin. 
Normal Toxicological Group (NTXC): Non-diabetic rats administered high dose (300 mg/kg 
bodyweight [bw]) of extract or fraction 
This grouping was applied to the 3 extracts selected for in vivo studies.  
Insulin resistance was induced in the diabetic groups by supplying them with 10% fructose ad 
libitum for 2 weeks. They were then fasted overnight and injected (i.p) with streptozotocin (40 
mg/kg BW) dissolved in citrate buffer (pH 4.5). The normal groups were injected (i.p) with citrate 
buffer. A week later, the non-fasting blood glucose (NFBG) levels of all the rats were checked 
with a glucometer. Rats with blood glucose level >200 mg/dL were considered diabetic and used 
for the studies. 
2.12.3 Intervention trial  
Diabetic rats in groups DLD and DHD were orally administered with low and high doses of the 
respective extract or fraction using a gastric gavage needle. Group NTX was administered high 
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dose of the respective extract or fraction. While groups NC and DC were administered with 
distilled water only. Daily food and water intake were recorded, while NFBG level was measured 
each weekly throughout the intervention trial. Treatment lasted for 6 weeks, except for rats treated 
with raffia palm wine which was 5 weeks 
2.12.4 Oral glucose tolerance test (OGTT)  
Oral glucose tolerance test (OGTT) was conducted in the last week of the intervention period to 
estimate the ability of the rats to tolerate glucose. The rats were orally administered glucose 
solution (2 g/kg bw) after overnight fasting. Thereafter, their blood glucose level was measured at 
0 (before administration of glucose), 30, 60, 90 and 120 mins after glucose ingestion using a 
portable glucometer (Glucoplus Inc., Quebec, Canada). 
2.12.5 Collection of blood and organs 
At the end of the experiment, the rats were humanely sacrificed by euthanizing with halothane 
anesthesia. Blood was collected via cardiac puncture and centrifuged at 3000 rpm for 20 mins to 
obtain the serum, which was collected in Eppendorf tubes and stored at -20°C until further studies. 
The pancreas, liver, muscle, and brain were collected, washed in 0.9% NaCl, weighed and stored 
at -20°C until further studies. Small portion of the pancreas was cut and stored in neutral buffered 
formalin and 2.5% glutaraldehyde (in 0.1 M phosphate buffer; pH 7.2) for histopathological and 
microscopy analysis respectively. 
2.12.6 Analytical methods  
Serum insulin concentration was determined using an ultrasensitive rat insulin ELISA kit 
(Mercodia, Uppsala, Sweden) in multi-plate ELISA reader (Biorad-680, BIORAD Ltd., Japan). 
Serum lipid profile (total cholesterol, triglycerides, and HDL-cholesterol), calcium ion, 
fructosamine, urea, and creatinine, aspartate and alanine aminotransferases (AST and ALT), and 
alkaline phosphatase (ALP) were analyzed with an Automated Chemistry Analyzer (Labmax 
Plenno, Labtest Co. Ltd., Lagoa Santa, Brazil) with commercial assay kits according to 
manufacturer’s manual.  
The low-density lipoprotein (LDL) cholesterol level was calculated with formula (Friedewald et 
al. 1972) 
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LDL − cholesterol =  Total cholesterol −  
Triglyceride
2.22
+ HDL − cholesterol 
Insulin resistance and β-cell function were computed using the homeostatic assessment models, 
HOMA-IR and HOMA-β respectively as shown below:  
HOMA − IR =  
Serum insulin (U/L) x Blood glucose level (mmol/L)
22.5
 
HOMA − β cell function =
20 x Serum insulin (U/L) 
Blood glucose level (mmol/L) −  3.5
 
2.12.8 Determination of oxidative stress and proinflammation biomarkers, purinergic and 
cholinergic enzyme activities 
The collected organs (0.5 g) were first chopped with scissors in ice, then homogenized in in 4 mL 
of homogenization buffer (50 mM sodium phosphate buffer with triton X-100, pH 7.5). The 
homogenized samples were centrifuged at 15,000 rpm for 10 mins at 4°C. The supernatants were 
then collected in 2 mL Eppendorf tubes and stored at -20°C until further analysis. 
The tissue homogenates and serum were analyzed for oxidative stress and proinflammation 
biomarkers (section 2.6.2 – 2.6.3), and purinergic enzymes activities (section 2.6.4). 
Acetylcholinesterase activity was determined by the Ellman’s method (Ellman et al. 1961). This 
was carried out by mixing 20 μL of the tissue with 10 μL of 3.3 mM Ellman’s reagent (pH 7.0) 
and incubating with 50 μL of 0.1 M phosphate buffer (pH 8) for 20 min at 25 °C. 10 μL of 0.05 M 
acetylcholine iodide was then added to the reaction mixture and read absorbance read at 412 nm 
at 3 min intervals. 
2.12.9 Determination of carbohydrate metabolic enzymes activities 
The serum and pancreatic homogenate were analyzed for α-amylase activities as describes in 
section 2.4.2. However, the serum and the tissue were used as the enzyme source and no extract 
or standard drug was utilized. 
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The glucose 6 phosphatase and glycogen phosphorylase activities were determined in the liver 
homogenate as described in section 2.6.5. For glycogen phosphorylase activity, glycogen was used 
as the substrate source (Balogun and Ashafa 2017; Cornblath et al. 1963). 
Fructose-1,6-bisphosphatase activity was determined in the liver homogenate using a previously 
established protocol (Balogun and Ashafa 2017; Gancedo and Gancedo 1971), with slight 
modification. One hundred microliters of the tissue homogenate were mixed with 1200 μL of Tris–
HCl buffer (0.1 M, pH 7.0), 100 μL of fructose (0.05 M), 250 μL 0.1 M MgCl2, 100 μL 0.1 M 
KCl, and 250 μL 1 mM EDTA. The reaction mixture was incubated at 37°C for 15 mins. The 
reaction was stopped with 1 mL of 10% TCA. The mixture was then centrifuged for 10 mins at 
3000 rpm at 4°C. 100 µL of the supernatant was pipetted into a 96-well plate and incubated with 
50 µL of 1.25% ammonium molybdate and freshly prepared 9% ascorbic acid for 20 mins at 
normal room temperature for colour development. Absorbance was read at 680 nm with a 
microplate reader and the activity calculated as the amount of inorganic phosphate (Pi) 
released/min/mg protein. 
2.12.10 Extraction of metabolites and metabolomics 
The metabolites of the collected tissues were extracted as described in section 2.8. Metabolic 
profiling was conducted via GC-MS analysis on an Agilent technologies 6890 Series GC coupled 
with (an Agilent) 5973 Mass Selective detector and driven by Agilent chemstation software. The 
metabolites were separated using a HP-5MS capillary column. Injections of 1 μL of the samples 
were made in splitless mode, with ultra-pure helium used as the carrier gas at a constant flow rate 
of 60 mL h−1. The initial oven temperature was set at 60 °C for 2 min before increasing to 285°C 
at the rate of 5 °C min-1 with a hold time of 3 min. The temperatures of the ion source and 
quadrupole were set at 230 and 150°C respectively, with electron ionization mode and electron 
multiplier voltage operated at 70 eV and 1859 V.   
The pathways were analyzed as described in section 2.8 
2.12.12 Histopathological and microscopic analysis  
Histological analysis of the brain (hypothalamus) and pancreatic tissues were carried out according 
to standard protocol for paraffin embedding. The respective tissues were sectioned to 4 μm in 
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slides. They were then deparaffinize with p-xylene and rehydrated in decreasing ethanol 
concentration gradient (100%, 80%, 70%, 50%). They were rinsed with tap water. The slides were 
stained with hematoxylin and nisili for pancreas and brain respectively for 5 mins, then rinsed with 
tap water. They were thereafter stained with eosin. The slides were mounted in DPX and cover-
slipped. Leica slide scanner (SCN 4000, Leicabiosystems Germany) was used in viewing the 
images. 
Microscopic analysis of the brain (hypothalamus and pancreatic tissues were carried out with a 
scanning electron microscope (SEM; Zeiss Ultra Plus). The fixed tissues were subjected to buffer 
wash to remove glutaraldehyde. This was done thrice at 5 mins intervals. Thereafter, they were 
post-fixed with 0.5% osmium tetroxide for 2 h. The tissues were washed with distilled water thrice 
at 5 mins interval, before subjecting to dehydration using ethanol of increasing concentrations: 
25% (twice at 5 mins interval), 50% (twice at 5 mins interval), 75% (twice at 5 mins interval) and 
100% (twice at 10 mins interval). The tissue samples were dried in a critical-point-dryer apparatus, 
gold coated, and observed at an accelerating voltage of 20–25 k with a SEM (Zeiss Ultra Plus). 
2.12.13 Immunohistochemistry 
Thin sections of 5 µm thickness were obtained from routine paraffin embedded pancreatic tissues 
prepared during histology. After deparaffinization, sections were subjected to heat-mediated 
antigen retrieval in citrate-based solution, pH 6.0. Endogenous peroxidase blocking was performed 
in 0.3 % hydrogen peroxide. Sections were then incubated overnight at 4 0C in primary rabbit 
antibodies: caspase-3 (Cell Signaling, MA, USA; #9662) and Nrf2 (Abcam, MA, USA; #ab31163) 
at 1:200 and 1:100 dilutions respectively. Secondary incubation was performed in ImmPRESS™ 
HRP Anti-Rabbit IgG (Peroxidase) Polymer Reagent, made in horse (Vector® #MP-7401). DAB 
Peroxidase (HRP) Substrate Kit (Vector® #SK-4100) was used for colour development, and 
sections were counter-stained in Harris hematoxylin. Control sections were similarly processed 
without primary antibody incubation. There was no specific immunoreactivity on the control 
sections. Immunoreactivity was quantified using the ImmunoRatio plugin on Image J software 
(NIH, USA) which separates and quantify percentage of DAB (positive immunoreactivity) by 
digital colour deconvolution (Tuominen et al. 2010). 
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2.13 Statistics 
The one-way analysis of variance (ANOVA) was used in establishing the statistical significance 
and set at p < 0.05. Data were presented as mean ± SEM/SD. Statistical analyses were carried out 
using IBM SPSS for Windows, version 23.0 (SPSS Inc., Chicago, IL, USA). 
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CHAPTER 3 
THE ANTI-OXIDATIVE AND ANTI-DIABETIC ACTIVITIES OF RAFFIA 
PALM (RAPHIA HOOKERI) WINE IN VITRO, EX VIVO, AND IN VIVO 
3.1 Raffia palm (Raphia hookeri) wine 
3.1.2 Background 
Palm wine is a traditional beverage with a milky flocculent appearance obtained from the sap of 
palm tree (Eze and Ogan 1988; Nwaiwu et al. 2016). It is consumed fresh (unfermented) and 
fermented. Its consumption cuts across West Africa, India and Indonesia. In Nigeria, its common 
name includes palmy, oguro, tombo, nkwu ocha, and nkwu enu. It is utilized in most socio-cultural 
activities in Nigeria, where it is consumed at most traditional events (Nwaiwu and Itumoh 2017) 
and employed in folkloric medicine. The high content of the yeast, Saccharomyces cerevisiae 
makes the palm wine susceptible to fermentation, leading to decreased sweetness with concomitant 
increase in alcohol content.  
3.1.3 Ethnopharmacological uses 
Children suffering from measles are often sprinkled with palm wine as part of the treatment 
process. It is often used as a macerating medium (unfermented or fermented) for some medicinal 
plants (Focho et al. 2009). Fresh (unfermented) palm wine are often given to breastfeeding mothers 
to boost milk production.  
3.1.4 Biological activities 
There are scanty scientific reports on the biological activities of palm wine. Few studies on its 
biological activities reveal palm wine as a good scavenger of free radicals (Oboh and Okhai 2012), 
which portrays its antioxidant activity.  
3.1.5 Nutritional properties 
Raffia palm wine is a rich dietary source of ascorbic acid and the B-vitamins complex, particularly 
thiamine (Bassir 1962; Eze and Ogan 1988; Tuley 1965). Obahiagbon and Osagie (2007) reported 
the presence of potassium, magnesium, calcium, sodium, phosphorus, and nitrogen. It has also 
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been reported to be rich in sucrose, glucose, xylose, raffinose and lactose (Ezeagu et al. 2003; 
Obahiagbon and Osagie 2007), which are responsible for its sweetness. 
3.1.6 Phytochemistry 
The volatile compounds of palm wine have been reported to consist of ethyl acetate, ethanol, 
trimethyldioxolane, propionic acid, propyl acetate, methyl cinnamate, butyl acetate, isopentyl 
alcohol, hexanoic acid, ethyl hexanoate, styrene, acetoin, ethyl lactate, methylpropylacetate, ethyl 
octanoate, acetic acid, methyl-2-methyl propanoate, ethyl dodecanoate, dimethylhydrazine, 3-
methyl-6,7-benzylisoquinoline, tetraacetyl-D-xylonic nitrile, oleic acid, 2-phenylethanol, 2-
phenylethanol, 4-hydroxy-2,5-dimethyl-3(2H)-furanone, 3-methylpentanoic acid, 2-ethyl-4-
hydroxy-5-dimethyl-3(2H)-furanone, ethylcinnamate, 3-hydroxy-4,5-dimethyl-2(5H)-furanone, 
diethylsuccinate, c-dodecalactone,  phenylacetic acid, vanillind, 4-Methoxy-2-methylphenol, and 
2-/3-Methylbutanol (Lasekan et al. 2007; Nwaiwu et al. 2016; Uzochukwu et al. 1997). 
Uzochukwu et al. (1997) also reported the presence of 3 terpenes namely: a-pinene, 3-carene and 
Isocumene. Other acids identified are benzoic, phenyl acetic, and phenyl propionic (Uzochukwu 
et al. 1997). 
3.1.7 Aims and objective 
This study aims at investigating the anti-oxidative and antidiabetic properties of unfermented and 
fermented raffia palm wine by determining their in vitro free radical scavenging and enzyme 
inhibitory activities, glucose absorption and uptake in vitro and ex vivo, antioxidative effect and 
modulation of dysregulated metabolic pathways in oxidative pancreatic injury ex vivo. The 
antidiabetic and antioxidant protective effects in type 2 diabetes was also determined in vivo. 
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3.2 Fermentation does not Affect Sugar Quality of Raffia Palm (Raphia 
hookeri) Wine but Alters Its Functional Chemistry and Antidiabetic Properties 
1,2Ochuko L. Erukainure, 1,3Chika I. Chukwuma, 1Md. Shahidul Islam* 
1. Department of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, 
(Westville Campus), Durban 4000, South Africa  
2. Nutrition and Toxicology Division, Federal Institute of Industrial Research, Lagos, Nigeria 
3. Department of Pharmacology, University of the Free State, Bloemfontein 9301, South 
Africa 
*Corresponding author: islamd@ukzn.ac.za; Tel: +27 (0)31-260-8717; Fax: +27 (0)31-260-7942 
Preface: This article investigated the in vitro antioxidant and enzyme inhibitory activities, as well 
as the ex vivo glucose absorption and uptake effects of raffia palm wine. It has been submitted to 
Food Bioscience for publication. 
3.2.1 Abstract 
The effect of short term fermentation on the sugar quality, functional chemistry, antioxidant and 
antidiabetic properties of raffia palm (Raphia hookeri) wine was investigated. Palm wine samples 
were subjected to open air fermentation for 24 and 48 hours, respectively. The samples showed 
significant (p<0.05) antioxidant activities with little or no differences between the unfermented 
and fermented. There was a dose-dependent inhibitory effect on α-glucosidase, α-amylase and 
intestinal glucose absorption with increasing fermentation time. All samples except the 48 h 
fermented caused an increased muscle glucose uptake dose-dependently. 1H-NMR spectroscopy 
revealed the presence of allose, cellobiose, d-tagatose, fructose, galactitol, gluconic acid, 
rhamnose, sucrose, xylose and β-N-acetylglucosamine. FTIR spectroscopy revealed the presence 
of alcohols, phenols, 1° and 2° amines, aromatics functional groups in all samples. Fermentation 
led to the addition of the functional group, bend alkenes. These results demonstrate the 
antioxidative and antidiabetic properties of unfermented and fermented raffia palm wine. 
Keywords: Antioxidant; Enzymes inhibition; Palm wine; and Type 2 Diabetes 
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3.2.2 Introduction 
Diabetes mellitus (DM) has been recognized as one of the world’s growing epidemic, and a major 
contributor of morbidity and mortality in Africa (Motala 2002). It is a metabolic disease affecting 
carbohydrate, protein and lipid metabolism, leading to increased blood glucose level (Saltiel and 
Kahn 2001). Inability of the pancreatic beta-cell to secrete insulin (type 1 diabetes) or inability for 
the body to utilized secreted insulin (type 2 diabetes[T2D]) have been implicated as the main 
culprit. T2D has been recognized as the most prevalent of diabetes, constituting more than 90% 
(IDF 2015). It is characterized by hyperglycemia, which has been implicated in the morbidity and 
mortality of T2D. Chronic hyperglycemia has been shown to alter the body’s redox balance due 
to increased production of reactive oxygen species (ROS) (Maritim et al. 2003; Tiwari et al. 2013). 
Alteration of the body’s redox balance in favour of ROS production over the body’s antioxidant 
system, will lead to oxidative stress (Erukainure et al. 2017). Oxidative stress is an important 
contributor to the pathogenic micro- and macro-vascular complications of T2D (Maritim et al. 
2003; Tiwari et al. 2013). Treatment of T2D with antioxidants have been demonstrated in several 
studies to reduce these complications have (Fiordaliso et al. 2004; Scott and King 2004; Ziegler et 
al. 2011). 
The role of medicinal plants in the treatment and management of T2D and its complications are 
well documented (Abo et al. 2008; Ezuruike and Prieto 2014; Mohammed et al. 2014). This has 
been attributed to their phytochemical and nutritional properties (Harbilas et al. 2009; Patel et al. 
2012). Some of these plants are often utilized singly or in combinations immersed in fresh 
(unfermented) or fermented palm wine.  
However, there have been concerns on the safety and efficacy of the use of palm wine in 
combination with medicinal herbs particularly in the treatment of T2D, owing to its sweetness 
(unfermented) and alcoholic content (fermented). Thus, we investigated the effect of short term 
fermentation on the sugar quality, functional chemistry, antioxidant and anti-diabetic properties of 
raffia palm (Raphia hookeri) wine. 
3.2.2 Materials and Methods 
Kindly refer to Chapter 2; sub sections 2.1 – 2.5; 2.7; 2.10; and 2.13 
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3.2.3 Results and Discussion 
The safety and efficacy of the use of palm wine in combination with antidiabetic medicinal herbs 
remains a major question to most health practitioners. This has been attributed to its sweetness and 
ease of fermentation. In this study, we reported for the first time the antidiabetic potential of raffia 
palm wine and the influential role of fermentation on its biological activity.  
Total Phenolic Content 
All samples had relative low total phenolic content as depicted in Figure 3.2.1. Fermentation for 
24 h led to significant (p<0.05) reduction in the total phenolic content, this was however increased 
after 48 h fermentation. The role of polyphenolics in the medicinal properties of plants is well 
documented (Erukainure et al. 2017). They are secondary metabolites with reported antioxidant 
activities (Adedayo et al. 2010). 
 
Figure 3.2.1: Total phenolic content of unfermented and fermented raffia palm wine. Data = mean 
± SD; n = 3. abValues with different letters above the bars for a given extract are significantly (p < 
0.05) different from each other. 
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In Vitro Antioxidant Activity 
There was with little or no significance difference between the antioxidant activities of the 
unfermented and fermented palm wine as shown in Figures 3.1.2A and B. Their IC50 values of 
1.00 (unfermented), 2.00 (24 h fermented) and 1.99 (48 h fermented) μg/mL for DPPH scavenging 
activity portrays a potent quenching activity, even higher than ascorbic acid (8.31 μg/mL) (Table 
3.2.1). Their IC50 values for FRAP activities, though higher than ascorbic also reveals a strong 
antioxidant potential. The role of antioxidants in the amelioration of complications implicated in 
type 2 diabetes is well documented (Rahimi et al. 2005). Thus, suggesting a protective role of palm 
wine against hyperglycemia induced oxidative stress. The antioxidant activities corresponds to 
previous reports on the DPPH scavenging properties of raffia palm wine (Oboh and Okhai 2012) 
and can be attributed to the total phenolic content (Figure 3.2.1). 
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Figure 3.2.2: (A) DPPH scavenging and (B) FRAP activities of unfermented and fermented raffia 
palm wine. Data = mean ± SD; n = 3. abValues with different letters above the bars for a given 
concentration are significantly (p < 0.05) different from each other. 
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Table 3.2.1: IC50 values of biological activities of unfermented and fermented Raffia palm wine 
Activities Unfermented 
(µg/mL) 
24 h Fermented 
(µg/mL) 
48 h Fermented 
(µg/mL) 
Ascorbic Acid 
(µg/mL) 
Acarbose 
(µg/mL) 
DPPH  1.00 2.00 1.99 8.31 – 
FRAP 186.20 977.23 229.08 29.98 – 
Alpha glucosidase 6.76 1.13 15.84 – 62.42 
Alpha amylase 537.03 109.64 29.51 – 0.04 
Glucose absorption 37.15 1.41 0.47 – – 
Glucose uptake 11.48 7.07 102.32 – – 
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Carbohydrate Digesting Enzyme Inhibitory Activity 
All samples showed significant inhibition of α-glucosidase as shown in Figure 3.2.3A. There was 
no dependent increased activity by the unfermented palm wine. However, the fermented samples 
showed a dose dependent inhibitory effect, with the 48 h fermented showing significantly (p<0.05) 
higher activity with increasing concentrations. Their IC50 values of 6.76, 1.13, 15.84 μg/mL for 
unfermented, 24 h and 48 h fermented respectively depicts a potent α-glucosidase inhibitory 
activity compared to the standard drug, acarbose (62.42 μg/mL) with the 24 h fermented showing 
the best activity (Table 3.2.1). 
 
Figure 3.2.3A: α-glucosidase inhibitory activities of unfermented and fermented raffia palm wine. 
Data = mean ± SD; n = 3. abcValues with different letters above the bars for a given concentration 
are significantly (p < 0.05) different from each other. 
The inhibitory effect of the palm wines on α-amylase activity was significantly lower than the 
standard drug, Acarbose as depicted in Figure 3.2.3B. All samples showed a dose – dependent 
inhibitory effect, which also increases with increasing time of fermentation. The low IC50 value 
for the 48 h fermented palm wine (29.51 μg/mL), insinuates the best activity (Table 3.2.1). The 
inhibition of these enzymes has been linked to the antidiabetic properties of most drugs and 
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medicinal plants (Bischoff 1995; Oboh et al. 2014). These enzymes involved in the breakdown of 
dietary carbohydrate to glucose. Therefore, their inhibition will limit the amount of glucose 
available to the blood stream. The inhibitory results from this study, thus demonstrates the 
antidiabetic properties of raffia palm wine. Fermentation has been shown to improve the 
antidiabetic properties of foods (Kumar et al. 2005; Kwon et al. 2010), which corroborates with 
the observed increased inhibitory activity of the fermented palm wines. 
 
Figure 3.2.3B: α-amylase inhibitory activities of unfermented and fermented raffia palm wine. 
Data = mean ± SD; n = 3. abcValues with different letters above the bars for a given concentration 
are significantly (p < 0.05) different from each other. 
Measurement of Glucose Absorption in Isolated Rat Jejunum 
Incubation of isolated rat jejunum with unfermented and fermented palm wine led to significant 
(p<0.05) inhibition of intestinal glucose absorption as shown in Figure 3.2.4. All samples showed 
a dose – dependent activity, which increased with increasing time of fermentation. This is evident 
by the decreasing IC50 values of the palm wines as the fermentation time increased, with the 48 h 
fermented having a value of 0.47 μg/mL. This result further portrays the ability of raffia palm wine 
to reduce blood glucose level by inhibiting intestinal glucose absorption. Glucose arising from the 
α-glucosidase breakdown of dietary carbohydrate is rapidly absorbed in the small intestine, 
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particularly at the proximal region (jejunal and duodenal regions) (Kellett and Helliwell 2000; 
Meddah et al. 2009). Thereby leading to elevated blood glucose level. This also corroborates with 
its (palm wine) inhibitory effect on α-glucosidase activities (Figure 3.2.3A). 
 
Figure 3.2.4: Effects of fermentation on glucose absorption in isolated rat jejunum by raffia palm 
wine. Data = mean ± SD; n = 3. abcValues with different letters above the bars for a given 
cocentration are significantly (p < 0.05) different from each other. 
Measurement of Glucose uptake in Isolated Rat Psoas Muscles 
There was a significant (p<0.05) increased glucose uptake in muscle tissues incubated with 
unfermented and 24 h fermented palm wines respectively, with the latter showing the best activity 
as depicted in Figure 3.2.5 and Table 3.2.1. The activities were dose dependent with increasing 
concentration. The 48 h showed little or no significant activity. Skeletal muscles play a major role 
in carbohydrate metabolism and glucose homeostasis (Sinacore and Gulve 1993). These has been 
attributed to the high concentration of GLUT-4 which aids glucose uptake (Satoh 2014). 
Stimulation of muscle glucose uptake has been shown to be a major therapy for maintaining normal 
glycaemia in T2D (Pereira et al. 2017). Thus, the increased glucose uptake by the unfermented 
and 24 h fermented raffia palm wines indicates an anti-hyperglycemic potential. 
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Figure 3.2.5: Effects of fermentation on glucose uptake in isolated rat psoas muscle by raffia palm 
wine. Data = mean ± SD; n = 3. abcValues with different letters above the bars for a given 
concentration are significantly (p < 0.05) different from each other. 
Proton NMR Spectroscopy Analysis 
1H-NMR spectroscopy of the palm wine samples revealed that fermentation had no effect on the 
sugar contents. The identified sugars were: allose, cellobiose, d-tagatose, fructose, galactitol, 
gluconic acid, rhamnose, sucrose, xylose, and β-N-acetylglucosamine as depicted in Figure 3.2.6.  
The identified sugars corroborate previous studies on the sugar content of raffia palm wine. Eze 
and Ogan (1988); Obahiagbon and Osagie (2007) reported the presence of sucrose, fructose, 
glucose and raffinose in raffia palm wine, with sucrose being the major sugar. The presence of 
maltose (Ezeagu et al. 2003), l-arabinose, d-xylose, l-rhamnose, and cellobiose (Faparusi 1981) 
have also been reported. The little or no change in sugar quality of the fermented palm wine 
however contradicts previous reports by (Van Pee and Swings 1971); (Faparusi 1969); and 
Obahiagbon & Osagie (2007). They reported reduced sugar levels owing to fermentation to yield 
alcohol, carbon dioxide and acetic acid. In this present study, the fermentation time was short and 
the identified sugars were not quantified. The observed antidiabetic properties of the studied palm 
wines (Figure 3.2.3 – Figure 3.2.5) can also be attributed to the synergetic effect of identified 
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sugars, particularly d-tagatose and rhamnose (Espinosa and Fogelfeld 2010; Lee et al. 2008). This 
also corroborates with reported antidiabetic properties of natural sweeteners (Chukwuma and 
Islam 2015; Chukwuma and Islam 2017). 
 
Figure 3.2.6: Identified sugars in unfermented and fermented raffia palm wine 
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Fourier Transform Infrared Spectroscopy (FTIR) Analysis 
FTIR spectroscopy of the palm wine samples revealed the presence of O–H stretch, H–bonded, 
N–H stretch, C–H stretch, N–H bend and C–C stretch (in–ring) bonds depicting alcohols, phenols, 
1° and 2° amines, aromatics functional groups in all samples as shown in Figure 3.2.7 and Table 
2. These chemical bonds portray an electron – deficient moiety, indicating susceptibility to 
accepting an electron (Erukainure et al. 2017; Harrold 2013). Thus, demonstrating an antioxidant 
potential which corroborates the observed antioxidative activity (Figure 3.2.2). Fermentation led 
to the addition of the functional group, bend alkenes. 48 h fermentation led to the addition of 
carbonyls (general), carboxylic acids, aldehydes, esters, saturated aliphatic and α, β–unsaturated 
esters functional groups as indicated by the presence of C=O stretch. 
 
Figure 3.2.7: FTIR spectroscopy of unfermented and fermented palm wine. 
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Table 3.2.2: Quantitative analysis of FTIR spectroscopy of unfermented and fermented raffia palm wine 
Unfermented 
(cm-1) 
24 hr Fermented 
(cm-1) 
48 hr Fermented 
(cm-1) 
Functional Group Chemical Bonds 
3274.90 3260.89 3259.08 alcohols, phenols 
1°, 2° amines, amides  
O–H stretch, H–bonded 
N–H stretch 
2933.71 2933.25 2935.19 Alkanes C–H stretch 
– – 1716.05 carbonyls (general) 
carboxylic acids 
aldehydes, esters, saturated aliphatic 
α, β–unsaturated esters 
C=O stretch 
1595.23 1591.31 1588.29 1° amines 
Aromatics 
N–H bend 
C–C stretch (in–ring) 
1401.09 1408.01 1416.88 Aromatics C–C stretch (in–ring) 
1250.30 1255.68 1250.13 alcohols, carboxylic acids, esters, ethers C–O stretch 
1037.19 1029.66 1037.05 aliphatic amines C–N stretch 
926.27 – 927.53 carboxylic acids 
alkenes 
O–H bend 
=C–H bend 
867.53 – 869.87 Aromatics C–H “oop” 
– 818.05 818.50 1°, 2° amines N–H wag 
– 779.54 776.18 bend alkenes =C–H 
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619.97 – 626.86 bend alkynes –C≡C–H: C–H 
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3.2.4 Conclusion 
These results demonstrate the antioxidative and antidiabetic properties of unfermented and 
fermented raffia palm wine. These can be attributed to the synergetic effect of the identified sugars 
and functional groups. The increased enzyme inhibitory activity with increasing fermentation time 
indicates a fermenting effect. These results also validate its use as a major ingredient in some 
folkloric antidiabetic medicine. Further studies are however required to validate its anti-
hyperglycemic activity in vivo 
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3.3 Raffia Palm (Raphia hookeri) Wine inhibits Glucose Diffusion; 
Exacerbates Antioxidative Activities; and Modulates Dysregulated Pathways 
and Metabolites in Oxidative Pancreatic Injury 
1,3Ochuko L. Erukainure, 1Olajumoke A. Oyebode, 4Chika I. Chukwuma, 4Motlalepula G. 
Matsabisa, 2Neil A. Koorbanally 1Md. Shahidul Islam* 
1. Department of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, 
(Westville Campus), Durban 4000, South Africa  
2. School of Chemistry and Physics, University of KwaZulu-Natal, (Westville Campus), 
Durban 4000, South Africa  
3. Nutrition and Toxicology Division, Federal Institute of Industrial Research, Lagos, Nigeria 
4. Department of Pharmacology, University of the Free State, Bloemfontein 9301, South 
Africa 
*Corresponding author: islamd@ukzn.ac.za; Tel: +27 (0)31-260-8717; Fax: +27 (0)31-260-7942 
Preface: This article investigated the effect of raffia palm wine on glucose uptake and diffusion in 
yeast cells and across dialysis membrane respectively. Its antioxidative and anti-proinflammatory 
effects on oxidative pancreatic injury and metabolic pathways involved were also investigated ex 
vivo. It has been accepted for publication in Journal of Food Biochemistry (JFBC-08-18-0641). 
3.3.1 Abstract 
The antidiabetic, antioxidative and anti-proinflammatory effects of raffia palm (Raphia hookeri) 
wine was investigated using in vitro and ex vivo models. Unfermented, 24, and 48 hours fermented 
raffia palm wine samples were respectively investigated for their ability to promote glucose uptake 
and inhibit glucose diffusion. Their effect on reduced glutathione (GSH), malondialdehyde (MDA) 
and nitric oxide (NO) levels, as well as superoxide dismutase (SOD), catalase, myeloperoxidase, 
and ATPase activities were investigated in Fe2+ induced oxidative pancreatic tissues. The samples 
significantly (p<0.05) promoted glucose uptake in yeast cells and inhibited glucose diffusion 
across dialysis membrane. Except for GSH level, all studied antioxidant and proinflammatory 
biomarkers were significantly reversed after treatment with the palm wine samples. This may be 
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attributed to the LC-MS identified compounds which were mainly polyphenols and their 
glycosides, vitamins and amino acids. Investigation of the oxidative pancreatic metabolites 
revealed depleted metabolites with concomitant generation of citric acid cycle metabolites owing 
to activation of energetic metabolic pathways involved in superoxide generation. These were 
depleted in the treated tissues with the generation of adenosine metabolic intermediates, sugar and 
inositol phosphorylation intermediates, as well as generation of enzyme co-factors, selenium and 
vitamin metabolites owing to concomitant activation of vitamins, lipid, steroids, inositol and its 
phosphates, and sulfate/sulfite metabolic pathways. These results suggest the antidiabetic and 
antioxidative effects of unfermented and fermented raffia palm wine. These activities can be 
attributed to the inhibition of metabolic pathways involved in free radical generation, and 
activation of pathways involved in antioxidant activities. 
Keywords: Antioxidative stress; Antidiabetes; Ex vivo; Metabolomics; and Raffia palm wine 
3.3.2 Introduction 
Plants have been employed from time immemorial in the treatment and management of several 
ailments and diseases including diabetes and its complications, making them a major contributor 
of the global health system (Iwu and Gbodossou 2000; Mpinga et al. 2013).  These plants are major 
constituents of phytochemicals, which are responsible for their medicinal properties (Erukainure 
et al. 2017). These plants either utilized singly or macerated in other liquid mediums (Focho et al. 
2009). Amongst such mediums is the raffia palm (Raphia hookeri) wine.  
Diabetes mellitus (DM) has been recognized as a global epidemic affecting over 425 million 
people globally in 2017, with Africa accounting for 3.76% (IDF 2018). A 48% increase in 
prevalence have been predicted for 2045 which amounts to 629 million people that will living with 
diabetics globally (IDF 2018). Diabetes is a metabolic disease arising from inability of the 
pancreatic tissue to secret insulin (type 1 diabetes) and/or inability of the body to utilize the 
secreted insulin owing to insufficiency (type 2 diabetes). Thereby affecting carbohydrate, lipid and 
protein metabolism. This leads to an uncontrolled increased blood glucose level termed, 
hyperglycemia. Chronic hyperglycemia arising from insulin resistance and pancreatic β-cell 
dysfunction has been recognized as the hallmark of type 2 diabetes (T2D), which is the 
predominant of all diabetes types (Kahn et al. 2014). Hyperglycemia triggers the production of 
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free radicals, which when surpasses the body’s endogenous antioxidant defense system causes 
oxidative stress (Maritim et al. 2003b). Oxidative stress has been implicated in the pathogenesis 
of complications associated with T2D (Erukainure et al. 2015; Maritim et al. 2003b) and often 
characterized by increased membrane lipid peroxidation and DNA insults owing to increased 
levels of superoxide (O2.−), hydrogen peroxide (H2O2) and hydroxyl radical (.OH). 
Despite the wide use of raffia palm wine in folkloric medicine, there is still a dearth in the scientific 
reports of its acclaimed medicinal properties and mechanism of actions. Thus, this study aims to 
report the antidiabetic and antioxidative properties of raffia palm wine by investigating its 
inhibitory activity on glucose diffusion and uptake, as well as the potential metabolic pathways 
involved in its antioxidative activities in Fe2+ - induced oxidative stress in pancreatic tissues.  
3.3.3 Materials and Methods 
Kindly refer to chapter 2; sub sections: 2.1.1 – 2.1.2; 2.5 – 2.6.2.4; 2.6.3 – 2.6.4.1; 2.8; 2.10.2; 
2.11.1; and 2.13 
3.3.4 Results 
Incubation of the palm wine samples with yeast cells in the presence of glucose, led to significant 
(p<0.05) increase in glucose uptake in a dose dependent manner as depicted in Figure 3.3.1A. The 
24 h fermented showed the best activity (IC50 = 158.80 µg/mL) as shown in Table 3.3.1, followed 
by the unfermented and 48 h fermented respectively. 
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Figure 3.3.1A: Effect of raffia palm wine on glucose uptake/ transport in yeast cells. Values = 
mean ± SD; n = 3. abcValues with different letters over the bars for a given concentration are 
significantly different from each other (p < 0.05, Tukey’s HSD-multiple range post-hoc test, IBM 
SPSS for Windows). 
The palm wine samples significantly (p<0.05) inhibited the movement of glucose across the 
dialysis bag, indicating an inhibitory effect on glucose diffusion as shown in Figure 3.3.2B. The 
effect was dose-dependent. Based on the IC50 values (Table 3.3.1), the 48 h fermented sample had 
the best activity, followed by the 24 h fermented, while the unfermented was the least. Thus, 
indicating an increasing activity with increased fermentation time. 
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Figure 3.3.1B: Effect of raffia palm wine on glucose diffusion. Values = mean ± SD; n = 3. 
abcValues with different letters over the bars for a given concentration are significantly different 
from each other (p < 0.05, Tukey’s HSD-multiple range post-hoc test, IBM SPSS for Windows). 
Table 3.3.1: IC50 values of studied biological activities 
Activities Unfermented 
Palm wine 
24 h 
fermented 
palm wine 
48 h fermented 
palm wine 
Gallic acid 
Glucose Diffusion (mg/mL) 3.03 2.16 1.91 ND 
Glucose uptake (µg/mL) 216.53 158.80 486.64 ND 
GSH (µg/mL) <1000 <1000 <1000 <1000 
SOD (µg/mL) 0.95 0.08 2.74 <1000 
Catalase (µg/mL) 0.08 0.01 0.17 <1000 
Lipid Peroxidation (µg/mL) 0.01 <1000 15.61 26.74 
NO (µg/mL) 208.86 338.81 438.99 38.94 
Myeloperoxidase (µg/mL) 209.52 142.43 544.2 362.81 
ATPase 0.61 5.99 <1000 0.01 
ND: not determined. 
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Incubation of pancreatic tissues with FeSO4 led to significant (p<0.05) reduction of GSH level as 
depicted in Figure 3.3.2A. Incubation with the palm wine samples showed little or no effect on 
the GSH level.  
 
Figure 3.3.2A: Effect of raffia palm wine on GSH level in oxidative pancreatic injury. Values = 
mean ± SD; n = 3. *Significantly different from untreated sample and #Significantly different from 
normal sample (p < 0.05, Tukey’s HSD-multiple range post-hoc test, IBM SPSS for Windows). 
There was a significant (p<0.05) decrease in SOD and catalase activities on incubation of 
pancreatic tissues with FeSO4 as shown in Figure 3.3.2B and Figure 3.3.2C. These were 
significantly (p<0.05) revised to near normal on incubation with the palm wine samples, indicating 
potent antioxidative potentials as portrayed by their low IC50 values (Table 3.3.1).  
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Figure 3.3.2: Effect of raffia palm wine on (B) SOD and (C) catalase activities in oxidative 
pancreatic injury. Values = mean ± SD; n = 3. *Significantly different from untreated sample and 
#Significantly different from normal sample (p < 0.05, Tukey’s HSD-multiple range post-hoc test, 
IBM SPSS for Windows). 
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The significant (p<0.05) increased MDA levels on incubation with FeSO4, indicates a peroxidative 
effect. This was reduced by the palm wine samples dose dependently (Figure 3.3.2D), with the 
unfermented showing the best activity (IC50 = 0.01 µg/mL). 
 
Figure 3.3.2.D: Effect of raffia palm wine on MDA level in oxidative pancreatic injury. Values = 
mean ± SD; n = 3. *Significantly different from untreated sample and #Significantly different from 
normal sample (p < 0.05, Tukey’s HSD-multiple range post-hoc test, IBM SPSS for Windows). 
Incubation of pancreatic tissues with FeSO4 led to significant (p<0.05) increased levels of NO as 
depicted in Figure 3.3.3A. The palm wine samples showed a dose dependent reduction activity, 
with the unfermented showing the best activity (IC50 = 208.86 µg/mL) (Table 3.3.1). 
The palm wine samples showed significant (p<0.05) inhibitory effect on myeloperoxidase 
activities in pancreatic tissues incubated with FeSO4, indicating an anti-myeloperoxidase effect as 
shown in Figure 3.3.3B. The effect was dose – dependent for the unfermented and 24 h fermented 
palm wines, with the unfermented showing the best activities showing the best activity (IC50 = 
142.43 µg/mL). While, the 48 h fermented palm wine showed a dose dependent decrease. 
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Figure 3.3.3: Effect of raffia palm wine on (A) nitric oxide level and (B) myeloperoxidase activity 
in oxidative pancreatic injury. Values = mean ± SD; n = 3. *Significantly different from untreated 
sample and #Significantly different from normal sample (p < 0.05, Tukey’s HSD-multiple range 
post-hoc test, IBM SPSS for Windows). 
The ATPase activity of pancreatic tissues incubated with the palm wine samples was significantly 
(p<0.05) reduced compared to the increased activity on incubation with FeSO4 only as depicted in 
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Figure 3.3.4. The inhibitory effect was dose-dependent, with the unfermented palm wine showing 
the best activity (IC50 = 0.61 µg/mL). 
 
Figure 3.3.4: Effect of raffia palm wine on ATPase activity in oxidative pancreatic injury. Values 
= mean ± SD; n = 3. *Significantly different from untreated sample and #Significantly different 
from normal sample (p < 0.05, Tukey’s HSD-multiple range post-hoc test, IBM SPSS for 
Windows) 
LC-MS analysis of the palm wine samples revealed the presence of gallic acid, (±)-cystine, l-
proline, l-sscorbic acid, l-phenylalanine and UDP-β-l-arabinofuranose in all three samples as 
revealed in Figure 3.3.5 and Table 3.3.2. Aside compounds common to all samples, 19 
compounds were identified in the unfermented, while 7 and 3 compounds were identified in the 
24 and 48 hrs fermented respectively. Of the 7 additional compounds identified in the 24 h 
fermented sample, 5 were common to those identified in the unfermented. Phenolics were noted 
to be the predominant compounds in all samples. 
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Figure 3.3.5: LC-MS identified compounds common in unfermented and fermented raffia palm 
wines 
Oral toxicity prediction of the identified compounds showed all the compounds to fall on the class 
range from 4 – 6, except (±)-cystine and α-D-glucose 6-phosphate which had a toxicity class of 3 
as depicted in Table 3.3.2. 
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Table 3.3.2: LC-MS identified compounds of unfermented and fermented raffia palm wine and 
their predicted toxicity 
Peak 
No. 
Compounds Unfermented 
palm wine 
24 h 
fermented 
palm wine 
48 h 
fermented 
palm wine 
Predicted 
LD50 
(mg/kg) 
Predicted 
toxicity 
class 
105 Gallic acid X x x 2000 4 
115 Coumarin-4-carboxylic 
acid 
X x - 1691 4 
121 Hydroxycaffeic acid X -  2980 5 
122 Daucic acid X -  1238 4 
135 D-Lactic acid x x - 75 3 
143 (±)-Cystine x x x 156 3 
152 α-D-glucose 6-phosphate x x - 1500 4 
172 Luteic acid x -  3200 5 
173 Tartaric acid x -  1600 4 
192 L-Proline x x x 2078 5 
219 Caffeic acid x   2980 5 
221 L-Ascorbic acid x x x 3367 5 
242 L-Phenylalanine x x x 2400 5 
244 Oxalic acid x -  660 4 
262 Selenomethyl 
selenocysteine 
x x - 660 4 
290 UDP-β-L-
arabinofuranose 
x x x 16877 6 
293 7,4'-Dihydroxyflavone x x - 2500 5 
306 1-Methylnicotinamide 
iodide 
x - - 2500 5 
349 2,7,4'-
trihydroxyisoflavanone 
x - - 825 4 
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365 Dihydrokaempferol x - - 2000 4 
388 4-Hydroxybenzyl 
isothiocyanate 
rhamnoside 
x - - 3750 5 
393 Protocatechuic acid 4-
glucoside 
x - - 3750 5 
409 Gallic acid 3-glucoside x - - 2190 5 
476 Flavogallol x - - 945 4 
497 Gallocatechin gallate x - - 1000 4 
206 2-oxo-5-
methylthiopentanoate 
- x - 3478 5 
222 4-(1-Guanidino)butyric 
acid 
- x - 12680 6 
359 7,4'-Dimethoxyflavone - - x 4000 5 
384 3-(Methylseleno)alanine - - x 660 4 
400 Glutathioselenol - - x 5000 5 
Key: + = present; - = not present 
Analysis of the metabolites of the normal pancreatic tissues revealed the presence of amino acids, 
vitamins, glycolytic, nucleotide, sugar, pyruvate and inosine metabolic intermediates as shown in 
Table 3.3.3. Induction of oxidative stress led to depletion of most of these metabolites, with the 
generation of oxalacetic acid, 2-keto-glutaramic acid, 2-phospho-d-glyceric acid, kynurenic acid, 
iduronic acid, 3-sulfopyruvic acid, d-erythro-imidazole-glycerol-phosphate and 2-
carboxyarabinitol 5-phosphate metabolites. Treatment with the palm wine samples led to the 
generation of the lipid and adenosine metabolic intermediates, sugar and inositol phosphorylation 
intermediates, as well as generation of enzyme co-factors, selenium and ascorbic acid metabolites. 
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Table 3.3.3: LC-MS identified pancreatic metabolites  
Key: + = present; - = not present 
Metabolites Normal 
 
 
Untreated Unfermented palm 
wine Treated 
24 h 
fermented 
palm wine 
Treated 
48 h fermented 
palm wine Treated 
Lactaldehyde X –  –  –  – 
L-Cystine X X –  –  – 
Carbamoyl phosphate X –  –  –  – 
Glycolaldehyde X –  –  –  – 
2'-deoxycytidine 5'-triphosphate X –  –  –  – 
6-Thiourate X –  –  –  – 
Uridine 2',3'-cyclic phosphate X –  –  –  – 
3-Sulfopyruvic acid X –  –  –  – 
Pamidronate X X –  –  – 
3-Hydroxyphenylpyruvic acid X –  –  –  – 
Phosphatidylcholine O-34:2 X –  –  –  – 
6-Methylnicotinamide X X –  –  – 
Phosphoenolpyruvic acid X –  –  –  – 
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L-Selenocystathionine X –  –  –  – 
Uridine triphosphate X X –  –  – 
O-Phosphohomoserine X X –  –  – 
Glycyl-Threonine X X –  –  – 
Inosine triphosphate X X –  –  – 
3-Iodopropanoic acid X X X –  – 
Phosphohydroxypyruvic acid X –  –  –  – 
N-Acetylglutamine X –  –  –  – 
Mevalonic acid-5P X X –  –  – 
Cysteinyl-Cysteine X X –  –  – 
Dopamine 4-sulfate X  –  –  – 
Linoleic acid X X –  –  – 
5-Methylthioribulose 1-phosphate X X –  –  – 
Pyridoxine 5'-phosphate X X –  –  – 
PC(o-18:0/22:0) X X –  –  – 
Cysteinyl-Proline X X –  –  – 
D-Glucuronic acid 1-phosphate X X –  –  – 
N-Acetyl-L-tyrosine X X –  –  – 
Oxalacetic acid –  X –  –  – 
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2-Keto-glutaramic acid –  X –  –  – 
2-Phospho-D-glyceric acid –  X –  –  – 
Kynurenic acid –  X –  –  – 
Iduronic acid –  X –  –  – 
3-Sulfopyruvic acid –  X –  –  – 
D-Erythro-imidazole-glycerol-phosphate –  X –  –  – 
2-Carboxyarabinitol 5-phosphate –  X –  –  – 
Nicotinate D-ribonucleoside –  –  X – X 
Uridine 5'-diphosphate –  –  X X X 
Selenomethionine se-oxide –  –  X X X 
Adenosine phosphosulfate –  –  X X – 
2'-deoxycytidine 5'-triphosphate (dCTP) –  –  X – – 
(Cardiolipin(82:18)) –  –  X X  
TG(i-24:0/21:0/i-19:0) –  –  X X X 
TG(22:1(13Z)/20:4(5Z,8Z,11Z,14Z)/o-18:0) –  –  X X X 
Luteolin 3'-(4''-acetylglucuronide) –  –  X X X 
Adenosine tetraphosphate –  –  X X X 
UDP-L-iduronate –  –  X X X 
CL(i-13:0/i-22:0/i-12:0/i-14:0) –  –  X   
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CL(i-14:0/i-12:0/i-12:0/i-16:0) –  –  X X X 
1,4,6-Trigalloyl-beta-D-glucopyranose –  –  X –  – 
1D-myo-inositol 1,4-bisphosphate (4-) –  –  X –  – 
CL(20:4(5Z,8Z,11Z,14Z)/16:1(9Z)/ 
20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)) 
–  –  X X X 
Molybdopterin-AMP –  –  X X X 
cytidine 5'-diphosphate –  –  X X X 
3,4-Dihydro-3-hydroxy-4-S-glutathionyl 
bromobenzene 
–  –  X X X 
L-lysine –  –  X X X 
5-Phosphoribosylamine – –  –  X X 
Cysteic acid – –  –  X – 
L-Glutamic acid 5-phosphate – –  –  X – 
Diguanosine pentaphosphate – –  –  X X 
Ascorbic acid-2-sulfate – –  –  X – 
CL(i-13:0/i-21:0/i-17:0/i-14:0) – –  –  X – 
CL(16:1(9Z)/18:1(9Z)/16:0/16:0) –  –  –  X X 
Dihydroneopterin triphosphate – – – – X 
3-Bromotyrosine – – – – X 
Molybdenum cofactor – – – – X 
93 
 
Inositol 1,3,4,5,6-pentakisphosphate – – – – X 
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Pathway enrichment of the identified metabolites revealed an alteration of the glycine and serine 
metabolic pathway on induction of oxidative stress, with concomitant activation of the malate-
aspartate shuttle, citric acid cycle, transfer of acetyl groups into the mitochondria, and the alanine, 
tryptophan, tyrosine metabolic pathways (Figure 3.3.6 and Table 3.3.4). Treatment with the palm 
wine deactivated of the oxidative induced metabolic pathways, with concomitant activation of 
biotin, carnitine synthesis, sulfate/sulfite, androstenedione, estrone, lysine degradation, androgen 
and estrogen, nicotinate and nicotinamide, porphyrin, and sphingolipid metabolic pathways 
(Figure 3.3.6 and Table 3.3.4). Treatment with the 24 h fermented sample also led to the activation 
of taurine and hypotaurine metabolic pathway, while the 48 h fermented led to additional activation 
of the inositol phosphate, pterine biosynthesis, and inositol metabolic pathways. 
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Figure 3.3.6: Identified metabolic pathways of (A) normal pancreatic tissue; (B) oxidative injured 
pancreatic tissue; (C) unfermented; (D) 24 h fermented; and (E) 48 h fermented raffia palm wine 
treated oxidative injure pancreatic tissues. 
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Table 3.3.4: Identified metabolic pathways 
Metabolic Pathways Normal 
 
 
Untreated Unfermented palm wine 
Treated 
24 h fermented palm 
wine Treated 
48 h fermented palm wine 
Treated 
Vitamin B6 Metabolism  X X – – – 
Pyrimidine Metabolism   X X X X X 
Amino Sugar Metabolism  X X X X X 
Pyruvate Metabolism  X X – – – 
Alpha Linolenic Acid and Linoleic 
Acid Metabolism  
X X – – – 
Lactose Synthesis  X X X X X 
Nucleotide Sugars Metabolism  X X – – – 
Glycolysis  X X – – – 
Urea Cycle  X X –  – 
Sucrose Metabolism X X X X X 
Ammonia Recycling X  – – – 
Aspartate Metabolism  X X – – – 
Gluconeogenesis  X X – – – 
Galactose Metabolism  X X X X X 
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Steroid Biosynthesis  X X –   
Glutamate Metabolism X X – X X 
Arginine and Proline Metabolism  X X – – – 
Warburg Effect  X X – – – 
Glycine and Serine Metabolism X – – – – 
Purine Metabolism  X X – X X 
Malate-Aspartate Shuttle – X – – – 
Alanine Metabolism – X – – – 
Transfer of Acetyl Groups into 
Mitochondria 
– X – – – 
Citric Acid Cycle – X – – – 
Tryptophan Metabolism – X – – – 
Tyrosine Metabolism – X – – – 
Biotin Metabolism – – X X X 
Carnitine Synthesis – – X X X 
Sulfate/Sulfite Metabolism  – – X X – 
Androstenedione Metabolism – – X X – 
Estrone Metabolism – – X X X 
Lysine Degradation – – X X X 
Androgen and Estrogen Metabolism – – X X X 
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Nicotinate and Nicotinamide 
Metabolism  
– – X – X 
Porphyrin Metabolism – – X X X 
Sphingolipid Metabolism  – – X X X 
Taurine and Hypotaurine 
Metabolism 
– – – X – 
Inositol Phosphate Metabolism – – – – X 
Pterine Biosynthesis – – – – X 
Inositol Metabolism – – – – X 
Key: + = present; - = not present 
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3.3.5 Discussion 
The epidemy of diabetes with its cost of treatment are huge economic burden to the world 
particularly sub-Saharan Africa, with poor health infrastructures. This may account for Africa 
having the highest rate of diabetes mortality for ages below 60 years in 2017 despite the lowest 
number of people living with diabetes (I.D.F., 2018). Hence, the search for and development of 
affordable treatments with little or no side effects. This has led to a paradigm shift to natural 
products. In this study, we investigated the ability of raffia palm wine to arrest glucose diffusion 
as well as mitigate pancreatic oxidative stress and the possible metabolic pathways that may be 
involved. 
Glucose uptake particularly in muscles have been demonstrated to be a potent antidiabetic 
mechanism, as its stimulation leads to reduced blood glucose levels and improves insulin 
sensitivity (Satoh 2014). Several studies have used the yeast cell as an in vitro model for studying 
glucose uptake (Nirupama et al. 2014; Sairam and Urooj 2013). In these studies, the authors 
correlated the yeast glucose uptake with antidiabetic potentials. Thus, the ability of raffia palm 
wine to enhance glucose uptake in yeast cells (Figure 3.3.1A) demonstrates a muscle glucose 
uptake enhancing potential.  
Inhibition of glucose transportation across the cell membrane has been shown as a potent 
mechanism for reducing blood glucose level (Nirupama et al. 2014), thus implying that the ability 
of the palm wine samples to inhibit glucose diffusion across the dialysis membrane (Figure 
3.3.1B) demonstrates a hypoglycemic potential. 
The pancreatic tissues have been reported to be very low in endogenous antioxidant concentration 
particularly the SOD and catalase enzymes (Pi et al. 2010; Tiedge et al. 1997), making them very 
prone to oxidative damage. The decreased and increased levels of GSH and MDA respectively, 
and activities of SOD and catalase in the untreated tissues indicates an occurrence of oxidative 
stress (Figure 3.3.2). This is further evident by the activation of the citric acid cycle (Figure 3.3.6B 
and Table 3.3.4) leading to the formation of the citric acid intermediates: oxalacetic acid and 2-
Keto-glutaramic acid (Table 3.3.3). The continuous drive of the citric acid and the concomitant 
generation of these intermediates leads to an increased accumulation of the electron donors, 
NADH and FADH2 (Brownlee 2001). Activation of the transfer of acetyl groups into the 
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mitochondria in the untreated pancreatic oxidative tissue (Figure 3.3.6B and Table 3.3.4), also 
corroborates an occurrence of oxidative stress as electron donors are generated by acylCoA 
dehydrogenase (ACAD) and electron transfer flavoprotein (ETF) (Quijano et al. 2016). 
Metabolism of alanine, tryptophan, and tyrosine also fuels the citric acid cycle by providing 
intermediates, thus further driving the cycle with concomitant generation of electron donors. The 
activation of these pathways will lead to accumulation of electron donors and may be responsible 
for the activation of the malate-aspartate shuttle (Figure 3.3.6B and Table 3.3.4) via which the 
electrons are translocated to the mitochondria (Fernie et al. 2004). Once in the mitochondria, these 
electron donors trigger a high mitochondrial membrane potential, which inhibits electron transport 
at complex II with concomitant reduction of oxygen to (O2) to superoxide (O2.
-) (Brownlee 2001; 
Du et al. 2001). 
The generated superoxide radical (O2
. –) is dismutated to hydrogen peroxide (H2O2) by SOD, which 
is then converted to oxygen and water in a reaction catalyzed by catalase. If not broken down by 
catalase, the generated H2O2 will be broken down to hydroxy radicals (
•OH). Hydroxyl radicals 
have been recognized as the key starter of membrane lipid peroxidation (Aslan et al. 2000). H2O2 
also serves as a substrate for the enzyme, myeloperoxidase which converts it to HOCl- (Furtmüller 
et al. 2000). Nitric oxide can react with O2
. – to generate peroxynitrate (ONOO-). Accumulation of 
HOCl- and ONOO- will lead to proinflammation. Thus, implying that the increased NO level and 
myeloperoxidase activity in the untreated pancreatic oxidative tissues (Figure 3.3.2) portrays an 
occurrence of proinflammation.  
The increased SOD, catalase, myeloperoxidase activities as well as decreased levels of MDA and 
NO in the palm wine treated tissues, therefore indicate antioxidative and anti-proinflammatory 
potentials of raffia palm wine (Figures 3.3.2 and 3.3.3). These activities can be attributed to the 
LC-MS identified compounds particularly the polyphenols and ascorbic acid which have been 
reported for their potent antioxidant and anti-inflammatory activities (Klimczak et al. 2007). This 
is further evident by the presence of their metabolites (Table 3.3.3) and deactivation of the electron 
donor generating pathways (Table 3.3.4).  
Carnitine has been reported for its free radical and antioxidative activities in cells (Gülcin 2006; 
Kolodziejczyk et al. 2011; Ribas et al. 2014), thus activation of its synthesis in pancreatic tissues 
treated with the palm wine samples (Table 3.3.4) may portray an increased antioxidative effective 
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owing to concomitant increased level of cellular carnitine. The antioxidant protective effect of the 
palm wine samples against oxidative pancreatic tissues is also evident by the activation of 
metabolism of the sex hormones, androgen and estrogen. The receptors of these hormones have 
been reported in pancreatic tissues, and dysregulation of their metabolism have been implicated in 
pancreatitis and pancreatic β – cell proliferation in diabetes (Corbishley et al. 1986; Fernández-del 
et al. 1990; Li et al. 2008). These hormones have also been shown to modulate antioxidant enzyme 
activities (Bellanti et al. 2013). Similarly, activation of the B vitamins metabolism as well as that 
of sulfate/sulfite (Figure 3.3.6 and Table 3.3.4) portrays increased antioxidant activities as well 
as generation of essential cofactors required for DNA repair and antioxidant enzyme activities 
(Kamat and Devasagayam 1999; Mukwevho et al. 2014; Sauve 2008). The antioxidant and 
antidiabetic properties of inositol and its phosphates have been demonstrated (Foster et al. 2017; 
Özturan et al. 2017; Phillippy and Graf 1997). Thus, activation of their metabolism by the 48 h 
fermented sample (Figures 3.3.6E and Table 3.3.4) further indicates an antioxidant and 
antidiabetic potential. 
The increased ATPase activity in the untreated oxidative pancreatic tissue (Figure 3.3.4) indicates 
an impaired depolarization of the β – cell membrane (Erukainure et al. 2017). Depolarization of 
the β – cell membrane has been correlated with decreased ATPase activity, leading to the influx 
of Ca2+ which is a major mechanism involved in insulin secretion (Costa et al. 2010; Owada et al. 
1999). Thus, the decreased activity on treating with palm wine samples may indicate a therapeutic 
benefit in the treatment and management of diabetes and its complications. The increasing activity 
in tissues treated with the 48 h fermented sample, may suggest caution in its usage at high 
concentrations.   
3.3.6 Conclusion 
These results suggest the antidiabetic and antioxidative effects of unfermented and fermented 
raffia palm wine as evident by their ability to inhibit glucose diffusion and promote glucose uptake, 
as well as increase the antioxidant enzyme activities while depleting the levels of MDA, NO and 
myeloperoxidase activity. This is further evident by the inhibition of metabolic pathways involved 
in free radical generation, and activation of pathways involved in antioxidant activities. Thus, 
giving credence to the traditional use of this drink in the treatment and management of diabetes 
and its complications amongst other diseases. 
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3.4 Raffia Palm (Raphia hookeri) Wine Modulates Glucose Homeostasis by 
Enhancing Insulin Secretion; Inhibiting Redox Imbalance, Glycolytic and 
Cholinergic Enzymes Activities; and Downregulates Pancreatic Nrf2 
Expression in Type 2 Diabetic Rats 
1,3Ochuko L. Erukainure, 1Olajumoke A. Oyebode,4Omamuyovwi M. Ijomone, 5Chika I. 
Chukwuma, 2Neil A. Koorbanally, 1Md. Shahidul Islam* 
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Preface: This article investigated the antidiabetic effect of Raffia palm wine in type 2 diabetic rats. 
Its antioxidative, anti-proinflammatory, antilipemic and insulin stimulatory effects were 
investigated. Its inhibitory effect on glycolytic, cholinergic and carbohydrate digesting enzymes 
were also investigated. Its ability to inhibit Nrf2 expression was also investigated. The article 
presently under review for publication in Chemico-Biological Interactions 
(CHEMBIOINT_2018_1532). 
3.4.1 Abstract 
The antidiabetic effect of Raffia palm (Raphia hookeri) wine (RPW) and its possible mechanism 
of action were investigated in a type 2 diabetes (T2D) model or rats. Diabetes was induced in the 
four groups of male albino rats (Sprague-Dawley) by supplying 10% fructose solution ad libitum 
for first 2 weeks followed by an intraperitonial injection of streptozotocin (40 mg/kg bw). Two 
diabetic groups were administered RPW at 150 and 300 mg/kg bodyweight (bw) respectively, a 
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group were administered with metformin (200 mg/kg bw), while the other group was untreated 
and served as negative control. Two other groups of normal rats were administered water and RPW 
(300 mg/kg bw), with the former serving as normal control and the latter, normal toxicological 
group. After 5 weeks of intervention, treatment with RPW led to significant (p<0.05) increase in 
serum insulin and HDL-cholesterol levels with concomitant reduction in blood glucose, 
fructosamine, ALT, uric acid, triglycerides and LDL-cholesterol levels in T2D rats. Rats treated 
with RPW had elevated levels of GSH, SOD, catalase, ATPase and α-amylase activities, while 
reducing NO level and myeloperoxidase activity was observed in both serum and pancreatic 
tissues. RPW also caused an improved β-cell function as well as restored pancreatic β-cells and 
acinar cells morphology, and capillary networks. The activities of glycogen phosphorylase, 
fructose-1,6-biphosphatase, glucose-6-phosphatase, and acetylcholinesterase activities were also 
inhibited in RPW-treated T2D rats, with concomitant downregulation of Nrf2 expression. These 
results indicate the antidiabetic effect of RPW, which may be attributed to the synergetic influence 
of its phytochemical constituents identified in this study by GC-MS analysis.  
Keywords: Dyslipidemia; Glycolytic enzymes; Nrf2; Pancreatic β-cell; Type 2 diabetes;  
3.4.2 Introduction 
Diabetes mellitus (DM) is amongst the fastest growing global epidemic, with over 425 million 
people estimated to be diabetic in 2017 (Cho et al. 2018; I.D.F. 2018). This estimation portrays a 
2.35% increase from 2015 estimates (I.D.F. 2016; Ogurtsova et al. 2017). The International 
Diabetic Federation (IDF) further projected a 35.35% increase in the number of people that will 
be diabetic by 2045 (Cho et al. 2018; I.D.F. 2018).  
Diabetes affects carbohydrate, protein and lipid metabolism, leading to increase blood glucose 
level. This has been attributed to inability of the pancreatic β-cells to secrete insulin and/or inability 
of the body to utilize the secreted insulin (Erukainure et al. 2018a). The former condition is referred 
to as type 1 diabetes (T1D), while the latter, type 2 diabetes (T2D). Of these diabetes types, T2D 
is the most prevalent as it accounts for more than 90% of all diabetic cases as well as morbidity 
and mortality (I.D.F. 2016; I.D.F. 2018). Pancreatic β-cell dysfunction and insulin resistance have 
been implicated in the progression of T2D, leading to chronic hyperglycemia and dyslipidemia 
(Bardini et al. 2012; DeFronzo and Ferrannini 1991; Kahn 2003). An increased oxidative stress 
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has been reported in chronic hyperglycemia, and has been recognized as a major player in the 
pathogenesis and progression of complications associated with T2D (Evans et al. 2002; Giacco 
and Brownlee 2010). Oxidative stress occurs when the body’s endogenous antioxidant defense 
system is suppressed by increased generation of free radicals. In T2D, the generation of these free 
radicals is increased owing to continuous glucose oxidation (Maritim et al. 2003b; Tiwari et al. 
2013a).  
Antioxidants have been demonstrated in several pre-clinical and clinical studies to ameliorate and 
manage oxidative-complications in diabetes (Sabu and Kuttan 2002; Tiong et al. 2013). This has 
been attributed to their ability to scavenge free radicals, as well as enhance the endogenous 
antioxidant activities. Medicinal plants have been reported for their antioxidant and hypoglycemic 
activities, which have been attributed to their nutritional and phytochemical constituents 
(Erukainure et al. 2017b). Their availability and affordability, as well as little or no side effects 
compared to synthetic drugs have led to increase in the use of medicinal plants in the treatment 
and management of several ailments. 
Although Raffia palm wine is used traditionally in treating DM and its complications, there are 
still scientific dearth of its antidiabetic properties. Thus, the study was undertaken to investigate 
its antidiabetic properties in fructose-streptozotocin induced T2D rats. Its inhibitory effect on key 
glycolytic, cholinergic and carbohydrate digesting enzymes were also investigated as well as its 
modulatory effect on pancreatic oxidative injury, and morphology. Additionally, its ability to alter 
the expressions of nuclear factor erythroid 2–related factor 2 (Nrf2) and caspase-3 were also 
investigated. 
3.4.3 Materials and Methods 
Kindly refer to Chapter 2, subsections 2.1.1; 2.1.3; 2.10.1; 2.12 – 2.13 for details materials and 
methods.  
3.4.4 Results 
As shown in Figure 3.4.1A, induction of T2D led to a significant (p<0.05) decrease in body 
weights of diabetic groups. Increase in body weights were observed in all treatment groups as the 
intervention period proceeded, with rats treated with low dose of Raffia palm wine having the 
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highest weight gain. The body weights of the diabetic control (DC) were significantly (p<0.05) 
reduced as the intervention period proceeded. There was a significant (p<0.05) increase in food 
and fluid intake in all diabetic groups, with the DC having the highest intake as depicted in Figure 
3.4.1B. There was a significant (p<0.05) decrease in the weight and relative weight of the pancreas 
in the untreated diabetic rats (Figure 3.4.1C). These were slightly increased in diabetic rats treated 
with Raffia palm wine. 
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Figure 3.4.1: (A) Body weight; (B) feed and fluid intake; and (C) weight and relative weight of 
pancreas of experimental groups. Values = mean ± SD; n = 5 (NC and PHD) and 7 (DC, DSG-
LD, DSM, and DG). *Statistically (p<0.05) significant to DC, #statistically significant (p<0.05) to 
NC. NC = normal rats, DC = diabetic control, DSG-LD = diabetic rats + Raffia palm wine (150 
g/kg bw), DSG = diabetic rats + Raffia palm wine (300 g/kg bw), DSM = diabetic rats + metformin 
(200 g/kg bw), and PHD = Normal rats + Raffia palm wine (300 g/kg bw).                                                                                                                                                                                                          
Induction of T2D led to significant increase in blood glucose level as shown in Figure 3.4.2A. 
These were reduced in all treatment groups, with Raffia palm wine showing significant (p<0.05) 
reduction as both doses led to 44.29 and 53.57% reduction respectively, with fasting blood glucose 
was measured only at week 5.  
There was a significant (p<0.05) increase in blood glucose levels of all the experimental animals 
at 30 min after oral dosing with glucose (2 g/kg BW), indicating a peak rise (Figure 3.4.2B). The 
glucose level reduced with increasing time for all groups, with the lowest levels recorded at 120 
min. 
Induction of T2D led to significant (p<0.05) reduction in serum insulin level, with concomitant 
reduction in pancreatic β-cell function as shown in Fig. 2C. The insulin level was significantly 
(p<0.05) increased to near normal in rats treated with low dose of Raffia palm wine, with a 93.14% 
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increase in pancreatic β-cell function (Figure 3.4.2C). Treatment with high dose of Raffia palm 
wine also led to a significant increase in serum insulin level, with concomitant increase (88.29%) 
in pancreatic β-cell function. Both serum insulin and pancreatic β-cell function were slightly but 
significantly (p<0.05) increased in metformin-treated rats. Administration of Raffia palm wine to 
normal rats, led to a significant (p<0.05) reduction in serum insulin level (51.40%) and pancreatic 
β-cell function when compared to the normal control (NC).  
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Figure 3.4.2: (A) Blood glucose level; (B) oral glucose tolerance; and (C) serum insulin and β-
cell function of experimental groups. Values = mean ± SD; n = 5 (NC and PHD) and 7 (DC, DSG-
LD, DSM, and DG). *Statistically (p<0.05) significant from DC, #statistically significant (p<0.05) 
from NC. NC = normal rats, DC = diabetic control, DSG-LD = diabetic rats + Raffia palm wine 
(150 g/kg bw), DSG = diabetic rats + Raffia palm wine (300 g/kg bw), DSM = diabetic rats + 
metformin (200 g/kg bw), and PHD = Normal rats + Raffia palm wine (300 g/kg bw).                                                                                                                                                                                                          
As shown in Figure 3.4.3, there was no significant difference in the total cholesterol (TC) levels 
of all the experimental groups. However, induction of T2D led to a significant (p<0.05) increase 
in triglycerides (TG), LDL-C, and concomitant decrease in HDL-C levels. These were 
significantly (p<0.05) reversed in all the treatment groups, with rats treated with low dose of Raffia 
palm wine showing the best results. 
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Figure 3.4.3: Serum lipid profile of experimental groups. Values = mean ± SD; n = 5 (NC and 
PHD) and 7 (DC, DSG-LD, and DG). *Statistically (p<0.05) significant from DC, #statistically 
significant (p<0.05) from NC. NC = normal rats, DC = diabetic control, DSG-LD = diabetic rats 
+ Raffia palm wine (150 g/kg bw), DSG = diabetic rats + Raffia palm wine (300 g/kg bw), DSM 
= diabetic rats + metformin (200 g/kg bw), and PHD = Normal rats + Raffia palm wine (300 g/kg 
bw).                                                                                                                                                                                                          
Induction of T2D led to significant increase in serum and pancreatic α-amylase activities as 
depicted in Table 3.4.1. These were significantly (p<0.05) decreased in all treatment groups, with 
metformin showing the best result. Among the Raffia palm wine treated diabetic groups, the high 
dose had the best decreasing activity for serum α-amylase, while the low dose was best for 
pancreatic α-amylase.  
There was also a significant (p<0.05) decrease in serum ATPase activity, with concomitant and 
significant (p<0.05) increase in pancreatic ATPase activity (Table 3.4.1). These were significantly 
(p<0.05) reversed in all treatment group, with low dose of Raffia palm wine and metformin having 
the best activities for serum and pancreatic ATPase respectively. 
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As shown in Table 3.4.1, the significant (p<0.05) increased acetylcholinesterase activity on 
induction of T2D was significantly decreased in all treatment group, except for rats treated with 
low dose of Raffia palm wine which had little or no effect on the activity. 
Induction of T2D led to significant increase in the activities of the studied glycolytic enzymes as 
shown in Table 3.4.1. Their activities were (p<0.05) significantly decreased in all the treatment 
groups, with the Raffia palm wine treated groups having the best results. 
There was a significant (p<0.05) increase in NO and MDA levels and myeloperoxidase activity, 
with concomitant decrease in SOD and catalase activities and GSH level in both serum and 
pancreatic tissues on induction of T2D as shown in Table 3.4.2, indicating an occurrence of 
oxidative stress. These were significantly (p<0.05) reversed in all the treatment groups. 
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Table 3.4.1: Enzyme activities of experimental groups. 
Enzyme Activities NC DC DSG-LD DSG DSM PHD 
Serum α-amylase 25.38±3.50* 72.36±4.25# 59.41±5.56# 64.73±3.19# 41.57±9.53* 37.42±4.39* 
Pancreatic α-amylase 46.90±4.25* 89.72±4.21# 56.80±2.16# 41.81±4.80* 28.02±3.37* 19.44±3.27* 
Serum ATPase 279.18±5.60* 201.24±17.89# 340.33±4.52* 287.86±15.08* 241.92±12.42* 259.67±6.12* 
Pancreatic ATPase 144.35±21.59* 234.49±7.781# 136.24±15.86* 194.76±14.36# 103.95±14.28* 84.85±13.75* 
Acetylcholinesterase  29.56±3.24* 44.20±3.24# 41.33±3.25# 24.68±3.03* 22.96±3.76* 21.81±2.84* 
Glycogen Phosphorylase 174.22±9.98* 209.89±17.50# 146.92±6.10* 164.76±12.98* 169.35±24.65* 152.19±7.98* 
Fructose 1,6 Biphosphatase 177.19±7.93* 247.46±9.90# 163.41±6.03* 155.57±1.15* 191.78±19.49* 149.35±10.32* 
Glucose 6 Phosphatase 153.68±3.06* 223.14±12.03# 164.22±7.62* 168.54±4.87* 176.92±23.96* 139.08±15.29* 
Values = mean ± SD; n = 5 (NC and PHD) and 7 (DC, DSG-LD, DSM, and DG). *Statistically (p<0.05) significant from DC, 
#statistically significant (p<0.05) from NC. NC = normal rats, DC = diabetic control, DSG-LD = diabetic rats + Raffia palm wine (150 
g/kg bw), DSG = diabetic rats + Raffia palm wine (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and PHD = Normal 
rats + Raffia palm wine (300 g/kg bw).                                                                                                                                                                                                          
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Table 3.4.2: Antioxidant status of (A) serum and (B) pancreas of experimental groups 
(A) 
 GSH  
(mol/L) 
SOD  
(U/mg protein) 
Catalase  
(U/mg protein) 
MDA 
(mol/L) 
NO (µml) Myeloperoxidase  
(U/mg protein) 
NC 64.28±11.90* 86.21±8.13* 636.37±29.48* 63.09±4.57* 0.075±0.006* 100.27±9.68* 
DC 36.65±2.47# 40.23±3.32# 490.64±42.75# 71.19±4.52# 0.102±0.007# 121.08±18.63# 
DSG-LD 55.35±3.24* 71.84±2.44* 584.35±29.37* 53.11±6.48* 0.04±0.007* 67.32±5.75* 
DSG 51.16±7.29* 64.66±3.5* 636.37±29.48* 52.54±7.16* 0.044±0.007# 35.99±6.36* 
DSM 53.31±2.27* 68.97±8.78* 650.50±4.82* 50.09±9.53* 0.053±0.008* 47.44±1.53* 
PHD 40.19±3.55# 34.48±8.30# 687.69±21.84* 41.24±6.79* 0.039±0.004# 66.67±5.60* 
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(B) 
 GSH 
(mol/L) 
SOD  
(U/mg protein) 
Catalase  
(U/mg protein) 
MDA 
(mol/L) 
NO (µml) Myeloperoxidase  
(U/mg protein) 
NC 104.87±3.09* 659.96±57.9* 783.32±28.21* 40.96±5.79* 0.24±0.02* 20.31±5.75* 
DC 54.06±5.01# 150.86±10.6# 711.48±34.46# 71.75±3.60# 0.70±0.02# 35.35±3.61# 
DSG-LD 72.45±5.47* 580.46±20.31* 779.71±26.9* 42.66±5.59* 0.27±0.02* 19.49±1.83* 
DSG 85.35±7.75* 647.99±58.92* 750.02±59.56* 48.02±7.69* 0.27±0.01* 21.29±1.89* 
DSM 51.80±6.38# 583.33±31.8* 754.29±40.8* 55.08±5.99* 0.34±0.03* 17.85±1.81* 
PHD 46.64±3.94*# 655.17±6.09* 772.80±17.76* 43.64±7.39* 0.17±0.02* 16.30±2.89* 
Values = mean ± SD; n = n = 5 (NC and PHD) and 7 (DC, DSG-LD, DSM, and DG). *Statistically (p<0.05) significant from DC, 
#statistically significant (p<0.05) from NC. NC = normal rats, DC = diabetic control, DSG-LD = diabetic rats + Raffia palm wine (150 
g/kg bw), DSG = diabetic rats + Raffia palm wine (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and PHD = Normal 
rats + Raffia palm wine (300 g/kg bw).                                                                                                                                                                                                          
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Table 3.4.3: Toxicity biomarkers of experimental groups 
Enzyme Activities NC DC DSG-LD DSG DSM PHD 
ALP U/L 101.00±5.55* 1235.00±29.88# 558.00±10.89* 523.00±46.67* 582.33±10.67* 133.00±1.41* 
ALT U/L 91.00±4.24 87.50±0.71 84.00±2.58 86.00±1.41 88.00±3.20 87.33±1.15 
CK-MB U/L 625.00±15.80* 959.00±25.10# 572.75±14.42* 813.70±68.45# 739.40±12.89# 478.00±10.73* 
Fructosamine mg/dL 656.00±12.6* 743.00±15.56# 702.00±17.21* 686.00±21.11# 658.50±12.02* 506.67±12.728* 
Urea mg/dL 58.00±0.71 46.00±5.67 37.00±4.51# 36.00±4.8# 31.50±6.81# 61.00±2.89 
Uric acid mg/dL 2.46±0.24 3.48±0.70 2.85±0.475 2.87±0.18 1.60±0.23*# 2.81±0.66 
Values = mean ± SD; n = n = 5 (NC and PHD) and 7 (DC, DSG-LD, and DG). *Statistically (p<0.05) significant to DC, #statistically 
significant (p<0.05) to NC. NC = normal rats, DC = diabetic control, DSG-LD = diabetic rats + Raffia palm wine (150 g/kg bw), DSG 
= diabetic rats + Raffia palm wine (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and PHD = Normal rats + Raffia 
palm wine (300 g/kg bw).                                                                                                                                                                                                          
 
115 
 
Induction of T2D led to increase serum level of ALP, CK-MB, fructosamine and uric acid as 
depicted in Table 3.4.3. These levels were significantly (p<0.05) reduced in all the treatment 
groups. Induction of T2D had a little or no effect on serum levels of ALT and urea. However, the 
urea levels of the treatment groups were significantly reduced compared to the normal and diabetic 
control groups, respectively (Table 3.4.3). However, the administration of Raffia palm wine to 
normal rats (PHD) caused an increase in serum urea level. 
Figure 3.4.4A reveals intact β-cells, acinar cells and intralobular ducts in the pancreatic tissue of 
the normal control (NC). The intact morphology was however altered on induction of T2D as 
depicted by the decreased number of acinar and normal β-cells, and increased number of inflamed 
β-cells (red coloured) (Figure 3.4.4B). Treatment with the Raffia palm wine led to the restoration 
of normal pancreatic tissue morphology (Figures 3.4.4C and 3.4.4D), with the low dose treated 
rats showing near normal intactness (Figure 3.4.4C). Treatment with metformin led to a slight 
increase in the number of β-cells but its morphology was altered (Figure 3.4.4E). 
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Figure 3.4.4: Morphological changes in pancreatic tissues of experimental groups. Magnification: 
10x. (A) = NC, (B) = DC, (C) = DSG-LD, (D) = DSG, (E) = DSM, and (F) = PHD. NC = normal 
rats, DC = diabetic control, DSG-LD = diabetic rats + Raffia palm wine (150 g/kg bw), DSG = 
diabetic rats + Raffia palm wine (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), 
and PHD = Normal rats + Raffia palm wine (300 g/kg bw). Black arrow: normal β-cells; Green 
arrow: inflamed β-cells; and Blue arrow: slightly altered β-cells morphology                                                                                                                                                                                                         
SEM analysis of the pancreatic tissue revealed clusters of the exocrine cells, acini as shown in Fig. 
5A. On the surface of the cell clusters were rich networks of capillaries. These networks were 
however altered in the diabetic tissue, making the acini cell clusters conspicuous as depicted in 
Fig. 5B. The acini cells of the diabetic tissue were also enlarged compared to the normal. Treatment 
with Raffia palm wine led to restoration of the capillaries network (Figures 3.4.5C and 3.4.5D), 
with the high dose showing a reduced acini cell size (Figure 3.4.5D). The tissue from the 
metformin treated group (DSM) revealed a much-restored capillary network (Figure 3.4.5E). 
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While the pancreatic acini cells of normal rats administered Raffia palm wine were enlarged and 
conspicuous, with less capillary networks (Figure 3.4.5F). 
 
Figure 3.4.5: Electron microscopy of pancreatic tissues of experimental groups. Magnification = 
1000x. (A) = NC, (B) = DC, (C) = DSG-LD, (D) = DSG, (E) = DSM, and (F) = PHD. NC = normal 
rats, DC = diabetic control, DSG-LD = diabetic rats + Raffia palm wine (150 g/kg bw), DSG = 
diabetic rats + Raffia palm wine (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), 
and PHD = Normal rats + Raffia palm wine (300 g/kg bw). Arrow: Black = blood vessels; Red = 
acini                                                                                                                                                                                                   
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Induction of T2D led to upregulation of caspase-3 expression although not significant as shown in 
Figures 3.4.6B and 3.4.6G. The expression was rather slightly increased (not significant) in 
diabetic rats treated with Raffia palm wine (Figures 3.4.6C, 3.46D and 3.4.6G).  
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Figure 3.4.6: Immunohistochemistry photomicrographs of caspase3 expression in pancreatic 
tissues of experimental groups. Magnification = 200x; (A) = NC, (B) = DC, (C) = DSG-LD, (D) 
= DSG, (E) = DSM, and (F) = PHD. NC = normal rats, DC = diabetic control, DSG-LD = diabetic 
rats + Raffia palm wine (150 g/kg bw), DSG = diabetic rats + Raffia palm wine (300 g/kg bw), 
DSM = diabetic rats + metformin (200 g/kg bw), and PHD = Normal rats + Raffia palm wine (300 
g/kg bw). Arrow: β-cells                                                                                                                                                                                                         
There was also an upregulation of Nrf2 expression in the pancreatic tissues on induction of T2D 
as shown in Figures 3.4.7B and 3.4.7G. This was however significantly (p<0.05) inhibited in 
diabetic rats treated with both doses of Raffia palm wine as shown in Figures 3.4.7C, 3.4.7D and 
3.4.7G. Administration of Raffia palm wine did not increase the expression in pancreatic tissues 
of normal rats (Figure 3.4.7F and 3.4.7G). 
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Figure 3.4.7: Immunohistochemistry photomicrographs of Nrf2 expression in pancreatic tissues 
of experimental groups. Magnification = 200x; (A) = NC, (B) = DC, (C) = DSG-LD, (D) = DSG, 
(E) = DSM, (F) = PHD, and (G) = Immunoreactivity of Nrf2 expression (Values = mean ± SD; n 
= 5 (NC and PHD) and 7 (DC, DSG-LD, and DG);  *Statistically (p<0.05) significant to DC, 
#statistically significant (p<0.05) to NC). NC = normal rats, DC = diabetic control, DSG-LD = 
diabetic rats + Raffia palm wine (150 g/kg bw), DSG = diabetic rats + Raffia palm wine (300 g/kg 
bw), DSM = diabetic rats + metformin (200 g/kg bw), and PHD = Normal rats + Raffia palm wine 
(300 g/kg bw). Arrow: β-cells                                                                                                                                                                                                          
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GC-MS analysis of Raffia palm wine revealed the presence of sugars, phenolics, glycosides 
alkaloids, and fatty acids as shown in Table 3.4.4. 
Table 3.4.4: GC-MS identified compounds in Raffia palm wine 
Retention time Compounds A/H 
6.59 Ethyl 1-thio-alpha-d-arabinofuranoside 2.15 
6.69 Glycerin 6.73 
7.96 Valeric acid, 3,5-dihydroxy-2,4-dimethyl-, .delta.-lactone 3.50 
8.83 5-Keto-D-fructose 5.22 
9.05 L-Erythro-ascorbate 3.4 
9.33 Catechol 2.50 
10.27 Nonadecanoic acid 1.78 
10.77 beta.-d-Lyxofuranoside, O-nonyl- 4.77 
11.29 1-Deoxy-d-arabitol 7.03 
11.67 2-Hydroxyoctanoic acid 3.48 
12.02 Biphenyl 1.82 
12.81 Methyl 8-(5-octyl-1,2,4-trioxolan-3-yl)octanoate 3.24 
12.87 Echinopsine 1.79 
13.15 Cymarin 2.70 
14.13 Dodecanoic aci 1.59 
15.31 3-Deoxy-d-mannoic lactone 7.65 
16.43 Tetradecanoic acid 1.79 
17.35 d-Methyl-1-fucoside 3.90 
17.49 Quinic acid 2.78 
17.87 d-Mannitol, 1-O-hexyl- 5.89 
18.32 Palmitoleic acid 2.53 
18.54 l-(+)-Ascorbic acid 2,6-dihexadecanoate 1.74 
18.90 Myo-inositol 0.83 
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20.45 Octadecanoic acid 1.77 
25.67 Squalene 1.55 
*A = peak area; H = peak height 
3.4.5 Discussion  
The cost of treating diabetes is of tremendous concern coupled with its rising epidemic. These can 
be described as a double-edged sword particularly for most developing countries who are 
struggling with other non-communicable diseases such as malaria and HIV/AIDS, with little or no 
proper health infrastructures. Hence, the search and development of novel and/or traditionally-
recognized treatment alternatives particularly from plants. Africa is well known for the richness of 
her indigenous flora, which have vastly contributed to her traditional health system. Despite the 
endemicity of this flora and the traditional health system, some of these plants are yet to be 
scientifically authenticated for their acclaimed folkloric use. In this study, we investigated the 
ability of Raffia palm wine to reduce blood glucose level in T2D rats as well as the possible 
mechanism involved. 
Studies have reported polyphagia, polydipsia, and body weight loss as major symptoms and signs 
of DM (Ibrahim et al. 2016; Okon et al. 2012), which is consistent with the weight loss and 
concomitant increased food and fluid intake after induction of T2D in the present study (Figures 
3.4.1A and 3.4.1B). The reduced food and fluid intake, and weight gain in the treatment groups, 
may indicate a therapeutic role of Raffia palm wine against T2D-induced polyphagia, polydipsia, 
and weight loss. 
Chronic hyperglycemia has been recognized as the hallmark of T2D and has also been attributed 
to decreased pancreatic β-cell mass and number leading to β-cell dysfunction and insulin 
insufficiency (Donath and Halban 2004). This corresponds with the increased blood glucose level 
(Figure 3.4.2A), decreased pancreas weight (Figure 3.4.1C), reduced serum insulin level and 
pancreatic β-cell function (Figure 3.4.2C) in the diabetic control (DC). This also corroborates the 
depleted β-cells as revealed by histological analysis of the pancreas (Figure 3.4.4B), thus 
demonstrating an occurrence of T2D. The reduced blood glucose levels in the treatment groups, 
particularly the Raffia palm wine treated rats portrays an anti-hyperglycemia activity. The ability 
of both doses of Raffia palm wine to increase serum insulin level (Figure 3.4.2C), improve 
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pancreatic β-cell function (Figure 3.4.2C), as well as regeneration of pancreatic β-cells (Figure 
3.4.4B) further demonstrates their therapeutic effect in the treatment and management of T2D.  
This is further evident by the improved glucose tolerance in the Raffia palm wine treated rats 
(DSG-LD and DSG) (Figure 3.4.2B). This corroborates previous report on the low glycemic index 
of Raffia palm wine (Oboh et al. 2011). This corresponds with reported antidiabetic mechanisms 
of several medicinal plants which bring about their activity by instigating pancreatic β-cell 
regeneration and/or insulinotropic action (Erukainure et al. 2015b; Ibrahim et al. 2016; Islam and 
Choi 2007). 
Increased glycogenolysis, gluconeogenesis and glycolysis have been reported in T2D (Clore et al. 
2000; Guo et al. 2012; Wu et al. 2005). This has been attributed to activation of key enzymes 
involved in these pathways. Increased glycogenolysis and gluconeogenesis in T2D leads to the 
continuous production of glucose from glycogen and non-carbohydrate, thereby exacerbating 
hyperglycemia. While increased glycolysis could lead to the generation of metabolites for the 
hexosamine, polyol, protein kinase C, and AGE pathways which have been linked to the 
pathogenesis of T2D (Luo et al. 2016; Rolo and Palmeira 2006). The elevated activities of 
glycogen phosphorylase and fructose 1,6 biphosphatase in the diabetic control (DC) group (Table 
3.4.1), insinuates glycogenolytic and gluconeogenetic activities respectively, which correlates 
with the elevated blood glucose level (Figure 3.4.2A). While an elevated glycolysis in DC is 
portrayed by the increased activities of glucose 6 phosphatase. The increased activities of these 
enzymes can also be attributed to insufficient insulin secretion by the pancreatic β-cell as seen in 
DC (Figure 3.4.2C), as insulin has been reported for its glycogenic activity (Cersosimo et al. 2018; 
Gardner et al. 1993). The decreased activities of these enzymes in the treatment groups correlates 
with the reduced blood glucose levels (Figure 3.4.2A) and serum insulin level (Figure 3.4.2C). 
These also portrays an antidiabetic potential of Raffia palm wine. 
The role of pancreatic α-amylase in elevated postprandial glucose level is well documented 
(Adisakwattana et al. 2011; Kim et al. 2005). It breaks down dietary carbohydrate to glucose, 
leading to increased postprandial blood glucose level. The increased α-amylase activities in the 
pancreas and serum of DC (Table 3.4.2), insinuate an elevated postprandial blood glucose level 
which may also contribute to the elevated blood glucose level (Figure 3.4.2A). This agrees with 
previous reports on elevated α-amylase activities in T2D (Aughsteen et al. 2005; Ewadh et al. 
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2014; Yadav et al. 2013). The reduced activities in diabetic rats treated with the Raffia palm wine 
portrays an inhibitory potential, which also corroborates the reduced blood glucose level (Figure 
3.4.2A). This also demonstrates a therapeutic effect of Raffia palm wine against T2D, as some 
commercial antidiabetic drugs such as acarbose and miglitol bring about their activity by inhibiting 
carbohydrate enzymes (Chelladurai and Chinnachamy 2018; Rahimzadeh et al. 2014). 
The role of pancreatic ATPase in insulin secretion has been reported (Costa et al. 2010; Owada et 
al. 1999). A decreased activity leading to depolarization of the pancreatic β – cell membrane, and 
influx of Ca2+ have been suggested as a major mechanism by which glucose stimulates insulin 
secretion (Owada et al. 1999). Thus, the increased pancreatic ATPase in DC (Table 3.4.1), reflects 
a decrease in insulin secretion which correlates with the reduced serum insulin level (Figure 
3.4.2C). The decreased serum ATPase activity in DC is in correlation with previous reports on 
decreased activities in T2D (Kiziltunç et al. 1997; Zadhoush et al. 2015). The reversed activities 
of these enzymes in diabetic rats by Raffia palm wine, further insinuates its antidiabetic potential, 
which also correlates with other studies on the ability of medicinal plant to inhibit and stimulate 
pancreatic and serum ATPase activities respectively (Baxi et al. 2010; Erukainure et al. 2017b).  
Alteration of lipid metabolism, characterized by elevated levels of triglyceride, LDL-cholesterol 
and low HDL-c level, with normal or elevated total cholesterol have been reported in T2D (Boden 
and Laakso 2004; Parhofer 2015; Sugden and Holness 2011). This is often described as diabetic 
dyslipidemia, and has been attributed to hyperglycemia and insulin resistance (Parhofer 2015; 
Vijayaraghavan 2010). Thus, the elevated levels of triglyceride, LDL-c and low HDL-c level, 
despite the normal level of total cholesterol in the untreated diabetic rats depicts diabetic 
dyslipidemia as shown in Figure 3.4.3. The reduced levels of triglyceride, LDL-c and elevated 
levels of HDL-c in the treatment groups, particularly DSG-LD and DSG insinuates an 
antidyslipidemic activity by Raffia palm wine. This correlates with previous studies on the use of 
medicinal plants in the treatment of dyslipidemia (Erukainure et al. 2018a; García-Carrasco et al. 
2015; Puri et al. 2007). 
The toxic effect of chronic hyperglycemia on pancreatic islets in the progression of DM have been 
linked to redox imbalance caused by elevated production of ROS (Acharya and Ghaskadbi 2010; 
Donath 2014). This redox imbalance can be attributed to the extremely low levels of the pancreatic 
endogenous antioxidant enzymes (Pi et al. 2010; Robertson and Harmon 2007), thus leading to 
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oxidative damage of the pancreatic β-cells. This is evidenced by the depleted GSH level, SOD and 
catalase activities in the serum and pancreatic tissues of the untreated diabetic rats (Table 3.4.2). 
The elevated MDA levels indicate an occurrence of lipid peroxidation which can be attributed to 
the reduced catalase activity. Reduced catalase activity has been implicated in excessive 
accumulation of hydrogen peroxide (H2O2) arising from SOD dismutation of superoxide anion 
(O2
•-), leading to generation of hydroxyl radical (•OH). The generated •OH binds with the 
membrane lipids, triggering peroxidative chain reactions. The accumulated H2O2 can also be 
converted to the potent radical, hypochlorous acid (HOCl) in a reaction catalyzed by 
myeloperoxidase in the presence of react with hydrochloric acid (HCl). High concentrations of 
NO can react with O2
•- to produce peroxynitrite (ONOO-), also a potent free radical. Elevated NO 
level and myeloperoxidase activity have also been recognized as proinflammatory markers 
(Bedoya et al. 2012; Erukainure et al. 2018b). Their elevation in the serum and pancreatic tissue 
(Table 2), therefore indicates an occurrence of proinflammation. This corroborates with the 
increased pancreatic acetylcholinesterase activity (Table 3.4.1), as its increased activity has been 
linked to inflammatory effects (Zhang et al. 2012). Elevation of these biomarkers in the untreated 
diabetic rats may be responsible for their β-cell dysfunction and reduced insulin secretion (Figure 
3.4.2C) and inflamed pancreatic β-cells (Figure 3.4.4B). The ability of Raffia palm wine to elevate 
the GSH level, SOD and catalase activities, while reducing NO and MDA levels, and 
myeloperoxidase activity in diabetic rats, indicates its therapeutic potential against hyperglycemia-
induced oxidative and proinflammatory injuries. These effects correlate with previous studies on 
the antioxidant and anti-inflammatory properties of antidiabetic medicinal plants (Erukainure et 
al. 2018a; Grzanna et al. 2005; Modak et al. 2007). 
Multiple arteries derived from the abdominal aorta have been reported to perfuse the pancreas, and 
they play major roles in the maintenance of the internal milieu of the islets and normal endocrine 
physiology (Honka et al. 2014; Jansson et al. 2016). This perfusion is however altered in the onset 
and progression of T2D resulting from β-cell dysfunction (Honka et al. 2014). In this study, the 
decreased capillary networks on the pancreatic surfaces of the untreated diabetic rats (Figure 
3.4.5B) may portray an altered perfusion, which may also be responsible for the significant β-cell 
dysfunction and reduced serum insulin level (Figure 3.4.2C). The increased network in the 
treatment groups (Fig. 5C – 5E), particularly in rats treated with Raffia palm wine (DSG-LD and 
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DSG) reflects an increased perfusion which corroborates with the elevated serum insulin levels 
and decreased significant β-cell dysfunctions (Figure 3.4.2C). 
Apoptosis of the pancreatic β-cells have been recognized as a major contributor to the 
pathogenesis, pathophysiology and progression of T2D (Rojas et al. 2018; Tomita 2016). Often 
characterized by chromatic condensation, DNA fragmentation and cell shrinkage, β-cell apoptosis 
can be triggered by prolonged inflammation and oxidative stress arising from persistent 
hyperglycemia in T2D (Acharya and Ghaskadbi 2010; Kaneto et al. 1996; Tomita 2016). The 
caspase family have been recognized as a major orchestrator of the extrinsic apoptotic pathway, 
with caspase 3 being a major effector in β-cell apoptosis (Liadis et al. 2005; Tomita 2016). The 
elevated expression of caspase-3 in the pancreatic tissue of the untreated diabetic rats (Figures 
3.4.6B) therefore indicates an occurrence of apoptosis. This may be attributed to the elevated levels 
of NO, MDA, and myeloperoxidase activities and concomitant depletion of GSH level, SOD and 
catalase activities in the pancreas (Table 3.4.2). Although these biomarkers were improved in the 
pancreatic tissues of the treatment groups, the Raffia palm wine showed a rather insignificant 
increased effect on caspase-3 expression (Figures 3.4.6C and 3.4.6D). Thus, implying that its 
antidiabetic mechanism may not involve the caspase-3 apoptotic pathway. 
The increased expression of Nrf2 in pancreatic tissues of untreated diabetic rats (Figure 3.4.7B) 
correlates with reported exacerbated Nrf2 expression on the onset of T2D  (He et al. 2012; Miao 
et al. 2012). Although increased Nrf2 has been reported to be beneficial in the recruitment of 
antioxidants and a therapeutic target in T2D (David et al. 2017; Dieter 2014),  its activation of 
oxidative stress have however been reported (Wrighten et al. 2009; Zucker et al. 2014). Thus, 
implying that its increased expression in this study may be a major contributor to the pancreatic 
redox imbalance (Table 3.4.2). The reduced expressions in diabetic rats treated with Raffia palm 
wine (Fig. 7C, 7D and 7G), further portrays a therapeutic effect against T2D. 
Fructosamine has been recognized as a glycemic biomarker for diabetes indication and control 
respectively (Malmström et al. 2014). It is a product of early stage glycated protein which is 
oxidatively cleaved to form advanced glycation end (AGE) products (Ibrahim et al. 2016; Sen et 
al. 2011). Its increased level in the untreated diabetic rats indicates a glycation cascade (Table 
3.4.1). Thus, the reduced levels in the Raffia palm wine treated rats, suggests an interruption of 
the glycation cascade by the palm wine.  
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Although several studies have acknowledged the relative safety of natural products, there are 
however concerns on their toxic effects on tissues (Ezuruike and Prieto 2014). The elevated levels 
of ALP, CK-MB and uric acids in the untreated diabetic rats (Table 3.4.4), reflects hepato, cardio, 
and nephro – toxicities (Erukainure et al. 2018a; Mortazavi et al. 2016). Elevation of these 
biomarkers have been reported in T2D (Čaušević et al. 2010; Erukainure et al. 2017a; Fazel et al. 
2005), and has been attributed to inflammation of the liver, heart, and kidney leading to their 
leakage to the serum (Giordano et al. 2015; Kim et al. 2008; Peppes et al. 2008). The depleted 
levels of these biomarkers in diabetic and normal rats treated with Raffia palm wine, do not only 
indicate a protective effect of Raffia palm wine against diabetic hepato, cardio and nephro - 
toxicities but also the safety of its consumption on healthy tissues.  
These activities by Raffia palm wine in T2D can be attributed to the synergetic effect of the GC-
MS identified compounds (Table 3.4.4). The antioxidative and proinflammatory activities can be 
attributed to the presence of catechol, quinic acid, echinopsine and cimarin, as they have been 
reported for their antioxidant, anti-inflammatory and antidiabetic properties (Halim et al. 2011; 
Sarian et al. 2017; Wojdyło et al. 2016). The ascorbic acid derivatives, l-Erythro-ascorbate and l-
(+)-Ascorbic acid 2,6-dihexadecanoate derivatives have also been reported for their antioxidant 
activities (Okwu and Emenike 2006). Although its high concentration of sugars maybe a question 
of concern, the identified sugars are however non-caloric and have been reported for their ex vivo 
and in vivo antidiabetic activities (Bobiş et al. 2018; Chukwuma and Islam 2017b; Nichol et al. 
2018). 
3.4.6 Conclusion 
These results suggest the therapeutic and protective effects of Raffia palm wine against T2D and 
its complications. This is evidenced by its ability to improve pancreatic β-cell function and 
stimulate insulin secretion with concomitant inhibition of glycolytic and carbohydrate-digesting 
enzymes, leading to reduced blood glucose level while attenuating oxidative pancreatic injury and 
proinflammatory, dyslipidemia and Nrf2 expression. Its reduction of serum, liver, cardiac, and 
kidney biomarkers suggests its safety on diabetic and healthy organs. These activities can be 
attributed to the synergetic effect of the GC-MS identified compounds. 
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3.5 Type 2 Diabetes Induced Oxidative Brain Injury involves Altered 
Cerebellar Neuronal Integrity and Elemental distribution, and Exacerbated 
Nrf2 Expression: Therapeutic Potential of Raffia Palm (Raphia hookeri) Wine 
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4. Department of Human Anatomy, Federal University of Technology, Akure, Nigeria 
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Preface: This article investigated the antioxidative protective effect of Raffia palm wine on type 
2 diabetes induced brain injury. Its antioxidative and anti-proinflammatory effects were 
investigated. Its inhibitory effect on cholinergic enzyme activity and Nrf2 expression were 
investigated. Its ability to protect against oxidative induced neuronal damages was also 
investigated as well as its ability to stimulate brain glucose uptake. The article presently under 
review for publication in Nutritional Neuroscience (NNS1452). 
3.5.1 Abstract 
Neurodegenerative diseases, such as Alzheimer’s disease have been recognized as one of the 
microvascular complications of type 2 diabetes (T2D). In this study, the effect of T2D on neuronal 
integrity and elemental distribution in the cerebellar cortex, as well as the therapeutic effect of 
Raffia Palm (Raphia hookeri) wine (RPW) were investigated in male albino rats. T2D was induced 
in 4 groups of rats using the fructose and streptozotocin. One group served as negative control 
which was administered water, the second and third group were administered with 150 and 300 
mg/kg bodyweight of RPW, while the fourth group was administered with metformin (200 mg/kg 
bodyweight). Two other groups of normal rats were administered distilled water (control) and of 
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RPW (300 mg/kg bodyweight). The rats were sacrificed after 5 weeks of treatment, and brains 
were collected. The cerebellum was removed, and several parts analyzed by immunochemistry, 
histology and scanning electron microscope (SEM) analyses. Other parts of the brain were 
analyzed for oxidative stress biomarkers and acetylcholinesterase activity. These analyses revealed 
oxidative damage with concomitant increased in acetylcholinesterase activity and upregulation of 
Nrf2 expression in the diabetic brain cerebellar cortexes. Histological and microscopic analysis 
also revealed altered distribution of neurons and axonal nodes with concomitant elevation of 
several heavy metals. Treatment with RPW significantly elevated glutathione (GSH) level, 
superoxide dismutase (SOD) and catalase activities, as well as depleted acetylcholinesterase and 
malondialdehyde (MDA) level, while concomitantly inhibiting Nrf2 expression. It also led to 
improved neuronal integrity and reduction in the levels of heavy metals. Taken together, these 
studies suggest RPW may afford a novel neuroprotective potential against diabetic 
neurodegeneration. 
Keywords: EDX; Neurodegeneration; Nrf2; Raffia Palm Wine; and Type 2 diabetes  
3.5.2 Introduction  
Being a major global epidemic, diabetes mellitus (DM) is a metabolic disease characterized by 
increased blood glucose level due to the incapability of pancreatic β-cells to synthesize insulin as 
seen in type 1 diabetes (T1D) and/or insufficient utilization of synthesized insulin as seen in type 
2 diabetes (T2D) (Unnikrishnan et al. 2017; van Crevel et al. 2017). T2D is the predominant of all 
DM types, and it is characterized by insulin resistance and β-cell dysfunction, leading to chronic 
hyperglycaemia. Chronic hyperglycemia, in turn, leads to excess production of free radicals, which 
can initiate oxidative stress when they surpass the tissue’s endogenous antioxidant capacity 
(Erukainure et al. 2017b; Maritim et al. 2003b). Hyperglycaemia-induced oxidative stress has been 
associated with the pathogenesis and progression of micro- and macro- vascular complications in 
T2D.  
Neurodegeneration has been recognized as one of the microvascular complications in T2D 
(Vagelatos and Eslick 2013; Whitlow et al. 2015; Wrighten et al. 2009), with oxidative stress 
playing a key role in mediating this effect (Kim et al. 2015; Uttara et al. 2009). The brain utilizes 
glucose as its predominant source of energy and it is transported by glucose transporters across the 
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blood-brain barrier (BBB) (McEwen and Reagan 2004; Reagan et al. 2008; Wrighten et al. 2009). 
However, this homeostasis is disrupted in T2D due to impaired signaling and downregulation of 
glucose transporters (GLUTs) (Gejl et al. 2017; Hwang et al. 2017; Pardridge et al. 1990; Wrighten 
et al. 2009), leading to neuronal loss, structural alterations, and metal accumulation (Folarin et al. 
2017; Kim et al. 2015; Wrighten et al. 2009). 
The role of nuclear factor erythroid 2–related factor 2 (Nrf2) have been correlated with redox 
homeostasis as it mediates the activation and recruitment of endogenous antioxidants in response 
to oxidative stress (Dieter 2014; Ma 2013). Its beneficiary role has been reported in cerebellar 
function and neurodegenerative diseases such as Alzheimer and Parkinson (Ma 2013; Sandberg et 
al. 2014), cardiovascular diseases (Barančík et al. 2016), and hepatoxicity (Ma 2013). Its role in 
the activation of oxidative stress has been reported (Wrighten et al. 2009; Zucker et al. 2014). The 
activation of Nrf2 on the onset of T2D with concomitant generation of ROS, leading to 
downstream of antioxidants has also been reported (He et al. 2012; Miao et al. 2012). 
This study aims to investigate the effect of Raffia palm wine on the redox status, ATPase and 
acetylcholinesterase activities in whole brain, as well as the morphology, neuronal distribution, 
elemental distribution, and Nrf2 expression in the cerebellar cortex of T2D rats. Brain glucose 
uptake have been reported to be altered in T2D due to downregulation of GLUTs (Gejl et al. 2017; 
Hwang et al. 2017; Pardridge et al. 1990), thus the ability of Raffia palm wine to stimulate glucose 
uptake in brain tissues was also investigated ex vivo. 
3.5.2 Materials and Methods 
Kindly refer to Chapter 2, subsections 2.1.1; 2.1.3; 2.10.5; 2.12 – 2.13 for details materials and 
methods.  
3.5.3 Results 
As shown in Figures 3.5.1A – 3.5.1D, induction of T2D led to a significant (p<0.05) decrease in 
GSH levels, SOD and catalase activities, with concomitant increase in MDA levels. These were 
reversed on treatment with Raffia palm wine and metformin to levels indistinguishable from 
controls. Administration of Raffia palm wine to normal rats had no significant effect on GSH levels 
and SOD activities but reduced the catalase activity compared to the control. 
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Figure 3.5.1: Antioxidant status of experimental groups. Values = mean ± SD; n = 5 (NC and 
PHD) and 7 (DC, DSG-LD, DG, and DSM). *Statistically (p<0.05) significant from DC, 
#statistically significant (p<0.05) from NC. NC = normal rats, DC = diabetic control, DSG-LD = 
diabetic rats + Raffia palm wine (150 g/kg bw), DSG = diabetic rats + Raffia palm wine (300 g/kg 
bw), DSM = diabetic rats + metformin (200 g/kg bw), and PHD = Normal rats + Raffia palm wine 
(300 g/kg bw).  
Induction of T2D led to a significant (p<0.05) increase in myeloperoxidase activity as shown in 
Figure 3.5.2, indicating a proinflammatory response. This was significantly reduced in the Raffia 
palm wine treated groups, with the low dose showing a better activity, and comparable with 
metformin. Raffia palm wine had no significant effect on the activity in normal rats compared to 
the control. 
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Figure 3.5.2: Myeloperoxidase activities of experimental groups. Values = mean ± SD; n = 5 (NC 
and PHD) and 7 (DC, DSG-LD, DG, and DSM). *Statistically (p<0.05) significant from DC, 
#statistically significant (p<0.05) from NC. NC = normal rats, DC = diabetic control, DSG-LD = 
diabetic rats + Raffia palm wine (150 g/kg bw), DSG = diabetic rats + Raffia palm wine (300 g/kg 
bw), DSM = diabetic rats + metformin (200 g/kg bw), and PHD = Normal rats + Raffia palm wine 
(300 g/kg bw).                                                                                                                                                                                                          
As shown in Figure 3.5.3, ATPase activity in the diabetic group was significantly (p<0.05) higher 
compared to the control. This effect was attenuated in response to treatment with Raffia Palm wine, 
with the high dose showing a significant (p<0.05) reduction reaching levels indistinguishable from 
controls. Metformin had no significant effect on the activity. The activity significantly increased 
in normal rats administered Raffia palm wine compared to controls. 
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Figure 3.5.3: ATPase activities of experimental groups. Values = mean ± SD; n = 5 (NC and PHD) 
and 7 (DC, DSG-LD, DG, and DSM). *Statistically (p<0.05) significant from DC, #Statistically 
significant (p<0.05) from NC. NC = normal rats, DC = diabetic control, DSG-LD = diabetic rats 
+ Raffia palm wine (150 g/kg bw), DSG = diabetic rats + Raffia palm wine (300 g/kg bw), DSM 
= diabetic rats + metformin (200 g/kg bw), and PHD = Normal rats + Raffia palm wine (300 g/kg 
bw).                                                                                                                                                                                                          
Induction of T2D led to significant (p<0.05) increase in acetylcholinesterase activity as depicted 
in Figure 3.5.4. This effect was significantly reduced in rats treated with low dose of Raffia palm 
wine. The metformin treated group, DSM also showed a significant reduction in 
acetylcholinesterase activity. Acetylcholinesterase activity in normal rats administered Raffia 
palm wine was indistinguishable from the controls. 
*
#
#
*#
#
*#
0.00
20.00
40.00
60.00
80.00
100.00
120.00
NC DC DSG-LD DSG DSM PHD
A
TP
as
e
 A
ct
iv
it
y 
(µ
m
o
l P
i/
m
g)
134 
 
 
Figure 3.5.4: Acetylcholinesterase activities of experimental groups. Values = mean ± SD; n = 5 
(NC and PHD) and 7 (DC, DSG-LD, DG, and DSM). *Statistically (p<0.05) significant from DC, 
#statistically significant (p<0.05) from NC. NC = normal rats, DC = diabetic control, DSG-LD = 
diabetic rats + Raffia palm wine (150 g/kg bw), DSG = diabetic rats + Raffia palm wine (300 g/kg 
bw), DSM = diabetic rats + metformin (200 g/kg bw), and PHD = Normal rats + Raffia palm wine 
(300 g/kg bw). 
Histological analysis of the cerebellar cortex revealed intact Purkinje and granular cell layers as 
shown in Figure 3.5.5A. The intactness of these layers was distorted upon induction of T2D 
(Figure 3.5.5B), with evidence for compromised neuronal integrity. These layers appeared normal 
in rats treated with low dose of Raffia palm wine and metformin (Figures 3.5.5C and 3.5.5E), 
indicating a protective activity and maintenance of optimal neuronal integrity.  
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Figure 3.5.5: Morphological changes in cerebellar tissues of experimental groups. Magnification: 
10x. (A) = NC, (B) = DC, (C) = DSG-LD, (D) = DSG, (E) = DSM, and (F) = PHD. NC = normal 
rats, DC = diabetic control, DSG-LD = diabetic rats + Raffia palm wine (150 g/kg bw), DSG = 
diabetic rats + Raffia palm wine (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), 
and PHD = Normal rats + Raffia palm wine (300 g/kg bw). Arrows: Black = Purkinje cell layer; 
Red = Granule cell layer; White = white matter; Blue = Molecular layer 
SEM analysis of the cerebellar cortex revealed intact Purkinje and glial cells, with a vast network 
of dendrites and axons (Figure 3.5.6A). This intactness was also distorted in the untreated diabetic 
group (Figure 3.5.6B) as evidenced by a depleted number of Purkinje and glial cells, and altered 
network of dendrites and axons. The dendrites and axon networks were more conspicuous in the 
low dose Raffia Palm wine treated group (Figure 3.5.6C), while the Purkinje and glial cells, and 
nerve networks were more intact in the high dose treated group (Figure 3.5.6D). These cells and 
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networks were altered in metformin treated rats (Figure 3.5.6E). Administration of Raffia palm 
wine to normal rats had no discernible effect on the Purkinje and glial cells as well as dendrites 
and axons networks (Figure 3.5.6F). 
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Figure 3.5.6: SEM analysis of cerebellar tissues of experimental groups. Magnification = 1000x. 
(A) = NC, (B) = DC, (C) = DSG-LD, (D) = DSG, (E) = DSM, and (F) = PHD. NC = normal rats, 
DC = diabetic control, DSG-LD = diabetic rats + Raffia palm wine (150 g/kg bw), DSG = diabetic 
rats + Raffia palm wine (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and PHD 
= Normal rats + Raffia palm wine (300 g/kg bw). Arrows: Black = Purkinje cells; Blue = dendrite 
network; Red = axon 
Figure 3.5.7A (1 – 6) reveals the EDX mapping of the cerebellar cortex, showing elemental 
distribution in the cortex. Quantitative analysis revealed depleted levels of carbon, nitrogen and 
iron, with concomitantly elevated levels of oxygen, magnesium, aluminum and calcium Figure 
3.5.7B). Induction of T2D had little or no effect on the cerebellar potassium content. These were 
reversed in the Raffia palm wine treated rats, with the low dose showing elevated levels of carbon 
and iron, and depleted levels of potassium. While the high dose showed higher levels of nitrogen 
and potassium compared to the control. Magnesium, calcium and iron were largely depleted in the 
cerebellar cortex of diabetic rats treated with high dose of Raffia palm wine. The cerebellar 
aluminum contents were highly depleted in diabetic rats treated with both doses of Raffia palm 
wine. 
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Figure 3.5.7A: EDX mapping of cerebellar tissues of experimental groups. Magnification = 
1000x. (1) = NC, (2) = DC, (3) = DSG-LD, (4) = DSG, (5) = DSM, and (6) = PHD. Legends: C = 
carbon, N = nitrogen, O = oxygen, Na = sodium, Mg = magnesium, K = potassium, Ca = calcium, 
Fe = iron, and Al = aluminum  
 
 
 
 
 
 
 
 
Figure 3.5.7B: Quantitative analysis of EDX scans 
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Induction of T2D led to significantly (p < 0.05) increased expression of Nrf2 in the cerebellar 
cortex, particularly in the Purkinje and granular cell layers compared to the normal controls, (NC). 
Treatment with Raffia palm wine attenuated the increase in Nrf2 expression in T2D rats (Figure 
3.5.8). 
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Figure 3.5.8: (A) Immunohistochemistry photomicrographs of Nrf2 expression in cerebellar 
cortex of experimental groups. Magnification = 200x; (1) = NC, (2) = DC, (3) = DSG-LD, (4) = 
DSG, (5) = DSM, and (6) = PHD. B; Nrf2 immunoreactivity in cerebellar cortex of experimental 
groups. *Statistically (p<0.05) significant from DC, #statistically significant (p<0.05) from NC. 
NC = normal rats, DC = diabetic control, DSG-LD = diabetic rats + Raffia palm wine (150 g/kg 
bw), DSG = diabetic rats + Raffia palm wine (300 g/kg bw), DSM = diabetic rats + metformin 
(200 g/kg bw), and PHD = Normal rats + Raffia palm wine (300 g/kg bw). Arrows: Black = 
Molecular layer; Red = Granule cell layer; White = White matter; Blue = Purkinje cell layer                                                                                                                                                                                                         
Incubation of rat brain with Raffia palm wine led to decrease glucose level of the incubating buffer, 
suggesting increased glucose uptake, as depicted in Figure 3.5.9. This enhanced glucose uptake 
activity increased in a concentration-dependent manner. Incubation with metformin did not alter 
glucose uptake vs. control. 
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Figure 3.5.9: Effect of Raffia palm wine on brain glucose uptake ex vivo. Values = mean ± SD. 
*Statistically (p<0.05) significant from metformin, #Statistically significant (p<0.05) from glucose 
only. 
3.5.4 Discussion 
The brain dependence on glucose as its primary source of energy is well established, with neurons 
being the highest consumers owing to their high energy demand (Howarth et al. 2012; 
Mergenthaler et al. 2013). Hence, the continuous need for a constant supply of glucose from the 
blood across the BBB to the brain via glucose transporters. This supply has been reported to be 
altered in T2D (Vagelatos and Eslick 2013; Whitlow et al. 2015), and has been attributed to 
downregulation of glucose transporters at the BBB (Gejl et al. 2017; Hwang et al. 2017). 
Diminished brain supply of glucose might, in turn, lead to neurodegenerative diseases 
characterized by oxidative stress, defective physiology, neuronal loss and dysfunction. In this 
study, the therapeutic effect of Raffia palm wine on T2D-induced oxidative brain injury as well as 
its ability to promote brain glucose uptake ex vivo were investigated. 
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The high consumption of O2 and concomitant dependence on glucose by the brain has been 
attributed for its high susceptibility to oxidative stress, which has been recognized as a major 
mechanism of T2D-induced neurodegeneration (Das et al. 2009; Patel 2016). This susceptibility 
can also be attributed to its low endogenous antioxidative system, high polyunsaturated fatty acid 
content, as well as the excitotoxic and auto-oxidizable activities of neurotransmitters (Patel 2016). 
The depleted GSH level, SOD and catalase activities upon induction of T2D (Figure 3.5.1A – 
3.5.1C) portray a distorted pro-oxidant/antioxidant equilibrium, reflected by increased ROS 
production. This corroborates earlier reports on the increased activities of these biomarkers in brain 
tissues of STZ-induced diabetic rats (Mastrocola et al. 2005; Moreira et al. 2003). ROS, such as 
O2.
- and .OH are toxic to neuronal cells (Uttara et al. 2009). SOD catalyzes the dismutation of O2.
- 
to H2O2 and O2. Catalase further catalyzes the breakdown of H2O2 to H2O and O2 (Erukainure et 
al. 2017b). In the absence of its breakdown by catalase, H2O2 generates hydroxyl ions (
•OH). Both 
H2O2 and 
•OH which can initiate peroxidation of polyunsaturated fatty acids. The elevated MDA 
level in brain tissues of the diabetic control (DC) rats (Figure 3.5.1D) indicate the occurrence of 
lipid peroxidation, which correlates with the depleted GSH levels, SOD and catalase activities. 
H2O2 can also be converted to hypochlorite (HOCl) in a reaction catalyzed myeloperoxidase in the 
presence of hydrochloric acid (HCl) (Patel 2016). HOCl is known to have proinflammatory 
activities (Erukainure et al. 2018b). The increased myeloperoxidase activity in the untreated 
diabetic group (DC) (Figure 3.5.2), may thus reflect a proinflammatory activity. The reversal of 
these levels and activities to near normal in the Raffia palm wine-treated groups, indicates an 
antioxidative and anti-proinflammatory potential of the palm wine. 
Altered ATP levels have been reported in neurodegenerative diseases (Mochel et al. 2012; Zhang 
et al. 2015), as a consequence of increased ATPase activity. Increased brain ATPase activity, 
particularly the Na+/K+ ATPase have also been implicated in impaired glucose facilitative 
transportation across the BBB (Falkowska et al. 2015; Magistretti and Allaman 2015). In this 
study, the increased ATPase activity in the diabetic control (DC) (Figure 3.5.3) may insinuate an 
impaired glucose transport across the BBB and/or altered brain ATP concentration. The decreased 
activity in the treated groups, particularly DSG likely reflects increased ATP concentration as well 
as increased glucose uptake. This corroborates the increased glucose uptake in rat brains incubated 
with Raffia palm wine in the presence of glucose (Figure 3.5.9). The slight decrease in ATPase 
activities in brains of metformin-treated rats might be attributed to the fact that metformin activates 
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GLUTs 2 and 4, which are less concentrated at the BBB (Kellett and Brot-Laroche 2005; Rice et 
al. 2011). This may also explain its lesser effect on brain glucose uptake (Figure 3.5.9). 
The role of acetylcholinesterase in exacerbating neurodegenerative diseases have been well 
established (Kuhl et al. 1999; Mushtaq et al. 2014; Pavlov et al. 2009). Its hydrolyzing effect on 
the neurotransmitter, acetylcholine has been implicated in impaired cognition, pathogenesis and 
progression of Alzheimer disease, and motor neuron dysfunction amongst other neurodegenerative 
diseases (Hwang et al. 1999; Kuhad et al. 2008; Tabet 2006). Increased acetylcholinesterase 
activity has been reported in diabetic rat brains (Ghareeb and Hussen 2008; Kuhad et al. 2008), 
correlating with the increased activity in the diabetic control in our present study (Figure 3.5.4). 
The increased activity further corroborates an occurrence of brain injury due to induction of T2D. 
The increased activity also corroborates the increased myeloperoxidase activity (Figure 3.5.2), as 
acetylcholinesterase activity has been correlated with the inhibition of the cholinergic anti-
inflammatory pathways (Martelli et al. 2014; Pavlov et al. 2009). Increased oxidative stress has 
also been correlated with elevated acetylcholinesterase activity (Melo et al. 2003; Mushtaq et al. 
2014), consistent with increased oxidative stress (Figure 3.5.1). The decreased 
acetylcholinesterase activities in treated diabetic rats, particularly the low dose Raffia palm wine 
treated group, DSG-LD indicate an acetylcholinesterase-inhibitory activity as well as a protective 
effect against hyperglycemia-induced neurodegeneration by Raffia palm wine.  
Changes in brain morphology have been correlated with the pathogenesis and progression of most 
neurodegenerative diseases, with oxidative stress playing a major role (Ojo et al. 2014; Sidhu and 
Nehru 2004). The cerebellum controls motor and muscular activities in the brains as well as body 
balance (Imosemi 2013), with Purkinje cells as the main neurons present (Lopez et al. 2009). The 
morphological changes in the cerebellar cortex of the diabetic control rats (Figure 3.5.5) as 
depicted by distorted Purkinje and granular cell layers indicate brain injury, which can be attributed 
to the T2D induced oxidative stress (Figure 3.5.1). The vulnerability of Purkinje cells to oxidative 
stress has been reported (Chen et al. 2003; Kern and Jones 2006; Lopez et al. 2009). Their altered 
morphology and distribution has also been reported in diabetes (Solmaz et al. 2017; Yamano et al. 
1986). This is further evident the altered distribution and loss of Purkinje and glial cells as well as 
dendrites and axons networks as revealed in Figure 3.5.6B. These changes indicate an altered 
neuronal integrity, which is common in most neurodegenerative diseases such as Alzheimer’s 
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disease. These results are in consent with reports on the alteration of cerebellar cortex on induction 
of DM in rats (Hernández-Fonseca et al. 2009; Nagayach et al. 2014; Ozdemir et al. 2016). The 
near-intactness of these cells and networks in the treated groups (Figure 3.5.5C – 3.5.5F and 
3.5.6C – 3.5.6F), particularly diabetic rats treated with Raffia palm wine correlates with the 
observed antioxidant activities (Figure 3.5.1). Thus, indicating a neuro-protective potential of 
Raffia palm wine against T2D-induced neurodegeneration.  
Altered elemental distribution, particularly accumulation of metals has been implicated in 
oxidative neurodegeneration (Patel 2016). Unless altered, these metals are involved in the normal 
physiology of the brain as they act as co-factors for most enzymes and are integral component of 
most redox reactions (Uttara et al. 2009). Altered elemental distributions and accumulations have 
been reported in cerebellar toxicity (Folarin et al. 2017; Kamal and Kamal 2013). The increased 
O2 content (Figure 3.5.7B) correlates with the induced oxidative stress in DC, as oxygen is the 
major precursor of ROS and its increased accumulation may lead to generation of O2.
-  (Patel 
2016). The increased Ca and Al contents portrays toxic effect as their accumulation have been 
implicated in the pathogenesis and progression of neurodegeneration (Kamal and Kamal 2013; 
Wojda et al. 2008). The role of magnesium in neurodegeneration is still debatable. However, its 
aggregative and negative effect on neurodegeneration has been reported (Van Den Heuvel and 
Vink 2004). The modulation of these elemental levels to near normal in the treated groups, further 
portrays the neuro-protective effects of Raffia palm wine. 
Exacerbated Nrf2 expression has been implicated in the onset of T2D and antioxidant suppression, 
leading to ROS generation (He et al. 2012; Miao et al. 2012). This correlates with the increased 
expression in Purkinje and granular layers in the cerebellar cortex of the diabetic control group 
(Figure 3.5.8B). The increased expression also corroborates the diminished antioxidant enzymes 
(SOD and catalase) activities and lipid peroxidation in the diabetic control (Figure 3.5.1). The 
downregulation of the expressions particularly in rats treated with Raffia palm wine, indicates an 
attenuative effect on cerebellar Nrf2 expression. This Attenuative effect also corroborates the 
exacerbated antioxidative activity in the rat brains (Figure 3.5.1). 
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3.5.5 Conclusion 
These results indicate the neuroprotective potentials of Raffia palm wine against oxidative brain 
injury in T2D. This is evident by its ability to attenuate oxidative stress and proinflammation, 
inhibit acetylcholinesterase and ATPase activities, modulate elemental distribution, attenuation of 
Nrf2 expression, with concomitant maintenance of cerebellum neuronal integrity, while 
stimulating brain glucose uptake.  
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3.6 Raffia Palm (Raphia hookeri) Wine Extenuates Redox Imbalance and 
Modulates Activities of Glycolytic and Cholinergic Enzymes in Hyperglycemia 
Induced Testicular Injury in Type 2 Diabetes Rats  
1,2Ochuko L. Erukainure, 1Rebecca Reddy, 1Md. Shahidul Islam* 
1. Department of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, 
(Westville Campus), Durban 4000, South Africa  
2. Nutrition and Toxicology Division, Federal Institute of Industrial Research, Lagos, Nigeria 
*Corresponding author: islamd@ukzn.ac.za; Tel: +27 (0)31-260-8717; Fax: +27 (0)31-260-7942 
Preface: This article investigated the antioxidative protective effect of Raffia palm wine on type 
2 diabetes induced testicular injury. Its antioxidative and anti-proinflammatory effects were 
investigated. Its inhibitory effect on glycolytic and cholinergic enzyme activities were 
investigated. The article presently under review for publication in Journal of Food Biochemistry 
(JFBC-10-18-0815). 
3.6.1 Abstract 
This study investigated the effects of Raffia palm wine (RPW) on redox imbalance, glycolytic and 
cholinergic enzymes, and ATPase activities in type 2 diabetic-induced oxidative testicular injury. 
Type 2 diabetes (T2D) was induced in male albino rats (Sprague-Dawley) by first administering 
10% fructose for 14 days, before injecting with 40 mg/kg streptozotocin. RPW was administered 
to two T2D rat groups at 150 and 300 mg/kg bodyweight (bw), a T2D group without treatment 
served as a negative control, while metformin served as the standard drug for another group. Non-
diabetic (ND) rats served as the normal control, while ND rats administered a 300 mg/kg bw RPW 
was served as a toxicology group. The rats were sacrificed after 5 weeks of treatment, and the 
testes were harvested. Analysis of the testes revealed elevated levels of nitric oxide, 
malondialdehyde and myeloperoxidase activity, with concomitant depleted level of reduced 
glutathione, superoxide dismutase and catalase activities on induction of T2D, indicating an 
oxidative stress and proinflammation. These were significantly (p<0.05) reversed after the 
treatment with RPW. Treatment with RPW led to decreased activities of glycogen phosphorylase, 
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glucose-6-phosphatase, and fructose-1,6-bisphosphatase in T2D rats. RPW also caused an 
elevation of ATPase activity and inhibition of acetylcholinesterase activity. Altered testicular 
morphology by T2D were restored to near-normal after the treatment with RPW. These results 
demonstrate the therapeutic potentials of RPW against the detrimental effects of T2D on testicular 
functions and morphology. 
Keywords: Oxidative stress; Raffia palm wine; Testicular injury; and Type 2 diabetes 
3.6.2 Introduction 
Male infertility has been recognized as a neglected complication of diabetes mellitus (DM) (Dias 
et al. 2014; Kilarkaje et al. 2014; Xu et al. 2014). This has been attributed to the polyunsaturated 
fatty acids (PUFAs) rich content of the testicular tissues, which is highly susceptible to oxidative 
damage from hyperglycaemia-generated free radicals (Erukainure et al. 2012; Obode et al. 2015). 
Oxidative damage occurs when the generated free radicals overwhelms the testicular endogenous 
antioxidant system, leading to impaired spermatogenesis and steroidogenesis, and finally infertility 
(Alves et al. 2013; Xu et al. 2014). Hyperglycaemia accounts for the generation of free radicals in 
DM, owing to chronic increase in blood glucose level (Maritim et al. 2003b). The continuous 
increase in blood glucose level in DM have been attributed to the inability of the pancreatic β-cells 
to secrete insulin and/or inability of the body to utilize secreted insulin (Erukainure et al. 2017b). 
The former is referred to as type 1 diabetes (T1D) and the latter, type 2 diabetes (T2D) which 
accounts for over 90% of all diabetes types (I.D.F. 2016; I.D.F. 2018). 
This study aimed to investigate the effects of Raffia palm wine on redox imbalance, glycolytic and 
cholinergic enzymes, and ATPase activities as well as tissue morphology in oxidative testicular 
injury in a type 2 diabetes model of rats.  
3.6.3 Materials and Methods 
Kindly refer to Chapter 2, subsections 2.1.1; 2.1.3; 2.12 – 2.13 for details materials and methods.  
3.6.4 Results 
Induction of T2D led to significant reduction in GSH level, SOD and catalase activities, with 
concomitant increase in MDA level depicting an occurrence of oxidative stress as shown in 
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Figures 3.6.1A – 3.6.1.1D. This was significantly reversed after the treatment with Raffia palm 
wine, with the high dose showing a better activity for GSH and MDA levels, and SOD activity. 
Treatment with metformin had a little or no effect on the MDA level. 
 
Figure 3.6.1: Effect of Raffia palm wine on (A) GSH level; (B) SOD activity; (C) catalase activity; 
and (D) MDA level in testicular tissues of experimental groups. Data = mean ± SD; n = 5 (NC & 
PHD) and 7 (DC, DSG-LD, DSG, & DSM). *Significantly different (p<0.05) from DC; 
#Significantly different from NC. NC = normal rats, DC = diabetic control, DSG-LD = diabetic 
rats + Raffia palm wine (150 g/kg bw), DSG = diabetic rats + Raffia palm wine (300 g/kg bw), 
DSM = diabetic rats + metformin (200 g/kg bw), and PHD = Normal rats + Raffia palm wine (300 
g/kg bw). 
There was a significant (p<0.05) increase in NO level and myeloperoxidase activity on the onset 
of T2D, indicating an occurrence of proinflammation as depicted in Figure 3.6.2A and 3.6.2B. 
These were significantly reduced in all treatment groups, with metformin showing the least activity 
for NO. 
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Figure 3.6.2: Effect of Raffia palm wine on (A) NO level; and (B) myeloperoxidase activity in 
testicular tissues of experimental groups. Data = mean ± SD; n = 5 (NC & PHD) and 7 (DC, DSG-
LD, & DSG). *Significantly different (p<0.05) from DC; #Significantly different from NC. NC = 
normal rats, DC = diabetic control, DSG-LD = diabetic rats + Raffia palm wine (150 g/kg bw), 
DSG = diabetic rats + Raffia palm wine (300 g/kg bw), DSM = diabetic rats + metformin (200 
g/kg bw), and PHD = Normal rats + Raffia palm wine (300 g/kg bw). 
The studied glycolytic enzymes were significantly (p<0.05) elevated after the induction of T2D as 
shown in Figures 3.6.3A – 3.6.3C. These activities were depleted in all the treatment groups, with 
rats treated with high dose of Raffia palm wine and metformin showed the significant (p<0.05) 
depletion. 
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Figure 3.6.3: Effect of Raffia palm wine on (A) glycogen phosphorylase; (B) fructose 1,6 
biphosphatase; and glucose 6 phosphatase activities in testicular tissues of experimental groups. 
Data = mean ± SD; n = 5 (NC & PHD) and 7 (DC, DSG-LD, DSG, & DSM). *Significantly 
different (p<0.05) from DC; #Significantly different from NC. NC = normal rats, DC = diabetic 
control, DSG-LD = diabetic rats + Raffia palm wine (150 g/kg bw), DSG = diabetic rats + Raffia 
palm wine (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and PHD = Normal 
rats + Raffia palm wine (300 g/kg bw). 
Induction of T2D led to significant (p<0.05) decrease in ATPase activity as depicted in Figure 
3.6.4. Treatment with Raffia palm wine at both doses led to a significant (p<0.05) increase in the 
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activity (Fig. 4A), while treatment with metformin as well as administration of Raffia palm wine 
to normal rats had a little or no effect. 
 
Figure 3.6.4: Effect of Raffia palm wine on ATPase activities in testicular tissues of experimental 
groups. Data = mean ± SD; n = 5 (NC & PHD) and 7 (DC, DSG-LD, DSG, & DSM). *Statistically 
significant (p<0.05) to DC; #statistically significant to NC. NC = normal rats, DC = diabetic 
control, DSG-LD = diabetic rats + Raffia palm wine (150 g/kg bw), DSG = diabetic rats + Raffia 
palm wine (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and PHD = Normal 
rats + Raffia palm wine (300 g/kg bw). 
There was a significant (p<0.05) reduction in inhibitory effect of acetylcholinesterase activity after 
the induction of T2D, indicating an increased enzyme activity as depicted in Figure 3.6.5. This 
was significantly (p<0.05) increased in all treatment groups, depicting a depleted 
acetylcholinesterase activity. 
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Figure 3.6.5: Inhibitory effect of Raffia palm wine on acetylcholinesterase activities in testicular 
tissues of experimental groups. Data = mean ± SD; n = 5 (NC & PHD) and 7 (DC, DSG-LD, & 
DSG). *Significantly different (p<0.05) to DC; #statistically significant to NC. NC = normal rats, 
DC = diabetic control, DSG-LD = diabetic rats + Raffia palm wine (150 g/kg bw), DSG = diabetic 
rats + Raffia palm wine (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and PHD 
= Normal rats + Raffia palm wine (300 g/kg bw). 
Histological analysis of the testicular tissues revealed an intact spermatogonia, spermatocytes, 
spermatozoa, seminiferous epithelium, leydig cells, and a reduced lumen depicting an undistorted 
morphology (Figure 3.6.6A(1 and 2)). This morphology was however distorted on induction of 
T2D as portrayed by the wide lumen, decreased numbers of spermatogonia, spermatocytes, and 
spermatozoa depicting testicular injury (Figure 3.6.6B(1 and 2)). Treatment with low dose of 
Raphia palm wine led to increased number of these cells as well as a reduced lumen (Figure 
3.6.6C(1 and 2)). The high-dose treated group (DSG) revealed an intact tissue morphology, with 
the numbers of cells and the width of the lumen close to that of the control (NC) (Figure 3.6.6D(1 
and 2)). Treatment with metformin also led to distortion of the tissue morphology, with decreased 
number of spermatogonia, spermatocytes, and spermatozoa (Figure 3.6.6E(1 and 2)). Similarly, 
administration of Raffia palm wine to normal rats (PHD) showed a slight distorted morphology 
(Figure 3.6.6F (1 and 2)). 
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Figure 3.6.6: Effect of Raffia palm wine on testicular morphology of experimental groups. Keys: 
A(1 & 2) = NC; B(1 & 2) = DC; C(1 & 2) = DSG-LD; D(1 & 2) = DSG; E(1 & 2) = DSM; F(1 & 
2) = PHD. NC = normal rats, DC = diabetic control, DSG-LD = diabetic rats + Raffia palm wine 
(150 g/kg bw), DSG = diabetic rats + Raffia palm wine (300 g/kg bw), DSM = diabetic rats + 
metformin (200 g/kg bw), and PHD = Normal rats + Raffia palm wine (300 g/kg bw). 
Image analysis of the generated histological images revealed a decreased cell size on induction of 
T2D as shown in Figure 3.6.7. The low dose palm wine treated group (DSG-LD) showed little or 
no effect, while the high dose (DSG) had a significant (p<0.05) increase. Metformin (DSM) also 
showed a little or no significant effect, while PHD showed a slight increase in cell size. 
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Figure 3.6.7: Cell size analysis of testicular tissues of experimental groups. Data = mean ± SD; n 
= 5 (NC & PHD) and 7 (DC, DSG-LD, & DSG). *Significantly different (p<0.05) from DC; 
#Significantly different from NC. NC = normal rats, DC = diabetic control, DSG-LD = diabetic 
rats + Raffia palm wine (150 g/kg bw), DSG = diabetic rats + Raffia palm wine (300 g/kg bw), 
DSM = diabetic rats + metformin (200 g/kg bw), and PHD = Normal rats + Raffia palm wine (300 
g/kg bw). 
3.6.5 Discussion  
Hyperglycaemia -mediated oxidative stress has been linked to the pathogenesis and progression of 
T2D complications, owing to impairments of several intracellular signaling pathways (Kilarkaje 
et al. 2014; Maritim et al. 2003b). Alterations of these pathways have been implicated in the onset 
of macro- and microvascular diseases (Boden 2011; Kilarkaje et al. 2014). Of particular interest is 
the impairment of the male reproductive system, which is characterized by peroxidation of the 
testicular PUFAs constituents, morphological changes in the testes, and erectile dysfunction 
amongst others (Kilarkaje et al. 2014; Obode et al. 2015; Xu et al. 2014). In this study, the 
therapeutic effect of Raffia palm wine was investigated in hyperglycaemic-induced oxidative 
injury in T2D. 
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The depleted GSH level, SOD and catalase activities as well as increased MDA level in the 
untreated diabetic rats (DC) (Figure 3.6.1) connotes an occurrence of oxidative stress. GSH have 
been recognized as the first line component of the cellular antioxidant defense system, and plays 
a major role in testicular redox balance (Olayinka and Ore 2015). The reduced GSH level on 
induction of T2D may be attributed to overwhelming effect of the hyperglycaemia generated free 
radicals over its biosynthesis and turnover. The testes have been reported for having the highest 
cellular level of SOD (Aitken and Roman 2008; Mruk et al. 2002), which can be attributed to the 
catalytic  dismutation of superoxide anion (O2
−) to oxygen (O2) and hydrogen peroxide (H2O2) 
by SODs (Abreu and Cabelli 2010). O2
− is also the major reactive oxygen species (ROS) 
generated by the spermatozoa (Hsieh et al. 2002). Under normal physiological conditions, 
spermatozoa produces superoxide (O2
−) in smaller quantities for capacitation and acrosomal 
reaction (Agarwal and Prabakaran 2005). This physiological production is however compromised 
during disease states, leading to increased testicular O2
− levels with detrimental effect on male 
fertility (Hsieh et al. 2002; Mazzilli et al. 1994). The reduced testicular SOD activities on induction 
of T2D (Figure 3.6.1B) may therefore imply an increased testicular O2
− production. This also 
correlates with the increased NO level on the onset of T2D (Figure 3.6.2A), as NO reacts with O2
− to produce peroxynitrite (ONOO-), which triggers nitrosative stress and proinflammation 
leading to testicular dysfunction, impaired sperm motility, decreased gonadotropin secretion, and 
finally infertility (Doshi et al. 2012; Uribe et al. 2014). The elevated SOD activities in the treatment 
groups (Figure 3.6.1B), therefore indicates a decreased testicular level of O2
− and its dismutation 
to H2O2 and O2. It also implies a reduced O2
− availability for reaction with NO to produce ONOO-
, which correlates with the reduced NO level (Figure 3.6.2A). The generated H2O2 if not converted 
to H2O and O2 by catalase, will be broken down to hydroxyl ions (
•OH). Both •OH and H2O2 have 
been reported for their detrimental oxidative roles in male infertility, as they induce lipid 
peroxidation (Hsieh et al. 2002; Mruk et al. 2002). H2O2 is regarded as the main toxic ROS for 
spermatozoa (Hernández et al. 1995; Hsieh et al. 2002), owing to the susceptibility of the rich 
PUFAs constituents of the testicular tissue to peroxidation. Furthermore, H2O2 can also be 
converted to hypochlorous acid (HOCl-) by myeloperoxidase in the presence of hydrochloric acid 
(HCl) (Furtmüller et al. 2000a). This correlates with the increased myeloperoxidase activity in the 
DC group (Figure 3.6.2B), indicating proinflammation. The increased MDA level on induction of 
T2D (Figure 3.6.1D), indicates an occurrence of lipid peroxidation which correlates with the 
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depleted SOD and catalase activities (Figure 3.6.1B and 3.6.1C). Peroxidation of testicular lipids 
has been implicated in morphological changes of the testes, testicular dysfunction, decreased 
spermatogenesis and cell death (Asadi et al. 2017). The decreased level in the treatment groups 
indicates an antiperoxidative effect which corroborates the increased GSH level, SOD, and 
catalase activities (Figures 3.6.1A – 3.6.1C). Similarly, the decreased NO and myeloperoxidase 
activity in the treated groups connotes an anti-proinflammatory activity.  
Maintenance of testicular glucose homeostasis have been reported to be of great importance to the 
male reproductive system, with glycogen playing an essential role (Rato et al. 2015a). Alterations 
of this homeodynamics have been reported in T2D, with implications on testicular functions and 
spermatogenesis (Alves et al. 2013; Rato et al. 2015a). The increased activities of glycogen 
phosphorylase, fructose 1,6 biphosphatase, and glucose 6 phosphatase on induction of T2D 
(Figures 3.6.3A – 3.6.3C) indicates a breakdown of testicular glycogen, leading to increased 
testicular glucose level. Previous studies correlated an increased testicular expression of glycogen 
phosphorylase with upregulation of GLUT1 and GLUT3 in testicular tissues of T2D rats (Rato et 
al. 2015a), implying an increased glucose uptake. In its enediol form, glucose is oxidized to an 
enediol radical in the presence of transition metal, leading to the production of reactive 
ketoaldehydes and O2
− (Maritim et al. 2003b). The increase in testicular glucose level coupled to 
the presence of the testicular transferrin synthesized by the seminiferous epithelium may thus 
imply an increased production of ROS, leading to oxidative stress. The decreased activities of the 
studied glycolytic enzymes in the treated groups therefore portrays a decreased testicular glucose 
level, thus reducing the amount of glucose available to produce ROS. Thereby reducing oxidative 
stress as corroborated by the increased antioxidant biomarkers (Figures 3.6.1A – 3.6.1C) 
Several studies have linked to decrease testicular ATPase activity with testicular toxicity (El‐
Missiry and Shalaby 2000; Shen and Sangiah 1995). These studies correlated the decreased 
activity with oxidative stress, which corroborates this present study. Thus, the decreased activity 
on induction of T2D (Figure 3.6.4) portrays testicular toxicity, while the increased activity on 
treatment with Raffia palm wine reflects a therapeutic potential. 
Testicular non-neuronal acetylcholine has been reported for its role in germ cell differentiation 
(Schirmer et al. 2011) and its deficiency has been demonstrated to reduce sperm motility and 
production (Bray et al. 2005; Schirmer et al. 2011; Yamamoto et al. 1998). Acetylcholinesterase 
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inhibits the actions of acetylcholine, which could have a negative effect on testicular functions. 
The decreased inhibition of acetylcholinesterase activity on induction of T2D (Figure 3.6.5) thus 
portrays a reduced acetylcholine function, further portraying the detrimental effect of T2D on male 
reproductive health. The increased inhibition in the treatment groups insinuates an increased 
acetylcholine function, which may demonstrate an improved testicular function. 
The distorted testicular morphology on induction of T2D (Figure 3.6.6B) can be attributed to the 
peroxidation of the lipid membrane by hyperglycaemia-generated free radicals, leading to loss of 
cellular integrity (Armagan et al. 2006; Merker et al. 1996). The decreased numbers of 
spermatogonia, spermatocytes, and spermatozoa connotes impaired spermatogenesis, which 
correlates with previous reports on the detrimental effect of diabetes and oxidative stress on 
testicular functions (Asadi et al. 2017; Erukainure et al. 2012; Kaur and Bansal 2004; Turner and 
Lysiak 2008; Zhao et al. 2017). The near-intactness of the tissue morphology after treatment with 
high dose of Raffia palm wine indicates a therapeutic effect (Figure 3.6.6D). The restoration of 
the numbers spermatogonia, spermatocytes, and spermatozoa to near normal, further portrays a 
spermatogenic effect. The altered morphology and cells of DSM (Figure 3.6.6E) and PHD 
(Figure 3.6.6F), may portray toxic effects of metformin on diabetic-testicular injury and Raffia 
palm wine on healthy testicular tissues. These morphological changes correlate with the ImageJ 
analyzed cell size (Figure 3.6.7), with the increased size of DSG further reflecting the therapeutic 
effect of Raffia palm wine (high dose).  
These therapeutic activities of Raffia palm win may be attributed to its reported mineral and 
vitamin constituents, particularly ascorbic acid (Bassir 1962; Cunningham and Wehmeyer 1988; 
Eze and Ogan 1988; Obahiagbon and Osagie 2007; Tuley 1965). 
3.6.6 Conclusion 
These results indicate the therapeutic potentials of Raffia palm wine against the detrimental effect 
of T2D on testicular functions and morphology. Thus, giving credence to its folkloric claims. 
However, its morphological effect on healthy tissues may require caution in its consumption. 
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Preface: This article investigated the effect of Raffia palm wine on lipid metabolites and metabolic 
pathways in type 2 diabetes induced testicular injury. The lipid metabolites, hormones and 
antioxidant markers and the pathways involved were reported. It is presently under review for 
publication in Biomedicine and Pharmacotherapy (BIOPHA_2018_5945). 
3.7.1 Abstract 
Testicular lipids play important functions on male fertility but also increases the susceptibility of 
the testes to peroxidative damage. This study investigates the effect of Raffia palm wine on 
dysregulated lipid metabolic pathways in testicular tissues of type 2 diabetic (T2D) rats. Raffia 
palm wine (150 and 300 mg/kg bodyweight) was administered to two T2D groups respectively, 
another T2D group was not administered treatment and served as negative control, while 
metformin served as the standard drug. After 6 weeks of treatment, the rats were sacrificed, and 
the testes collected. After weighing, the organs were homogenized in 20% methanol/ethanol and 
centrifuged at 20,000 g to extract the lipid metabolites. GC-MS analysis of the supernatants 
revealed an alteration of the metabolites on induction of T2D, with concomitant generation of 10 
metabolites. Raffia palm wine inhibited the T2D-generated metabolites while replenishing 
cholesterol and squalene levels, with concomitant generation of 7 and 8 metabolites for low and 
high dose treatment respectively. Pathway enrichment analysis of the metabolites revealed a 
decreased level of steroid biosynthesis and increased level of fatty acid biosynthesis. Raffia palm 
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wine inactivated glycerolipid, fatty acid, and arachidonic acid metabolisms, fatty acid biosynthesis 
and fatty acid elongation in mitochondria pathways, and activated pathways for plasmalogen 
synthesis, mitochondrial beta-oxidation of long chain saturated fatty acids. The replenishment and 
generation of these metabolites and additional ones as well as activation of pathways involved in 
energy generation, phospholipids, antioxidant activity, steroidogenesis and spermatogenesis 
suggest a therapeutic effect of Raffia palm wine against hyperglycemic-induced testicular 
dysfunction. 
Keywords: Lipid metabolites; Metabolic pathways; Testicular Dysfunction; Type 2 diabetes. 
3.7.2 Introduction 
The increasing incidence of diabetes mellitus (DM) is a major concern to global health 
practitioners. It is an endocranial disorder arising from inability of the pancreatic β-cells to secrete 
insulin (type 1 diabetes [T1D]) and/or inability of the tissues to utilized secreted insulin (type 2 
diabetes [T2D]) (Erukainure et al. 2017b; Erukainure et al. 2018b). Of these types, T2D is the 
predominant and have been implicated in chronic hyperglycemia which compromises male fertility 
by impairing sperm quality, reducing fecundity, and fragmenting spermatozoa DNA (Dias et al. 
2014; Rato et al. 2015b). This has been attributed to metabolic syndrome and hyperglycemic 
induced hormonal and metabolic dysfunction, concomitantly impairing spermatogenesis and 
steriodogensis (Dias et al. 2014; Ehala-Aleksejev and Punab 2018; Xu et al. 2014). The high lipid 
composition of the testicular tissue and sperm cells makes them susceptible to peroxidative damage 
by hyperglycaemic-induced oxidative stress (Erukainure et al. 2012; Obode et al. 2015). Oxidative 
stress occurs when the testicular antioxidant system is overwhelmed by reactive oxygen species 
(ROS) generated by hyperglycaemia (Erukainure et al. 2017b; Maritim et al. 2003b). Peroxidation 
of these lipids alters their normal homeostasis, leading to testicular and erectile dysfunction as 
testicular lipids play major roles in spermatogenesis and steriodogensis (Maqdasy et al. 2013; 
Sèdes et al. 2017). 
Medicinal plants have been employed in the treatment and management of T2D and its 
complications (Ezuruike and Prieto 2014; Mohammed et al. 2014), as well as male infertility 
(Mbongue et al. 2005; Nantia et al. 2009) from time immemorial. This has been attributed to their 
phytochemical and nutritional constituents. These plants are readily available and affordable, with 
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little or no reported side effects. Amongst such plants is the Raffia palm (Raphia hookeri) and its 
constituent, Raffia palm wine. 
This study aims to report the effect of T2D on testicular lipid metabolites and metabolic pathways 
and the therapeutic potentials of Raffia palm wine in male albino rats. 
3.7.3 Materials and Methods 
Kindly refer to Chapter 2, subsections 2.1.1; 2.1.3; 2.12 – 2.13 for details materials and methods.  
3.7.4 Results 
Induction of T2D led to a reduction in the weight of the testes organs as shown in Figure 3.7.1. 
There was an increase in weight after treatment with Raffia palm wine, with the lower dose having 
the highest gain compared to the high dose and metformin – treated groups. 
 
Figure 3.7.1: Weight of testes organs of experimental groups. Data = mean ± SD; n = 5 (NC & 
PHD) and 7 (DC, DSG-LD, DSG, & DSM). NC = normal rats, DC = diabetic control, DSG-LD 
= diabetic rats + Raffia palm wine (150 g/kg bw), DSG = diabetic rats + Raffia palm wine (300 
g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and PHD = Normal rats + Raffia palm 
wine (300 g/kg bw). 
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GC-MS analysis of the extracted testicular lipid metabolites from the normal rats (NC) revealed a 
very high level of cholesterol as depicted in Table 3.7.1. A high percentage of unsaturated fatty 
acids and their esters as well as low percentage of saturated fatty acids were also identified. The 
vitamin D metabolite, 24,25-dihydroxyvitamin D and the androsterone metabolite, androstane-
3,11,17-triol were present in minute percentages. Other identified metabolites include 2-heptanone 
and cholesta-4,6-dien-3-one.  
Induction of T2D led to inhibition of 82.1% of these metabolites, while retaining pentadecanoic 
acid, ethyl hexadecanoate, arachidonic acid, cholesterol and icosapentaenoic acid as shown in 
Table 3.7.1. The levels of arachidonic acid and cholesterol were significantly reduced, while the 
others increased. Onset of T2D also led to generation of 10 metabolites, with ethyl linoleate and 
(E)-9-octadecenoic acid ethyl ester being the most abundant (12.12 and 13.78% respectively), 
while eicosanoic acid (1.39%), methyl stearate (1.05%), and cholest-8-en-3-yl acetate (0.34%) 
were the least.  
Treatment with low dose of Raffia palm wine led to the restoration of squalene and increased 
cholesterol level (Table 3.7.1). It also caused an inhibition of the T2D – generated metabolites 
except icosapentaenoic acid, methyl linoleate and eicosanoic acid, ethyl ester which were 
significantly reduced. They also led to concomitant generation of 7 metabolites particularly the 
antioxidant, vitamin A aldehyde and the eicosanoic acid triglyceride, triarachidin. 
Treatment with high dose of Raffia palm wine led to significant increase in squalene and 
cholesterol levels, while inhibiting ethyl hexadecanoate and all T2D – generated metabolites 
(Table 3.7.1). It also led to concomitant generation of other 8 metabolites particularly the 
testosterone anabolic metabolite, 11.alpha.-Hydroxy-17.alpha.-methyl testosterone and 
glycoprotein, N-acetylgalactosamine. Octadecanoic acid was common to both Raffia palm wine 
treated groups, with DSG-LD having a higher level (2.79%). 
Treatment with metformin also caused a significant increase in squalene and cholesterol levels and 
regeneration of pentadecanoic acid and ethyl icosanoate (Table 3.7.1). Except for 10-octadecenoic 
acid, methyl ester and methyl stearate, the T2D-generated metabolites were inhibited.  There was 
concomitant generation of 10 metabolites particularly the antioxidant metabolite, ascorbic acid 
dipalmitate. The group had higher levels of methyl palmitate (1.85%) and 11,14-eicosadienoic 
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acid, methyl ester (3.12%) compared to that of DSG, while the ethyl oleate level (6.93%) was 
higher than that of DSG-LD. 
Administration of Raffia palm wine to normal rats (PHD) led to increased levels of pentadecanoic 
acid (2.79%) and cholesterol (48.37%), while depleting that of ethyl icosanoate, arachidonic acid 
and squalene as compared to NC. It also led to the generation of 9 metabolites particularly the 
vitamin D metabolite, 1,25-Dihydroxyvitamin D3, TMS derivative. 
Table 3.7.1: GC-MS identified testicular lipid metabolites of experimental groups 
Metabolites NC 
(%) 
DC 
(%) 
DSG-LD 
(%) 
DSG 
(%) 
DSM 
(%) 
PHD 
(%) 
Pentadecanoic acid 1.34 2.91 4.8 2.81 – 2.68 
Palmitic acid 1.55 2.91 – – – – 
Ethyl hexadecanoate 2.15 9.09 2.88 – 4.38 – 
Linoleic acid ethyl ester 1.02 – – – – – 
9-Octadecenoic acid, ethyl ester 1.05 – – – – – 
Ethyl icosanoate 1.48 – – – 2.02 1 
Arachidonic acid 1.37 0.88 – 0.66 0.9 0.44 
Docosahexaenoic acid 3.3 – – – – – 
2-Heptanone 0.77 – – – – – 
24,25-Dihydroxyvitamin D 0.52 – – – – – 
Nonyl isovalerate 0.27 – – – – – 
Squalene 1.35 – 0.61 1.04 0.88 0.7 
Cholesterol 43.16 17.43 34.95 53.1 34.12 48.37 
Androstane-3,11,17-triol 0.29 – – – – – 
Cholesta-4,6-dien-3-one 0.63 – – – – – 
Isosteviol 0.56 – – – – – 
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Icosapentaenoic acid 0.37 2.77 1.49 – 1.9 – 
Glycerol 1,2-dipalmitate – 1.9 – – – – 
Tetradecanoic acid – 2.58 – – – – 
Methyl linoleate – 4.17 2.54 – – – 
10-Octadecenoic acid, methyl ester – 4.51 – – 3.27 – 
Methyl stearate – 1.05 – – 1.11 – 
Ethyl linoleate – 12.12 – – – 0.95 
(E)-9-Octadecenoic acid ethyl ester – 13.78 – – –  
Eicosanoic acid – 1.39 – – – – 
Eicosanoic acid, ethyl ester – 3.37 1.71 – – – 
Cholest-8-en-3-yl acetate – 0.34 – – – – 
Methyl 14-methylpentadecanoate – – 1.25 – – – 
Methyl 9-eicosenoate – – 2.42 – – – 
9,12-Octadecadienoic acid, ethyl ester – – 8.11 – – – 
Ethyl oleate – – 5.68 – 6.93  
Octadecanoic acid – – 2.79 1.27 – – 
Triarachidin – – 0.41 – – – 
Vitamin A aldehyde – – 0.56 – – – 
Ethyl docosanoate – – – 0.85 – – 
Methyl palmitate – – – 1.17 1.85 – 
2-Dodecenoic acid – – – 1.66 – – 
11,14-Eicosadienoic acid, methyl ester – – – 1.32 3.12 – 
Methyl 15-acetoxyhexadecanoate – – – 1.22 – – 
N-Acetylgalactosamine – – – 0.32 – – 
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11.alpha.-Hydroxy-17.alpha.-methyl 
testosterone 
– – – 0.42 – – 
Globulol – – – 0.77 – – 
Dodecanolactone – – – – 1.25 – 
Ascorbic acid dipalmitate – – – – 1.75 – 
Ethyl octadeca-9,12-dienoate – – – – 7.41 – 
Ethyl 9-tetradecenoate – – – – 1.05 – 
Stearic acid – – – – 0.68 0.86 
2,4-Dimethyladipic acid – – – – 0.3 – 
Cholesterol, myristate – – – – 0.57 – 
10,12-Docasadiyndioic acid – – – – – 0.69 
15-Hydroxypentadecanoic acid – – – – – 1.47 
Oleamide – – – – – 0.34 
1,25-Dihydroxyvitamin D3, TMS 
derivative 
– – – – – 1.48 
5-Hexylsulfanylpentane-1,2,3,4-tetrol – – – – – 1.59 
Cholesta-3,5-diene – – – – – 0.6 
Distearin – – – – – 0.42 
Methyl 5-eicosenoate – – – – – 0.41 
Key: – = not present. NC = normal rats, DC = diabetic control, DSG-LD = diabetic rats + Raffia 
palm wine (150 g/kg bw), DSG = diabetic rats + Raffia palm wine (300 g/kg bw), DSM = diabetic 
rats + metformin (200 g/kg bw), and PHD = Normal rats + Raffia palm wine (300 g/kg bw). 
 Pathway enrichment analysis of the GC-MS identified lipid metabolites revealed the activation of 
metabolic pathways for steroid biosynthesis, alpha linolenic and linoleic acids metabolism, bile 
acid biosynthesis, glycerolipid metabolism, fatty acid biosynthesis, metabolism and elongation in 
mitochondria, steroidogenesis, and arachidonic acid metabolism as depicted in Table 3.7.2 and 
Figure 3.7.2. These pathways were not inactivated on induction of T2D but base on their p-values, 
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the level of fatty acid and steroid biosynthesis were respectively higher and lower on the onset of 
T2D (Figure 3.7.2).  
Table 3.7.2: Metabolic pathways of testicular lipid metabolites of experimental groups 
Pathways NC DC DSG-LD DSG DSM PHD 
Steroid Biosynthesis X X X X X X 
Alpha Linolenic Acid and Linoleic Acid 
Metabolism 
X X X X X X 
Bile Acid Biosynthesis X X X X X X 
Glycerolipid Metabolism X X – – – – 
Fatty Acid Biosynthesis X X – X – – 
Fatty Acid Elongation in Mitochondria X X – – – – 
Fatty acid Metabolism X X – – – – 
Steroidogenesis X X X X X X 
Arachidonic Acid Metabolism X X – X X X 
Plasmalogen Synthesis – – X X X X 
Mitochondrial Beta-Oxidation of Long Chain 
Saturated Fatty Acids 
– – X X X X 
Retinol Metabolism – – X – – – 
Key: X = present; – = not present. NC = normal rats, DC = diabetic control, DSG-LD = diabetic 
rats + Raffia palm wine (150 g/kg bw), DSG = diabetic rats + Raffia palm wine (300 g/kg bw), 
DSM = diabetic rats + metformin (200 g/kg bw), and PHD = Normal rats + Raffia palm wine 
(300 g/kg bw). 
Treatment with low dose of Raffia palm wine led to inactivation of glycerolipid, fatty acid, and 
arachidonic acid metabolisms, fatty acid biosynthesis and mitochondria fatty acid elongation 
pathways (Figure 3.7.2). Base on the p-value (Figure 3.7.2), biosynthesis of bile acid was 
significantly reduced. There was an activation of 3 additional pathways for plasmalogen synthesis, 
mitochondrial beta-oxidation of long chain saturated fatty acids, and retinol metabolism.  
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Figure 3.7.2: Pathway enrichment analysis of GC-MS identified testicular lipid metabolites of (A) NC; (B) DC; (C) DSG-LD; (D) DSG; 
(E) DSM; and (F) PHD. NC = normal rats, DC = diabetic control, DSG-LD = diabetic rats + Raffia palm wine (150 g/kg bw), DSG = 
diabetic rats + Raffia palm wine (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and PHD = Normal rats + Raffia palm 
wine (300 g/kg bw).
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Higher dose of Raffia palm wine inactivated glycerolipid, and fatty acid metabolisms and fatty 
acid elongation in mitochondria pathways in T2D rats (Table 3.7.2), while concomitantly 
activating plasmalogen synthesis and mitochondrial beta-oxidation of long chain saturated fatty 
acids pathways. Based on the p-value (Figure 3.7.2), arachidonic acid was the least activated. 
Treatment with metformin also activated plasmalogen synthesis and mitochondrial beta-oxidation 
of long chain saturated fatty acids pathways (Table 3.7.2), and inactivated the pathways for 
glycerolipid, fatty acid metabolisms, fatty acid biosynthesis, and elongation in mitochondria. This 
was also observed in normal rats administered Raffia palm wine (Table 3.7.2). 
3.7.5 Discussion 
The importance of testicular lipids has been demonstrated in their roles in spermatogenesis, sperm 
maturity, viability and capacitation, steroidogenesis, membrane remodeling of developing germ 
cells, and fertilization (Maqdasy et al. 2013; Pushpendra and Jain 2015; Shi et al. 2018). These 
lipids also increase the testes and sperm cells susceptibility to peroxidative damage inspite of the 
testicular oxygen torsion (Asadi et al. 2017; Erukainure et al. 2012), which alters the testicular 
functions. In this study, we investigated the effect of T2D on testicular lipid metabolites and their 
metabolic pathways. 
Cholesterol has been recognized as a crucial lipid in the male reproductive system, as the testicular 
physiology is dependent on its homeostasis (Maqdasy et al. 2013; Pushpendra and Jain 2015). This 
is demonstrated by its role in endocytosis, intracellular signaling, membrane permeability, fluidity, 
and composition (Maqdasy et al. 2013). The high cholesterol level of the normal rats (NC) 
correlates with the identified metabolic pathways: steroid biosynthesis, bile acid biosynthesis, and 
steroidogenesis (Table 3.7.2). These pathways are involved in spermatogenesis and the generation 
of steroids important for fertility (Ajiboye et al. 2016; Maqdasy et al. 2013; Sèdes et al. 2017), 
with cholesterol as their major precursor (Maqdasy et al. 2013). Thus, their activation may indicate 
a functional reproductive system. The presence of the androgen derivative, androstane-3,11,17-
triol may also attest to this. Palmitic acid is the most studied saturated fatty acid component of the 
testicular and sperm phospholipids (Štramová et al. 2015). Its presence in the NC group correlates 
with the steroid, bile acid, and fatty acid biosynthesis, glycerolipid, and fatty acid metabolisms, 
and fatty acid elongation metabolic pathways (Table 3.7.2). These pathways are also involved in 
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optimal testicular functions (Maqdasy et al. 2013; Sèdes et al. 2017), thus further demonstrating a 
functional reproductive system in the normal rats. Although both NC and DC groups had the same 
metabolic pathways, the high level of fatty acid biosynthesis in the latter can be attributed to the 
presence of tetradecanoic acid (myristic acid). The depleted cholesterol level coupled with the 
complete depletion of androstane-3,11,17-triol as well as the reduced level of steroid biosynthesis 
pathway in DC may suggest a suppressive effect on the reproductive system on induction of T2D. 
This corroborates previous reports on the suppressive effect of T2D on male fertility (Dinulovic 
and Radonjic 1990; Erukainure et al. 2012; Obode et al. 2015; Xu et al. 2014). The increased 
cholesterol level on treatment with Raffia palm wine, suggests a therapeutic potential as evident 
by the increased level of steroid biosynthesis and steroidogenesis (Figure 3.7.2). The reduced level 
of bile biosynthesis in the treated groups can be attributed to the complete depletion of palmitic 
acid, which is also evident in the inactivation of glycerolipid and fatty acid metabolisms, fatty acid 
biosynthesis and elongation pathways (Figure 3.7.2 and Table 3.7.2). 
There was activation of mitochondrial beta-oxidation of long chain saturated fatty acids in all the 
treated group (DSG-LD, DSG, DSM and PHD) (Table 3.7.2), which can be attributed to the 
presence of stearic acid (Table 3.7.1). Stearic acid, a non-essential fatty acid has been reported in 
the lipid composition of testicular tissues and sperm cells (Mateo and Roldan 2015) as well as a 
precursor and/or fuel for mitochondria beta-oxidation of long chain saturated fatty acids pathway 
(Singh et al. 1989). This pathway plays a major role in ATP production in tissues associated with 
high energy requirement (Adeva-Andany et al. 2018; Bastin 2014). It generates the electron 
carriers NADH and FADH2, which is channeled to respiratory chain to produce ATPs. The acetyl-
coA also produced, can either be channeled to the citric acid cycle to yield more electron carriers 
for ATP production or used as a precursor for the biosynthesis of other metabolites and/or 
hormones. The activation of this pathway also potentiates the therapeutic effects of the treatments 
on T2D-induced male reproductive toxicity, as spermatogenesis as well as sperm motility have 
been shown to be energy-demanding (Guraya 2012; Mukai and Travis 2012). 
Similarly, the activation of plasmalogen synthesis (Table 3.7.2) in the treatment groups can also 
be attributed to the presence of stearic acid (Table 3.7.1). Plasmalogens have been recognized as 
one of the most predominant phospholipids commonly found in tissue membrane, with 
ethanolamine and choline-linked headgroups being the majors in animal cells (Gorgas et al. 2006; 
Nagan and Zoeller 2001). The activation of this pathway may be attributed to the development and 
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maintenance of testicular membrane integrity by Raffia palm wine and metformin, owing to the 
inactivation of glycerolipid metabolism. Plasmalogens have also been implicated in male fertility 
as they play a major role in spermatogonial amplification and differentiation during 
spermatogenesis (Gorgas et al. 2006), which is also evident on the arrest of spermatogenesis in 
plasmalogen-deficient mice (Gorgas et al. 2006; Zhang et al. 2005). They also makeup the plasma-
membrane of spermatozoa (Gorgas et al. 2006).  
The presence of the vitamin D metabolites, 24,25-dihydroxyvitamin D and 1,25-dihydroxyvitamin 
D3, TMS derivative in NC and PHD respectively (Table 3.7.1) connotes vitamin D metabolism in 
the normal rats. The physiological role of 24,25-dihydroxyvitamin D is still controversial, but it 
has been linked to calcium transportation and homeostasis (St-Arnaud and Glorieux 1998). 
Calcium plays an important role in cell signaling and spermatogenesis (Golpour et al. 2017; Lee 
et al. 2006), thus emphasizing the importance of this metabolite. While 1,25-dihydroxyvitamin D3 
and its derivatives have been reported for their role in steroidogenesis and other testicular functions 
(Hofer et al. 2014; Lundqvist 2011; Lundqvist et al. 2010). The absence of these metabolites in 
T2D rats (untreated and treated) further denotes a suppressive effect on normal testicular functions. 
The presence of the antioxidant metabolites, vitamin A aldehyde and ascorbic acid dipalmitate in 
DSG-LD and DSM respectively depicts an antioxidant activity. Oxidative stress has been 
recognized as a major mechanism by which DM induces testicular damage (Erukainure et al. 2012; 
Obode et al. 2015). It occurs when the hyperglycemia-generated free radicals surpasses the 
testicular antioxidant system (Obode et al. 2015). The antioxidant activities of both metabolites 
have been established (Mueller and Boehm 2011; Sirmali et al. 2014) as well as their therapeutic 
role in male reproductive dysfunction (Azari et al. 2014; Goralczyk et al. 1992; Hogarth et al. 
2011; Vernet et al. 2006). The presence of vitamin A aldehyde correlates with the activation of 
retinal metabolism in DSG-LD group (Table 3.7.2) which plays a key role in spermatogenesis by 
regulating germ cell differentiation (Hogarth and Griswold 2010). The presence of vitamin A 
aldehyde can be attributed to the reported vitamin A content of Raffia palm wine (Chandrasekhar 
et al. 2012; Ogbonna et al. 2013). 
Arachidonic, icosapentaenoic, docosahexaenoic, alpha‐ linolenic, and linoleic acids constitute the 
most studied polyunsaturated fatty acids (PUFA) in testicular and sperm phospholipids 
(Safarinejad et al. 2010; Štramová et al. 2015). Their roles in testicular – functions and antioxidant, 
and male fertility have been established (Safarinejad et al. 2010; Wathes et al. 2007). Due to their 
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unsaturation, they are susceptible to peroxidative attack (Štramová et al. 2015; Wathes et al. 2007) 
which also explains the susceptibility of the testicular tissue to oxidative damage. In this study, the 
presence of arachidonic, icosapentaenoic, and docosahexaenoic acids, as well as linolenic, and 
linoleic esters correlates with the activation of alpha linolenic acid and linoleic, and arachidonic 
acids metabolisms pathways (Table 3.7.2). Although induction of T2D had little or no effect on 
these pathways, the levels of the PUFAs were however altered with the complete depletion of 
docosahexaenoic acid. Docosahexaenoic acid has been reported for its diverse biological activities, 
particularly its role in steroidogenesis and male fertility (Maillard et al. 2018; Roqueta-Rivera et 
al. 2009). Thus, implying that the complete depletion in T2D rats may contribute to suppressed 
steroidogenesis. 
3.7.6 Conclusion 
These results potentiate the alterative effect of T2D on testicular lipids metabolites and their 
metabolic pathways which may have detrimental effect on steroidogenesis and spermatogenesis. 
The replenishment and generation of these metabolites and additional ones as well as activation of 
pathways involved in energy generation, phospholipids, antioxidant activity, steroidogenesis and 
spermatogenesis in the treated groups, suggests a therapeutic effect of Raffia palm wine against 
hyperglycemic – induced testicular lipid dysregulation. 
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CHAPTER 4 
THE ANTI-OXIDATIVE AND ANTI-DIABETIC ACTIVITIES OF 
PHASEOLUS LUNATUS Linn (LIMA BEANS) IN VITRO AND EX VIVO 
4.1 Phaseolus lunatus L. 
 
Figure 4.1: Phaseolus lunatus seeds; Common names: lima beans (English); akidi (Igbo, 
Nigeria); fève créole, haricot de lima (French); indische mondbohne, limabohne, mondbohne 
(German); sem phali (Hindi); alubia de lima (Spanish). Photo: https://phytomaniac.com/high-
protein-legumes/ (accessed on July 11, 2018 without permission). 
4.1.2 Background 
Phaseolus lunatus L. is regarded globally as a minor crop and amongst the underutilized legumes 
despite its nutritional and medicinal properties, diversity, and yield potential (Nwokolo and Smartt 
1996). It is an annual perennial crop cultivated in both temperate and sub-tropic regions of the 
world, with wide spread in Canada, Argentina, as well as in Asia, Africa, Europe and Australia 
(Adeparusi 2001; Baudoin et al. 2008; Nwokolo and Smartt 1996).  
4.1.3 Ethnopharmacological uses 
The seeds have been reported for their low glycaemic and insulinomic indices (Brand et al. 1990). 
Decoctions of the seeds are used in treating and managing diabetes (Ezuruike and Prieto 2014). 
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Macerations from the seeds are rubbed on small cuts, tumors and boils for pus discharge (Royal 
Botanic Gardens 2016). The seeds are employed in treating fever (Saleem et al. 2016). 
4.1.4 Biological activities 
The protein hydroxylates from P. lunatus have been demonstrated to inhibit Angiotensin 
converting enzyme-1 (ACE-I) activity (Betancur-Ancona et al. 2015; Chel-Guerrero et al. 2012). 
They have been reported for their potent free radical scavenging activities (Agostini-Costa et al. 
2015; Sundaram et al. 2013). Its other reported biological activities include antidiabetic and 
hypocholesterolemic (Johnson et al. 2013; Oboh and Omofoma 2008), antifungal and 
antiproliferative (Saleem et al. 2016), cysteine proteinase, trypsin and chymotrypsin inhibition 
(Lawrence and Nielsen 2001; Saleem et al. 2016). 
4.1.5 Nutritional properties 
The seeds of P. lunatus are rich sources of the dietary minerals, calcium, magnesium, sodium, 
iron, zinc, potassium and phosphorus (Saleem et al. 2016). They are also rich in vitamins A, B2, 
B3, B6, C, E and K (Bolade et al. 2017; Saleem et al. 2016). The seed coats have been reported to 
be rich in threonine, valine, isoleucine, tryptophan, leucine, lysine and histidine (Seidu et al. 2015). 
4.1.6 Phytochemistry 
Phytochemical studies on P. lunatus revealed the presence of tannins, saponins and its derivatives, 
sapogenol and sojasapogenol (Oboh et al. 1998), robinin, cyanidin (Onyilagha and Islam 2009), 
lunatusin, kievitone and its derivatives, kievitol and cyclokievitone (Wong and Ng 2005), 
phaseollidin, coumestrol, lunatone, psoralidin (O'Neill et al. 1986), cyanogenic glycosides 
(Akande et al. 2010), cytokinin (Mok et al. 1982), linamarin (Frehner and Conn 1987), phaseolin 
(Moraes et al. 2000), and phytic acid (Adeparusi 2001). 
3.1.7 Aims and objective 
The aims of this study are to investigate the antioxidative and antidiabetic activities of the aqueous 
extract of P. lunatus, using in vitro and ex vivo models as well as its phytochemical and amino acid 
constituents. 
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4.2 Phaseolus lunatus (Lima Beans) Abates Fe2+-induced hepatic redox 
imbalance; inhibits Intestinal Glucose Absorption and Major Carbohydrate 
and Lipids Catabolic Enzymes; and Modulates Muscle Glucose Uptake 
1,3Ochuko Lucky Erukainure, 1Ramgopal Mopuri, 1Chika Ifenyi Chukwuma, 2Neil Anthony 
Koorbanally, 1Md. Shahidul Islam* 
1. Department of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, 
(Westville Campus), Durban 4000, South Africa  
2. School of Chemistry and Physics, University of KwaZulu-Natal, (Westville Campus), 
Durban 4000, South Africa  
3. Nutrition and Toxicology Division, Federal Institute of Industrial Research, Lagos, Nigeria 
*Corresponding author: islamd@ukzn.ac.za; Tel: +27 (0)31-260-8717; Fax: +27 (0)31-260-7942 
Preface: This article investigated the in vitro antioxidant and enzyme inhibitory activities, as well 
as the ex vivo antioxidative, and glucose absorption and uptake effects of P. lunatus. The amino 
acid and phytochemical constituents were also investigated. It has been published in Journal of 
Food Biochemistry (Erukainure OL, Mopuri R, Chukwuma CI, Koorbanally NA, Islam MS 
(2018) Phaseolus lunatus (Lima Beans) Abates Fe2+-induced hepatic redox imbalance; inhibits 
Intestinal Glucose Absorption and Major Carbohydrate Catabolic Enzymes; and Modulates 
Muscle Glucose Uptake. Journal of Food Biochemistry. DOI: 10.1111/jfbc.12655). 
4.2.1 Abstract 
The antioxidative and antidiabetic effects of the aqueous extract of Phaseolus lunatus were 
investigated in vitro and ex vivo. The seeds were subjected to aqueous extraction, after defatting 
with n-hexane. The extract (15, 30, 60, 120, 240 µg/mL) showed significant (p<0.05) free radical 
scavenging and enzyme inhibitory activities in vitro. It significantly (p<0.05) elevated GSH level 
with concomitant depletion of malondialdehyde (MDA) level as well as increased superoxide 
dismutase (SOD) and catalase activities in rat liver. Fe2+-induced hepatic DNA fragmentation was 
also significantly (p<0.05) suppressed. The extract significantly inhibited intestinal glucose 
absorption and increased muscle glucose uptake with and without insulin. The inhibitory activities 
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and reversion of hepatic redox imbalance, as well as inhibition of intestinal glucose absorption and 
increased muscle glucose uptake by P. lunatus suggest its anti-oxidative and anti-hyperglycemic 
effects. These can be ascribed to the synergistic effect of the phytochemicals and amino acids 
identified in the extract. 
KEYWORDS: Anti-hyperglycemia; Antioxidative; Enzymes inhibition; Legumes; and Phaseolus 
lunatus 
4.2.2. Introduction 
Oxidative stress in type 2 diabetes (T2D) has been attributed to hyperglycemia–induced elevated 
reactive oxygen species (ROS), which causes an imbalance in the body’s antioxidant system 
(Tiwari et al. 2013). It has been implicated in the progression of T2D, which could lead to chronic 
pathogenic micro- and macro-vascular complications such as nephropathy, microangiopathy, 
retinopathy and death (Barar 2000; Constantino et al. 2013). Thus, making T2D one of the major 
contributors to global mortality and morbidity (IDF 2016). Unlike type 1 diabetes, T2D has been 
described as a metabolic disorder, which affects carbohydrate, protein and lipid metabolism and 
characterized by insulin resistance and pancreatic β-cell dysfunction (Maritim et al. 2003).  
In most regions of the world, legumes have been recognized as an important source of dietary 
protein especially in developing countries where animal proteins are not affordable by most human 
beings. Legumes are also good source of carbohydrates, dietary fibres, bioactive peptides, essential 
amino acids and vitamins (Yellavila et al. 2015). In addition to the nutritional benefits, their 
medicinal properties have also been reported in many previous studies. Protective effects against 
cardiovascular disease and diabetes have also been correlated with the consumption of legumes 
(Bahadoran and Mirmiran 2014). The abilities of legume to inhibit α-amylase and β-glucosidase 
activities have also been reported previously (Yao et al. 2012). Their attenuation of postprandial 
glycemic response and suppression of dyslipidemia has also been reported previously (Preuss 
2009; Thompson et al. 2012). These activities can be linked to the reported presence of amino 
acids, isoflavones, phenolic acids, saponins, and phytic acid in legumes (Bahadoran and Mirmiran 
2014).  
However, there are little or no scientific evidences to ascertain the antidiabetic claims of P. lunatus. 
Thus, this paper aimed to report the antioxidative activities of the aqueous extract of P. lunatus 
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seeds on oxidative imbalance in hepatic tissues; its inhibitory effect on key carbohydrate and lipids 
digestive enzymes linked to T2D; its effect on intestinal glucose absorption and muscle glucose 
uptake; as well as its amino acid and phytochemical compositions.  
4.2.3 Materials and Methods 
Kindly refer to chapter 2; sub sections 2.1 – 2.1.2; 2.1.5; 2.6 – 2.7.2; 2.10.1; 2.10.6, 2.11.1 and 
2.13 for details. 
4.2.4 Results 
Total phenol analysis revealed a rather very low phenolic content (2.89 ± 0.006 µg/g Gallic Acid 
Equivalent) in the P. lunatus extract. However, the extract showed significant (p<0.05) antioxidant 
activities compared to ascorbic acid measured by DPPH and FRAP methods as depicted in Figures 
4.2.1A and 4.2.1B, respectively. Their lower IC50 values indicate potent antioxidant activities of 
P. lunatus compared to ascorbic acid.  
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Figure 4.2.1: (A) DPPH scavenging activity; and (B) ferric reducing power of P. lunatus 
aqueous extract. Data are presented as mean ± SEM. abValues with different letters above the 
bars for a given concentration are significantly different from each other (p< 0.05, Tukey’s HSD-
multiple range post-hoc test, IBM SPSS for Windows). 
Incubation of hepatic tissues with FeSO4 caused a significant (p<0.05) reduction in GSH level 
indicating an incidence of oxidative injury as depicted in Figure 4.2.2A. Treatment with the extract 
significantly (p<0.05) elevated the GSH levels as compared to gallic acid, with the highest 
concentration of P. lunatus showing an 83.39% increase which portrays a potent antioxidant 
activity. 
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Figure 4.2.2A: Effects of P. lunatus aqueous extract on GSH level in oxidative hepatic injury. 
Data are presented as mean ± SEM. *Significantly different from untreated sample and 
#Significantly different from normal sample (p< 0.05, Tukey’s HSD-multiple range post-hoc test, 
IBM SPSS for Windows). 
The reduced SOD and catalase activities in hepatic tissues further indicate an occurrence of 
oxidative injury on incubation with FeSO4 as depicted in Figures 4.2.2B and 4.2.2C respectively. 
Treatment with the extract caused an increase in their activities, with their highest concentration 
causing 77.91 and 44.87% increases respectively. P. lunatus showed a more potent SOD activity 
(Figure 4.2.2B) than gallic acid as indicated by its lower IC50 value.  
IC50 (µg/mL): P. lunatus = 52.48; Gallic Acid = 50.56 
202 
 
 
 
Figure 4.2.2: Effect of P. lunatus aqueous extract on (B) SOD and (C) catalase activities in 
oxidative hepatic injury. Data are presented as mean ± SEM; U = µmol/mL. #Significantly different 
from normal sample and *Significantly different from untreated sample (p< 0.05, Tukey’s HSD-
multiple range post-hoc test, IBM SPSS for Windows). 
The increased hepatic MDA level on incubation with FeSO4 indicates a manifestation of lipid 
peroxidation as shown in Figure 4.2.2D. Treatment with the extract caused a dose–dependent 
reduction, with the highest concentration causing a 40.82% decrease. 
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Figure 4.2.2D: Effect of P. lunatus aqueous extract on lipid peroxidation in oxidative hepatic 
injury. Data are presented as mean ± SEM. *Significantly different from untreated sample and 
#Significantly different from normal sample (p< 0.05, Tukey’s HSD-multiple range post-hoc test, 
IBM SPSS for Windows). 
The extract significantly inhibited α–glucosidase activity compared to acarbose as depicted in 
Figures 4.2.3A. The extract showed little or no significant inhibitory activity on pancreatic lipase 
as depicted in Figure 4.2.3B. The extract also showed significant inhibition of α-amylase 
compared to acarbose particularly at 15 µg/mL as depicted in Figure 4.2.3C. 
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Figure 4.2.3: (A) α-glucosidase, (B) pancreatic lipase, and (C) α-amylase inhibitory activities of P. lunatus 
aqueous extract. Data are presented as mean ± SEM. abValues with different letter above the bars for a given 
concentration are significantly different from each other (p< 0.05, Tukey’s HSD-multiple range post-hoc test, 
IBM SPSS for Windows). 
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Induction of oxidative injury on incubation with FeSO4 led to significant (p<0.05) increase in 
glucose-6-phosphatase activity as depicted in Figure 4.2.4. Treatment with the extract 
significantly inhibited the activity, when a dose dependent effect was observed as the concentration 
increased from 60 – 240 µg/mL. The highest concentration caused a 59.52% inhibitory effect, thus 
portraying a hypoglycemic potential. 
 
Figure 4.2.4:  Effect of P. lunatus aqueous extract on Glucose-6-Phosphatase activity in oxidative 
hepatic injury. Data are presented as mean ± SEM; U = µmol/mL. *Significantly different from 
untreated sample and #Significantly different from normal sample (p< 0.05, Tukey’s HSD-multiple 
range post-hoc test, IBM SPSS for Windows). 
Induction of oxidative hepatic injury led to significant (p<0.05) increase in DNA fragmentation as 
shown in Figure 4.2.5. This was significantly (p<0.05) and dose dependently reduced after the 
treatment with extract, when highest concentration caused a 39.12% reduction. 
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Figure 4.2.5: Effect of P. lunatus aqueous extract on DNA fragmentation in oxidative hepatic 
injury. Data are presented as mean ± SEM. *Significantly different from untreated sample and 
#Significantly different from normal sample (p< 0.05, Tukey’s HSD-multiple range post-hoc test, 
IBM SPSS for Windows). 
Incubation of isolated rat jejunal tissue with P. lunatus extract led to significant (p<0.05) inhibition 
of glucose absorption dose-dependently with an IC50 of 0.53% and the highest concentration 
causing an 81.25% inhibition as depicted in Figure 4.2.6A. Incubation of isolated rat psoas muscle 
with P. lunatus extract without insulin exhibited a significant (p<0.05) and dose-dependent 
increase in glucose uptake, 94.44% increase was observed for the highest concentration as depicted 
in Figure 4.2.6B. This effect was significantly (p<0.05) enhanced by P. lunatus extract on 
incubation with insulin as the highest concentration caused a 92.31% increase depicting a 
synergetic effect.  
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Figure 4.2.6: Effects of P. lunatus aqueous extract on (A) glucose absorption in isolated rat 
jejunum and (B) glucose uptake with or without insulin in isolated rat psoas muscle. Data are 
presented as mean ± SEM. abValues with different letter above the bars for a given concentration 
are significantly different from each other (p< 0.05, Tukey’s HSD-multiple range post-hoc test, 
IBM SPSS for Windows). 
GC-MS analysis of P. lunatus aqueous extract showed the presence of 6,7-pentadecadien-1-ol; 
phytol acetate; hexadecanoic acid methyl ester; 9,12-octadecadienoic acid methyl ester; 
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Octadecanoic acid methyl ester; N-Acetyl-l-alanine ethylamide; 2-Acetylpyridine; beta.-
stigmasterol; and stigmast-5-en-3-yl (9Z)-9-octadecenoate as shown in Figure 4.2.7 and Table 
4.2.1. 
 
Figure 4.2.7: Structures of the compounds identified in the aqueous extract of P. lunatus 
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Table 4.2.1: Identified compounds of the aqueous extract of the seeds of P. lunatus by GC-MS  
Compounds RT (min) Molecular 
mass (g/mol) 
Relative 
abundance 
(%) 
N-Acetyl-l-alanine ethylamide 
2-Acetylpyridine 
5.39 
6.29 
 
131 
121 
4.68 
7.56 
 
Phytol acetate 
16.36 338 3.16 
Hexadecanoic acid methyl ester 17.26 270 8.23 
9,12-octadecadienoic acid methyl ester 18.90 294 2.10 
Octadecanoic acid methyl ester 
6,7-pentadecadien-1-ol 
Beta.-Stigmasterol 
Stigmast-5-en-3-yl (9Z)-9-octadecenoate 
19.20 
19.37 
26.42 
26.84 
298 
224 
413 
679 
3.48 
10.70 
6.75 
4.90 
 
Amino acid analysis of P. lunatus revealed the concentration of glutamic acid to be the highest 
(Table 4.2.2). This was followed by aspartic acid and leucine, while cysteine was the least. The 
essential amino acids constituted 39.28% of the total amino acids concentration, of which the 
branched chain amino acids were 17.46% with leucine having the highest in concentration. 
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Table 4.2.2: Amino acids composition of the aqueous extract of the seeds of P. lunatus 
Amino Acids Concentration (g/100g protein) 
Leucine 7.70 ± 0.50 
Lysine 5.54 ± 0.09 
Isoleucine 2.29 ± 0.01 
Phenylalanine 3.55 ± 0.10 
Tryptophan 0.81 ± 0.02 
Valine 4.00 ± 0.08 
Methionine 1.01 ± 0.11 
Proline 3.25 ± 0.03 
Arginine 6.53 ± 0.05 
Tyrosine 2.75 ± 0.29 
Histidine 3.19 ± 0.07 
Cystine 0.84 ± 0.02 
Alanine 4.28 ± 0.44 
Glutamic acid 12.11 ± 0.59 
Glycine 4.20 ± 0.13 
Threonine 3.80 ± 0.40 
Serine 4.00 ± 0.26 
Aspartic acid 10.29 ± 0.91 
Values = mean ± SEM; n = 3. 
Prediction of oral toxicity of the identified compounds on ProTox (tox.charite.de) web-based 
server showed that all the identified compounds are in class 6, except hexadecanoic acid methyl, 
octadecanoic acid methyl esters, N-Acetyl-l-alanine ethylamide, 2-Acetylpyridine, beta.-
stigmasterol, and stigmast-5-en-3-yl (9Z)-9-octadecenoate. Hexadecanoic acid methyl, 
octadecanoic acid methyl esters, 2-Acetylpyridine and stigmast-5-en-3-yl (9Z)-9-octadecenoate 
were in class 5. While N-Acetyl-l-alanine ethylamide and beta.-stigmasterol were class 4 as 
depicted in Table 4.2.3. 
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Table 4.2.3: Oral Toxicity prediction of identified compounds of the aqueous extract of P. lunatus 
Ligands       Predicted LD50 (mg/kg) Toxicity Class       Prediction Accuracy (%) 
6,7-pentadecadien-1-ol     5600     6   70.97 
Phytol acetate       8000     6   72.9 
Hexadecanoic acid methyl ester    5000     5   100 
9,12-octadecadienoic acid methyl ester   20000     6   72.9 
Octadecanoic acid methyl ester    5000     5   100 
N-Acetyl-l-alanine ethylamide    1750     4   69.26 
2-Acetylpyridine      2280     5   100 
Beta.-Stigmasterol      890     4   72.9 
Stigmast-5-en-3-yl (9Z)-9-octadecenoate   3000     5   70.97 
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4.2.5. Discussion 
The increasing prevalence of diabetes with concomitant high cost of treatment particularly in 
developing countries has led to the search for novel affordable therapies to combat the disease. 
The antioxidative and anti-hyperglycemia properties of pulses particularly legumes are well 
documented (Pari and Venkateswaran 2003; Singhal et al. 2014). This has been attributed to the 
synergetic effect of their phytochemicals as well as amino acid constituents (Grover et al. 2002; 
Newsholme et al. 2007). In this study, the aqueous extract of P. lunatus was investigated for its 
antioxidative vis-à-vis anti-diabetic potentials in vitro and ex vivo. 
The dose-dependent DPPH scavenging activity of the extract suggests a free radical mopping 
potential of P. lunatus (Figure 4.2.1A). This is further evident by the potent reducing power 
displayed by the extract (Figure 4.2.1B). Several studies have documented the in vitro free radical 
scavenging properties of legumes (Sowndhararajan et al. 2011, Zia-Ul-Haq et al. 2013, Adefegha 
et al. 2017). The abilities of Vigna vexillata, Vigna unguiculata and Mucuna pruriens to scavenge 
free radicals in vitro have been reported as well (Adefegha et al. 2017; Sowndhararajan et al. 2011; 
Zia-Ul-Haq et al. 2013). The antioxidant activities were linked to their total phenolic contents. The 
total phenolic content of P. lunatus in this study was rather very low, thus suggesting synergistic 
effect of the amino acids, especially the hydrophobics, which have been reported in peptides with 
high antioxidant activity (Zou et al. 2016). The antioxidant activity of phytol derivatives have also 
been studied (Santos et al. 2013), thus suggesting the presence of phytol acetate (Table 4.2.1 and 
Figure 4.2.7) may also contributed to the free radical scavenging activity. 
The depleted level of GSH on incubation of hepatic tissue with FeSO4 indicates an occurrence of 
oxidative damage, as depleted levels have been regarded as a marker for oxidative stress (Figure 
4.2.2A). It is the body’s first line of endogenous antioxidant defense system and abundantly found 
in hepatic tissues (Mohamed et al. 2016; Tiwari et al. 2013). The observed depletion can be 
attributed to the oxidation of Fe2+ to Fe3+ leading to the production of ROS. The increased level 
on treatment with the P. lunatus extract indicates an anti-oxidative therapeutic activity against 
oxidative hepatic injury.  
Abundant levels of SOD and catalase levels have been reported in hepatic tissues (Davari et al. 
2013). SOD catalyzes the dismutation of O2
. – to H2O2, which is then converted to O2 and H2O 
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(Erukainure et al. 2017). Thus, their depleted activities in the hepatic tissue on incubation with 
FeSO4 depict an incidence of oxidative hepatic injury (Figures 4.2.2B and 4.2.2C). Their 
significant (p<0.05) increase on treatment with P. lunatus extract also substantiates its 
antioxidative potentials.  
Depletion of cellular GSH level and concomitant decreased catalase activity leads to an 
accumulation of H2O2. In Fe
2+ toxicity, there is a continuous reaction of the accumulating H2O2 
with the unstable cation yielding hydroxyl radicals (•OH) (Aslan et al. 2000). The generated 
hydroxyl radicals then attack the membrane lipid, leading to production of highly reactive 
aldehydes, including MDA, acrolein, 4-hydroxynonenal (HNE), 4-oxononenal (ONE), and 
isolevuglandins (IsoLGs) (Guo et al. 2012). This causes a disturbance in the membrane assembly 
and normal metabolic processes. The increased MDA level in the untreated tissues indicates an 
occurrence of lipid peroxidation. This also corroborates with the depleted GSH level and decreased 
catalase activity, thus further depicting an incidence of oxidative damage on incubation with 
FeSO4. This was significantly (p<0.05) reversed by P. lunatus extract, indicating an anti-
peroxidative effect (Figure 4.2.2D).  
Inhibition of key carbohydrate catabolic enzymes has been demonstrated in several studies as the 
mode of action of most antidiabetic drugs and herbs (Ademiluyi and Oboh 2012; Ademiluyi and 
Oboh 2013). Their inhibition translates to a lower postprandial blood glucose level (Chukwuma 
and Islam 2015). The dose–dependent inhibition of α–glucosidase (Figure 4.2.3A) by the extract 
portrays the ability of P. lunatus to cause a delay in carbohydrate digestion, depicting an anti-
hyperglycemic effect. Furthermore, the inhibition of α-amylase (Figures 4.2.3C) by the extract 
also indicates the anti-hyperglycemia activity of P. lunatus. Similar activities reported by 
Ademiluyi & Oboh (2012, 2013) for soybean, African locust bean, bambara groundnut, African 
yam bean, and melon seed corroborates the inhibitory effect of legumes on α–glucosidase. The 
little or no inhibitory effect by P. lunatus on pancreatic lipase suggests a weak anti-obesogenic 
activity. 
The increased glucose-6-phosphatase activity in the untreated tissue indicates an incidence of 
increased gluconeogenesis and glycogenolysis (Figure 4.2.4). This reflects an occurrence of 
hyperglycemia, which has been linked to the progression and pathogenesis of T2D (Ghosh et al. 
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2004). The reduced activity on treatment with the extract, thus suggests an anti-hyperglycemia 
activity by P. lunatus, which corroborates with its inhibitory activities (Figures 4.2.3A – 4.2.3C).  
Hepatocellular apoptosis, characterized by DNA fragmentation and cellular shrinkage in T2D has 
been reported to be majorly influenced by hyperglycemia – induced oxidative stress (Donath et al. 
1999). The increased DNA fragmentation in the untreated tissue, may indicate an incidence of 
apoptosis (Figure 4.2.5). This can be attributed to the Fe2+ - induced oxidative injury via the 
Fenton pathway which corresponds to previous the reports on iron induced apoptotic cell death in 
isolated rat hepatocytes (Allameh et al. 2010). The decreased fragmentation on treatment with the 
extract indicates an anti-apoptotic activity by P. lunatus.  
The dose – dependent inhibition of intestinal glucose absorption (Figure 4.2.6A) by the extract 
correlates with its inhibitory effects on the studied carbohydrate catabolic enzymes particularly 
intestinal alpha – glucosidase activity (Figure 4.2.3A), further depicting an anti-hyperglycemia 
effect of P. lunatus. This can be attributed the amino acid constituents particularly L- and D-
alanine, which has been demonstrated to inhibit D-glucose uptake by intestinal membrane (Murer 
et al. 1975).  The increased muscle glucose uptake by the extract with insulin (Figure 4.2.6B) 
demonstrates the ability of P. lunatus to improve insulin sensitivity. Insulin resistance or 
insensitivity has been recognized as a major metabolic abnormality in T2D and has been 
implicated in most diabetic complications such as dyslipidemia, hypertension and high coronary 
and cerebrovascular mortality (Monzillo and Hamdy 2003). The observed muscle glucose uptake 
effect of P. lunatus aqueous extract can also be attributed to its amino acid composition (Table 
4.2.2), as their impact on muscle glucose uptake is well known (Kleinert et al. 2011). Kleinert et 
al. (2011) demonstrated the ability of an amino acid mixture of isoleucine, cysteine, methionine, 
valine, and leucine to improve insulin-stimulated glucose uptake in isolated rat epitrochlearis 
muscle.  
The increasing paradigm shift to medicinal plants in the treatment and management of several 
ailments has led to increased concerns of their safety and toxic effects. Their various extracts elicit 
different effects in the body, which could be toxic (Ezuruike and Prieto 2014). Analysis of the 
identified compounds (Table 4.2.1 and Figure 4.2.7) on the ProTox server predicted them to be 
safe when swallowed as they fell between classes 5 – 6 (Table 4.2.3). Computational prediction 
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of drugs and small molecules toxicity has been gaining much ground due to increasing ethical 
questions and animal rights in most developed countries.  
4.2.6. Conclusion 
The inhibitory activities and reversion of hepatic redox imbalance by P. lunatus suggests anti-
hyperglycemia and anti-oxidative effects. This is further portrayed by its ability to inhibit intestinal 
glucose absorption and increase muscle glucose uptake with and without insulin. This can be 
attributed to the synergistic effect of the identified phytochemicals and amino acids. These findings 
also validate the folkloric use of P. lunatus in the treatment and management of diabetes. 
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CHAPTER 5 
THE ANTI-OXIDATIVE AND ANTI-DIABETIC ACTIVITIES OF 
VERNONIA AMYGDALINA (BITTER LEAF) IN VITRO AND EX VIVO 
5.1 Vernonia amygdalina 
 
Figure 5.1: Vernonia amygdalina leaves. Common names: bitter leaf (English); Ewuro, Onugbu, 
Oriwo, Etidot, Ityuna, Chusar doki, Fatefata (Nigeria); Omubirizi, Mululuza (Uganda); 
Awonwono (Ghana); Aluma, Gbondutsi (Togo); Omubilizi (Tanzania); Umubilizi (Rwanda); and 
Ndoleh, Ying (Cameroon). Photo: (Udochukwu et al. 2015). 
5.1.2 Background 
Vernonia amygdalina is a is a perennial shrub belonging to the Asteraceae family, with petiolate 
leaf of about 6 mm in diameter and elliptic shape (Ijeh and Ejike 2011). It is commonly known as 
bitter leaf owing to its bitter taste. It is amongst the common leafy vegetable in West Africa utilized 
for its nutritional and medicinal properties.  
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5.1.3 Ethnopharmacology 
The leaves are consumed usually after washing to remove the bitter taste. They are employed as 
digestive stimulants. The leaf concoctions are used in the treatment of fever, diabetes, and 
hypertension well to reduce fever. The leaves are squeezed and placed on skin and tissue burns 
and cuts.  
5.1.4 Biological activities 
The leaves have been widely studied for their medicinal properties which include antidiabetes 
(Ong et al. 2011; Saliu et al. 2012), antioxidant (Adesanoye and Farombi 2010; Iwalokun et al. 
2006), antihypertensive (Ajibola et al. 2011; Saliu et al. 2012), anti-sickling (Afolabi et al. 2012; 
Chikezie 2006), and anti-obesogenic (Adaramoye et al. 2008) activities. It is also used in the 
treatment and management of gastrointestinal disorders (Akah and Ekekwe 1995), dysentery 
(Moundipa et al. 2005), as well as antimicrobial and antiparasitic activities (Oyeyemi et al. 2018; 
Udochukwu et al. 2015). 
5.1.5 Phytochemistry 
The leaves of V. amygdalina have been studied for their phytochemical properties. This includes 
(1) sesquiterpene lactones which consists of vernolide, vernodalol, vernodalin, 
hydroxyvernolide, vernodalinol, vernomygdin, epivernodalol, 11,13-dihydrovernodalin, and 
3′deoxyvernodalol; (2) flavonoids: luteolin, luteolin 7-O-β-glucuronoside, and lluteolin 7-O-β-
glucoside; (3) steroidal saponins: vernoamyosides A, vernoamyosides B, vernoamyosides C, and 
vernoamyosides D; (4) steroidal glucosides: vemonioside B1 (Farombi and Owoeye 2011; Ijeh 
and Ejike 2011; Oyeyemi et al. 2018; Saliu et al. 2012; Yeap et al. 2010). 
5.1.6 Aim and objectives 
The aim of this study was to investigate the in vitro and ex vivo antioxidative, and antidiabetic 
activities of the extracts and hot water infusion of V. amygdalina, and to identify the metabolic 
pathways that may be involved in this process. The histochemical and phytochemical properties 
of the leaves were also investigated in this study. 
  
223 
 
5.2 Phytol – Rich Extracts of Vernonia Amygdalina Stimulates Muscle 
Glucose Uptake, and Modulates Redox Activities and Functional Chemistry in 
Oxidative Hepatic Injury 
1,2Ochuko L. Erukainure, 1Md. Shahidul Islam* 
1. Department of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, 
(Westville Campus), Durban 4000, South Africa  
2. Nutrition and Toxicology Division, Federal Institute of Industrial Research, Lagos, Nigeria 
*Corresponding author: islamd@ukzn.ac.za; Tel: +27 (0)31-260-8717; Fax: +27 (0)31-260-7942 
Preface: This article investigated the antioxidant, antidiabetic, and chemical properties of the ethyl 
acetate, ethanol and aqueous extracts of V. amygdalina leaves in vitro and ex vivo.  
5.2.1 Abstract 
The ethyl acetate, ethanol and aqueous extracts were obtained from the leaves of Vernonia 
amygdalina and investigated for their antidiabetic and antioxidant protective in oxidative hepatic 
injury. The 2,2'-diphenyl-1-picrylhydrazyl (DPPH) scavenging and Ferric reducing antioxidant 
power (FRAP) protocols were utilized in determining the in vitro antioxidant activities of the 
extracts. Their antidiabetic properties were determined via their inhibitory effect on α-glucosidase 
and α-amylase activities, and stimulation of muscle glucose uptake. Their mitigative effects on 
antioxidative biomarkers in Fe2+-induced oxidative hepatic injury were also investigated ex vivo. 
The chemical functional chemistry of the tissues were investigated using FTIR spectroscopy. The 
extracts showed significant (p<0.05) free radical scavenging and reducing activities. They 
significantly (p<0.05) elevated the level of reduced glutathione (GSH) as well as increased the 
activities of superoxide dismutase and catalase, with concomitant depletion of malondialdehyde 
level. Treatment with the ethanol and aqueous extracts led to removal of oxidative chemical 
functional group at 1500-1200 (amide II) cm-1 region, while there was an inclusion of functional 
group at 3000-2800 (carboxylic acid) cm-1 region in tissues treated with the aqueous extract. The 
extracts significantly (p<0.05) inhibited the activities of α-glucosidase and α-amylase, and 
stimulated glucose uptake in rat muscles. GC-MS analysis of the ethyl acetate and ethanol extracts 
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revealed phytol as the predominant compound, with ethanol having the highest concentration. 
These results suggest the antioxidative and antidiabetic properties of V. amygdalina as evident by 
their ability to scavenge free radicals, modulate antioxidant biomarkers and oxidative chemistry 
changes, and stimulate muscle glucose uptake. 
Keywords: Functional chemistry; Glucose uptake; Oxidative stress; and Vernonia amygdalina 
5.2.2 Introduction 
Diabetes mellitus (DM) has been recognized as the most prevalent of endocrine pathology 
affecting carbohydrate, protein and lipid metabolism (Saltiel and Kahn 2001; Volek et al. 2009). 
These metabolic alterations have been associated with inability of the pancreas to secrete insulin 
and/or inability of the body to utilize the insulin secreted, thereby leading to elevated blood glucose 
level also known as hyperglycemia (Erukainure et al. 2017a). Occurrence of hyperglycemia is 
often referred to as type 2 diabetes (T2D) and accounts for more than 90% of all types of DM, 
making it the major contributor of diabetic morbidity and mortality (I.D.F. 2016). In T2D, 
excessive hyperglycemia can be attributed to insulin insensitivity and pancreatic β-cell dysfunction 
(Erukainure et al. 2017a). Excessive hyperglycemia stimulates the production of ROS, leading to 
oxidative stress when it surpasses the body’s endogenous antioxidant defense system (Saeed et al. 
2012; Tiwari et al. 2013). Oxidative stress has implicated in the pathogenesis and progression of 
T2D complications.  
Several studies have shown the therapeutic effect of antioxidants against hyperglycemia induced 
oxidative stress (Coskun et al. 2005; Rahimi et al. 2005). With natural products from medicinal 
plants showing better activities owing to their antioxidative-phytochemical constituents 
(Erukainure et al. 2013; Ezuruike and Prieto 2014; Saeed et al. 2012). Common amongst such 
plants is Vernonia amygdalina. 
Despite the numerous reports on its medicinal properties, there are however a dearth on the 
functional chemistry of targeted tissues treated with V. amygdalina. Thus, this study aims to report 
the modulatory effect of V. amygdalina extracts on the functional chemistry and antioxidant 
activities in oxidative hepatic injury. The ability of the extracts to stimulate muscle glucose uptake 
and to inhibit major carbohydrate catabolic enzymes was also investigated. 
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5.2.3 Materials and Methods 
Kindly refer to chapter 2, sections 2.1 – 2.4; 2.6.1 – 2.6.2; 2.6.6; 2.7.2; 2.10.1 and 2.10.4 
5.2.4 Results 
The total phenolic contents of the ethanol and aqueous extracts were significantly (p<0.05) higher 
than that of the ethyl acetate as depicted in Figure 5.2.1, with the ethanol extract having the highest 
content of phenolics. 
 
Figure 5.2.1: Total phenolic contents of V. amygdalina extracts. Data = mean ± SD; n = 3. 
abcValues with different letter above the bars for a given extract are significantly (p < 0.05) different 
from each other. 
All extracts significantly scavenged DPPH radicals, indicating a potent free radical scavenging 
activity as compared to the standard drug, ascorbic acid (Figure 5.2.2A).  The low IC50 value of 
the ethanol extract, suggests it as the most active as shown in Table 5.2.1. 
There was a dose dependent increase in FRAP activity by the extracts which was significantly 
(p<0.05) lower than the standard drug as shown in Figure 5.2.2B. The ethanol extract showed the 
best activity with an IC50 value of 638.86 µg/mL (Table 5.2.1). 
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Figure 5.2.2: (A) DPPH scavenging and (B) FRAP activities of V. amygdalina extracts. Data = 
mean ± SD; n = 3. abcValues with different letter above the bars for a given extract are significantly 
(p < 0.05) different from each other. 
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Table 5.2.1: IC50 values of studied biological activities 
Activities Ethyl Acetate Ethanol Aqueous  Ascorbic acid Acarbose Gallic acid 
DPPH 0.08 0.07 0.10 8.32 – – 
FRAP >1000 638.86 >1000 34.04 – – 
α-glucosidase 0.27 0.01 13.52 – 62.73 – 
α-amylase 289.95 102.51 32.08 – 0.04 – 
GSH 392.86 120.01 314.93 – – 3.80 
SOD 25.67 17.60 41.97 – – 84.42 
Catalase 178.09 178.11 171.67 – – 533.41 
Lipid peroxidation 3.65 14.12 7.05 – – 137.56 
Glucose uptake 48.84 41.11 160.61 – – – 
Values are expressed as µg/mL. Key: – = not applicable 
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The ethyl acetate and ethanol extracts showed significant (p<0.05) inhibitory effect on α-
glucosidase activities (Figure 5.2.3A), with IC50 values of 0.27 and 0.01 µg/mL respectively 
(Table 5.2.1). This was much higher than the standard drug, acarbose (IC50 = 62.73 µg/mL). The 
inhibitory activity of the aqueous extract was observed to reduce with increasing concentrations. 
The aqueous extract had the highest inhibitory effect on α-amylase activity amongst the extracts, 
with an IC50 value of 32.08 µg/mL as depicted in Figure 5.2.3B and Table 5.2.1. This was 
followed by the ethanol extract (IC50 = 102.51 µg/mL), with the ethyl acetate having the least (IC50 
= 289.95 µg/mL).  
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Figure 5.2.3: (A) α-glucosidase and (B) α-amylase inhibitory activities of V. amygdalina. Data = 
mean ± SD; n = 3. abcdValues with different letter above the bars for a given extract are significantly 
(p < 0.05) different from each other. 
Incubation of hepatic tissues with FeSO4 led to depleted GSH levels as depicted in Figure 5.2.4A. 
This was significantly increased on incubation with the extracts to near normal, with the ethanol 
extract showing the best activity (IC50 = 120.01 µg/mL).  
Similarly, the extracts significantly (p<0.05) increased the activities of SOD and catalase in 
oxidative hepatic tissues as depicted in Figures 5.2.4B and 4C, with the ethanol (IC50 = 17.60 
µg/mL) and aqueous (IC50 = 171.67 µg/mL) extracts showing the best activities for SOD and 
catalase respectively. The increased hepatic MDA level on incubation with FeSO4 was 
significantly (p<0.05) reduced by the extracts as shown in Fig. 4D, with the ethyl acetate (IC50 = 
3.65 µg/mL) and aqueous (IC50 = 7.05 µg/mL) extracts showing the best activities.  
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Figure 5.2.4: Effect of V. amygdalina extracts on (A) GSH level, (B) SOD activity, (C) catalase 
activity, and (D) MDA level in oxidative pancreatic injury. Values = mean ± SD; n = 3. 
*Significantly different from untreated sample and #Significantly different from normal sample (p 
< 0.05, Tukey’s HSD-multiple range post-hoc test, IBM SPSS for Windows). 
FTIR spectroscopy of the hepatic metabolite revealed that oxidative injury led to loss of chemical 
functional groups at 2175 – 2140 (thiocyanates) cm-1 regions, as well as addition of a chemical 
functional group at 1500 – 1200 (amide II) cm-1 region as shown in Figure 5.2.5 and Table 5.2.2. 
Treatment with the ethanol and aqueous extracts led to removal of the added chemical functional 
group as well as amide I and aromatic amines (1500 – 1200 cm-1 region). The aqueous extract also 
led to the addition of another functional group at 3000 – 2800 (carboxylic acid) cm-1 region. 
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Figure 5.2.5: FTIR spectroscopy of oxidative hepatic tissues treated with V. amygdalina extracts 
Incubation of psoas muscle with extracts of V. amygdalina in the presence of glucose led to 
significant (p<0.05) glucose uptake in a dose dependent manner, with the ethyl acetate (IC50 = 
48.84 µg/mL) and ethanol (IC50 = 41.11 µg/mL) extracts showing the best activities as depicted in 
Figure 5.2.6 and Table 5.2.1. 
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Figure 5.2.6: Effects of V. amygdalina extracts on glucose uptake in isolated rat psoas. Data = 
mean ± SD; n = 3. abValues with different letter above the bas for a given extract are significantly 
(p < 0.05, Tukey’s HSD-multiple range post-hoc test, IBM SPSS for Windows) different from 
each other
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Table 5.2.2: Qualitative FTIR table of oxidative hepatic tissues treated with V. amygdalina extracts 
Regions (cm-1) Normal Untreated Ethyl Acetate Ethanol Aqueous Assignments 
900 – 700 878.92 879.07 878.99 879.15 879.65 1o, 2o amines 
1200 – 900 950.67 950.67 950.24 950.91 951.84 Nucleic acid 
1043.09 1045.16 1045.07 1045.28 1045.78 Nucleic acid 
1086.92 1087.05 1086.97 1087.12 1087.57 Nucleic acid 
1500 – 1200 1326.20 1328.41 1326.91 – – Amide I; Aromatic amines 
1381.91 1381.89 1382.29 1381.41 1380.89 Phenol –O–H 
1414.52 1417.24 1414.94 1416.40 1416.26 Nitramines 
– 1450.58 1450.24 – – Amide II 
1800 – 1500 1650.82 1649.36 1651.07 1651.40 1655.20 β-ketoaldehyde in enol form; ketones 
2175 – 2140  2169.64 – – – – Thiocyanates 
3000 – 2800 – – – – 2897.88 Carboxylic acids 
2975.82 2975.32 2975.64 2975.25 2974.09 Carboxylic acids 
3500 – 3300 3327.89 3328.18 3329.20 3330.18 3328.41 Amine and imine 
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GC-MS analysis of the extract revealed phytol to be the predominant compound in the analyzed 
extracts, with the ethanol having the highest concentration as depicted in Figure 5.2.7A and B, 
and Table 5.2.3).  
 
Figure 5.2.7A: GC-MS identified compounds in V. amygdalina ethyl acetate extract 
Other compounds common in both extracts are: phytol, acetate; eicosanoic acid, ethyl ester; and 
chondrillasterol. Eicosanoic acid; 2,6,10,15-Tetramethylheptadecane; 9,12-Octadecadienoic acid 
(Z,Z)-; 2,6-Octadiene, 4,5-dimethyl-; 3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol; n-Tetracosanol-
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1; alpha.-Tocopherol-.beta.-D-mannoside; and stigmasterol were identified in the ethyl acetate 
extract (Fig. 6A and table 3). While 3,7,11,15-tetramethyl-2-hexadecen-1-ol; 9-eicosyne; 
tridecanoic acid; alpha-linolenic acid; vitamin E; and ethyl iso-allocholate were identified in the 
ethanol extract (Figures 5.2.7B and Table 5.2.3). 
 
Figure 5.2.7B: GC-MS identified compounds in V. amygdalina ethyl acetate extract 
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Table 5.2.3: GC-MS identified compounds in ethyl acetate and ethanol extracts of V. amygdalina 
Compounds Ethyl Acetate Extract (%) Ethanol Extract (%) 
Phytol, acetate 1.03 8.23 
Eicosanoic acid 5.49 –  
Eicosanoic acid, ethyl ester 1.69 1.00 
2,6,10,15-Tetramethylheptadecane 2.54 – 
Phytol 15.68 21.69 
9,12-Octadecadienoic acid (Z,Z)- 2.34 –  
2,6-Octadiene, 4,5-dimethyl- 1.33 –  
3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol 2.07 –  
n-Tetracosanol-1 0.82 –  
alpha.-Tocopherol-.beta.-D-mannoside 0.82 –  
Stigmasterol 0.72 –  
Chondrillasterol 1.71 2.40  
3,7,11,15-Tetramethyl-2-hexadecen-1-ol – 1.51 
9-Eicosyne – 2.52 
Tridecanoic acid – 3.30 
alpha-Linolenic acid – 2.82 
Vitamin E – 1.50 
Ethyl iso-allocholate – 1.32 
Key: – = Absent 
5.2.5 Discussion 
The role of oxidative stress in the progression and pathogenesis of complications associated with 
T2D have been widely studied (Robertson et al. 2004; Wellen and Hotamisligil 2005). It arises 
owing to hyperglycemia as well as uncontrolled production of free radicals on the onset of 
hyperglycemia. The excess free radicals react with cell biomolecules, causing an alteration in their 
biochemistry and function (Toyokuni 1999). In this study, the effect of oxidative stress on the 
functional chemistry of hepatic tissues was investigated as well as the oxidant mitigative effect of 
V. amygdalina and its antidiabetic activity. 
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Plants have been demonstrated to be potent antioxidants (Dudonné et al. 2009), which is evident 
by the potent free radical scavenging activities as well as the reducing power of the V. amygdalina 
extracts (Figure 5.2.1). This can be attributed to their total phenol constituents (Figure 5.2.1). 
Polyphenols scavenge free radicals by donating of H-atom from their OH group/s (Papuc et al. 
2017) and/or delocalization of the double bonds in the benzene ring (Dreosti 2000). The vitamin 
E content and its glycoside, alpha-tocopherol-beta-D-mannoside as well as phytol in the ethanol 
and ethyl acetate extracts (Figure 5.2.7 and Table 5.2.3) may also play a synergetic role, as they 
have been reported for their potent free radical scavenging activities (Kamal‐ Eldin and 
Appelqvist 1996; Santos et al. 2013). 
Iron toxicity has been attributed to the pro-oxidant activity of its ferrous (Fe2+) state via the 
Fenton’s reaction which distorts the cell’s redox balance (Andrews 1999; Jiang et al. 2004; 
Rajpathak et al. 2009). This may be responsible for the depleted GSH level with concomitant 
increased MDA level (lipid peroxidation) as well as decreased SOD and catalase activities in 
hepatic tissues incubated with FeSO4 (Figure 5.2.3A – 3D), signifying oxidative injury. Depleted 
level of GSH is the marker of oxidative stress as it is regarded as the first line of the endogenous 
antioxidant system (Tiwari et al. 2013). SOD catalyzes the dismutation of O2
. – to H2O2, which if 
not broken down by catalase to O2 and H2O would further react with Fe
3+ to generate •OH (Aslan 
et al. 2000). Hydroxyl radicals (•OH) have been reported as potent initiators of membrane lipid 
peroxidation, as they attack the membrane lipids (Dinis et al. 1994; Gutteridge 1995). The 
reversion of these levels and enzymatic activities by the extracts (Figure 5.2.3A – 3D), further 
portrays the antioxidative activities of V. amygdalina which also correlates with its reported 
hepatotoxic protective activities (Adesanoye and Farombi 2010; Arhoghro et al. 2009; Atangwho 
et al. 2007). These activities can also be attributed to the identified phytochemicals, particularly 
phytol, vitamin E and its glycoside, unsaturated fatty acids and esters (Figure 5.2.7 and Table 
5.2.3). The antioxidative protective effects of these phytochemicals have been demonstrated, with 
vitamin E regarded as the most potent (Kamal‐ Eldin and Appelqvist 1996; Richard et al. 2008; 
Santos et al. 2013). 
Some antidiabetic drugs such as acarbose exhibit their actions by inhibiting major carbohydrate 
digestive enzymes implicated in T2D (Scheen 1997; Yee and Fong 1996). These enzymes digest 
dietary carbohydrate, leading to the increase of postprandial glucose level. Thus, the inhibition of 
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α-glucosidase and α-amylase by the extracts (Figure 5.2.4) indicates an antidiabetic potential 
which correlates with the reported antidiabetic properties of V. amygdalina (Atangwho et al. 2009; 
Michael et al. 2010; Okolie et al. 2008; Ong et al. 2011). This can be attributed to the synergetic 
effect of the polyphenol constituents and the identified phytochemicals, as polyphenols are 
reported as potent inhibitors of the studied enzymes as well as modulator of glucose homeostasis 
(Ong et al. 2011; Saliu et al. 2012). 
Fourier Transform Infra-Red spectroscopy (FT-IR) techniques was utilized in this study to 
characterize the oxidative hepatic metabolites. The respective altered and added functional groups 
in the untreated tissues (Figure 5.2.5 and Table 5.2.2) can be attributed to the induction of 
oxidative stress, causing amino acid residues fragmentation and functional loss (Berlett and 
Stadtman 1997; Dalle-Donne et al. 2003). The removal of the added oxidative – functional group 
by the ethanol and ethyl acetate extracts may demonstrate a therapeutic effect. However, the 
removal of amide I and aromatic amines may portray toxicity. Similarly, the inability of the ethyl 
acetate to remove the generated functional group may also portray toxicity. 
Stimulation of skeletal muscle glucose uptake have been demonstrated as an effective mechanism 
employed by some antidiabetic drugs such as metformin in regulation of blood glucose 
homeostasis (Pereira et al. 2017a). This has been attributed to  the activation of GLUT-4 
translocation, which transports glucose to the muscle (Satoh 2014). The stimulated glucose uptake 
by the extracts (Figure 5.2.6) thus indicates an antidiabetic therapeutic effect of V. amygdalina. 
This corresponds with previous studies which reported the ability of the V. amygdalina to stimulate 
glucose uptake and utilization in Chang-liver, C2C12 muscle and 3T3-L1 cells (Erasto et al. 2009). 
This also corroborates previous report on the ability of the leaf extract to down regulate the 
expressions of gluconeogenic enzymes consisting of glucose 6-phosphatase, fructose 1,6-
bisphosphatase and phosphoenol pyruvate carboxykinase in diabetic rats’ muscles (Atangwho et 
al. 2014). 
5.2.6 Conclusion 
These results suggest V. amygdalina leaves may bring about its antioxidative and antidiabetic 
properties via free radical scavenging, modulation of antioxidant biomarkers and oxidative-
induced chemistry changes, and stimulation of muscle glucose uptake. These can be attributed to 
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the synergetic effects of the identified phytochemicals particularly phytol, and vitamin E and its 
glycoside. This further corroborates and validates previous reports on its antidiabetic properties. 
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Preface: This article investigated the phytochemical distribution, antioxidant, and antidiabetic 
properties of the hot water infusion of the leaves of V. amygdalina in vitro and ex vivo. The 
manuscript has been published in the Journal of Food Biochemistry (Erukainure OL, Chukwuma 
CI, Sanni O, Matsabisa MG, Islam MS. (2018). Histochemistry, phenolic content, antioxidant, and 
anti‐ diabetic activities of Vernonia amygdalina leaf extract. J Food Biochem., e12737. 
https://doi.org/10.1111/jfbc.12737) 
5.3.1 Abstract 
Vernonia amygdalina leaves were investigated for their histochemical properties and antidiabetic 
activities. Histochemical analysis of the leaf revealed distributions of acidic lipid, mucilage and 
pectin, lipids, polyphenols and alkaloids at the mid rib, glandular trichome and epidermis. HPLC 
analysis of the leaves hot-water infusion revealed the presence of quercetin and (-)-epi-catechin. 
The infusion had significant (p<0.05) 2,2'-diphenyl-1-picrylhydrazyl (DPPH) scavenging and 
ferric reducing antioxidant power (FRAP) activities. Ex vivo antioxidative analysis revealed the 
ability of the infusion to increase GSH level, SOD and catalase activities, while concomitantly 
depleting MDA level and DNA fragmentation in Fe2+-induced hepatic injury. The infusion 
showed significant (p<0.05) inhibitory activity against α-glucosidase and pancreatic lipase. It also 
inhibited intestinal glucose absorption and enhanced muscle glucose uptake respectively. The 
ability of the infusion to inhibit oxidative stress, DNA fragmentation and stimulate muscle glucose 
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uptake may suggest an antioxidative, anti-apoptotic and insulin-sensitivity activity of V. 
amygdalina. 
Keywords: Antioxidative; Anti-hyperglycemia; Histochemistry; and Vernonia amygdalina 
5.3.2 Introduction 
The use of medicinal plants in the treatment and management of several ailments and diseases 
dates to time immemorial, making these plants and their uses an incumbent part of most cultures. 
About 80% of the third world population are estimated to still rely on medicinal plants as their 
main healthcare source (Ekor 2014), which indicates the relevance of these plants in modern days. 
Several studies have attributed the medicinal properties of these plants to their phytochemical 
constituents (Bruneton 1993; Van Wyk et al. 1997). The efficacies of these plant and 
phytochemicals constituents have been authenticated in several studies to be potent in the treatment 
of several disease types (Chevallier 1996; Ghani 1998; Hutchings 1996). Amongst the many 
diseases treated with medicinal plants with proven efficacy, is diabetes mellitus (DM). 
Diabetes mellitus remains the one of the fastest rising global epidemics, with 425 million people 
globally reported to be living with the disease in 2017 (I.D.F. 2018). This figure has been 
postulated to increase to 625 million in 2045, when Africa to account for 6.5% of the increase 
(I.D.F. 2018). It is a metabolic disease which is resulting from insulin deficiency (type 1 diabetes) 
and/or inability of the body to utilize secreted insulin (type 2 diabetes), thus leading to increased 
blood glucose level (Erukainure et al. 2013; Vinayagam et al. 2016).  
T2D accounts for 90% of all diabetes types, thus a major contributor to diabetic morbidity and 
mortality (Erukainure et al. 2017a; Giugliano et al. 1996; I.D.F. 2018; Lauritzen et al. 2000). It 
arises from insulin resistant and pancreatic β cell dysfunction, leading to hyperglycemia 
(Erukainure et al. 2017a). Chronic hyperglycemia then causes an increased production of free 
radicals which overwhelms the body’s endogenous antioxidant, thereby leading to oxidative stress 
(Giugliano et al. 1996; Saeed et al. 2012; Tiwari et al. 2013). Oxidative stress has been recognized 
as the major underlying factor behind T2D’s micro and macro – vascular complications such as 
retinopathy, neuropathy, nephropathy, and hypertension (Baynes and Thorpe 1999; Stadler 2013). 
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Antioxidative and inhibition of carbohydrate metabolizing enzymes are amongst the most studied 
mechanism of antidiabetic drugs and medicinal plants (Coskun et al. 2005; Rahimi et al. 2005). 
This has been attributed to the ability of these drugs and plants’ constituents to scavenge free 
radicals and inhibit key carbohydrate digestive enzymes particularly the α-glucosidase and α-
amylase. Several studies have demonstrated better carbohydrate digesting enzymes activities by 
medicinal plants due to their phytochemical constituents (Erukainure et al. 2013; Ezuruike and 
Prieto 2014; Saeed et al. 2012).  
In this study, we aimed at investigating the histochemistry of the leaves of V. amygdalina which 
describes the distribution of its phytochemical for the first time. The effect of its hot infusion on 
key carbohydrate digestive enzymes linked to T2D as well as glucose absorption and uptake were 
also investigated to further ascertain its antidiabetic properties. 
5.3.3 Materials and Methods 
Kindly refer to chapter 2, sections 2.1 – 2.4; 2.6.1 – 2.6.2; 2.7.1; and 2.7.2 
5.3.4 Results  
Histochemical analysis of V. amygdalina revelead the presence of acidic lipid as portrayed by the 
blue colour (Figure 5.3.1A). Mucilage and pectin were also identified by the red/rose pink colours 
(Figure 5.3.1B), with much concentration at the mid rib (Figure 5.3.1C). Lipids were identified 
by the orange/red colouration of the glandular trichome (Figure 5.3.1D). The blue coloration of 
the epidermis and mid rib depicts the presence of polyphenols (Figure 5.3.1E and 1F).  While the 
brown coloration of the mid rib indicates the presence of alkaloids (Figure 5.3.1G). 
Total phenolic analysis of V. amygdalina infusion revealed a total phenolic concentration of 13.96 
± 3.10 GAE/mg. 
243 
 
 
Figure 5.3.1: Histochemical properties of V. amygdalina leaves 
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According to HPLC chromatogram, quercetin and (-) epi-catechin were identified in the infusion 
at retention times 25.04 and 16.08 min, respectively. The percentage peak areas were 6.25% and 
1.91%, respectively (Figure 5.3.2). HPLC retention time of standard quercetin and (-) epi-catechin 
were 25.21 and 16.8 min, respectively. 
 
Figure 5.3.2: HPLC chromatogram of V. amygdalina infusion 
The infusion significantly (p<0.05) scavenged DPPH radical and significantly (p<0.05) increased 
FRAP activity, portraying a potent antioxidant activity as depicted in Figures 5.3.3A and 3B. This 
is further portrayed by their low IC50 values (7.03 and 58.64 µg/mL respectively) as shown in 
Table 5.3.1. 
245 
 
 
Figure 5.3.3: (A) DPPH scavenging and (B) FRAP activities of V. amygdalina infusion. Data = 
mean ± SD; n = 3. abValues with different letter above the bars for a given concentration are 
significantly (p < 0.05) different from each other. 
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Table 5.3.1: IC50 values of studied biological activities 
Activities Infusion Ascorbic acid Acarbose Gallic acid Orlistat 
DPPH 7.03 8.32 – – – 
FRAP 58.64 34.04 – – – 
α-glucosidase 124.72 – 62.73 – – 
Lipase >1000 – 0.04 – 0.15 
GSH 5.24 – – 3.80 – 
SOD 26.32 – – 84.42 – 
Catalase 1.08 – – 533.41 – 
Lipid 
peroxidation 
20.25 – – 137.56 – 
DNA 
Fragmentation 
33.11 – – 27.13 – 
Values are expressed as µg/mL. Key: – = not applicable 
Induction of oxidative stress in hepatic tissues led to significant (p<0.05) depletion of GSH level, 
SOD and catalase activities, with concomitant increase in MDA level as depicted in Figures 
5.3.4A – 4D. These activities and levels were significantly (p<0.05) reversed on treatment with 
the infusion as portrayed by the increased GSH level (Figure 5.3.4A), SOD and catalase (Figure 
5.3.4B and 4C), and reduced MDA level (Figure 5.3.4A). Their respective IC50 values of 5.24, 
26.32, 1.08, and 20.25 µg/mL (Table 5.3.1) indicate a potent antioxidative activity. 
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Figure 5.3.4: Effect of V. amygdalina infusion on (A) GSH level, (B) SOD activity, (C) catalase 
activity, and (D) MDA level in oxidative pancreatic injury. Values = mean ± SD; n = 3. 
*Significantly different from untreated sample and #Significantly different from normal sample (p 
< 0.05). 
There was a significant (p<0.05) inhibition of α-glucosidase activity by the infusion in a dose – 
dependent manner as shown in Fig. 4A. While the infusion caused a slight inhibition of pancreatic 
lipase activity (Figure 5.3.5B). 
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Figure 5.3.5: (A) α-glucosidase and (B) pancreatic lipase inhibitory properties of V. amygdalina 
infusion. Data = mean ± SD; n = 3. abValues with different letter above the bars for a given 
concentration are significantly (p < 0.05) different from each other. 
Incubation of isolated rat jejunum with the infusion in the presence of glucose led to significant 
(p<0.05) reduction in glucose absorption with increasing concentrations, indicating a dose- 
dependent inhibitory effect as shown in Figure 3.6.6A. There was a dose-dependent increased 
glucose uptake in isolated psoas muscles incubated with the infusion (with and without insulin) in 
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the presence of glucose (Figure 5.3.6B). Incubation with insulin had little or no effect on the 
glucose-uptake enhancing activity of the infusion. 
 
Figure 5.3.6: Effect of V. amygdalina infusion on (A) intestinal glucose absorption and (B) muscle 
glucose uptake. Data = mean ± SD; n = 3. *Significantly different from untreated sample (Control) 
and #Significantly different from treated samples; abValues with different letter above the bars for 
a given extract are significantly (p < 0.05) different from each other. 
There was a significant increase in DNA fragmentation on incubation with hepatic tissue with 
FeSO4 as depicted in Figure 5.3.7. Treatment with the infusion led to significant (p<0.05) 
reduction of the fragmentation in a dose dependent manner, with an IC50 value of 33.11 µg/mL 
(Table 5.3.1). 
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Figure 5.3.7: Effect of V. amygdalina infusion on hepatic DNA fragmentation. Significantly 
different from untreated sample and #Significantly different (p < 0.05) from normal sample. 
5.3.5 Discussion 
There has been an increased trend on the use medicinal plants in the treatment and management of 
DM and its complications (Ezuruike and Prieto 2014; Mohammed et al. 2014). This can be 
attributed to its reduced side effects coupled to its affordability compared to synthesized 
commercial drugs. In this study, we investigated the distribution of phytochemicals in V. 
amygdalina leaves and its ability modulate enzymes and activities involved in glucose 
homeostasis. 
The total phenolic content, and the identified flavonoids, quercetin and (-) epi-catechin (Figure 
5.3.2) correlates with the phenolic distribution of V. amygdalina leaves (Figures 5.3.1E and 
5.3.1F). These properties also portray potent biological activities, as phenols have been recognized 
as the most influential phytochemical responsible for the medicinal properties of most plants (Lin 
et al. 2016; Rasouli et al. 2017; Selamoglu 2017). 
The role of oxidative stress in the etiogenesis, pathogenesis and progression of T2D complications 
makes it an important aspect in the treatment and management of T2D. Antioxidants particularly, 
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the polyphenols have been demonstrated to be beneficial in the management of T2D and its 
complication (Hanhineva et al. 2010; Kim et al. 2016). The ability of the infusion to scavenge 
DPPH and reduce Fe3+ (Figure 5.3.2), indicates an antioxidant potential and corroborates previous 
reports on the free radical mopping activities of V. amygdalina leaves (Ho et al. 2012; Saliu et al. 
2012). The depleted GSH level, SOD and catalase activities, as well as elevated MDA level on 
incubation of hepatic tissue with FeSO4 (Figure 5.3.3) indicates an onset of oxidative stress. This 
can be attributed to the pro-oxidant activity of FeSO4 owing to oxidation of Fe
2+ to Fe3+ via the 
Fenton’s reaction, thereby initiating iron toxicity (Andrews 1999; Jiang et al. 2004; Rajpathak et 
al. 2009). The ability of infusion to reverse these activities further portrays its antioxidative 
potentials, which correlates with its free radical scavenging activities (Figure 5.3.3A). These 
activities can be attributed to the total phenol, quercetin and (-) epi-catechin contents of the 
infusion (Figure 5.3.2), as well as the other identified phytochemicals distributed in the leaf, 
particularly the phenolic distribution on the epidermis and mid rib (Figure 5.3.1). Polyphenols are 
the most studied plant antioxidant phytochemicals and have been shown to exhibit their antioxidant 
activities by reducing free radicals via donation of H-atom from their OH group/s (Papuc et al. 
2017). (-) epi-catechin has been recognized as the most common flavonoids of green teas (Forester 
and Lambert 2011; Kim et al. 2014). Identification of (-) epi-catechin in medicinal plants have also 
been correlated with their antioxidant activities (Chen et al. 2018; Grzesik et al. 2018). Quercetin 
is one of the most studied flavonoids and has been reported for its potent antioxidant activities 
(Bentz 2009; Ozgen et al. 2016). Several studies of reported have also reported the antioxidant 
activities of alkaloids (Erukainure et al. 2017b; Tiong et al. 2013), thereby indicating an influential 
role of the identified alkaloids on the mid rib of V. amygdalina leaf (Figure 5.3.1G).  
The inhibitory effect of the infusion on α-glucosidase and pancreatic lipase activities (Figure 
5.3.5) indicates an antidiabetic activity. These enzymes catalyze the breakdown of dietary 
carbohydrate and fats respectively. Inhibition of these enzymes reduces the amount of dietary 
glucose and fatty acids absorbed via the intestinal villi, thereby delaying postprandial rise in blood 
glucose and fatty acid levels (Erukainure et al. 2017a; Erukainure et al. 2018b). Several studies 
have reported the inhibition of these enzymes by phytochemicals (Ranilla et al. 2010), which 
portrays that the identified phytochemicals (Figure 5.3.1) and total phenolic content may be 
responsible for the inhibitory activity. Quercetin and (-) epi-catechin have been reported as major 
constituents of plant extracts with enzyme inhibitory activities (Li et al. 2009; Liu et al. 2016; 
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Proença et al. 2017; Yilmazer-Musa et al. 2012), and may also contribute to the enzyme inhibiting 
properties of V. amygdalina infusion. 
The dose-dependent inhibition of intestinal glucose absorption (Figure 5.3.6A) indicates a 
potential of the infusion to inhibit postprandial rise in blood glucose level. This may be attributed 
to its ability to inhibit intestinal α-glucosidase activity (Figure 5.3.5A), thus delaying the 
breakdown of dietary carbohydrate to glucose while concomitantly inhibiting intestinal absorption 
of the glucose. Most antidiabetic drugs such as metformin act by stimulating muscle glucose 
uptake. Thus, the stimulation of muscle glucose uptake by the infusion with and without insulin 
(Figure 5.3.6B) further indicates its anti-hyperglycemia activity. Glucose uptake in skeletal 
muscle under resting conditions have been shown to be insulin dependent (Pereira et al. 2017b; 
Sinacore and Gulve 1993). However, this is impaired in T2D patients owing to insulin resistant 
(Alvim et al. 2015). The increased glucose uptake on incubation with insulin may therefore 
indicate improved insulin-sensitivity by V. amygdalina.  
The increased DNA fragmentation on induction of oxidative hepatic injury (Figure 5.3.7) may 
reflect an occurrence of apoptosis (Erukainure et al. 2017a). Induction of apoptosis have been 
reported in rat hepatocytes subjected to iron overload induced oxidative stress (Allameh et al. 
2010). Thus, implying that the induced DNA fragmentation in this study may be attributed to the 
pro-oxidant activity of the ferrous moiety of FeSO4 via the Fenton reaction (Andrews 1999; Jiang 
et al. 2004; Rajpathak et al. 2009). Reduction in DNA fragmentation by the infusion may indicate 
an anti-apoptotic activity in oxidative hepatic injury, which correlates with its anti-oxidative 
activities (Figure 5.3.4) (Erukainure et al. 2017a).  
5.3.6 Conclusion 
This study portrays the distribution of phytochemicals in various parts of V. amygdalina leaf, 
which may be responsible for the antioxidative and antidiabetic activity of the infusion. The ability 
of the infusion to inhibit DNA fragmentation and stimulate muscle glucose uptake may suggest an 
anti-apoptotic and insulin-sensitivity activity of V. amygdalina. Thereby, indicating its anti-
hepatotoxic and anti-hyperglycemia potentials. 
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5.4 Vernonia Amygdalina Stimulated Glucose Uptake in Brain Tissues 
Exacerbates Antioxidative and Anti-Proinflammatory Activities; and 
Modulates Functional Chemistry and Dysregulated Metabolic Pathways 
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Preface: This article investigated the ability of the hot water infusion of V. amygdalina leaves to 
stimulate glucose uptake in brain tissues ex vivo. It also investigated the effect of stimulated 
glucose uptake on the antioxidant, and metabolic pathways of brain tissues. The manuscript has 
been accepted for publication in Metabolic Brain Disease (MEBR-D-18-00320). 
5.4.1 Abstract 
Brain glucose uptake is usually reduced in type 2 diabetes owing to downregulation of brain 
glucose transporters. The ability of Vernonia amygdalina to stimulate glucose uptake as well as 
ameliorate glucose-induced oxidative stress and proinflammation were investigated in rat brains. 
Hot infusion of V. amygdalina leaves was incubated with rat brain tissues for 2 hours in the 
presence of glucose. Another incubation with glucose only, served as negative control while 
metformin served as the standard drug. Incubation of brain tissues with V. amygdalina led to 
significant (p<0.05) increased glucose uptake, reduced glutathione, nitric oxide and non-thiol 
proteins levels, superoxide dismutase, catalase and ATPase activities, while concomitantly 
decreasing myeloperoxidase activity and malondialdehyde level compared to the control. 
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Incubation with glucose only, led to the development of nitrate, amide II and amide I functional 
groups which were removed on incubation with the infusion. LC-MS analysis revealed depletion 
of oxidative-induced generated 2-keto-glutaramic acid and cysteinyl-tyrosine metabolites in brain 
tissues, with concomitant generation of S-formylglutathione and adenosine tetraphosphate by the 
infusion. Pathway analysis of the metabolites revealed an activation of the pyruvate metabolism 
pathway in the negative control, with the infusion reducing the intensity fold. LC-MS analysis of 
the infusion revealed the presence of l–serine, l-cysteine, l-proline, nicotinic acid, cumidine, 
salicylic acid, isoquinoline, 3-methyl-, and γ-octalactone. Except for l–serine, l-cysteine and l-
proline, the other compounds were predicted to be permeable across the blood brain barrier. These 
results indicate the brain glucose uptake stimulatory and neuroprotective effect of V. amygdalina. 
Keywords: Antioxidative; Diabetic Brain; Glucose uptake; Proinflammatory; and Vernonia 
amygdalina  
5.4.2 Introduction  
Diabetes mellitus (DM) has been recognized as a global epidemic affecting over 425 million 
people in 2017, with an estimated 48% increase postulated for 2045 (I.D.F. 2018). It is metabolic 
disorder characterized by high blood glucose (hyperglycemia) owing to failure of the pancreatic β 
cell to secrete insulin and/or inability of the cells to utilize secreted insulin as seen in type 1 
diabetes (T1D) and type 2 diabetes (T2D) respectively (Erukainure et al. 2017a). T2D accounts 
for more than 90% of all diabetes types, thus making it a major contributor to diabetic mobility 
and mortality (I.D.F. 2018). Increased production of reactive oxygen species (ROS) have been 
reported in extreme hyperglycemia in T2D (Erukainure et al. 2018a; Maritim et al. 2003). Inability 
of the tissues’ endogenous system to mop these free radicals, results to oxidative stress which has 
been implicated in the pathogenesis and progression of microvascular and macrovascular 
complications in T2D (Whitlow et al. 2015). Studies have implicated T2D in microvascular 
complications in the brain (Vagelatos and Eslick 2013; Whitlow et al. 2015; Wrighten et al. 2009). 
This has been attributed to alteration in insulin signaling and glucose homeostasis in the CNS 
(Wrighten et al. 2009). Glucose is the predominant source of energy in the brain and is transported 
across the blood brain barrier (BBB) by glucose transporters (McEwen and Reagan 2004; Reagan 
et al. 2008; Wrighten et al. 2009). These transporters are often down regulated in T2D, thus 
impairing glucose uptake in the brain (Gejl et al. 2017; Hwang et al. 2017; Pardridge et al. 1990). 
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The neuroprotective effects of medicinal plants have been established (Aslam and Sial 2014; 
Mohebbatia et al. 2017; Pandit 2011; Uddin et al. 2013). These effects have been attributed to the 
phytochemical constituents of the plants, particularly the phenolics with reported antioxidant, 
antidiabetic and ability to transverse the BBB (Rice-Evans et al. 1997; Saravanan and 
Parimelazhagan 2014; Youdim et al. 2003). Some of these plants have also been reported for their 
antidiabetic properties, indicating their protective potential against diabetic brain degeneration. 
Amongst such plants is Vernonia amygdalina. 
Although the neuroprotective effect of V. amygdalina has been reported, there is however a dearth 
in its ability to stimulate glucose uptake in brain tissues and the metabolic pathways that may be 
involved. Hence, this study was undertaken to investigate the glucose uptake enhancing properties 
of V. amygdalina hot infusion, and its antioxidative and anti-proinflammatory effects in brain 
tissues, as well as the metabolic pathways and metabolites that may be involved. 
5.4.3 Materials and Methods 
Kindly refer to chapter 2, sections 2.1, 2.7.3 – 2.8 
5.4.4 Results 
Incubation of brain tissues in V. amygdalina infusion in the presence of d-glucose, led to significant 
(p<0.05) increase in glucose uptake compared to the control (glucose only) and metformin as 
depicted in Figure 5.4.1. The uptake was dose dependent, with the highest concentration 
stimulating the highest uptake. Metformin showed little or no significant effect on glucose uptake. 
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Figure 5.4.1: Effect of V. amygdalina infusion on brain glucose uptake. Data = mean + SD; n = 
3. *Statistically significant compared to Glucose-only treated tissues 
Incubation of brain tissues with d-glucose significantly (p<0.05) depleted GSH and NTP level, 
SOD and catalase activities, with concomitant increased levels of MDA as depicted in Figures 
5.4.2A – 2E. These were significantly (p<0.05) reversed on incubation with V. amygdalina and 
metformin respectively, depicting an antioxidative effect.  
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Figure 5.4.2: Effect of V. amygdalina infusion on (A) GSH level; (B) SOD and (C) catalase 
activities; (D) MDA; and (E) non-thiol proteins levels in glucose treated brain. Data = mean + SD; 
n = 3. *Statistically significant compared to Glucose-only treated tissues. #Statistically significant 
compared to normal tissues 
 
 
 
(E) 
258 
 
There was an increased NO level and myeloperoxidase activity on incubation of brain tissues with 
d-glucose only as shown in Figures 5.4.3A and 3B, portraying an occurrence of proinflammation. 
Incubation with the infusion and metformin led to significant (p<0.05) depleted level and activity. 
 
 
Figure 5.4.3: Effect of V. amygdalina infusion on (A) NO level and (B) myeloperoxidase activity 
in glucose treated brain. Data = mean + SD; n = 3. *Statistically significant compared to Glucose-
only treated tissues; #Statistically significant compared to normal tissues 
Incubation of brain tissues with d-glucose only, caused a significant (p<0.05) increase in ATPase 
activity as depicted in Figure 5.4.4. This was significantly reduced dose – dependently on 
incubation with the infusion, with metformin showing little or no effect. 
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Figure 5.4.4: Inhibitory activities of V. amygdalina infusion on ATPase activity in glucose – 
treated brain. Data = mean + SD; n = 3. *Statistically significant compared to Glucose-only treated 
tissues; #Statistically significant compared to normal tissues 
Molecular docking of d-glucose with catalase, myeloperoxidase, and ATPase revealed significant 
interactions, with ATPase showing the highest interaction (-5.45 kcal/mol) as depicted in Figures 
5.4.5A – 5C and Table 5.4.1. The core amino acid residues and hydrogen bond distance between 
the residues and ligand are shown in Table 5.4.1, with ATPase interaction having the highest 
number of residues (threonine (THRE), asparagine (ASN), leucine (LEU), and glycine (GLY)) 
and atoms of residues (oxygen (O), nitrogen (N) and hydrogen (H)). 
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Figure 5.4.5: Molecular interactions of D-glucose with (A) myeloperoxidase; (B) catalase; and 
(C) ATPase activities. 
Table 5.4.1: Calculated binding energies, core amino acid residue and hydrogen bond distance 
between residues and ligand from molecular docking 
Enzymes Binding 
energies 
(kcal/mol) 
Residues Atoms of the 
residues 
Distance (Å) 
ATPase -5.45 THRE, ASN, LEU, 
GLY 
O, N, H 2.56 
Catalase -4.20 HIS, PHE H, N 2.06 
myeloperoxidase 1.49 PRO, GLN C, N 2.86 
     
Incubation of brain tissues with glucose only, led to the development of nitrate, amide II and amide 
I functional groups as shown in Figure 5.4.6 and Table 5.4.2. Incubation with the infusion and 
metformin led to removal of these functional groups.  
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Figure 5.4.6: FTIR Spectroscopy of the effect of V. amygdalina infusion on glucose – oxidative 
brain metabolites 
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Table 5.4.2: Quantitative Analysis of FTIR Spectra of Glucose Brain Metabolites 
Regions (cm-
1) 
Normal 
(cm-1) 
Glucose 
only (cm-1) 
V. amygdalina 
(cm-1) 
Metformin 
(cm-1) 
Assignment 
900 - 680  – 834.85  –  – Nitrate 
 878.92 879.09 879.09 878.93 1°, 2° amines 
1200 - 900 951.14 951.52 951.34 950.88 Nucleic acid 
 1045.07 1045.34 1045.26 1045.15 Nucleic acid 
 1086.92 1087.36 1086.99 1086.95 Phosphates 
1500 – 1200 1275.56 1284.50 1275.63 1275.68 Amide 1 
 1324.42 1326.02 1331.77 1325.42 Aromatic amines 
 1382.87 1382.82 1381.95 1382.53 Phenol –O–H  
 1416.85 1420.77 1416.70 1413.51 Nitramines 
 1450.26 – 1451.16 1451.38 Amide II 
1800 – 1500 – 1540.09 – – Amide II 
 – 1606.51 – – Amide I 
 1648.08 1647.32 1647.63 1643.61 Alkenes 
3000 – 2800 2938.70 2928.95 2975.30 2931.57 Lipid (CH2) 
 2901.91 2896.84 – 2975.91 Lipid (CH2 
 2975.59 2975.52 2975.30 2975.91 Lipid (CH2) 
3180 – 3030 3327.11 3311.62 3333.92 3331.03 1°, 2° amines, amides 
Key: – = absent 
LC-MS characterization of V. amygdalina infusion revealed an alkaloid rich extract consisting of 
nicotinic acid, cumidine, and isoquinoline, 3-methyl- (Figure 5.4.7). Amino acids consisting of l-
serine, l-cysteine and l-proline were also identified. Other compounds identified were salicylic 
acid and γ-octalactone. 
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Figure 5.4.7: LC-MS identified compounds of V. amygdalina infusion 
Analysis of the metabolites of the normal brain tissues revealed the presence of ganglioside, 
glucose, cardiolipin, triglyceride, inosine, molybdenum cofactor, monosaccharide, nucleotide, and 
iduronic acid metabolic intermediates as shown in Table 5.4.3. Incubation with d-glucose led to 
depletion of dTDP-D-glucose and ganglioside GM2 (d18:0/22:1(13Z)), with concomitant 
generation of 2-keto-glutaramic acid, cysteinyl-tyrosine, acetyl adenylate, 
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CL(18:1(11Z)/18:1(11Z)/18:1(11Z)/18:1(11Z)), Ganglioside GM1 (d18:1/25:0), 4-
Methylnonacosane, Ganglioside GT3 (d18:1/16:0) and Ganglioside GT3 (d18:0/16:0). Treatment 
with the infusion led regeneration of dTDP-D-glucose, with concomitant depletion of P1,P4-
Bis(5'-uridyl) tetraphosphate, CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z)/16:1(9Z)), 2-keto-
glutaramic acid and cysteinyl-tyrosine. It also led to the generation of S-formylglutathione and 
adenosine tetraphosphate. Metformin led to regeneration of the glucose-induced depleted 
metabolites, with concomitant depletion of cysteinyl-tyrosine, acetyl adenylate, 
CL(18:1(11Z)/18:1(11Z)/18:1(11Z)/18:1(11Z)), ganglioside GT3 (d18:1/16:0) and ganglioside 
GT3 (d18:0/16:0), and generation of superoxide, glycerol 3-phosphate and guanosine 
tetraphosphate adenosine. 
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Table 5.4.3: Identified metabolites in glucose treated brain tissues 
Metabolites Normal 
Tissues 
Glucose 
only 
Tissues 
V. amygdalina 
Treated 
Tissues 
Metformin 
Treated 
Tissues 
Uridine 5'-diphosphate X X X X 
Ganglioside GM2 X X X X 
1-Phosphatidyl-1D-myo-inositol 3-phosphate X X X X 
Ganglioside GD3 (d18:0/26:0) X X X X 
TG(24:1(15Z)/o-18:0/18:4(6Z,9Z,12Z,15Z)) X X X X 
3-Methylellagic acid 8-(4-acetylrhamnoside) X X X X 
UDP-L-iduronate X X X X 
UDP-4-keto-6-deoxy-D-glucose X X X X 
Ganglioside GT3 (d18:1/26:0) X X X X 
dTDP-D-glucose X – X X 
Cyanidin 3-(6''-dioxalylglucoside) X X X X 
Adenosine tetraphosphate X X X X 
ADP-ribose 1"-2" cyclic phosphate X X X X 
CL(16:0/18:0/16:0/18:1(9Z)) X X X X 
Ganglioside GT1b (d18:0/14:0) X X X X 
Ganglioside GM2 (d18:0/22:1(13Z)) X – – X 
CL(16:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z) 
/22:5(7Z,10Z,13Z,16Z,19Z)/16:1(9Z)) 
X X X X 
Sedoheptulose 1,7-bisphosphate X X X X 
P1,P4-Bis(5'-uridyl) tetraphosphate X X – X 
CL(18:2(9Z,12Z)/18:2(9Z,12Z)/18:2(9Z,12Z) 
/16:1(9Z)) 
X X – X 
Molybdopterin-AMP X X X X 
Ganglioside GM1 (18:1/22:0) X X X X 
2-Keto-glutaramic acid – X – X 
Cysteinyl-Tyrosine – X – – 
Acetyl adenylate – X X – 
CL(18:1(11Z)/18:1(11Z)/18:1(11Z)/18:1(11Z)) – X X – 
Ganglioside GM1 (d18:1/25:0) – X X X 
4-Methylnonacosane – X X – 
Ganglioside GT3 (d18:1/16:0) – X X – 
Ganglioside GT3 (d18:0/16:0) – X X X 
S-Formylglutathione – – X – 
Adenosine tetraphosphate – – X – 
Superoxide – – – X 
Glycerol 3-phosphate – – – X 
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Guanosine tetraphosphate adenosine – – – X 
Key: – = absent, X = present 
Pathway enrichment analysis of the identified metabolites revealed metabolic pathways for lactose 
synthesis, androstenedione, estrone, sucrose, amino sugar, androgen and estrogen, inositol, 
galactose, porphyrin, sphingolipid, and pyrimidine metabolisms in normal brain tissues (control) 
as shown in Table 5.4.4. These pathways were unaltered on incubation with d-glucose, with 
activation of pyruvate metabolism pathway. Although incubation with V. amygdalina infusion did 
not affect these pathways, the intensity fold of the pyruvate metabolism pathway was significantly 
lower than that of glucose-only treated tissues. Treatment with metformin deactivated the pyruvate 
metabolism pathway, with concomitant activation of de novo triacylglycerol biosynthesis, 
cardiolipin biosynthesis, degradation of superoxides, glycerol phosphate shuttle, mitochondrial 
electron transport chain, glycerolipid metabolism, and phospholipid biosynthesis pathways. 
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Table 5.4.4: Identified metabolic pathways in glucose treated brain tissues 
Metabolic Pathways Normal 
Tissues 
Glucose only 
Tissues 
V. amygdalina 
Treated Tissues 
Metformin 
Treated Tissues 
Lactose Synthesis X X X X 
Androstenedione Metabolism X X X X 
Estrone Metabolism X X X X 
Starch and Sucrose Metabolism X X X X 
Amino Sugar Metabolism X X X X 
Androgen and Estrogen 
Metabolism 
X X X X 
Inositol Metabolism X X X X 
Galactose Metabolism X X X X 
Porphyrin Metabolism X X X X 
Sphingolipid Metabolism X X X X 
Pyrimidine Metabolism X X X X 
Pyruvate Metabolism – X X – 
De Novo Triacylglycerol 
Biosynthesis 
– – – X 
Cardiolipin Biosynthesis – – – X 
Degradation of Superoxides – – – X 
Glycerol Phosphate Shuttle – – – X 
Mitochondrial Electron Transport 
Chain 
– – – X 
Glycerolipid Metabolism – – – X 
Phospholipid Biosynthesis – – – X 
Key: – = absent, X = present 
Except the amino acids, the other identified compounds of V. amygdalina infusion were predicted 
to be able to cross the blood brain barrier (Table 5.4.5). All the identified compounds were 
predicted to be orally safe as they fell between classes 4 – 6, except for l-serine which fell on class 
2. 
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Table 5.4.5: BBB Permeability and Predicted toxicity of compounds from V. amygdalina 
infusion 
Compounds BBB Permeability Predicted LD50 (mg/kg) Predicted Toxicity Class 
L – Serine No 2000 2 
L – Cysteine  No 660 4 
L - Proline No 2078 5 
Nicotinic Acid Yes 3720 5 
Cumidine Yes 500 4 
Salicylic acid Yes 480 4 
Isoquinoline, 3-
methyl- 
Yes 1230 4 
γ-Octalactone Yes 4390 5 
 
5.4.5 Discussion  
Diminished brain glucose uptake has been recognized as one of the complications of type 2 
diabetes despite chronic hyperglycemia (Vagelatos and Eslick 2013; Whitlow et al. 2015). This 
has been attributed to down regulation of glucose transporters at the BBB, thus reducing facilitative 
transportation of glucose to the brain (Gejl et al. 2017; Hwang et al. 2017). Vernonia amygdalina 
amongst other medicinal plants have been reported for its antidiabetic and neuroprotective 
properties. To the best of our knowledge, this study reports for the first time the ability of V. 
amygdalina to stimulate brain glucose uptake and its effect on brain metabolic pathways and 
metabolites. 
The increased brain glucose uptake by the infusion (Figure 5.4.1) indicates a glucose uptake 
facilitative potential of V. amygdalina. This can be attributed to the identified alkaloid, polyphenol 
and lactone constituents of the infusion (Figure 5.4.7), as they were predicted to be BBB 
permeable (Table 5.4.5). Their predicted permeability across BBB may facilitate the 
transportation of glucose to the brain by activation of glucose transporters notably GLUTs 1, 3 and 
5 which are highly concentrated at the BBB (Simpson et al. 1994). Studies have reported the 
influence of phytochemicals particularly polyphenols on the activation of glucose transporters by 
medicinal plants (León et al. 2017; Williamson 2013). The reduced glucose uptake in brain tissues 
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incubated with metformin can be attributed to the fact that metformin exhibits its action by 
activation of GLUTs 2 and 4, which are less expressed at the BBB (Kellett and Brot-Laroche 2005; 
Rice et al. 2011). The increased glucose uptake by V. amygdalina can also be attributed to its 
ability to decrease ATPase activities in brain tissues (Figure 5.4.4), as decreased ATPase activity, 
particularly the Na+/K+ ATPase have been implicated in facilitating glucose transportation across 
the BBB (Falkowska et al. 2015; Magistretti and Allaman 2015). The high binding energy on 
docking d-glucose with ATPase (Figure 5.4.5C and Table 5.4.1) portrays a strong molecular 
interaction, which is evident by the increased ATPase activity (Figure 5.4.4) and decreased 
glucose uptake (Figure 5.4.1) in brain tissues incubated with glucose only. Similarly, the increased 
ATPase activity in the metformin treated brain tissues (Figure 5.4.4) corroborates its decreased 
glucose uptake (Figure 5.4.1). 
Oxidative stress and inflammation have been reported for its influential role in the pathogenesis 
and progression of neuropathology (Das et al. 2009; Patel 2016), which have been attributed to the 
high consumption of O2 and glucose dependence by the brain (Patel 2016). Although the brain’s 
anatomy allows for a reductive environment which minimizes ROS generation, its low endogenous 
antioxidant system, redox-active metal load, polyunsaturated fatty acids, and excitotoxic and auto-
oxidizable neurotransmitters dependence makes it prone to oxidative stress (Butterfield et al. 2001; 
Huang et al. 2004; Patel 2016). The depleted levels of GSH, NPT, and increased SOD and catalase 
activities, with concomitant increased MDA level in brain tissues incubated with glucose only 
(Figures 5.4.2A – 2E) depicts an occurrence of oxidative stress. This can be attributed to activation 
of the pyruvate metabolism pathway (Table 5.4.4). Activation of this pathway will lead to the 
production of lactate with concomitant generation of the essential cofactor, NAD+. The continuous 
drive of this pathway lead to accumulation of lactate and increased generation of NAD+ which 
sustains the glycolytic flux, which in turn increases the turnover of glycolysis production of the 
electron donor, NADH. This electron donor has been implicated in the production of ROS, as it  
inhibits the electron transport at complex II leading to the reduction of O2 to O2.
- (Brownlee 2001; 
Du et al. 2001). The activation of this pathway can also be attributed to the decreased glucose 
uptake, owing to the need for the brain to switch energy source from glucose to ketones. This is 
evident by the presence of the ketone metabolite, 2-keto-glutaramic acid in the glucose-only 
treated tissue (Table 5.4.3). 2-keto-glutaramic acid can also act as a substrate for the enzyme, 
alanine transaminase which catalyzes the reversible conversion of alanine to pyruvate. The 
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presence of sphingolipids and triglyceride derivatives (Table 5.4.3) in the glucose-only treated 
brain tissue, may be responsible to the increased MDA level (Figure 5.4.2D) as they can act as 
substrates for lipid peroxidation. The strong molecular interactions between d-glucose and catalase 
(Figure 5.4.5B and Table 1) suggests the potential of d-glucose to inhibit catalase activity. 
The increased GSH and NTP levels, and SOD and catalase activities, with concomitant depletion 
of MDA level in the treated brain tissues indicate an antioxidative effect. The antioxidative effect 
of the infusion can be attributed to its identified phytochemical constituents particularly nicotinic 
acid, salicylic acid and γ-Octalactone, as these compounds have been reported for their antioxidant 
and neuroprotective activities (De La Cruz et al. 2004; Shoaib et al. 2017; Tupe et al. 2011). This 
can also be attributed to their predicted permeability across the BBB (Table 5.4.5), which 
corroborates other reports on the ability of polyphenols and alkaloids to cross the BBB (Youdim 
et al. 2003; Zhang et al. 2017).  The standard antidiabetic drug, metformin caused an inhibition of 
the pyruvate metabolism, with concomitant activation of the glycerol phosphate shuttle and 
mitochondrial electron transport chain (Table 5.4.5). This indicates activation of a proper channel 
of transporting the electron donors generated by the glycolytic pathway, thus mopping up free 
radicals while generating ATPs for the brain use. This is corroborated by the superoxide and 
glycerol 3-phosphate metabolites (Table 5.4.3) and superoxide degradation pathway (Table 
5.4.4), which is evident by its high SOD activity (Figure 5.4.2B). The activated lipid metabolic 
pathways in the metformin treated tissues, indicates a maintenance of tissue integrity which may 
also be responsible for the decreased MDA level (Figure 5.4.2D).  
The increased NO level and myeloperoxidase activity (Figures 5.4.3A and 3B) indicates an 
occurrence of proinflammation in the brain tissue incubated in glucose only. This is evident by the 
presence of nitrate functional group (Figure 5.4.6 and Table 5.4.2). Similarly, the molecular 
interaction between d-glucose and myeloperoxidase (Figure 5.4.5A and Table 5.4.1) indicates the 
potential of the former to activate the latter. The reversed level and activity on incubation with V. 
amygdalina infusion and metformin indicates an anti-proinflammatory activity, which is evident 
by the absence of the nitrate functional groups (Figure 5.4.5A and Table 5.4.1). This corroborates 
previous reports on the anti-proinflammatory activity of V. amygdalina (Farombi and Owoeye 
2011; Georgewill and Georgewill 2010), and can be attributed to the identified phytochemical 
constituents (Figure 5.4.7) as well as their predicted BBB permeability (Table 5.4.5). Thus, 
further indicating the neuroprotective effect of V. amygdalina.  
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The predicted toxicity of the identified phytochemical constituents (Table 5.4.5) may indicate a 
relative safety of the infusion when ingested orally. 
5.4.6 Conclusion 
These results suggest the ability of V. amygdalina to stimulate glucose uptake in brain tissue, with 
concomitant antioxidative and anti-proinflammatory activities. Thus, indicating its 
neuroprotective potential against diabetic brain. This can be attributed to the identified 
phytochemicals and their permeability across the BBB. Thus, further giving credence to the reports 
and folkloric use of this plant in the treatment of neurodegeneration diseases. 
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CHAPTER 6 
ANTI-OXIDATIVE, ANTI-DIABETIC, AND CYTOTOXIC ACTIVITIES 
OF CLERODENDRUM VOLUBILE L. IN VITRO AND EX VIVO 
6.1 Clerodendrum volubile 
 
Figure 6.1: Clerodendrum volubile. Common names: obenetete (Urhobo, Nigeria); eweta, dagba 
and marugbo (Yoruba, Nigeria); and belentientien (Itsekiri, Nigeria). Photo: Mr. Edega 
Erukainure at Warri, Nigeria on May 19, 2016. 
6.1.2 Background 
Clerodendrum volubile L. is amongst the underutilized leafy vegetable consumed and employed 
for medicinal purposes mostly by tribes of the Niger-Delta, Nigeria. It is a climbing shrub 
belonging to the Lamiaceae (Verbenaceae) family (Erukainure et al. 2011a). It climbs up to 3 m 
high, it is glabrous (except the inflorescences) with numerous flowers (Burkill 1985; Erukainure 
et al. 2011a). It is found in the deciduous forest and secondary jungle, across the Region, Senegal 
to Fernando Po (Burkill 1985; Shrivastava and Patel 2007). 
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6.1.3 Ethnopharmacology 
The leaves of C. volubile are employed in the treatment of arthritis, rheumatism, dropsy, swellings, 
oedema, gout, general healing, pain-killers, pregnancy, antiaborifacients, sedatives, and diabetes 
(Burkill 1985; Erukainure et al. 2011a).  
6.1.4 Biological activities 
Clerodendrum volubile leaves have been reported for their antioxidative activities (Adefegha and 
Oboh 2011; Adefegha and Oboh 2016; Erukainure et al. 2016b; Molehin et al. 2017b); 
antihypertensive activity (Adefegha and Oboh 2016; Erukainure et al. 2018); antidiabetic activity 
(Adefegha and Oboh 2016; Erukainure et al. 2018; Erukainure et al. 2017a); immunomodulatory 
and anti-inflammatory activity (Erukainure et al. 2017a; Erukainure et al. 2016a; Erukainure et al. 
2017d); and hypolipidemic activity (Erukainure et al. 2018; Erukainure et al. 2017a). 
6.1.5 Phytochemistry 
Identified phytochemicals in C. volubile leaves include hydroxycinnamic acids, flavonoids, 
trihydroxybenzoic acids, ellagitannins, and terpenes (Adefegha and Oboh 2016; Erukainure et al. 
2014; Erukainure et al. 2018; Erukainure et al. 2017a; Erukainure et al. 2017b; Molehin et al. 
2017a; Oboh et al. 2017a). 
6.1.6 Aims and objective 
The aims of this study are to investigate the in vitro and ex vivo antioxidative, antidiabetic, and 
cytotoxic activities of the extracts and fractions of C. volubile. A comprehensive review on its 
phenolic and medicinal properties was also carried out.  
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6.2 Clerodendrum volubile: Phenolics and Applications to Health 
1,2Ochuko L. Erukainure, 1Olakunle Sanni, 1Md. Shahidul Islam* 
4. Department of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, 
(Westville Campus), Durban 4000, South Africa  
5. Nutrition and Toxicology Division, Federal Institute of Industrial Research, Lagos, Nigeria 
*Corresponding author: islamd@ukzn.ac.za; Tel: +27 (0)31-260-8717; Fax: +27 (0)31-260-
7942 
Preface: This article reviewed the phenolic properties of C. volubile and its applications to health. 
It has been published as a chapter in “Polyphenols: Mechanisms of Action in Human Health and 
Disease”. (Erukainure LO, Sanni O, Islam MS. (2018). Clerodendrum volubile: Phenolics and 
Applications to Health. In: Watson R, Preedy V, Zibadi S (Eds). Polyphenols: Mechanisms of 
Action in Human Health and Disease. 2nd Edn., Elsevier. DOI: 10.1016/B978-0-12-813006-
3.00006-4) 
6.2.1 Abstract 
The medicinal and health benefits of most medicinal plants are attributed to their phenolic 
constituents. Phenolics are secondary metabolites consisting of an aromatic ring with one or more 
hydroxyl groups, and/or other functional groups. Clerodendrum volubile are amongst medicinal 
plants studied for their phenolic constituents and health benefits. It is folklorically employed in the 
treatment of various diseases and ailments such as type 2 diabetes, cancer, immuno-disorders, 
neurodegeneration and hypertension. In this review, the medicinal/health benefits of C. volubile 
were discussed in relationship to its phenolic constituents. Its possible mechanism of action was 
also proposed.  
Keywords: Antioxidative Stress; Anticancer; Immunomodulation; Phenolics; and Type 2 
Diabetes 
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6.2.2. Introduction 
The health benefits of phenolics are well documented (Lin et al. 2016; Vermerris and Nicholson 
2008). Phenolics are secondary metabolites in plants responsible for most of their health promoting 
properties (Tomás‐ Barberán and Espin 2001). They are utilized in plants as defense mechanism 
against pathogens and protection against ultraviolent rays (Beckman 2000). They also contribute 
to the color, acidity, taste, fragrance and oxidative permanence of plants (Pandey and Rizvi 2009). 
Chemically, phenolics possess an aromatic ring with one or more hydroxyl groups, including 
functional derivatives such as methyl ethers, esters, and glycosides (Harborne 1989). They are 
classified into phenolic acids, hydroxycinnamic acids, flavonoids and lignans, which all arise from 
the amino acids, phenylalanine or tyrosine. The amino acids are deaminated to cinnamic acids, 
before entering the phenylpropanoid pathway (Pereira et al. 2009). One or more hydroxyl groups 
are then introduced into the phenyl rings to forming the common carbon skeleton, the C6-C3 
phenylpropanoid unit (Pereira et al., 2009). This is well reflected in the C6 aromatic ring of 
hydroxybenzoic acids, C6–C3 structure of hydroxycinnamic acids, C6–C3–C6 structure of 
flavonoids, and C6–C4–C6 structure of lignans (Xiao et al. 2013). 
6.2.3. Phenolics and Health 
Several studies have reported the inverse correlation between phenolics intake and chronic human 
diseases such as cardiovascular diseases, diabetes, cancer, obesity and inflammation (Arts and 
Hollman 2005; Pandey and Rizvi 2009; Scalbert et al. 2005). This is dependent on their absorption 
and metabolism by the gastro-intestinal (GI) system into the circulatory system and transportation 
to the liver (Ozcan et al. 2014). Their structures play a major influential role in this regard by 
determining conjugation with other phenolics, degree of glycosilation/acylation, molecular size 
and solubility (Bravo 1998; Crozier et al. 2009; Ozcan et al. 2014). 
These medicinal properties have been attributed to the potent antioxidative effect of phenolics, 
owing to their ability to (i) scavenge free radicals, (ii) chelate divalent cations and (iii) modulate 
endogenous antioxidant enzymes (Ozcan et al. 2014; Pandey and Rizvi 2009). These abilities are 
dependent on the hydroxylation of the aromatic rings. Phenolics have also been reported to bring 
about their medicinal effect by modulating intracellular signaling cascades involved in cellular 
metabolism (Crozier et al. 2009; Ozcan et al. 2014). 
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Clerodendrum volubile 
Phenolics are widely distributed in plants and are responsible for most of their medicinal properties 
(Tomás‐ Barberán and Espin 2001). The phenolic contents of some of these plants have been 
analyzed and their protective activities reported. Amongst such plant is Clerodendrum volubile 
which belongs to the genus Clerodendrum L. under the Labiatae family. 
The genus, Clerodendrum L. is very large and diverse with over 580 identified species comprising 
small trees, shrubs, and herbs which are widely distributed in the tropics and subtropics 
(Shrivastava and Patel 2007). Most of these species are employed as folk medicine in Asian and 
African continents (Shrivastava and Patel 2007). 
Clerodendrum volubile is indigenously known as obenetete by the Urhobos and Itsekiris, as well 
as eweta, dagba or marugbo by the Yorubas all in Southern Nigeria (Erukainure et al. 2010; 
Ogunwa et al. 2016). It is often regarded as magic leaf owing to its use in folkloric medicine for 
the treatment and management of several diseases such as diabetes mellitus, cancers, arthritis, 
ulcers, and neurological disorders (Burkill 1985). Despite these folkloric claims, there are however 
limited scientific data on its biological activities and phenolic constituents. 
This chapter discusses the studied biological activities and phenolic constituents of C. volubile. 
6.2.4. Phytochemistry of Clerodendrum volubile 
1. Preliminary Phytochemical Screening 
Preliminary phytochemical screening of the leaves of C. volubile revealed the presence of the 
presence of flavonoids, tannins, and phenols as summarized in Table 6.2.1.  
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Table 6.2.1: Summary of Preliminary Studies on Phenolic Constituents of Clerodendrum volubile 
Phytochemicals Extracts Plant Part References 
Flavonoids Methanol; 
Aqueous; Ethanol; 
Diethyl ether 
Leaf (Akinpelu et al. 2016; Erukainure et al. 
2011a; Jaiyesimi and Adekoya 2013; 
Ogunwa et al. 2015; Ogunwa et al. 
2016; Senjobi et al. 2017) 
Tannins Methanol; 
Aqueous; Ethanol; 
Diethyl ether 
Leaf  (Akinpelu et al. 2016; Erukainure et al. 
2011a; Jaiyesimi and Adekoya 2013; 
Ogunwa et al. 2015; Ogunwa et al. 
2016; Senjobi et al. 2017) 
Phenol Methanol; 
Aqueous; Ethanol; 
Diethyl ether 
Leaf  (Akinpelu et al. 2016; Erukainure et al. 
2011a; Ogunwa et al. 2015; Ogunwa et 
al. 2016; Senjobi et al. 2017) 
 
I. Flavonoids 
Flavonoids are hyroxylated phenolics with a benzo-𝛾-pyrone structure, and one of the most 
abundant groups of plant phenolics (Kumar and Pandey 2013). Their pharmacological roles have 
been well established and dependent on the structural class, hydroxylation degree, conjugations, 
substitution, and polymerization (Kumar and Pandey 2013). Thus, illustrating a structural 
dependent activity (Heim et al. 2002; Kumar and Pandey 2013). This is evident in their ability to 
donate electrons (Amić et al. 2003), chelate iron catalysis (Flora 2009), reduce Fe2+ (Catapano et 
al. 2017), attenuate oxidation (Aviram and Fuhrman 1998), and activate antioxidant enzymes 
(Masella et al. 2005).  
Ogunwa (2016) revealed the presence of flavonoids in the aqueous, ethanol and methanol extracts 
of C. volubile leaves, with the ethanol extract having the highest concentration. Akinpelu et al. 
(2016), Ogunwa et al. (2016) and Senjobi et al. (2016) also reported similar observations in ethanol 
and methanol extracts. These studies correspond with a previous study by Erukainure et al. (2011) 
on the phytochemical contents of the leaves.  
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II. Tannin  
Tannins are water-soluble polyphenolic biomolecules responsible for the astringency of most 
plants (Chung et al. 1998; Ukoha et al. 2011). They are mostly consist of a large number of 
hydroxyl and other functional groups, a characteristic that makes them cable of binding with 
macromolecules especially proteins (Chung et al. 1998). This binding ability have been reported 
to have a negative impact on animal nutrition as it decreases feed intake, feed efficiency, net 
metabolizable energy, and protein digestibility (Bele et al. 2010; Ukoha et al. 2011).  
Tannins are classified as hydrolyzable and condensed tannins. Hydrolyzable tannins consist of a 
polyhydric alcohol and hydroxyl groups which are partially or wholly esterifies by gallic acid or 
hexahydroxydiphenic acid (Chung et al. 1998). While condensed tannins consist of a group of 
polyhydroxy-flavan-3-ol oligomers and polymers that are linked by carbon – carbon bonds 
between flavanol subunits (Schofield et al. 2001).  
Erukainure et al. (Erukainure et al. 2011a) reported the presence of tannin in the aqueous extract 
of C. volubile leaves. This was further corroborated in a study by Ogunwa et al. (Ogunwa et al. 
2016). Ogunwa et al. (2016) also compared the concentration in the aqueous and methanol extracts, 
and concluded the methanol extract had a higher concentration, which corresponded with previous 
reports (Jaiyesimi and Adekoya 2013). Senjobi et al. (Senjobi et al. 2017) however reported the 
highest concentration in diethyl ether, when they compared the tannin contents in aqueous, 
methanol and diethyl ether extracts. The presence of tannin in the ethanol extract reported by 
Akinpelu et al. (Akinpelu et al. 2016), however contradicts that of Ogunwa et al. (2016) who 
reported the absence of tannin in the extract.  
Although tannins may be considered as anti-nutrients, their presence in C. volubile leaves also 
poses therapeutic benefits. Tannins have been reported for their antioxidant, anti-hemorrhagic, 
antiseptic, anti-inflammatory, antihelmintics, anticancer, antimicrobial and antiviral activities 
(Buzzini et al. 2008; Koleckar et al. 2008).  
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2. High-performance liquid chromatography (HPLC) Fingerprinting 
Studies on the high-performance liquid chromatography (HPLC) analysis of various extracts of C. 
volubile leaves have revealed the presence of phenolic compounds as shown in Figure 6.2.1 and 
Table 6.2.2. 
Table 6.2.2: HPLC – identified phenolics in C. volubile leaves 
Phenolics Compounds Extracts References 
Hydroxycinnamic 
acids 
Caffeic acid Phenolic-rich extract; ethyl 
acetate, ethanol and methanol 
extracts 
(Adefegha and Oboh 2016; 
Molehin et al. 2017a; Oboh et 
al. 2017a) 
Chlorogenic 
acid 
Phenolic-rich extract (Adefegha and Oboh 2016; 
Oboh et al. 2017a) 
p-Coumaric acid Phenolic-rich extract (Oboh et al. 2017a) 
Flavonoids Rutin  Phenolic-rich extract; ethyl 
acetate, ethanol and methanol 
extracts 
(Adefegha and Oboh 2016; 
Molehin et al. 2017a; Oboh et 
al. 2017a) 
Isoquercitrin Phenolic-rich extract (Adefegha and Oboh 2016) 
Quercitrin Phenolic-rich extract; ethyl 
acetate, ethanol and methanol 
extracts 
(Molehin et al. 2017a; Oboh 
et al. 2017) 
Quercetin  Phenolic-rich extract; ethyl 
acetate, ethanol and methanol 
extracts 
(Adefegha and Oboh 2016; 
Molehin et al. 2017a; Oboh et 
al. 2017a) 
Kaempferol Phenolic-rich extract; ethyl 
acetate, ethanol and methanol 
extracts 
(Molehin et al. 2017a; Oboh 
et al. 2017) 
Apigenin Phenolic-rich extract; ethyl 
acetate, ethanol and methanol 
extracts 
(Molehin et al. 2017a; Oboh 
et al. 2017) 
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Catechin Phenolic-rich extract; ethyl 
acetate, ethanol and 
methanol extracts 
(Molehin et al. 2017a; Oboh 
et al. 2017) 
Luteolin Ethyl acetate, ethanol and 
methanol extracts 
(Molehin et al. 2017a) 
Trihydroxybenzoic 
acids 
Gallic acid Phenolic-rich extract; ethyl 
acetate, ethanol and methanol 
extracts 
(Molehin et al. 2017a; Oboh 
et al. 2017) 
Ellagitannins Ellagic acid Phenolic-rich extract (Oboh et al. 2017a) 
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Figure 6.2.1: HPLC – identified phenolics in C. volubile leaves 
I. Hydroxycinnamic acids 
Hydroxycinnamic acids (HCAs) are natural phenylpropenoic acid compounds, which occurs as 
esters, glycosides, and/or conjugates of proteins (Chen and Ho 1997; Zhang et al. 2018). A few 
also exists as natural free acids (Chen and Ho 1997). They are major intermediates in the 
biosynthetic pathways of polyphenols (El-Seedi et al. 2012). They have been recognized as an 
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important source of antioxidants and play an influential role in the stability, flavor, color, 
nutritional bioavailability of foods rich in the compounds (Chen and Ho 1997; Rocha et al. 2012).  
HCAs are derived from phenylalanine and tyrosine, comprising of a nine carbon (C6-C3) skeleton 
with a side chain double bond (with cis or a trans configuration), representing a phenylpropanoid 
structure (El-Seedi et al. 2012; Razzaghi-Asl et al. 2013). The presence of hydroxyl functional 
groups on the benzene ring, and the unsaturated bond of its ethylenic side chain are important sites 
for reactions with reactive oxygen species (ROS), portraying a structure - activity relationship 
(Barone et al. 2009; Razzaghi-Asl et al. 2013). Thus, their biological activity depends on the 
pattern of substitution of the aromatic moiety (Razzaghi-Asl et al. 2013). 
The most common HCAs are cinnamic acid, caffeic acid, sinapic acid, o-coumaric acid, m-
coumaric acid, p-coumaric acid and ferulic acid. Adefegha and Oboh (Adefegha and Oboh 2016) 
reported the presence of caffeic and chlorogenic acids in a phenolic rich extract of C. volubile 
leaves. This was confirmed by Oboh et al. (Oboh et al. 2017a), who also reported the presence of 
p-coumaric acid in the phenolic rich extract. Molehin et al. (Molehin et al. 2017a) also reported 
the presence of caffeic acid in the ethyl acetate, ethanol and methanol extracts of the leaves. 
II. Flavonoids 
The presence of flavonoids reported the preliminary screening of C. volubile leaves was further 
confirmed by HPLC analysis of the leaf extracts.  
Adefegha and Oboh (41), and Oboh et al. (42) reported the presence of quercetin and its glycone 
rutin in the phenolic rich extract of the leaves. This was further confirmed by Molehin et al. (43) 
in the ethyl acetate, ethanol and methanol extracts. Quercetin is one of the most studied dietary 
flavonoid with diverse pharmacological applications particularly antioxidant, anticancer and 
neuroprotection (Maalik et al. 2014). It consists of 5 hydroxyl groups and 2 benzene rings that is 
linked by a heterocyclic pyrane ring, forming the backbone for other flavonoids such as naringenin, 
hesperidins and tangeritin (Kumar and Pandey 2013; Lakhanpal and Rai 2007; Materska 2008). 
Although quercetin is an aglycon, it also exists in most plants as glycone (Lakhanpal and Rai 
2007). Aside rutin, Adefegha and Oboh (41), and Oboh et al. (42) reported the presence of 
isoquercitrin and quercitrin. These qlycones brings about their biological activities by undergoing 
hydrolysis to release quercetin (Comalada et al. 2005). 
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Other well studied flavonoids identified in C. volubile leaves are kaempferol, apigenin, catechin, 
and luteolin (Adefegha and Oboh 2016; Molehin et al. 2017a; Oboh et al. 2017a). Apigenin and 
luteolin belong to the flavonoid class, flavones which is distinguished from other classes by the 
absence of a 3-hydroxyl group (Kumar and Pandey 2013). Kaempferol and catechin are flavonols, 
whose benzene ring is condensed with a 𝛼-pyrone or a dihydro-derivative (Kumar and Pandey 
2013). It is distinguished from flavones by the presence of a 3-hydroxyl group and C2–C3 double 
bond (Kumar and Pandey 2013; Narayana et al. 2001).  
III.  Trihydroxybenzoic acids 
Gallic acid is the most popular of trihydroxybenzoic acids. Also known as 3,4,5-trihydroxybenzoic 
acid, gallic acid has been reported in most plants. Adefegha and Oboh (41) and Oboh et al. (42) 
reported its presence in the phenolic rich extract of C. volubile leaves. Molehin et al. (43) also 
compared its concentration in the ethyl acetate, ethanol and methanol extracts of C. volubile leaves, 
with the ethyl acetate extract having the least concentration. 
Gallic acid is biosynthesized from 3-dehydroshikimate in a reaction catalyzed by shikimate 
dehydrogenase to give 3,5-didehydroshikimate, which then undergoes tautomerization to form 
gallate (Dewick and Haslam 1969; Muir et al. 2011). 
It consists of 3 hydroxyl groups and a carboxylic acid group attached to a benzene ring. The 
bonding of the hydroxyl groups in an ortho position results to a coplanar and bent configuration, 
which is favorable for antioxidative activities (Badhani et al. 2015; Sroka and Cisowski 2003)  
IV. Ellagitannins 
Ellagitannins are esters of hexahydroxydiphenoic acid and monosaccharide, and are classified 
under hydrolysable tannins (Lipińska et al. 2014). They are recognized as the largest group of 
tannins, with over 500 compounds reported (Khanbabaee and van Ree 2001; Landete 2011). Their 
easy labilization in solution, makes them prone to hydrolysis and polymerization reactions. On 
hydrolysis with acid and/or base, their hexahydroxydiphenoyl (HHDP) group undergoes a 
spontaneous rearrangement to the gallic acid dimeric derivative, ellagic acid (Landete 2011). 
The presence of ellagic acid has been reported in many plants. Oboh et al. (2017a) reported its 
presence in the phenolic rich extract of C. volubile leaves, thus confirming the previous reports on 
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the presence of tannins in the leaves (Table 6.2.1) (Akinpelu et al. 2016; Erukainure et al. 2011a; 
Jaiyesimi and Adekoya 2013; Ogunwa et al. 2015; Senjobi et al. 2017). 
Ellagic acid consists of a hydrophilic domain made up of 4 phenolic groups and 2 lactones, and a 
lipophilic domain made up of four rings (García-Nino and Zazueta 2015). These domains play an 
influential role in its biological activities, particularly the hydrophilic which can hydrogen bond 
and accept electrons (García-Nino and Zazueta 2015; Sepúlveda et al. 2011). Thus, denoting a 
structure – activity relationship. 
3. Bioavailability 
Several studies have investigated the absorption and metabolism of these phenolics, thereby 
providing useful insights to their health benefits. Their bioavailability is summarized in Table 
6.2.3. 
297 
 
Table 6.2.3: Bioavailability of HPLC-identified phenolics in C. volubile leaves 
Phenolics Bioavailability Compounds References 
Hydroxycinnamic acids Chlorogenic acid is hydrolyzed to caffeic and quinic 
acids in the stomach and intestine.  Highest dose 
ingestion is associated with reduced bioavailability. 
p-Coumaric acid has a higher bioavailability than 
chlorogenic and caffeic acids. In rats, it is absorbed in 
all sections of the gastrointestinal tract, with the 
jejunum having the highest absorption rate. In the 
liver, it is conjugated with glucuronide, sulfate and 
sulfoglucuronide. 
Caffeic acid 
Chlorogenic acid 
p-Coumaric acid 
(Pei et al. 2016; Zhao and 
Moghadasian 2010) 
 
Flavonoids It is absorbed from both the small intestine and colon, 
with absorption from the latter being the most 
efficient. They are conjugated with glucoronic acid or 
sulphate, after absorption from the small intestine. 
They may also undergo O-methylation.  
Those that to the colon are metabolized by microflora 
enzymes. 
Rutin  
Isoquercitrin 
Quercitrin 
Quercetin  
Kaempferol 
Apigenin 
(Dangles and Dufour 2006; 
Viskupičová et al. 2008) 
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Catechin 
Luteolin 
Trihydroxybenzoic acids It is readily absorbed from the gastrointestinal tract 
resulting to peak plasma concentration 1 – 2 hours 
after ingestion. It is mostly excreted unchanged in 
urine. Once absorbed, they undergo methylation, 
decarboxylation and dehydroxylation 
Gallic acid (Shahrzad and Bitsch 1998) 
Ellagitannins It is absorbed from the stomach and/or the proximal 
small intestine. At the distal part of the small intestine 
and the colon, they are metabolized by microflora 
enzymes. They are then acted on by Phase II UGTs 
and/or methyltransferases before excretion in urine 
Ellagic acid (Rodriguez-Mateos et al. 2014; 
Seeram et al. 2006) 
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4. Isolation and Structural Elucidation 
In addition to HPLC fingerprinting, some phenolic compounds depicted in Figure 6.2.2 and Table 
6.2.4 have been isolated and structurally elucidated via different chromatography and spectroscopy 
techniques. The isolation of these compounds affirms the reported presence of phenol and 
flavonoids in the preliminary phytochemical investigation (Table 6.2.1) (Erukainure et al. 2011a; 
Ogunwa et al. 2015; Senjobi et al. 2017). 
Table 6.2.4: Isolated compounds from C. volubile leaves 
Isolated Compounds Common Name Fraction Reference 
5-hydroxy-7-methyl-1-(3,4,5-
trihydroxy-6-(hydroxymethyl) 
tetrahydro-2H-pyran-2-yloxy)-
1,4a,5,6,7,7a-
hexahydrocyclopenta[c]pyran-7-yl  
Ajugoside Butanol (Erukainure et al. 2014) 
3, 4–dihydroxybenzoic acid  Protocatechuic 
acid 
Ethyl acetate (Erukainure et al. 
2017a) 
5,7-Dihydroxy-6,4’-
dimethoxyflavone  
Pectolinarigenin  
Dichloromethane 
(Erukainure et al. 
2017b) 
4'-Methoxy-5,7-dihydroxy 
isoflavone  
Biochanin (Erukainure et al. 2018) 
5,7,4'-Trimethoxykaempferol  (Erukainure et al. 2018) 
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Figure 6.2.2: Isolated phenolics from leaves of C. volubile leaves 
6.2.5. Biological Activities of Clerodendrum volubile  
Although C. volubile have been employed in folkloric medicine for the treatment of several 
diseases and ailments, there are however fewer studies to back its medicinal properties. To the best 
of our knowledge, the studies done so far on the biological activities of C. volubile are summarized 
in Table 6.2.5. 
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Table 6.2.5: Studied biological activities of C. volubile leaves 
Biological Activities Experimental 
Type 
Target 
Organ/cells 
Mechanism Plant 
Part 
Phenolic 
Compounds 
Non-Phenolic 
Compounds 
References 
Free radical 
scavenging/Reducing 
power/Fe2+ chelating  
In vitro  Scavenges 
DPPH, NO, 
OH-, SO and 
ABTS; 
chelates and 
reduces Fe2+ 
Leaves 
Flower 
Chlorogenic acid 
Caffeic acid  
Rutin  
Isoquercitrin 
Quercitrin 
Quercetin  
Kaempferol 
Gallic acid 
Catechin 
Luteolin 
Apigenin 
Ellagic acid 
p-Coumaric acid 
Triacetin 
3,6-dimethyl-3-
octanol  
2R-Acetoxymethyl-
1,3,3-trimethtyl–4t– 
(3-methyl-2-buten-1-
yl)-1c-cyclohexanol 
Stigmastan-3,5-diene 
 
(Adefegha and Oboh 
2011; Adefegha and 
Oboh 2016; 
Erukainure et al. 
2010; Erukainure et 
al. 2016a; Molehin et 
al. 2017a; Oboh et al. 
2017a; Ogunwa et al. 
2016) 
 
Antioxidative stress Ex vivo Brain; Liver  Increases SOD 
and catalase 
activities; 
Leaves Ajugoside 
Chlorogenic acid 
 (Adefegha and Oboh 
2016; Erukainure et 
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decreases lipid 
peroxidation 
Caffeic acid  
Rutin  
Isoquercitrin 
Quercitrin 
Quercetin  
Kaempferol 
Gallic acid 
Catechin 
Apigenin 
Ellagic acid 
p-Coumaric acid 
al. 2014; Oboh et al. 
2017a) 
In vivo Liver; 
Pancreas 
Elevates GSH 
level; increases 
GPx, SOD, 
catalase 
activities; 
decreases lipid 
peroxidation 
Leaves Protocatechuic 
acid 
Biochanin 
5,7,4'-
Trimethoxykaem
pferol 
 (Erukainure et al. 
2018; Erukainure et 
al. 2017a; Molehin et 
al. 2017b) 
Anti-inflammatory In silico  Molecularly 
interacts with 
COX-2 and 
Flowers; 
Leaves 
Protocatechuic 
acid 
Triacetin (Erukainure et al. 
2017a; Erukainure et 
al. 2016a) 
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TNF-α with 
negative 
predicted free 
binding energy 
3,6-dimethyl-3-
octanol  
2R-Acetoxymethyl-
1,3,3-trimethtyl–4t– 
(3-methyl-2-buten-1-
yl)-1c-cyclohexanol 
In vivo Paws Time 
dependently 
reduces linear 
circumference 
of paws 
   (Jaiyesimi and 
Adekoya 2013) 
Immunomodulation Ex vivo Blood Suppresses 
phagocytic 
oxidative burst 
in neutrophils 
and 
macrophages 
Flowers; 
Leaves; 
Stem 
Protocatechuic 
acid 
Pectolinarigenin 
Triacetin 
3,6-dimethyl-3-
octanol  
2R-Acetoxymethyl-
1,3,3-trimethtyl–4t– 
(3-methyl-2-buten-1-
yl)-1c-cyclohexanol 
Stigmastan-3,5-diene 
Fatty acids 
(Erukainure et al. 
2017a; Erukainure et 
al. 2016a; Erukainure 
et al. 2017d) 
Hypolipidemic In vivo Serum Reduces 
cholesterol, 
LDL-C, 
triglyceride 
Leaves Protocatechuic 
acid 
Biochanin 
 (Akinpelu et al. 2016; 
Erukainure et al. 
2018; Erukainure et 
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and vLDL-C 
levels; elevates 
HDL-C level 
5,7,4'-
Trimethoxykaem
pferol 
 
al. 2017b; Molehin et 
al. 2017b) 
Analgesic In vivo Abdominal 
cavity 
Time 
dependently 
reduces 
writhing count; 
and inhibits 
abdominal 
constriction 
Leaves   (Senjobi et al. 2017) 
Anti-hypertensive  In vitro  Inhibits ACE  Leaves Biochanin 
5,7,4'-
Trimethoxykaem
pferol 
Chlorogenic acid 
Caffeic acid  
Rutin  
Isoquercitrin 
Quercitrin 
Quercetin 
 (Adefegha and Oboh 
2016; Erukainure et 
al. 2018) 
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In Silico Molecularly 
docks with 
ACE with a 
negative free 
binding energy 
Biochanin 
5,7,4'-
Trimethoxykaem
pferol 
Erukainure et al., 
2018 
Neuroprotection Ex vivo Brain Inhibits AChE, 
BChE, and 
MAO 
Leaves Apigenin 
Caffeic acid  
Catechin 
Chlorogenic acid  
Ellagic acid  
Gallic acid  
Kaempferol 
p-Coumaric acid 
Quercetin 
Quercitrin 
Rutin 
 (Oboh et al. 2017a) 
Anticancer In vitro Breast 
cancer cells 
(MCF-7) 
Inhibits cell 
proliferation, 
arrests cell 
cycle 
progression, 
Leaves  Oleic acid 
Octadecanoic acid 
n-Hexadecanoic 
(Erukainure et al. 
2016b) 
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downregulates 
MMP-9 
expression, and 
attenuates 
oxidative stress 
acid 
6-methyl-2-heptanone 
Antidiabetes In vitro  Inhibits α-
glucosidase, α-
amylase 
Leaves Chlorogenic acid 
Caffeic acid  
Rutin  
Isoquercitrin 
Quercitrin 
Quercetin 
Kaempferol 
 (Adefegha and Oboh 
2016; Erukainure et 
al. 2018) 
In silico  Molecularly 
docks with α-
glucosidase 
with negative 
binding energy 
Biochanin 
5,7,4'-
Trimethoxykaem
pferol 
Protocatechuic 
acid 
 (Erukainure et al. 
2018; Erukainure et 
al. 2017a) 
In vivo Pancreas; 
Serum 
Reduces blood 
glucose level; 
improves β-cell 
distribution 
and function, 
glucose 
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tolerance; 
Increases 
serum insulin 
and pancreatic 
Ca2+ levels 
Toxicity In vitro CC-1 cells  Increases cell 
proliferation 
Flower; 
Leaves 
Pectolinarigenin Triacetin 
3,6-dimethyl-3-
octanol  
2R-Acetoxymethyl-
1,3,3-trimethtyl–4t– 
(3-methyl-2-buten-1-
yl)-1c-cyclohexanol 
Stigmastan-3,5-diene 
(Erukainure et al. 
2016a; Erukainure et 
al. 2017b) 
In silico  Predicted 
toxicity class 
ranging from 
classes III – VI; 
Predicted 
inhibitors of 
cytochrome P 
(CYPs) 1A2, 
2D6 and 3A4 
Leaves; 
Stem 
Biochanin 
5,7,4'-
Trimethoxykaem
pferol 
Protocatechuic 
acid 
Pectolinarigenin 
3-Eicosyne  
Succinic acid, 2,4-
dimethylpent-3-yl 
ethyl ester 
(2,4,6-
Trimethylcyclohexyl) 
methanol 
4-Penten-1-ol, 
propanoate 
(Erukainure et al. 
2018; Erukainure et 
al. 2017a; Erukainure 
et al. 2017b; 
Erukainure et al. 
2017d) 
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3-Methyl-2-butenoic 
acid, 2-
ethylcyclohexyl ester 
In vivo Serum Decreases 
AST, ALT, 
ALP, and TB 
levels; 
Improves 
hepatic 
architecture in  
carbon 
tetrachloride-
induced 
toxicity 
Leaves Biochanin 
5,7,4'-
Trimethoxykaem
pferol 
Protocatechuic 
acid 
 (Erukainure et al. 
2018; Erukainure et 
al. 2017a; Molehin et 
al. 2017b) 
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1. Antioxidative Activities 
Oxidative stress has been implicated in the pathogenesis and progression of most diseases and their 
complications. It arises from an imbalance between free radicals generation and the endogenous 
antioxidants, with the former being the depleted. These free radicals are constituted of the reactive 
oxygen species (ROS) and reactive nitrogen species (RNS), which are continuously produced by 
oxidative metabolism, immune-activities, and cellular bioenergetics (Tan et al. 2018). Lipid 
peroxides, nitric oxide (NO), superoxide anion (O2
• −), hydroxy radicals, (OH•), hydrogen peroxide 
(H2O2), hypochlorite (ClO
−), and singlet oxygen (1O2) constitute the most studied free radicals. 
Due to their unstable nature, free radicals react very fast with the cells’ lipids and proteins leading 
to physiological and biochemical changes characterized by increased cell differentiation, 
proliferation, growth, and death (apoptosis and/or necrosis). The body has developed an 
endogenous antioxidant system to defend its self against excessive free radicals, thereby mitigating 
oxidative stress (Rahal et al. 2014). This system consists of enzymatic and non-enzymatic 
antioxidants. Superoxide dismutase (SOD), catalase, xanthene oxidase, glutathione peroxidase, 
and glutathione reductase are amongst the most studied antioxidant enzymes, while glutathione, 
ascorbic acid, and tocopherol for non-enzymatic. They act by scavenging free radicals, thus 
preventing oxidative damage. In addition to the endogenous antioxidant system, the body defends 
itself against free radicals by utilizing phytochemicals obtained from food and other natural 
products.  
Plant based antioxidant activities are well documented, with phenolics playing a major role. The 
ability of C. volubile leaves to scavenge free radicals have been reported. Erukainure et al. (2010) 
first reported the DPPH (1,1-diphenyl-2 picrylhydrazyl) radical scavenging activity of C. volubile, 
which he attributed to its total phenolic and flavonoids contents. This was also confirmed by 
Adefegha and Oboh (Adefegha and Oboh 2011; Adefegha and Oboh 2016), Ogunwa et al. (16), 
and Molehin et al. (43). DPPH is a readily available commercial transient free radical used in the 
study of scavenging potentials of natural products (Mishra et al. 2012). Ogunwa et al. (16) and 
Molehin et al. (Molehin et al. 2017a) also reported the ability of the leaf extract to scavenge another 
commercial free radical, ABTS (2, 2- azinobis (3-ethylbenzo-thiazoline- 6-sulfonate)). The leaves 
have also been reported to scavenge O2
• −, OH•, and H2O2 (Adefegha and Oboh 2011; Adefegha 
and Oboh 2016; Molehin et al. 2017a; Ogunwa et al. 2016). Molehin et al. (43), and Adefegha and 
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Oboh (41) attributed these activities to the identified phenolics (Table 2). Phenolics have been 
recognized as strong antioxidants (Pereira et al. 2009). This has been attributed to their hydroxyl 
groups, which donates an electron to the free radical. This leads to the formation of a more 
chemical stable product, as well as interaction of the hydroxyl groups with ∏-electrons of the 
benzene ring leading to delocalization of the radical (Pereira et al. 2009). These reactions quench 
the effect of the free radical, thus attenuating the oxidative damage in the cells. 
The antioxidant properties of phenolics have also been attributed to their ability to chelate metal 
ions involved in redox metabolism (Yang et al. 2001). Metals such as iron (Fe), copper (Cu), 
chromium (Cr), and cobalt (Co) have been shown to exacerbate the formation of O2
• − and OH• via 
the Fenton reaction, leading to peroxidation of the membrane lipids and fragmentation of DNAs 
(Jomova and Valko 2011). Adefegha and Oboh (41, 61) reported the antiperoxidative effect of the 
phenolic rich extract of C. volubile leaves against Fe2+-induced lipid peroxidation in rat liver and 
pancreas. Oboh et al. (42) further reported similar effect in rat brain. The reducing and chelating 
properties of C. volubile leaves on iron have also been reported (Adefegha and Oboh 2011; 
Adefegha and Oboh 2016; Erukainure et al. 2010; Molehin et al. 2017a), thus demonstrating the 
protective potential of the leaves against iron toxicity. The pro-oxidant properties of iron can be 
attributed to its ability to exist in both ferrous (Fe2+) and ferric (Fe3+) ionic states (Rajpathak et al. 
2009).  
The ability of C. volubile leaves to mitigate oxidative stress in disease states and toxicity has also 
been reported. Erukainure et al. (Erukainure et al. 2016b) reported an increased GSH level, SOD 
and catalase activities and decreased malondialdehyde (MDA) in breast cancer cells treated with 
the leaf extract. The antioxidative protective properties of the leaf extract were also reported in 
diabetic oxidative pancreas and serum (Erukainure et al. 2018), which was attributed to the isolated 
flavones, biochanin and 5,7,4'-trimethoxykaempferol. Molehin et al. (Molehin et al. 2017b) 
reported an aggravative GSH level, SOD, catalase, and GPx activities with a concomitant reduced 
MDA level in carbon tetrachloride-induced hepatotoxicity. These activities can be attributed to the 
ability of the hydrophobic benzenoid rings and hydroxyl groups of phenolics to interact with 
proteins (Pereira et al. 2009) 
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Figure 6.2.3: Antioxidative mechanism of C. volubile leaves  
2. Antihypertensive Activity 
Hypertension is the most common cardiovascular disease and has been recognized as a major 
contributor to global morbidity and motility, thus a global health epidemic (Adefegha and Oboh 
2016; Li et al. 2015; Miranda et al. 2016). It is characterized by high blood pressure which could 
lead to other cardiovascular complications, kidney failure, neurodegeneration and other 
complications (Li et al. 2015; Maione et al. 2013).  
Activation of angiotensin-I converting enzyme (ACE) has been implicated in the progression of 
hypertension owing to its regulation (Oboh et al. 2017c). It is activated after stimulation of the 
angiotensin 1 receptor, leading to an increased level of angiotensin II a potent vasoconstrictor 
(Adefegha and Oboh 2011; Oboh et al. 2017c) 
Adefegha and Oboh (41, 61) reported the ability of C. volubile leaves to inhibit ACE, which they 
attributed to the total phenol content and identified phenolics of the extracts (table 2). Erukainure 
et al. (Erukainure et al. 2018) further confirmed this ability and attributed it to the isolated flavones, 
biochanin and 5,7,4'-trimethoxykaempferol. The molecular interactions of these compounds with 
ACE were further investigated in silico. 5,7,4’-trimethoxykaempferol interacted with ACE by 
forming hydrogen bond with the residues HIS 387, TYR 523, LYS 511 (67). While biochanin 
interacted via HIS 383, GLU 411, HIS 387, TYR 523 (67). These results demonstrate the anti-
hypertensive properties of C. volubile leaves, which can be attributed to the phenolic contents.  
312 
 
An inverse relationship has been correlated with increased phenolics intake and decreased 
hypertension (Godos et al. 2017; Miranda et al. 2016). Phenolics have been shown to inhibit ACE 
by chelating its hydroxyl groups with the Zn2+ moiety of ACE (Li et al. 2015). Structure-inhibition 
studies on their relationship, revealed an increased inhibitory activity with increasing hydroxyl 
groups and less structural steric hindrance (Li et al. 2015).  
 
Figure 6.2. 4: Antihypertensive activity of C. volubile leaves 
6.5.3 Antidiabetic Activity 
Diabetes mellitus (DM) is a global epidemic with 425 million people reported with the disease in 
2017, and sub-Saharan Africa (SSA) accounting for 3.76% (IDF 2018). It is a metabolic disease 
that affects carbohydrate, fatty acid and lipids metabolism owing to inability of the pancreatic β 
cells to secret insulin (type 1 diabetes) or the body not being able to effectively utilize the insulin 
secreted (type 2 diabetes [T2D]) (Erukainure et al. 2013). Both types of diabetes are characterized 
by increased blood glucose, with T2D being the most prevalent (IDF 2018). Insulin resistance and 
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β-cell dysfunction has been recognized as the hallmarks of T2D, leading to chronic hyperglycemia 
(Prentki and Nolan 2006). 
Owing to cost of treatment, there have been increased interest in the use of medicinal plants for 
the treatment and management of T2D. The leaves of C. volubile have been investigated for their 
antidiabetic properties. Adefegha and Oboh (41) investigated the ability of its phenolic rich extract 
to inhibit α-glucosidase and amylase, key enzymes linked to T2D. They concluded the extract 
exhibited a dose-dependent inhibitory effect of the enzymes, depicting an anti-type 2 diabetic 
potential. The observed activity was attributed to the HPLC-identified phenolics (table 2). 
Similarly, Erukainure et al. (Erukainure et al. 2018) reported the inhibitory activities of the 
methanol extract and its fractions on α-glucosidase, which they attributed to biochanin and 5,7,4'-
trimethoxykaempferol. Erukainure et al. (Erukainure et al. 2018; Erukainure et al. 2017a) also 
investigated the molecular interactions of protocatechuic acid, biochanin and 5,7,4'-
trimethoxykaempferol with α-glucosidase in silico. Protocatechuic acid interacted with interacted 
with the active site residues: ASP 146 (4.3 Å), GLY 149 (3.6 Å) and LYS 164 (5.3 Å) via hydrogen 
bonding with the two meta and para oxygen atoms of its two free hydroxyl groups and oxygen of 
–OH of the –COOH (Erukainure et al. 2017a). 5,7,4’-trimethoxykaempferol interacted with 
residues ASP 203, ARG 526, and PHE 450, with the –OH and –COOH groups donating hydrogen 
bonds to ASP 203 and ARG 526 respectively (Erukainure et al. 2018). While biochanin interacted 
with residues ARG 526, TRP 406, ASP 443, and HIS 600, with the –OH and –COOH groups 
donating hydrogen bonds to ASP 443 and ARG 526 respectively (Erukainure et al. 2018). This 
reflects a structure-activity relationship. Unsaturation at 2,3-position and the presence of 4-
carbonyl group has been reported to increase the inhibitory property of phenolics on α-amylase 
(Adisakwattana et al. 2009). Similarly, hydroxylation and galloylation has been shown to improve 
their inhibitory effect (Xiao et al. 2013). Inhibition of α-glucosidase and α-amylase has been 
employed by most antidiabetic drugs such as acarbose in the reduction of blood glucose level 
(Erukainure et al. 2017c). These enzymes breakdown dietary carbohydrate to glucose, thereby 
increasing the postprandial blood glucose level. Their inhibition would therefore reduce the 
breakdown of dietary carbohydrate, thus reducing blood glucose level.   
Erukainure et al. (Erukainure et al. 2018; Erukainure et al. 2017a) reported the ability of the ethyl 
acetate and dichloromethane (DCM) fractions to reduce blood glucose level, and they attributed it 
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to the isolated phenolics, protocatechuic acid, biochanin and 5,7,4'-trimethoxykaempferol. The 
fractions improved β – cell function and increased serum insulin level. Further investigation with 
the DCM fraction revealed an improved distribution of pancreatic β-cells as well and glucose 
tolerance (Erukainure et al. 2018). The Ca2+ level of the pancreatic tissues was also increased. 
 
Figure 6.2.5: Antidiabetic activity of C. volubile leaves 
4. Immunomodulatory and Anti-inflammatory Activity  
Polymorphonuclear neutrophils (PMNs) are among the known phagocytes and the body’s first line 
of defense against pathogens invasions (Harbort et al. 2015). Their ability to modulate both pro- 
and anti-inflammatory activities indicates a major influence on the immune system (Ciz et al. 
2012). They (PMNs) release large volumes of ROS via NADPH oxidase activity upon stimulation, 
a process known as respiratory oxidative burst (Erukainure et al. 2017a; Erukainure et al. 2016a; 
Erukainure et al. 2017b). This process has been recognized as an efficient microbicidal 
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mechanism. Excessive oxidative burst has however been implicated in the recruitment of 
inflammatory cytokines, which leads to pathogenic inflammatory processes and related disorders 
with physiological consequences (Ciz et al. 2012). 
Over the years, medicinal plants have been employed as immunomodulators due to their 
antioxidant and anti-inflammatory properties (Erukainure et al. 2017b).  Erukainure et al. 
(Erukainure et al. 2017a; Erukainure et al. 2016a; Erukainure et al. 2017d) reported the ability of 
C. volubile leaves, stem and flowers to quench polymorphonuclear neutrophils (PMNs) respiratory 
oxidative burst, thereby portraying an immunomodulatory activity. They attributed the activity to 
the isolated phenolics, protocatechuic acid and pectolinarigenin which also displayed potent anti-
oxidative burst activity. The authors demonstrated the ability of pectolinarigenin to suppress T-
cell proliferation, portraying an anti-inflammatory potential (Erukainure et al. 2017b). The leaves 
have been reported to reduce the linear circumference of rat paws, which also portrays an anti-
inflammatory activity (Jaiyesimi and Adekoya 2013).   
Computational simulation of protocatechuic acid with T-cell showed that the para hydroxyl group 
hydrogen bonded to GLU 406, while the hydroxyl group (–OH) of the carboxylic acid (–COOH) 
bonded to PRO 437. Dual hydrogen bond interactions were observed on the carbonyl group with 
HIS 405 and HIS 415. There was a metal bond between the ligand and ZN 1. Electrostatic, covalent 
and van der Waals interactions were also observed between the ligand and with residues GLY 349, 
LEU 350, HIS 409 and TYR 436 (Erukainure et al. 2017a). This corresponds with previous reports 
that the scavenging activities of phenolics are greatly influenced by the number of hydroxyl 
substituents (Ciz et al. 2008). Ciz et al. (Ciz et al. 2008) further proposed that their C-2,3 double 
bond might play an influential role in the inhibition of phagocytic ROS production. 
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Figure 6.2.6: Immunomodulatory activity of C. volubile leaves 
5. Hypolipidemic Activity 
Hyperlipidemia is a medical condition characterized by elevated levels of serum cholesterol and/or 
low-density lipoprotein (LDL) cholesterol as well as alteration of other lipid parameters such as 
triglyceride, very low-density lipoprotein (vLDL) cholesterol and high-density lipoprotein (HDL) 
cholesterol (Erukainure et al. 2011b; Onwe et al. 2015). It has been recognized as a major 
cardiovascular risk factor which could give rise to cardiovascular diseases (CVD) and other 
atherosclerosis related conditions (Shattat 2015).  
It is divided into two subclasses, primary and secondary hyperlipidemia. The former is genetic 
related, while the latter arises from complications from other disease condition (Shattat 2015). 
Medicinal plants and diets have been used in the treatment and control of secondary 
hyperlipidemia, this has been attributed to their ability to modulate blood lipid profile, particularly 
reducing blood cholesterol and increasing HDL levels (Erukainure et al. 2011b). 
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The hypolipidemic properties of the leaves of C. volubile has been reported. Akinpelu (Akinpelu 
et al. 2016) reported the ability of the leaf ethanol extract to lower plasma cholesterol, LDL, vLDL 
and triglyceride levels, as well as increased HDL level in Poloxamer-407 induced hyperlipidemic 
rats. Molehin et al. (Molehin et al. 2017b) reported similar effects in carbon tetrachloride-induced 
hepatotoxicity. Erukainure et al. (Erukainure et al. 2018; Erukainure et al. 2017a) reported the 
ability of the leaf fractions to mitigate increased serum cholesterol, LDL, vLDL and triglyceride 
levels, while increasing HDL level concomitantly in type 2 diabetic rats. This was attributed to the 
isolated phenolics, protocatechuic acid, biochanin, and 5,7,4'-trimethoxykaempferol (Erukainure 
et al. 2018; Erukainure et al. 2017a) 
6. Toxicity 
The safety of medicinal plants has been a major concern, owing to issues of standardization, 
characterization and preparation (Ezuruike and Prieto 2014; Shan et al. 2007). Plants consist of a 
cocktail of phytochemicals which are extractable based on the type of extracting solvent. Different 
plant extracts exert different biological function, which can be toxic (Ezuruike and Prieto 2014).  
The toxicity of different extracts of C. volubile leaves have been reported. Erukainure et al. 
(Erukainure et al. 2017a; Erukainure et al. 2016a; Erukainure et al. 2017b) reported the cytotoxic 
effect of the fractions and isolated compounds of the leaves and flowers. They showed that DCM 
fractions were cytotoxic against CC-1 cells but the isolated compounds, biochanin, 5,7,4'-
trimethoxykaempferol, protocatechuic acid and pectolinarigenin had no cytotoxic effect.  
The toxicity of these isolated compounds was also predicted in silico. The toxicity classes of 
biochanin, 5,7,4'-trimethoxykaempferol, and pectolinarigenin were predicted to be V, while 
protocatechuic acid was IV. These classes further showed the relative safety of the compounds. 
Biochanin and 5,7,4'-trimethoxykaempferol were predicted as potent inhibitors of CYPs 1A2, 2C9, 
2D6, and 3A4, thus suggesting caution in co-usage with other prescribed drugs metabolized by the 
enzymes (Erukainure et al. 2018). 
In vivo studies showed the ability of the leaf extract to lower serum hepatic (AST and ALT) and 
renal (urea) biomarkers level in type 2 diabetic rats (Erukainure et al. 2018). Molehin et al. 
(Molehin et al. 2017b) reported similar effects in carbon tetrachloride-induced hepatotoxic rats. 
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They further reported the ability of the methanol extract to improve hepatic architecture in carbon 
tetrachloride-induced hepatoxicity (Molehin et al. 2017b). 
6.2.6. Proposed Mechanism of Action of C. volubile 
Based on the biological activities studied so far, C. volubile may bring about its health beneficiary 
effect by [1] modulation of the redox homeostasis, leading to decreased oxidative stress which in 
turn decreases the pathogenesis and complications of diabetes, hepatotoxicity, cancer and 
neurodegeneration; [2] down regulation of MMP-9 expression and concomitant arrest of the cell 
cycle, leading to decreased proliferation of cancer cells; [3] inhibition of ACE activity leading to 
decreased production of angiotensin II, thereby inhibiting vasoconstriction of the blood vessels; 
[4] inhibition of oxidative burst and inflammatory cytokines, thereby inhibiting immune-disorders 
and inflammations implicated in the pathogenesis of pancreatic β – cell dysfunction and insulin 
resistance. This in turn leads to increased insulin production and glucose tolerance; [5] inhibition 
of key carbohydrate catabolic enzymes leading to decreased postprandial blood glucose level; and 
[6] inhibition of cholinergic and monoaminergic enzymes implicated in neurodegeneration. 
This is summarized in Figure 6.2.7. 
 
Figure 6.2.7: Proposed mechanism of action of C. volubile and its medicinal activities 
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6.2.8 Conclusion 
 Studies so far on C. volubile authenticate its folkloric use in the management and treatment of 
various ailments. These health benefits can be attributed to the phenolics identified so far in the 
plant. However, cautions should be considered when using the plant with other drugs metabolized 
by CYPs 1A2, 2C9, 2D6, and 3A4. More studies should be conducted on the molecular 
mechanisms behind the pharmacological properties of the plant. 
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6.3 Flowers of Clerodendrum volubile Modulates Redox Homeostasis and 
Suppresses DNA Fragmentation in Fe2+ - induced Oxidative Injury; and 
Inhibits Carbohydrates and Lipids Catabolic Enzymes linked to Type 2 
Diabetes  
1,3Ochuko L. Erukainure, 1Olajumoke A. Daramola, 2Neil A. Koorbanally, 1Md. Shahidul Islam* 
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Preface: This article investigated the antioxidant, antidiabetic, chemical and predicted toxicity 
properties of the ethyl acetate, ethanol and aqueous extracts of C. volubile flowers in vitro, ex vivo, 
and in silico.  
6.3.1 Abstract 
The antioxidative and antidiabetic properties of Clerodendrum volubile flowers were investigated 
in vitro. The flowers were sequentially extracted with solvents of increasing polarity (n-hexane, 
ethyl acetate, ethanol and aqueous). The concentrated extracts were subjected to in vitro 
antioxidant assays using the 2,2'-diphenyl-1-picrylhydrazyl (DPPH) scavenging and Ferric 
reducing antioxidant power (FRAP) protocols. Their inhibitory activities were investigated on α-
glucosidase, pancreatic lipases, pancreatic ATPase and glucose-6-phospatase activities. Their 
antioxidative and anti-apoptotic effects on Fe2+-induced oxidative injuries were also investigated 
in pancreatic and hepatic tissues ex vivo. The extracts showed potent free radical scavenging 
activity and significantly (p<0.05) inhibited all studied enzymes. The GSH level was significantly 
(p<0.05) elevated in both tissues with concomitant increase in Superoxide Dismutase (SOD) and 
Catalase activities as well as reduced levels of malondialdehyde (MDA). The extracts significantly 
(p<0.05) suppressed DNA fragmentation in hepatic tissue. These activities were dose – dependent. 
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The ethanol extract showed the best activity and can be attributed to the synergetic effect of its 
chemical constituents identified via GC-MS. These results suggest the antioxidative, antidiabetic 
and anti-obesogenic potentials of C. volubile flowers.  
Keywords: Anti-hyperglycemia; C. volubile; Oxidative Stress; and Type 2 Diabetes 
6.3.2 Introduction 
Over the years there have been increasing interesting in the use of medicinal plants in the treatment 
and management of diabetes mellitus. This can be attributed to the high cost of treating diabetes, 
coupled to its increasing prevalence and toxic side effects of synthesized drugs. In 2015, 415 
million people were estimated to be diabetic which accounted for 12% of the global health 
expenditure and 5 million deaths (I.D.F. 2016).   
Type 2 diabetes (T2D) occurs owing to inability of the body to effectively utilize the insulin 
produced, leading to chronic hyperglycemia. It accounts for more than 90% of all diabetes, and 
has been recognized as a major contributor to global mortality and morbidity (I.D.F. 2018). 
Oxidative stress has been implicated in the pathogenesis and progression of type 2 diabetes. It 
arises due to hyperglycemia – induced elevated reactive oxygen species (ROS) production, causing 
an imbalance in endogenous antioxidant defense system (Tiwari et al. 2013). 
To the best of our knowledge, there remains a scientific dearth in the antioxidative and antidiabetic 
potential of C. volubile flowers. This paper thus aims to report the anti-oxidative potentials of the 
ethyl acetate, ethanol and aqueous extracts of C. volubile flowers on Fe2+ - induced oxidative 
pancreatic and hepatic injuries. As well as their antidiabetic potentials by investigating their 
inhibitory activity on key carbohydrate and lipid digestive enzymes linked to T2D. 
6.3.3 Materials and Methods 
Kindly refer to Chapter 2, subsections: 2.1.1, 2.1.3, 2.1.5, 2.1.6, 2.2 – 2.4, 2.6, 2.10.1, 2.11.1 and 
2.13 for details. 
6.3.4 Results 
Total phenol analysis revealed the ethyl acetate extract to have the highest phenolic content as 
depicted in Figure 6.3.1. This was followed by ethanol, with the aqueous extract having the lowest.  
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Figure 6.3.1: Total phenolic contents of the C. volubile flower extracts. Data are presented as 
mean ± SD. abcValues with different letter above the bars for a given extract are significantly 
different from each other (p < 0.05, Tukey’s HSD-multiple range post-hoc test, IBM SPSS for 
Windows). 
Significant (p<0.05) dose dependent DPPH scavenging and FRAP activities were observed for all 
extracts as shown in Figures 6.3.2A and 6.3.2B respectively. The low IC50 value of the ethanol 
extract portrays it as the best activity.   
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Figure 6.3.2: (A) DPPH and (B) Ferric reducing antioxidant power (FRAP) activity of C. volubile 
flower extracts. Data are presented as mean ± SEM. abcValues with different letter above the bars 
for a given extract are significantly different from each other (p < 0.05, Tukey’s HSD-multiple 
range post-hoc test, IBM SPSS for Windows). 
 
IC50 (µg/mL): Ethyl Acetate: 12.23; Ethanol: 8.99; Aqueous: >1000; Ascorbic Acid: 8.32  
IC50 (µg/mL): Ethyl Acetate: 2.32; Ethanol: 1.43; Aqueous: 2.17; Ascorbic Acid: 1.47 
   
(A) 
 
(B) 
 
324 
 
Incubation with FeSO4 led to induction of oxidative injury as portrayed by the significant (p<0.05) 
decreased GSH level in pancreatic tissue as depicted in Figure 6.3.3A. The effect was more 
pronounced in hepatic tissue (Figure 6.3.3B). A significant (p<0.05) reversible effect was 
observed on treatment with the extracts in both tissues depicting their therapeutic potentials. The 
aqueous extract showed the best activity in the pancreatic tissues, while the ethanol extract was 
the best for hepatic tissues.  
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Figure 6.3.3: Effect of C. volubile flower extracts on GSH level in oxidative (A) pancreatic and 
(B) hepatic injuries. Data are presented as mean ± SEM. *Significantly different from untreated 
sample and #Significantly different from normal sample; abcValues with different letter above the 
bars for a given extract are significantly different from each other (p < 0.05, Tukey’s HSD-multiple 
range post-hoc test, IBM SPSS for Windows). 
Induction of oxidative injury led to significant (p<0.05) reduced SOD activities in both tissues as 
shown in Figures 6.3.4A and 6.3.4B. A dose–dependent increased activities was observed on 
treatment with the extracts in both tissues, with the ethanol extract showing the best activity for 
both tissues as depicted by its low IC50 values. 
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Figure 6.3.4: Effect of C. volubile flower extracts on SOD activity in oxidative (A) pancreatic and 
(B) hepatic injuries. Data are presented as mean ± SEM. #Significantly different from normal 
sample and *Significantly different from untreated sample; abcValues with different letter above 
the bas for a given extract are significantly different from each other (p < 0.05, Tukey’s HSD-
multiple range post-hoc test, IBM SPSS for Windows). 
 
IC50 (µg/mL): Ethyl Acetate: 1.05; Ethanol: 0.25; Aqueous: 3.22; Gallic Acid: 10.28
 
(A) 
 
(B) 
IC50 (µg/mL): Ethyl Acetate: 1.17; Ethanol: 0.38; Aqueous: 0.60; Gallic Acid: 0.87
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Significant (p<0.05) reduced catalase activities were observed in both tissues on induction of 
oxidative injury with FeSO4 as depicted in Figures 6.3.5A and 6.3.5B. An increased activity was 
observed on treatment with the extracts in a dose – dependent pattern, with the ethanol showing 
the best activity for pancreatic tissues (Figure 6.3.5A) and aqueous extract for hepatic tissues 
(Figure 6.3.5B) as portrayed by their low IC50 values. 
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Figure 6.3.5: Effect of C. volubile flower extracts on catalase activity in oxidative (A) pancreatic 
and (B) hepatic injuries. Data are presented as mean ± SEM. *Significantly different from untreated 
sample and #Significantly different from normal sample (p < 0.05, Tukey’s HSD-multiple range 
post-hoc test, IBM SPSS for Windows). 
There were significant (p<0.05) increase in MDA levels on induction of oxidative injury with 
FeSO4 in both tissues as shown in Figure 6.3.6A and 6.3.6B. This was significantly (p<0.05) 
reduced on treatment with the extracts in a dose–dependent pattern in pancreatic tissue, with the 
aqueous showing the best activity for pancreatic tissues (Figure 6.3.6A) and ethanol for hepatic 
tissues (Figure 6.3.6B) as revealed by their low IC50 values.  
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Figure 6.3.6: Effect of C. volubile flower extracts on lipid peroxidation in oxidative (A) pancreatic 
and (B) hepatic injuries. Data are presented as mean ± SEM. *Significantly different from untreated 
sample and #Significantly different from normal sample; abValues with different letter above the 
bas for a given extract are significantly different from each other (p < 0.05, Tukey’s HSD-multiple 
range post-hoc test, IBM SPSS for Windows). 
All extracts showed significant (p<0.05) inhibitory activity on α – glucosidase and pancreatic 
lipase as depicted in Figures 6.3.7A and 6.3.7B, with the aqueous extract showing the best 
 
IC50 (µg/mL): Ethyl Acetate: 16.92; Ethanol: 64.56; Aqueous: 12.30; Gallic Acid: 127.56
(A) 
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inhibitory activity which compared favorably to acarbose and orlistat respectively as portrayed by 
its low IC50 values. 
 
Figure 6.3.7: (A) α-glucosidase and (B) pancreatic lipase inhibitory activities of C. volubile flower 
extracts. Data are presented as mean ± SEM. abcValues with different letter above the bas for a 
given extract are significantly different from each other (p < 0.05, Tukey’s HSD-multiple range 
post-hoc test, IBM SPSS for Windows). 
There was a significant (p<0.05) increase in ATPase activity on induction of oxidative injury in 
pancreatic tissues as depicted in Figure 6.3.8. This was significantly (p<0.05) reduced on 
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treatment with the extracts, with the ethyl acetate showing the best activity as revealed by its low 
IC50 value.  
 
 
Figure 6.3.8: Effect of C. volubile flower extracts on ATPase activity in oxidative pancreatic 
injury. Data are presented as mean ± SEM. *Significantly different from untreated sample and 
#Significantly different from normal sample (p < 0.05, Tukey’s HSD-multiple range post-hoc test, 
IBM SPSS for Windows).  
A significant (p<0.05) increase in glucose-6-phosphate activity was observed on induction of 
oxidative injury in hepatic tissues as shown in Figure 6.3.9. All extracts showed significant 
(p<0.05) dose – dependent inhibition of the activity to near normal, with the ethyl acetate showing 
the best activity as revealed by its low IC50 value. 
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Figure 6.3.9: Effect of C. volubile flower extracts on Glucose-6-Phosphatase activity in oxidative 
hepatic injury. Data are presented as mean ± SEM. *Significantly different from untreated sample 
and #Significantly different from normal sample; abValues with different letter above the bas for a 
given extract are significantly different from each other (p < 0.05, Tukey’s HSD-multiple range 
post-hoc test, IBM SPSS for Windows). 
Induction of oxidative injury led to significant (p<0.05) increased DNA fragmentation in both 
tissues as depicted in Figures 6.3.10A and 6.3.10B. The extracts showed better suppressive 
activities in hepatic tissues (Figure 6.3.10B) when compared to pancreatic tissues (Figure 
6.3.10A), with the ethyl acetate showing the best activity as revealed by its low IC50 value. 
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Figure 6.3.10: Effect of C. volubile flower extracts on DNA fragmentation in oxidative (A) 
pancreatic and (B) hepatic injuries. Data are presented as mean ± SD. *Significantly different from 
untreated sample and #Significantly different from normal sample (p < 0.05, Tukey’s HSD-
multiple range post-hoc test, IBM SPSS for Windows). 
GC – MS analysis of the ethanol extract revealed the presence of 2,3-dihydro-3,5-dihydroxy-6-
methyl-4H-pyran-4-one, 2-methylbenzofuran, D-allose, Methyl--D-glucopyranoside, Phytol 
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acetate, Trans-phytol, Octadecanoic acid, 9-(4-methoxyphenyl)xanthene, Stigmasterol and 
Sitosterol as shown in Figure 6.3.11 and Table 6.3.1. 
 
Figure 6.3.11: Structures of the compounds identified in the ethanol extract of C. volubile flower. 
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Table 6.3.1: Identified compounds of the ethanol extract of C. volubile flower by GC-MS  
Compounds RT (min) Molecular 
mass 
Relative 
abundance 
(%) 
    
2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-
one 
7.79 144 1.23 
2-methylbenzofuran 
8.33 132 0.75 
D-allose 12.47 180 1.65 
Methyl--D-glucopyranoside 14.05 194 2.16 
Phytol acetate 16.42 338 2.12 
Trans-phytol 19.10 296 1.47 
Octadecanoic acid 19.56 284 2.95 
9-(4-methoxyphenyl)xanthene 22.39 288 2.28 
stigmasterol 28.97 412 0.71 
sitosterol 29.77 414 0.69 
The compounds presented in the table are those which matched similar compounds in the NIST 
library software 
Prediction of oral toxicity of the identified compounds on ProTox (tox.charite.de) web-based 
server revealed D-allose and Octadecanoic acid fall into class 3 as shown in Table 6.3.2. 2-
methylbenzofuran and Trans-phytol fell into class 5. Methyl-β-D-glucopyranoside and Phytol 
acetate were on class 6, while the others were class 4. 
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Table 6.3.2: Oral Toxicity Prediction of Identified compounds of the ethanol extract of C. volubile flower by GC-MS  
Ligands       Predicted LD50          Toxicity Class       Prediction Accuracy 
2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one 595mg/kg    4   68.07%  
2-methylbenzofuran      2960mg/kg    5   67.38%  
D-allose       51mg/kg    3   70.97% 
Methyl--D-glucopyranoside     23000mg/kg    6   72.90% 
Phytol acetate       8000mg/kg    6   72.90% 
Trans-phytol       5000mg/kg    5   100% 
Octadecanoic acid      130mg/kg    3   100.00% 
9-(4-methoxyphenyl)xanthene    370mg/kg    4   68.07%  
Stigmasterol       890mg/kg    4   72.90%  
Sitosterol       890mg/kg    4   72.90 
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6.3.5 Discussion 
The high cost of treating diabetes coupled to the economic burden of most developing countries 
have led to an increased growth in the utilization of antidiabetic medicinal plants. Several studies 
have attributed the potency of these plants to the presence of phytochemicals particularly the 
phenols and flavonoids (Oboh and Ademosun, 2011). In this study, the antidiabetic potentials of 
C. volubile flowers were investigated using in vitro and ex vivo models. Its chemical constituents 
were also reported. 
Several studies have correlated total phenolic content with increased free radical scavenging 
activities (Saeed et al., 2012; Anahita et al., 2015; Hossain and Shah, 2015). In this study, the ethyl 
acetate and ethanol extracts showed the highest total phenolic contents (Figure 6.3.1) and the 
highest scavenging activities (Figure 6.3.2a). However, the ethyl acetate which showed the highest 
total phenolic content did not display the best scavenging activity. The observed DPPH scavenging 
activity corresponds with earlier reports by Erukainure et al. (2016) on the free radical scavenging 
activities of fractions of the methanolic extract of the flower. 
GSH has been recognized as a major maker of oxidative stress as it is the first line of the 
endogenous antioxidant system and its reduced level has been reported in the pathogenesis of T2D 
complications (Tiwari et al. 2013). The reduced levels in the untreated tissues therefore indicates 
an occurrence of oxidative stress (Figure 6.3.3A and 6.3.3B), which can be attributed to the 
oxidation of Fe2+ to Fe3+. The increased levels in the treated tissues indicates an antioxidative 
protective potential by the extracts, which also correlates with their observed in vitro antioxidant 
activities (Figures 6.3.2A and 6.3.2B). 
The SOD and catalase levels in pancreatic tissue has been reported to be much lower than that of 
the hepatic tissues, thus making it more susceptible to oxidative injury (Davari et al. 2013). Iron 
induced oxidative injury has been associated with increased production of superoxide (O2
. –) and 
hydroxyl (.OH) radicals via Fenton and Haber Weiss reactions (Aslan et al. 2000). SOD protects 
against oxidative cellular injury by catalyzing the dismutation of O2
. – to H2O2. Catalase then 
converts it to oxygen and water. The reduced activities of SOD and catalase on in the untreated 
tissues further indicates an incidence of oxidative injury (Figures 6.3.4A – 6.3.5B). Their 
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significant (p<0.05) increase on treating with the extracts, further corroborates their antioxidative 
properties.  
Accumulation of H2O2 owing to decreased catalase activity has been implicated in lipid 
peroxidation. In Fe2+ oxidative toxicity, the unstable cations react continuously with the 
accumulating H2O2 via Fenton reaction to yield hydroxyl radicals (
•OH) (Aslan et al. 2000). The 
generated •OH attacks the membrane lipids, there by initiating a peroxidative chain reaction (Aslan 
et al. 2000; Kanias and Acker 2010). The increased MDA level in the untreated tissues indicates 
an occurrence of lipid peroxidation (Figures 6.3.6A and 6.3.6B). Lipid peroxidation is also 
considered as a marker of oxidative stress and even argued as an early marker for diabetes (Arora 
et al., 2013). The decreased MDA level after treatment with the extracts particularly in the 
pancreatic tissue (Figure 6.3.6A), therefore indicates an anti-peroxidative effect which 
corroborates with the increased GSH levels (Figure 6.3.3A and 6.3.3B) as well as SOD and 
catalase activities (Figure 6.3.4A – 6.3.5B). 
Most antidiabetic drugs bring about their functions by inhibiting key metabolic enzymes linked to 
type 2 diabetes. The dose – dependent inhibition of intestinal α – glucosidase by the extracts 
(Figure 6.3.7A) indicates an anti-hyperglycemic potential as a result of delay in carbohydrate 
digestion. Studies have demonstrated that inhibition of α – glucosidase causes delayed and 
prolonged carbohydrate digestion, thus reducing the rate of glucose absorption (Bischoff ; Bischoff 
1995). The extracts also portrayed an anti-obesogenic activity as depicted by their dose – 
dependent inhibition of pancreatic lipase (Figure 6.3.7B). Pancreatic lipase is a major inhibitory 
target in the treatment and management of obesity, as it hydrolyzes triglycerides into 
monoglycerides and free fatty acids (Lunagariya et al. 2014). 
Inhibition of pancreatic ATPase activity particularly Na+, K+-ATPase has been suggested as a 
possible mechanism for glucose – initiated insulin secretion via membrane depolarization (Owada 
et al. 1999). The increased ATPase activity in the untreated pancreatic tissue may depict an 
impaired membrane depolarization thus signifying a decrease in insulin secretion (Figure 6.3.8). 
Consequently, the significant (p<0.05) reduced activity to near normal on treatment with the 
extracts may portray increased membrane polarization, implying an increased insulin secretion 
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An increased glucose-6-phosphatase activity has been implicated in type 2 diabetes as it plays a 
major role in the homeostasis of blood glucose levels (Ghosh et al. 2004; Van Schaftingen and 
Gerin 2002). Its increased activity on induction of oxidative stress in the hepatic tissues indicate 
an occurrence of increased gluconeogenesis and glycogenolysis (Figure 6.3.9). The observed dose 
– dependent inhibition by the extracts also portrays an anti-hyperglycemia activity. 
Studies have implicated hyperglycaemia and hyperlipidemia in the apoptosis of pancreatic β – 
cells and hepatocytes in T2D, with oxidative stress being the driving key (Donath et al. 1999). It 
is characterized by DNA fragmentation and cellular shrinkage. The increased fragmentation on 
incubation with Fe2+ indicates an occurrence of apoptosis (Figures 6.3.10A and 6.3.10B). This 
can be attributed to the oxidation of Fe2+ to Fe3+ as evident by the reduced GSH level (Figures 
6.3.3A and 6.3.3B) and antioxidant enzymes (Figures 6.3.4A – 6.3.5B). This also corresponds to 
reports that oxidative stress significantly influences apoptosis (Allameh et al. 2010). The extracts 
significantly (p<0.05) reduced the process particularly in the hepatic tissue (Figures 6.3.10B), 
indicating an apoptotic activity. 
The identified chemical constituents of the ethanol extract (Figures 6.3.11) has been reported for 
their antioxidative activities, particularly the phytol derivatives (Santos et al. 2013) and plant 
steroids (El-Kashef et al. 2015; Rao et al. 2013). The antidiabetic properties of sitosterol has also 
been documented (Karan et al. 2012). Thus, the antioxidative and antidiabetic activities of the 
extract can be attributed to the synergistic effect of the identified chemical compounds.  
The increasing interest in the use of medicinal plants over synthesized drugs have led to concerns 
about its toxicity and safety (Ezuruike and Prieto 2014; Yüce et al. 2006). Extracts from different 
plant parts have been shown to elicit different effects in the body, which could be toxic (Ezuruike 
and Prieto 2014). Due to ethical questions and animal rights in most developed countries, new 
computational methods for determining the toxicity of chemical compounds have been emerging. 
Amongst such is the ProTox server, which predicts the oral toxicity of small molecule compounds 
based on chemical similarities between compounds with known toxic effects and the presence of 
toxic fragments (Drwal et al. 2014). The toxicity classes (Table 6.3.2) of the identified compounds 
may indicate the ethanol extract is safe for oral consumption. 
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6.3.6 Conclusion 
The inhibitory activities and exacerbation of antioxidant activities suggest an anti-hyperglycemic 
and anti – oxidative potential of C. volubile flowers, with the ethanol extract showing the best 
activity. These can be attributed to the synergistic effect of the identified compounds. These 
findings further ascertain its folkloric use in the treatment and management of T2D and its 
complications. However, further studies are required on the underlying molecular mechanisms. 
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6.4 Clerodendrum volubile inhibits Key Enzymes linked to Type 2 Diabetes 
but Induces Cytotoxicity in Human Embryonic Kidney (HEK-293) Cells via 
Exacerbated Oxidative Stress and Proinflammation 
1,2Ochuko L. Erukainure, 1Nicholisha Narainpersad, 1Moganavelli Singh, 1Md. Shahidul 
Islam* 
1. Department of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, 
Westville Campus, Durban 4000, South Africa 
2. Nutrition and Toxicology Division, Federal Institute of Industrial Research, Lagos, Nigeria 
Corresponding Author: islamd@ukzn.ac.za; Tel: +27 (0)31-260-8717; Fax: +27 (0)31-260-7942 
Preface: This article investigated the antioxidant, antidiabetic, and cytotoxic properties of the 
dichloromethane (DCM) fraction of C. voluble leaves in vitro, as well as the mechanism by which 
it elicits its cytotoxicity. It has been published in Biomedicine and Pharmacotherapy. (Erukainure 
OL, Narainpersad N, Singh M, Olakunle S, Islam MS. (2018). Clerodendrum volubile inhibits key 
enzymes linked to type 2 diabetes but induces cytotoxicity in human embryonic kidney (HEK293) 
cells via exacerbated oxidative stress and proinflammation. Biomed Pharmacother., 106: 1144–
1152). 
6.4.1 Abstract 
The toxicity and safety associated with the use of medicinal plants remains a major concern. In 
this study, the antidiabetic properties of the dichloromethane (DCM) fraction of C. volubile leaves 
were investigated in vitro. Its cytotoxic effect and mechanism of toxicity were also investigated in 
Human Embryonic Kidney (HEK-293) cells. The fraction was subjected to in vitro antioxidant 
assays using the 2,2'-diphenyl-1-picrylhydrazyl (DPPH) scavenging and Ferric reducing 
antioxidant power (FRAP) protocols. Its enzyme-inhibitory properties were investigated on α-
glucosidase and α-amylase activities. Gas Chromatography Mass Spectroscopy (GC-MS) and 
Fourier Transform Infrared (FTIR) spectroscopic analysis were used to identify its 
phytoconstituents. Cytotoxicity was determined via MTT assay. The treated cells were assayed for 
reduced glutathione (GSH), non-protein thiol, nitric oxide and malondialdehyde (MDA) levels, as 
well as Superoxide Dismutase (SOD), catalase, myeloperoxidase and ATPase activities. Cell 
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apoptosis and/or morphological changes were determined using the acridine orange and ethidium 
bromide (AO/EB) dual staining method. The fraction showed significant (p<0.05) antioxidant and 
enzyme-inhibitory activity. It showed significant (p<0.05) cytotoxic effect against HEK-293 cells 
with concomitant depletion of antioxidative and elevation of proinflammatory biomarkers. 
Morphological changes were examined in the cells with an apoptotic index of 0.84. 1,1-
Dodecanediol, diacetate was identified as the most predominant compound, while aromatics and 
amines as the most functional groups present in the fraction. These results suggest the antidiabetic 
and cytotoxic effects of C. volubile leaves. The toxicity can be attributed to induced oxidative 
stress and proinflammation with concomitant depletion of ATP leading to apoptosis of the cells. 
Keywords: Apoptosis; Cytotoxicity; Oxidative Stress; Proinflammation; and Type 2 Diabetes 
6.4.2 Introduction 
Type 2 diabetes accounts for more than 90% of all diabetes, making it the most prevalent and a 
major contributor to diabetes-related mortality and morbidity (Deshpande et al. 2008; IDF 2015). 
Unlike type 1 diabetes, it arises owing to inability of the body to utilize the insulin produced and/or 
insufficient production of insulin (Deshpande et al., 2008). It is characterized by pancreatic β-cell 
dysfunction and insulin resistance, leading to hyperglycemia (Cerf 2013; Kahn 2003). Chronic 
hyperglycemia gives rise to increased production of free radicals, which when surpasses the 
endogenous antioxidant system induces oxidative stress (Tiwari et al. 2013). Oxidative stress has 
been implicated in the pathogenic micro- and macro-vascular complications associated with type 
2 diabetes (Lipinski 2001; Pi et al. 2010; Saeed et al. 2012). Mitigation of oxidative stress and 
inhibition of carbohydrate and lipid metabolizing enzymes particularly the alpha – glucosidase, 
alpha – amylase and pancreatic lipase have been demonstrated to be therapeutic in the management 
of type 2 diabetes and its complications (Ademiluyi and Oboh 2013; Oboh et al. 2017b). 
There are concerns about the toxicity and safety of medicinal plants as they consist of a myriad of 
phytochemicals which could elicit herbal – drug, herbal – food or herbal – herbal interactions 
(Ezuruike and Prieto 2014; Yüce et al. 2006). Issues of standardization, characterization, and 
preparation remain a question to most health practitioners (Shan et al. 2007). Methods of extraction 
have also been reported to elicit different biological actions in the body, some of which may be 
toxic owing to the type of phytochemicals extracted (Ezuruike and Prieto 2014; Liu 2004). Thus, 
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this study aims to report the ability of C. volubile to inhibit key enzymes linked to type 2 diabetes 
vis-à-vis alpha-glucosidase, alpha-amylase and pancreatic lipase as well as its cytotoxic effect and 
mechanism of toxicity on Human Embryonic Kidney (HEK-293) cells. 
6.4.3 Materials and Methods 
Kindly refer to Chapter 2, subsections: 2.1.1, 2.1.3, 2.1.5, 2.1.6, 2.2 – 2.4, 2.6, 2.9.3 – 2.9.4, 2.10.1, 
2.10.4, 2.11.1 and 2.13 
6.4.4 Results 
The DCM fraction of C. volubile leaves showed significant (p<0.05) scavenging activity against 
DPPH radical with an IC50 value of 25.51 µg/mL as depicted in Figure 6.4.1A and Table 6.4.1. 
This is further portrayed by its significant (p<0.05) FRAP activity with an IC50 value of 144.67 
µg/mL (Figure 6.4.1B and Table 6.4.1). These activities were dose – dependent and concomitant 
with increasing concentration. 
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Figure 6.4.1: (A) DPPH scavenging and (B) FRAP activities of C. voluble DCM fraction. Data = 
mean ± SD; n = 3. abValues with different letter above the bars for a given concentration are 
significantly different from each other 
Table 6.4. 1: IC50 values of biological activities of C. volubile 
Biological Activities C. volubile 
(µg/mL) 
Ascorbic acid 
(µg/mL) 
Acarbose 
(µg/mL) 
Orlistat 
(µg/mL) 
DPPH 25.51 8.31 – – 
FRAP 144.67 29.98 – – 
Alpha glucosidase 4.14 – 62.42 – 
Alpha amylase 1,114.46 – 0.04 – 
Lipase 0.02 – – 0.15 
MTT 229.52 – – – 
Value = mean; n = 3 
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The fraction showed significant (p<0.05) higher inhibitory effect on α-glucosidase activity with 
an IC50 value of 4.14 µg/mL compared to that of the standard drug (62.42 µg/mL) as shown in 
Figure 6.4.2A and Table 6.4.1. It also showed a favorable effect on pancreatic lipase activity with 
an IC50 value of 0.02 µg/mL (Figure 6.4.2C and Table 6.4.1). However, the fraction had little or 
no inhibitory effect on α-amylase activity as depicted in Figure 6.4.2B. 
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Figure 6.4.2: (A) Alpha glucosidase, (B) alpha amylase and (C) pancreatic lipase inhibitory 
activities of C. volubile. Values = mean ± SD; n = 3. abValues with different letter above the bas 
for a given extract are significantly (p < 0.05) different from each other 
As depicted in Figure 6.4.3, treatment of HEK-293 cells with the fraction caused a dose dependent 
inhibition of cell viability with an IC50 value of 229.52 µg/mL (Table 6.4.1), indicating a cytotoxic 
effect. 
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Figure 6.4.3: Effect of C. volubile on cell viability of HEK-293 cell lines. Values = mean ± SD; 
n = 3. *Significantly (p < 0.05) different from control. 
Treatment with the fraction led to significant (p<0.05) depletion of GSH and MDA levels in the 
cells, with concomitant reduction in SOD and catalase activities as shown in Figures 6.4.4A – 
6.4.4D.  
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Figure 6.4.4: Effect of C. volubile on (A) GSH level, (B) SOD activity, (C) catalase activity and 
(D) MDA level in HEK-293 cell lines. Values = mean ± SD; n = 3. *Significantly (p < 0.05) 
different from control. 
Myeloperoxidase activity and NO level were significantly (p<0.05) higher at the highest treatment 
concentration (240 µg/mL) as depicted in Figures 6.4.5A and 6.4.5B. The NPT levels were 
however significantly (p<0.05) depleted in all treatments as shown in Figure 6.4.5C. 
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Figure 6.4.5: Effect of C. volubile on (A) myeloperoxidase activity, (B) nitric oxide and (C) non 
protein thiol levels in HEK-293 cell lines. Values = mean ± SD; n = 3. *Significantly (p < 0.05) 
different from control. 
Treatment with the fraction led to significant (p<0.05) depletion of ATPase activity in the cells as 
depicted in Figure 6.4.6. 
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Figure 6.4.6: Effect of C. volubile on ATPase activity in HEK-293 cell lines. Values = mean ± 
SD; n = 3. *Significantly (p < 0.05) different from control. 
There were morphological changes in the fraction – treated cells with an apoptotic index of 0.84 
as depicted in Figure 6.4.7A and 6.4.7B. Live, early apoptotic, and late apoptotic cells were 
portrayed by green, bright green/yellow, and red/orange colours respectively. These corresponded 
to the observed condensed chromatin, fragmented nucleus and shrink cells compared to the round 
homogenous nuclei in the control (untreated cells). There were little or no morphological changes 
in the untreated tissue. 
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Figure 6.4.7A: Fluorescent micrographs of dual acridine orange/ethidium bromide stained cells 
showing C. volubile induced morphological changes in HEK-293 cell lines. Magnification = 200 
μM. Keys: LC = Life Cells; EA = Early Apoptosis; LA = Late Apoptosis 
 
 
Figure 6.4.7B: Apoptotic indices of dual acridine orange/ethidium bromide stained HEK-293 cell 
lines 
GC-MS analysis of the fraction revealed 1,1-Dodecanediol, diacetate as the most predominant 
compound as depicted in Figure 6.4.8 and Table 6.4.2. Other compounds identified are 
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hexadecanoic acid; oxalic acid, allyl pentadecyl ester; nitric acid, decyl ester; 4,6-O-Furylidene-d-
glucopyranose; and 2,3,4-trimethyl-1-pentanol. 
Table 6.4.2: GC-MS identified compounds in C. volubile 
Retention Time (Min) Compounds Relative Abundance 
30.5 Hexadecanoic acid 13.42% 
33.6 Oxalic acid, allyl pentadecyl ester 13.32% 
34.8 1,1-Dodecanediol, diacetate 33.15% 
36.5 Nitric acid, decyl ester 23.37% 
40.0 4,6-O-Furylidene-d-glucopyranose 3.48% 
54.5 2,3,4-trimethyl-1-pentanol 13.26% 
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Figure 6.4.8: GC-MS identified compounds in C. volubile 
FTIR analysis revealed aromatics and amines as the most functional groups present in the fraction 
as shown in Figure 6.4.9 and Table 6.4.3. Other functional groups identified are alkyl halides, 
alkenes, aldehydes, ketones, alkanes, and amides. 
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Table 6.4.3: Quantitative analysis of FTIR spectroscopy of C. volubile 
Frequency (cm-1) Functional Group Chemical Bonds 
788.43 Alkyl halides  C–Cl stretch  
834.73 Aromatics C–H “oop” 
895.37 1°, 2° amines N–H wag 
912.58 Carboxylic acids O–H bend 
968.19 Alkenes =C–H bend 
1035.15 Aliphatic amines C–N stretch 
1080.78 Alcohols, carboxylic acids, esters, 
ethers 
C–O stretch 
1121.92 Aliphatic amines C–N stretch 
1161.62 Alkyl halides C–H wag (–CH2X) 
1223.19 Aromatic amines C–N stretch 
1300.09 Nitro compounds N–O symmetric stretch 
1400.31 Aromatics C–C stretch (in–ring) 
1455.17 Alkanes C–H bend 
1498.37 Nitro compounds N–O asymmetric stretch 
1619.61 1° amines N–H bend 
1699.04 α,β–unsaturated aldehydes, 
ketones 
C=O stretch 
1735.09 Aldehydes, saturated aliphatic C=O stretch 
2850.79 Alkanes C–H stretch 
2919.58 Alkanes C–H stretch 
3394.29 1°, 2° amines, amides N–H stretch 
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Figure 6.4.9: FTIR spectra of C. volubile 
Hexadecanoic acid; oxalic acid, allyl pentadecyl ester; 1,1-Dodecanediol, diacetate and nitric acid, 
decyl ester were predicted to as CYP3A4 substrates, while Hexadecanoic acid and oxalic acid, 
allyl pentadecyl ester were predicted as inhibitors of CYP2A1 and CYP2C9 as depicted in Table 
6.4.4. 4,6-O-Furylidene-d-glucopyranose had the highest maximum human tolerated dose with a 
value of 22.18 mg/kg/day, while hexadecanoic acid had the least (0.19 mg/kg/day). Hexadecanoic 
acid; and 2,3,4-trimethyl-1-pentanol were predicted to have the least oral LD50 values for 130 and 
200 mg/kg respectively. This was followed by nitric acid, decyl ester with a value of 505 mg/kg. 
While 4,6-O-Furylidene-d-glucopyranose was the highest (4000 mg/kg). The toxicity class for 
hexadecanoic acid; and 2,3,4-trimethyl-1-pentanol was predicted to be class 3; nitric acid, decyl 
ester as class 4; while the others were class 5.  
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Table 6.4.4: Predicted metabolism and tolerable dose of GC-MS identified compounds in C. volubile  
 
 
 
 
Compounds GI Absorption CYP Substrate CYP Inhibition Max. tolerated 
dose (Human) 
(mg/kg/day) 
Predicted LD50 
(mg/kg) 
Predicted Toxicity 
Class 
Hexadecanoic acid High CYP3A4 CYP1A2, 
CYP2C9 
0.19 130 3 
Oxalic acid, allyl 
pentadecyl ester 
High CYP3A4 CYP2C9 4.14 3300 5 
1,1-Dodecanediol, 
diacetate 
High CYP3A4 – 3.18 3000 5 
Nitric acid, decyl ester High CYP3A4 – 1.88 505 4 
4,6-O-Furylidene-d-
glucopyranose 
High – – 22.18 4000 5 
2,3,4-trimethyl-1-
pentanol 
High – – 6.33 200 3 
357 
 
6.4.5 Discussion  
The cost of treating diabetes and its complications remain a huge bane in sub-Saharan Africa, 
where the burden of other non-communicable diseases such as HIV, hypertension, cardiovascular 
diseases and stroke as well as poor health infrastructures is a drain on the poor economies of her 
countries (Beran and Yudkin 2006). This has led to the search of alternative therapies from natural 
products, with plants being the major source (Chikezie et al. 2015; Farzaei et al. 2017; Mohammed 
et al. 2014). Though natural, there are increasing concerns about toxicity and safety of medicinal 
plants. In this study, the antidiabetic properties of the DCM fraction of C. volubile leaves 
methanolic extract and its cytotoxic effect on HEK-293 cells were investigated.  
The role of antioxidants in the management of type 2 diabetes and its complication is well 
documented (Bajaj and Khan 2012; Maritim et al. 2003). Oxidative stress plays an influential role 
in the pathogenesis of type 2 diabetes and its complication. This has been attributed to excessive 
levels of free radicals arising from oxidation of glucose to an enediol radical anion, which is 
converted into reactive ketoaldehydes and superoxide anion radicals (Maritim et al. 2003). 
Antioxidants protects against these free radicals by scavenging them, thus preventing them from 
attacking the cell proteins and membrane lipids (Rahimi et al. 2005). The free radical scavenging 
and FRAP activities (Figure 6.4.1) of the fraction therefore portrays an antioxidative protective 
potential against hyperglycemia–induced oxidative stress. These activities can be attributed to the 
identified functional groups particularly the N–H, C–H and =C–H bends, N–H, C–N and C=O 
stretches (Figure 6.4.9 and Table 6.4.3). Their electron – deficient moiety designates them as 
potent antioxidants owing to their electron-withdrawing ability (Harrold, 2013). The presence of 
ether and esters also portrays an antioxidant activity, as their oxygen atom are potent hydrogen 
acceptor (Berg and Tymoczko 2002; Harrold 2013). 
Some antidiabetic drugs function by inhibiting key enzymes linked to type 2 diabetes. These 
enzymes play a major role in the digestion of dietary carbohydrate and lipids to glucose and fatty 
acids respectively (Oboh et al. 2017b). The inhibitory effect by the fraction on α-glucosidase and 
pancreatic lipase activities (Figures 6.4.2A and 6.4.2C) portrays an antidiabetic and anti-
obesogenic potential. This corroborates previous reports on the inhibitory effect of the aqueous 
extract of the leaves on α-glucosidase and α-amylase (Adefegha and Oboh 2016). The inhibition 
of these enzymes by the fraction indicates its ability to slow down the digestion of dietary 
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carbohydrate and lipids, thus limiting blood glucose and fatty acids level. These activities can be 
attributed to the identified secondary metabolites (Figure 6.4.8 and Table 6.4.2), particularly 
hexadecanoic acid which has been reported as constituent of some plant extracts with antidiabetic 
properties (Ezuruike and Prieto 2014; Li et al. 2012) 
The cytotoxic effect of the fraction on HEK-293 cells as depicted by its inhibitory activity on cell 
viability (Figure 6.4.3) further brings to question the safety of medicinal plants. The cytotoxic 
effect of the fraction has earlier been reported against normal rat (Wistar) liver cell (CC-1) lines 
(Erukainure et al. 2017b). However, isolated compounds from the fraction had no cytotoxic 
activity thus suggesting the cytotoxicity may be synergistic effect of the chemical constituents 
(Erukainure et al. 2017b). Similar effect was also reported for the DCM fraction of the methanolic 
extract of the flower on CC-1 cell lines (Erukainure et al. 2016a). Dietary fatty acids from the 
leaves had little or no cytotoxic effect on CC-1 cell lines (Erukainure et al. 2016b). These effects 
correspond with reports that solvents play crucial roles in the toxicity and safety of medicinal 
plants (Ezuruike and Prieto 2014). The cytotoxic activity of the fraction may be attributed to the 
identified phytoconstituents (Figure 6.4.8 and Table 2), particularly hexadecanoic acid and Oxalic 
acid, allyl pentadecyl ester with reported cytotoxic activities (Manilal et al. 2011; Moravcova et 
al. 2015; Ravi and Krishnan 2017). 
Oxidative stress and proinflammation are well-known toxicity mechanisms in numerous cells often 
associated with the pathogenesis and complications of most diseases (Kim et al. 2010; McKim et 
al. 2016; Suliman et al. 2015). Adverse oxidative stress has been implicated in cytotoxicity and 
employed as distinct therapeutic mechanism in the treatment of certain diseases like cancer 
(Carrasco-Torres et al. 2017; Han and Chen 2012). Oxidative stress occurs when there is a 
depletion in the body’s antioxidant system, favoring increased production of free radicals. The 
depleted GSH level, SOD and catalase activities with concomitant increased MDA level (Figures 
6.4.4A – 6.4.4B) in cells treated with the fraction indicates an occurrence of oxidative stress. 
Increased oxidative stress in normal cells portrays a toxic effect as it has been linked to cell 
membrane rupture and increased DNA fragmentation (Aponte and Agarwal 2013; Dutta et al. 
2015).  
The increased myeloperoxidase activity and NO (Figure 6.4.5) level indicate proinflammation. 
The high NO level and decreased SOD activity portrays an increased concentration of 
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peroxynitrate due to the availability of O2
._ to react with the excess NO (Jourd'heuil et al. 2001). 
Likewise, the decreased catalase activity and GSH level portrays increased availability of H2O2 
for myeloperoxidase to convert to HOCl- (Furtmüller et al. 2000). Accumulation of these free 
radicals has been implicated in oxidative injury leading to cytotoxicity (Chen and Sulik 1996; 
Rankin et al. 2017). The depleted antioxidative (Figure 6.4.4) and increased proinflammatory 
activities (Figure 6.4.5) thus corresponds with the cytotoxic effect of the fraction (Figure 6.4.4). 
Impaired ATPase activity has been implicated in cytotoxicity as depleted ATP level triggers 
apoptotic processes (Hernández et al. 2017; Wang et al. 2003). The decreased ATPase activity 
(Figure 6.4.6) in the fraction treated cells therefore portrays a depleted ATP level, which may be 
responsible for apoptosis of the cells (Figures 6.4.7A and 6.4.7B). The high apoptotic index of the 
treated cells (Figure 6.4.7B) can also be attributed to the excess reactive oxygen species (ROS) 
production owing to the depleted antioxidative activities and increased lipid peroxidation (Figure 
6.4.3). ROS have been shown to induce mitochondrial Ca2+ cycling which leads to loss of 
membrane potential and ATP depletion (Nikoletopoulou et al. 2013; Richter et al. 1996). In 
addition, both NO and ONOO- have been implicated in induction of apoptosis. While the former 
induces apoptosis via expression of the tumor suppression gene p53, the latter induces by 
triggering mitochondrial Ca2+ (Meßmer et al. 1994; Richter et al. 1996). Thus, the morphological 
changes in the cells indicating apoptosis can be attributted to the depleted antioxidative and 
increased proinflammatory biomarkers.  
Induction and inhibition of cytochromes (CYPs) can have severe drug–drug, food – drug and 
herbal – drug interactions with tremendous health complications. Most of the identified 
compounds were predicted to be CYP3A4 substrates (Table 6.4.4), indicating their potentials to 
activate the enzyme. CYP3A is the most abundantl CYP in the human hepatic tissue (Li et al. 
1995). Mizuno et al. (Mizuno et al. 2009) implicated the hepatic cytotoxic effect of 
benzodiazepines to metabolic activation by CYP3A4. They attributted the activation to the 
presence of nitro group in the side chain of benzodiazepines (Mizuno et al. 2009). The presence of 
amines in the fraction (Figure 6.4.9 and Table 6.4.2) may thus be responsible for its metabolic 
activation by CYP3A4 (Table 6.4.4), which may lead to production of cytotoxic metabolites. 
Inhibition of CYP1A2 and CYP2C9 by hexadecanoic acid and oxalic acid, allyl pentadecyl ester 
may pose a toxic effect when the fraction is ingested with drugs metabolized by these enymes 
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particularly caffeine (Urry et al. 2016). The low maximum tolerated human dose (Table 6.4.4) by 
most of the compounds also portrays a toxic potential, particularly hexadecanoic acid with reported 
cytotoxic activity (Manilal et al. 2011; Moravcova et al. 2015; Ravi and Krishnan 2017). This also 
correlates with its predicted low oral LD50 and toxicity class (Table 6.4.4). 
6.4.6 Conclusion 
These results suggests further portrays the antidiabetic properties of the leaves of C. volubile but 
also indicates its toxic potential against normal cells. The toxicity can be attributted to the ability 
of its DCM fraction to induce oxidative stress and proinflammation with conconmittant depletion 
of ATP level leading to apoptosis of the cells 
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CHAPTER 7 
THE ANTI-OXIDATIVE AND ANTI-DIABETIC ACTIVITIES OF COLA 
NITIDA (KOLA NUT) WINE IN VITRO, EX VIVO, AND IN VIVO 
7.1 Cola nitida 
 
Figure 7.1.1: Cola nitida. Common names: Kola nut (English); Obi (Yoruba, Nigeria); Gworo 
(Hausa, Nigeria); Oji (Igbo, Nigeria); Colatier (French); kolabaum (German); and colatero 
(Spanish). Photo: https://www.herbazest.com/herbs/cola-nut (accessed on November 11, 2018 
without permission). 
7.1.2 Background 
Cola nitida from the genus, Cola is an evergreen tree which is native to the tropical rain forest of 
West Africa particularly, Ghana, Nigeria, Ghana, Leone, Liberia and Ivory Coast (Burdock et al. 
2009). It often attains a height of 12 to 20 m, with a trunk of 1.5 m in diameter and a thick fibrous 
bark (Tachie-Obeng and Brown 2004). The leaves are alternate, glabrous, oblong, leathery and 
touch, with stocks and waxy margins (FAO 1995; Tachie-Obeng and Brown 2004). The flowers 
grow from the leaf axils in panicles, without petals. The seeds are contained in pods, which splits 
when ripe (Tachie-Obeng and Brown 2004). 
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7.1.3 Ethnopharmacological uses 
In folkloric medicine, the seeds are used in treating asthma, stomach ulcers, headache, depression, 
whooping coughs, piles, and rheumatism (Asogwa et al. 2011; Dorathy et al. 2014; Ndagi et al. 
2012; Orwa et al. 2009). They are also used as aphrodisiac, appetite suppressants and anti-parasitic 
(Ezuruike and Prieto 2014). 
7.1.4 Biological activities 
C. nitida seeds have been reported for their ability to reduce blood sugar level in alloxan – induced 
diabetic rats (Dorathy et al. 2014). The ability of the aqueous and polyphenolic – rich extracts to 
scavenge free radicals in vitro have also been reported (Ayebe et al. 2012; Oboh et al. 2014b). Its 
antidiabetic and antioxidant properties have been demonstrated in vitro and in vivo (Ayebe et al. 
2012; Erukainure et al. 2017b; Oboh et al. 2014b). Its consumption with alcohol has been reported 
to modify neuronal processes (Obochi et al. 2009). Its influence on the etiology of malaria-
morbidity have been reported (Alaribe et al. 2003). Its chronic consumption has been shown to 
have little or no significant effect on locomotor activities (Umoren et al. 2009). 
7.1.6 Phytochemistry 
C. nitida seeds have been reported to be rich in caffeine, theobromine, kolatine, d-catechin, and L-
epicatechin (Lowor et al. 2010). 
7.1.7 Aims and objective 
The aim of this study was to investigate the antioxidative, antidiabetic, and neuroprotective 
activities of the hot infusion of C. nitida, using in vitro, ex vivo, in silico and in vivo models. Its 
modulatory effect on dysregulated metabolic pathways in oxidative hepatic injury was also 
investigated ex vivo. 
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7.2 Caffeine – Rich Infusion from Cola nitida (Kola Nut) inhibits Major 
Carbohydrate Catabolic Enzymes; Abates Redox Imbalance; and Modulates 
Oxidative Dysregulated Metabolic Pathways and Metabolites in Fe2+ - induced 
Hepatic Toxicity 
1,3Ochuko L. Erukainure, 2Mxolisi K. Sokhela, 2Suhas A. Shintre, 2Neil A. Koorbanally, 1Md. 
Shahidul Islam* 
6. Department of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, 
(Westville Campus), Durban 4000, South Africa  
7. School of Chemistry and Physics, University of KwaZulu-Natal, (Westville Campus), 
Durban 4000, South Africa  
8. Nutrition and Toxicology Division, Federal Institute of Industrial Research, Lagos, Nigeria 
*Corresponding author: islamd@ukzn.ac.za; Tel: +27 (0)31-260-8717; Fax: +27 (0)31-260-7942 
Preface: This article investigated the in vitro antioxidant and enzyme inhibitory activities of C. 
nitida hot infusion, as well as its modulatory effect on redox imbalance and dysregulated metabolic 
pathways in oxidative hepatic pathways ex vivo. The phytochemical constituents were also 
investigated using HPLC and LC-MS. It has already been published in Biomedicine and 
Pharmacotherapy (Erukainure OL, Oyebode OA, Sokhela MK, Koorbanally NA, Islam MS. 
(2017). Caffeine – Rich Infusion from Cola nitida (Kola Nut) inhibits Major Carbohydrate 
Catabolic Enzymes; Abates Redox Imbalance; and Modulates Oxidative Dysregulated Metabolic 
Pathways and Metabolites in Fe2+ - induced Hepatic Toxicity. Biomedicine and Pharmacotherapy, 
96: 1065–1074). 
7.2.1 Abstract 
The antioxidative, antidiabetic and toxicity of caffeine-rich infusion of cola nitida were 
investigated using in vitro, ex vivo and in silico models. C. nitida was infused in boiling water and 
allowed to cool before concentrating at >50oC. HPLC analysis of the infusion revealed a caffeine 
content of 80.08%. The infusion showed potent in vitro antioxidant activity by significantly 
(p<0.05) scavenging 2,2'-diphenyl-1-picrylhydrazyl (DPPH). It significantly (p<0.05) inhibited α-
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glucosidase and α-amylase activities. Treatment of Fe2+ induced oxidative hepatic tissues with the 
infusion led to increased Superoxide Dismutase (SOD) and catalase activities, and glutathione 
(GSH) level as well as decreased malondialdehyde (MDA) level. FTIR spectroscopy of hepatic 
metabolite revealed restoration of oxidative–induced depleted functional groups by the infusion. 
LC-MS analysis of the metabolite also revealed restoration of most depleted metabolites with 
concomitant generation of 4-O-Methylgallic, (-)-Epicatechin sulfate, L-Arginine, L-yrosine, Citric 
acid and Decanoic acid in infusion-treated tissues. Pathway analysis of the identified metabolites 
revealed the presence of 21 metabolic pathways involved in normal hepatic tissues, 12 in oxidative 
injured tissues and 17 in the treated tissues. Treatment with the infusion restored 4 metabolic 
pathways common to the normal tissue and further activated 4 additional pathways. Prediction of 
oral toxicity of caffeine showed it to belong to class 3, with a LD50 of 127 mg/kg. Its toxicity target 
was predicted as Adenosine Receptor A2a. It was also predicted to be an inhibitor of CYP1A2. 
These results suggest the antioxidative and antidiabetic properties of C. nitida infusion, with 
caffeine as the major constituent. 
Keywords: Antioxidative; Kola nuts; Metabolomics; Type 2 diabetes  
7.2.2 Introduction  
Diabetes mellitus (DM) remains one of the fast growing and unabated scourge in the world. It is a 
metabolic disorder affecting carbohydrate, protein and lipid metabolism (Maritim et al. 2003a). It 
is characterized by dearth of insulin secretion as seen in type 1 diabetes or inability to utilize insulin 
secreted in the case of type 2 diabetes. Of these two types, type 2 diabetes has been recognized as 
a major contributor to global mortality and morbidity (IDF 2015). It accounted for 12% of global 
health expenditure and five million deaths in 2015 (IDF 2015). Insulin resistance and pancreatic 
β-cell dysfunction leading to hyperglycemia have been implicated in the progression of type 2 
diabetes (Evans et al. 2003). Increased hyperglycemia elevates the production of reactive oxygen 
species (ROS) which triggers an imbalance in the endogenous antioxidant system resulting to 
oxidative stress (Tiwari et al. 2013). Oxidative stress plays an influential role in the chronic 
pathogenic micro- and macro-vascular complications associated with type 2 diabetes such as 
nephropathy, microangiopathy, retinopathy and death (Barar 2000; Constantino et al. 2013). 
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The economic cost of diabetes remains a huge burden to most developing countries with low Gross 
Domestic Product (GDP). The cost of synthesized drugs coupled to its side effects have led to a 
paradigm shift to medicinal plants (Erukainure et al. 2015). Their folkloric use dates back time 
immemorial and can be attributed to their phytochemical constituents (Erukainure et al. 2016). 
Amongst such plants is the kola nut fruit, Cola nitida.  
This study aims to report the antioxidative effect of C. nitida infusion on oxidative imbalance and 
metabolites in hepatic injury; its inhibitory effect on key carbohydrate digestive enzymes linked 
to T2D; as well as phytochemical constituents. 
7.2.3 Materials and Methods 
Kindly refer to chapter 2, subsections: 2.1.1, 2.1.4, 2.1.6, 2.3-2.4, 3.6, 2.8, 2.10.2 – 2.10.4, 2.11, 
and 2.13 for details.  
7.2.4 Results 
Total phenol analysis of the infusion revealed a total phenolic content of 23.30 ± 0.01 µg/g Gallic 
acid equivalent. 
C. nitida infusion showed significant (p<0.05) dose – dependent DPPH scavenging and FRAP 
activities as depicted in Figures 7.2.1A and 7.2.1B, respectively. The low IC50 value of 2.24 µg/mL 
portrays a strong scavenging and reducing potential compared to ascorbic acid (8.32 µg/mL).  
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Figure 7.2.1: (A) DPPH scavenging activity; and (B) Ferric reducing antioxidant power (FRAP) 
activity of C. nitida infusion. Data are presented as mean ± SD. abValues with different letters over 
the bars for a given concentration are significantly different from each other (p < 0.05, Tukey’s 
HSD-multiple range post-hoc test, IBM SPSS for Windows).  
The GSH level was significantly (p<0.05) depleted on incubation with FeSO4 indicating an 
occurrence of oxidative stress as shown in Figure 7.2.2A. Incubation with FeSO4 also led to 
decreased SOD and catalase activities as depicted in Figures 7.2.2B and 7.2.2C, further 
corroborating an occurrence of oxidative imbalance. These were significantly (p<0.05) reversed 
with increasing concentration of the infusion, indicating an antioxidative activity in a dose – 
dependent manner (Figures 7.2.2A – 7.2.2C).  
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IC50 (µg/mL): C. nitida = 10.62; Gallic Acid = 17.37 
IC50 (µg/mL): C. nitida = 17.33; Gallic Acid = 54.55 
(B) 
 
(C) 
IC50 (µg/mL): C. nitida = 14.12; Gallic Acid = 13.33 
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Figure 7.2.2: Effect of C. nitida infusion on (A) GSH level; (B) SOD and (C) catalase activities; 
and (D) MDA level in oxidative hepatic injury. Data are presented as mean ± SD. *Significantly 
different from untreated sample and #Significantly different from normal sample (p < 0.05, 
Tukey’s HSD-multiple range post-hoc test, IBM SPSS for Windows). 
Hepatic MDA level was significantly (p<0.05) increased on incubation with FeSO4, depicting an 
occurrence of lipid peroxidation as shown in Figure 7.2.2D. Incubation with the infusion led to a 
dose – dependent reduction, indicating an anti-peroxidative effect (p<0.05). 
The infusion showed significant (p<0.05) inhibitory activity against alpha – glucosidase as 
depicted in Figure 7.2.3a. A similar effect was also observed against pancreatic alpha – amylase 
(Figure 7.2.3B). However, the infusion showed a rather poor inhibitory activity against pancreatic 
lipase (Figure 7.2.3C). The activities were dose – dependent with increasing concentration. 
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Figure 7.2.3: (A) α-glucosidase; (B) α-amylase; and (C) pancreatic lipase inhibitory activities of 
C. nitida infusion. Data are presented as mean ± SD. abValues with different letters over the bars for 
a given concentration are significantly different from each other (p < 0.05, Tukey’s HSD-multiple 
range post-hoc test, IBM SPSS for Windows). 
Induction of hepatic oxidative imbalance caused a significant (p<0.05) increase in DNA 
fragmentation as depicted in Figure 7.2.4. Incubation with the infusion reduced the fragmentation 
dose – dependently with no statistical significance. 
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Figure 7.2.4: Effect of C. nitida infusion on DNA fragmentation in oxidative hepatic injury. Data 
are presented as mean ± SD. *Significantly different from untreated sample and #Significantly 
different from normal sample (p < 0.05, Tukey’s HSD-multiple range post-hoc test, IBM SPSS for 
Windows). 
HPLC analysis of caffeine content of the infusion revealed a high caffeine content of 80.08% as 
shown in Figure 7.2.5. 
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Figure 7.2.5: HPLC chromatogram of (A) caffeine standard and (B) caffeine in C. nitida 
infusion  
LC – MS analysis of the infusion also revealed the presence of other alkaloids namely: 2-Heptanol 
(7.04%); L-Cysteine (10.56%); trans-2-Decen-1-ol (11.27%); Spilanthol (40.85%); L-Methionine, 
N-(2-thienylcarbonyl)-, methyl ester (26.76); and Cinchonine (3.52) as shown in Figure 7.2.6 and 
Table 7.2.1. 
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Figure 7.2.6: LC-MS identified compounds of C. nitida infusion 
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Table 7.2. 1: Identified compounds of C. nitida infusion by LC-MS  
Compounds Molecular mass Relative abundance (%) 
2-Heptanol 116 7.04 
L-Cysteine 121 10.56 
trans-2-Decen-1-ol 156 11.27 
Spilanthol 221 40.85 
L-Methionine, N-(2-thienylcarbonyl)-, 
methyl ester  
273 26.76 
Cinchonine  297 3.52 
 
FTIR spectroscopy of the hepatic metabolite revealed that induction of oxidative injury led to an 
absence of functional groups at 1619.15 (Amide II) and 2852.23 (Lipid (CH2)) cm
-1 regions, with 
additions at 921.30 (nucleic acid), 1515.64 (amide II) and 1581.82 (amide I (αβ – unsaturated)) 
cm-1 regions when compared to normal tissues as depicted in Figure 7.2.7 and Table 7.2.2. 
Treatment with C. nitida infusion led to restoration of the depleted functional groups. It also 
removed the oxidative induced added functional groups except amide I (αβ – unsaturated). 
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Table 7.2.2: Quantitative analysis of FTIR spectra of hepatic metabolites  
Regions   Normal (cm-1)  Untreated (cm-1)  Treated (cm-1) Assignment 
1200 – 900 cm-1 -    921.30    -   Nucleic Acid 
1044.45   1075.00   1047.38  Nucleic Acid 
1500 – 1200 cm-1 1222.49   1352.60   1351.07  Amide I 
   1408.42   1403.79   1403.50  Amine I; Alcohol 
   1456.16   1456.76   1456.31  Amide II 
1800 – 1500 cm-1 -    1515.64   1516.17  Amide II 
-       1581.82   -   Amide I (αβ – unsaturated)  
1619.15   -    1602.97  Amide II   
3000 – 2800 cm-1 2852.23   -    2853.27  Lipid (CH2) 
   2921.28   2922.47   2921.96  Lipid (CH2) 
- = not present  
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Figure 7.2.7: FTIR spectra of hepatic metabolite  
LC – MS analysis of the extracted hepatic metabolites revealed the presence of amino acid, fatty 
acid, carbohydrate and Krebs cycle metabolites in normal hepatic tissues as shown in Table 7.2.3. 
Induction of oxidative injury led to a depletion of these metabolites with concomitant generation 
of the glycolytic deviated metabolite, 2,3-Diphosphoglyceric acid and cysteine metabolic 
intermediate, 3-Mercaptopyruvic acid (Table 7.2.2). Treatment with the infusion led to restoration 
of most of the depleted metabolites with concomitant generation of 4-O-Methylgallic, (-)-
Epicatechin sulfate, L – Arginine, L – Tyrosine, Citric acid and Decanoic acid (Table 7.2.3). 
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Table 7.2.3: Identified hepatic metabolites by LC-MS 
Metabolites      Accession number     Normal     Untreated  Treated 
4-O-Methylgallic  HMDB13198  –  –   X 
Hexandecanoic Acid  HMDB00535   X  X   –  
Succinate   HMDB00254  X  X   – 
Adenosine 2',3'-cyclic  
Phosphate   HMDB11616  X  –   X 
Creatinine   HMDB00064  X  X   X 
L – Malate   HMDB00156  X  X   X 
Fucose 1-phosphate  HMDB01265  X  –   – 
(-)-Epicatechin sulfate HMDB12467  –  –    X 
L – Lysine   HMDB00182  X  X   X 
Uridine 2',3'-cyclic phosphate HMDB11640  X  X   X   
L – Arginine   HMDB00517  –  –    X 
L – Tyrosine   HMDB00158  –  –   X 
Indole-3-propanoite  HMDB02302  X  –   X 
Citric acid   HMDB00094  –  –   X 
Decanoic acid   HMDB00638  –  –   X 
2,3-Diphosphoglyceric acid HMDB01294  –  X   – 
Cytidine triphosphate  HMDB00082  X  –   – 
Palmitic acid   HMDB00220  X  –   X 
3-Mercaptopyruvic acid HMDB01368  –  X   – 
UDP-D-Xylose  HMDB01018  X  X   – 
Trans-Vaccenic acid  HMDB03231  X  –   X 
Key: X = Present; – = Absent 
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Pathway analysis of the identified metabolites revealed the presence of 21 metabolic pathways in 
normal hepatic tissues, 12 in oxidative injured hepatic tissues and 17 in C. nitida treated hepatic 
tissues as depicted in Figure 7.2.8 and Table 7.2.4. Metabolic pathways common to normal and 
oxidative injured hepatic tissues were only 4: Beta oxidation of very long chain fatty acids; 
Glutamate metabolism; Mitochondrial electron transport chain; and Nucleotide sugars 
metabolism. Induction of oxidative injury led to activation of glycolytic and cysteine metabolism 
pathways. There were no common metabolic pathways between oxidative injured and C. nitida 
treated hepatic tissues, indicating a therapeutic effect of the infusion. Treatment with C. nitida 
restored 4 metabolic pathways common to the normal hepatic tissue namely: fatty acid elongation 
in mitochondria, fatty acid metabolism, glycerolipid metabolism, insulin signaling, and lysine 
degradation. The infusion further activated 4 additional pathways: catecholamine biosynthesis, 
phenylalanine and tyrosine metabolism, tyrosine metabolism, and urea cycle. 
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Figure 7.2.8: Identified metabolic pathways of (A) normal hepatic tissue; (B) oxidative injured hepatic tissue; and (C) treated hepatic 
tissue. 
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Table 7.2.4: Identified metabolic pathways of hepatic tissues 
Metabolic Pathways Normal Untreated Treated 
Arginine and proline metabolism X X X 
Beta oxidation of very long chain fatty acids X X – 
Biotin metabolism X X X 
Catecholamine biosynthesis – – X 
Citric acid cycle X X X 
Cysteine metabolism – X – 
Fatty acid elongation in mitochondria X – X 
Fatty acid metabolism X – X 
Fructose and mannose degradation X – – 
Gluconeogenesis X X X 
Glutamate metabolism X X – 
Glycerolipid metabolism X – X 
Glycine, serine and threonine metabolism X X X 
Glycolysis – X – 
Insulin signaling X – X 
Lysine degradation X – X 
Malate-aspartate shuttle X X X 
Mitochondrial electron transport chain X X – 
Nucleotide sugars metabolism X X – 
Phenylalanine and tyrosine metabolism - - X 
Protein biosynthesis X X X 
Pyrimidine metabolism X – – 
Pyruvate metabolism X – X 
RNA transcription X – – 
Tyrosine metabolism - - X 
Urea cycle - - X 
Key: X = Present; – = Absent 
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Prediction of oral toxicity of caffeine on ProTox (tox.charite.de) web-based server showed it to 
belong to class 3, with a predicted LD50 of 127 mg/kg and an accuracy of 100% as shown in Table 
7.2.5. The predicted toxicity target was identified as Adenosine Receptor A2a with an average 
similarity known ligands value of 96.8%. The intestinal absorption value was 100%, with a total 
clearance of 0.239 log ml/min/kg. It is hepatotoxic, with the maximum tolerated dose for human 
predicted to be 0.536 log mg/kg/day. It was also predicted to be a substrate for P-glycoprotein and 
an inhibitor of CYP1A2. 
Table 7.2.5: Predicted toxicity of caffeine  
Parameters Predicted Values 
Intestinal absorption (human)  100% 
P-glycoprotein substrate   Yes 
CYP2D6 substrate   No 
CYP3A4 substrate   No 
CYP1A2 Inhibitor   Yes 
CYP2C19 Inhibitor No 
CYP2C9 Inhibitor No 
CYP2D6 Inhibitor No 
CYP3A4 Inhibitor No 
Total Clearance   0.239  log ml/min/kg 
Max. tolerated dose (human)  0.536  log mg/kg/day 
Hepatotoxicity   Yes 
Oral toxicity LD50 (rats) 127 mg/kg 
Toxicity Class  3 
Toxicity Target Adenosine Receptor A2a 
 
7.2.5 Discussion 
The role of medicinal plants in the treatment and management of type 2 diabetes is well 
documented (Erukainure et al. 2017a; Ezuruike and Prieto 2014; Mohammed et al. 2014) and dates 
back to time immemorial before the advent of orthodox medicine. These antidiabetic properties 
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have been attributed to the phytochemical and nutritional constituents of the plants (Erukainure et 
al. 2016). However, there are few reports on the metabolic pathways through which these plants 
and their constituents bring about their biological activities. In this study, the antidiabetic and 
antioxidative properties of caffeine – rich infusion from Cola nitida as well as the metabolic 
pathways involved were investigated. 
The role of oxidative stress in the pathogenesis and progression of type 2 diabetes and its 
complications are well documented (Pi et al. 2010; Pitocco et al. 2013). This has been attributed 
to increased hyperglycemia with concomitant suppression of the body antioxidant system, thereby 
leading to dysregulated cellular metabolism (Pitocco et al. 2013). The suppressed hepatic SOD 
and catalase activities as well as depleted GSH level on incubation with FeSO4 indicates an 
occurrence of oxidative stress (Figure 7.2.2A – 7.2.2C). This is also evidenced by the increased 
MDA level, signifying lipid peroxidation (Fig. 2d). SOD dismutates O2
. – to H2O2 which is broken 
down by catalase to O2 and H2O2. If not broken down by catalase, H2O2 would further react with 
Fe3+ to generate •OH which attacks the lipid membrane leading to lipid peroxidation (Aslan et al. 
2000). Interestingly, the additional metabolites identified in the oxidative tissues (2,3-
Diphosphoglyceric acid) have been recognized as biomarkers of oxidative stress (Richards et al. 
2007). 2,3-Diphosphoglyceric acid is a three-carbon isomer of the glycolytic intermediate, 1,3-
bisphosphoglyceric acid which reflects the activated glycolytic pathway in the oxidative injured 
tissue (Figure 7.2.8B and Table 7.2.4). The other metabolite, 3-Mercaptopyruvic acid (Figure 
7.2.8B and Table 7.2.4) is an intermediate of cysteine metabolism and involved in oxidoreductase 
activity (Módis et al. 2013; Rose et al. 2017). The reversed antioxidant activities, GSH and MDA 
levels after treatment with the infusion (Figure 7.2.2A – 7.2.2D), demonstrates an antioxidative 
activity. This is also reflected in its free radical scavenging and FRAP activities (Figs. 1a and 1b). 
These activities can be attributed to the high caffeine content and other identified alkaloids of the 
infusion with reported antioxidative activities (Figures 7.2.5 and 7.2.6, Table 7.2.1). Caffeine and 
alkaloids have been  reported for their antioxidative properties (Azam et al. 2003; Jasiewicz et al. 
2016). The absence of 2,3-Diphosphoglyceric and 3-Mercaptopyruvic acids as well as deactivation 
of their pathways in the treated tissue, further portrays the antioxidant therapeutic effect of the 
infusion. Interestingly, 4-O-Methylgallic and (-)-epicatechin sulfate (Table 7.2.3) are metabolic 
intermediates of gallic acid and (-)-epicatechin metabolism with reported antioxidative activities 
(Actis-Goretta et al. 2012; Ottaviani et al. 2012). Although not detected in the infusion, cola nitida 
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has been reported for its high content of catechins and gallic acid (Niemenak et al. 2008; Umoren 
et al. 2009). Thus, responsible for the identified metabolites. 
 The inhibitory effect of the infusion on α – glucosidase and amylase activities (Figs. 3a and 3b) 
portrays an antidiabetic potential as both enzymes play major roles in carbohydrate catabolism and 
have been implicated in the progression of type 2 diabetes (Oboh et al. 2017). This correlates with 
the reactivated insulin signaling and deactivated glycolytic pathways in the infusion – treated 
hepatic tissues (Figure 7.2.8C and Table 7.2.4). The reactivated insulin signaling pathway can be 
attributed to catecholamine biosynthesis in the treated tissue (Figure 7.2.8C and Table 7.2.4). 
Catecholamines play a major role in insulin release via the α2 and β2-adrenergic receptors. 
Stimulation of α2-adrenergic receptors causes an inhibition of insulin release, leading to increase 
in blood glucose level (Cawston and Miller 2010). While stimulation of β2-adrenergic receptors 
causes insulin release, leading to decreased blood glucose level (Barth et al. 2007). The activation 
of the catecholamine biosynthetic pathways also correlates with the activated phenylalanine and 
tyrosine, and tyrosine metabolic pathways in the treated tissue (Figure 7.2.8C and Table 7.2.4). 
This is also portrayed by the metabolite, L – Tyrosine (Table 7.2.3) as it is a major amino acid in 
the biosynthesis of catecholamines (Fernstrom and Fernstrom 2007). Caffeine has also been 
demonstrated to inhibit to monoamine oxidases (MAO), a major degrader of catecholamines 
(Akomolafe et al. 2017). Thus, inferring that the high level of caffeine implies maintenance of 
high catecholamine levels. The urea cycle in the treated tissue (Figure 7.2.8C and Table 7.2.4) 
can be attributed to the breakdown of catecholamines (Kuntz and Kuntz 2009). 
The safety and toxicity of herbal medicine and their constituents are of major concern, as studies 
have reported complications arising from herbal – drugs and herbal – food interactions (Fugh‐
Berman and Ernst 2001; Posadzki et al. 2013). The predicted toxicity class and hepatotoxicity of 
caffeine (Table 7.2.5) indicates that caution should be considered when using the infusion. 
CYP1A2 plays a major role in the metabolism of caffeine (Urry et al. 2016). Its presence has been 
reported in type 2 diabetics on caffeine therapy and/or consumes coffee (Urry et al. 2016). Its 
predicted inhibition by caffeine portrays a low metabolism thereby leading to high dose 
consequences because of high concentration of caffeine, which corroborates its low total clearance 
(Table 7.2.5). The predicted toxicity target, adenosine A2a receptor (A2AR) has been recognized 
to be non-selectively blocked by caffeine (Beukers et al. 2006). Adenosine play major roles on 
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glucose and homeostasis via the activation of A1, A2 or A3 receptors (Koupenova and Ravid 2013), 
thus its blockade could lead to unfavorable metabolic consequences. 
7.2.6 Conclusion 
These results suggest the antioxidative and antidiabetic properties of C. nitida infusion, with 
caffeine as the major constituent. This can be attributed to the ability of the infusion to reactivate 
the insulin signaling and pyruvate metabolic pathways as well as activation of catecholamine 
biosynthesis, phenylalanine and tyrosine metabolism, and tyrosine metabolism pathways in 
oxidative injured hepatic tissues. However, the predicted toxicity class and target of caffeine may 
require caution in its utilization.  
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7.3 Cola nitida Modulates Glucose Homeostasis in Type 2 Diabetes by 
Inducing Insulin Secretion; Abating Redox Imbalance and Dyslipidemia; 
Inhibiting Glycolytic and Cholinergic Enzymes Activities; and Downregulating 
Nrf2 Expression 
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Preface: This article investigated the antidiabetic effect of Cola nitida hot water infusion in type 
2 diabetic rats. Its antioxidative, anti-proinflammatory, antilipemic and insulin stimulatory effects 
were investigated. Its inhibitory effect on glycolytic, cholinergic and carbohydrate digesting 
enzymes were also investigated. Its ability to inhibit Nrf2 expression was also investigated in vivo 
and in silico 
7.3.1 Abstract 
The antidiabetic properties of the hot infusion of Cola nitida was investigated in type 2 diabetic 
rats for its effects on hyperglycemia, insulin level, lipid profile, pancreatic β-cell function, 
perfusion and morphology, redox imbalance, glycolytic and cholinergic enzymes, as well as of 
caspase-3 and Nrf2 expressions. Treatment with the infusion led to significant depleted levels of 
blood glucose, triglycerides, LDL-c, fructosamine, ALT, and uric acids, while elevating serum 
insulin and HDL-c levels. The infusion also significantly (p<0,05) elevated the GSH, SOD, 
catalase, α-amylase, and ATPase, with concomitant depletion of myeloperoxidase activity, NO 
and MDA levels in the serum and pancreas. There were significantly (p<0.05) improved pancreatic 
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β-cell function and morphology in rats treated with C. nitida, while restoring pancreatic capillary 
networks. C. nitida inhibited the activities of glycogen phosphorylase, fructose-1,6-biphosphatase, 
glucose-6-phosphatase, and acetylcholinesterase, while downregulating Nrf2 expression. NMR 
analysis of the infusion revealed the presence of caffeine and theobromine. The identified 
compounds displayed strong molecular interactions when molecularly docked with caspase-3 and 
Nrf2. These results insinuate the antidiabetic activities of C. nitida hot infusion and may be 
attributed to the NMR-identified compounds. 
Keywords: Anti-hyperglycemia; Cola nitida; Glycolytic enzymes; Nrf2; Type 2 diabetes 
7.3.2 Introduction 
There have been increasing interest in the use of plants in treating various diseases and ailments. 
The efficacies of these plants have been attributed to their phytochemical and nutritional 
constituents. This can be attributed to the quest of natural products with little or no side effects, 
coupled with affordability and availability, which have also led to a paradigm shift from 
commercial drugs to medicinal plants (Erukainure et al. 2013). The use of medicinal plants remains 
the oldest health system and are mostly rooted in the traditions and cultural beliefs of most 
communities. From time immemorial, medicinal plants have been employed in the folkloric 
treatment of various diseases and ailments such as dysentery, cancers, and diabetes. Amongst these 
plants is Cola nitida from the genus, Cola.  
Diabetes mellitus (DM) is amongst the common ailments reported to be treated with C. nitida. It 
is regarded as the fastest growing epidemy, with over 425 million people estimated to be diabetic 
in 2017 (Cho et al. 2018; I.D.F. 2018). These figures have been projected to increase by 35.35% 
in 2045 (Cho et al. 2018; I.D.F. 2018). DM is a metabolic disease affecting carbohydrate, protein 
and fatty acid metabolism leading to increased blood glucose level. Of the 2 common types of DM, 
type 2 diabetes (T2D) is most prevalent as it accounts for more than 90% of all morbidity and 
mortality attributed to DM (I.D.F. 2016; I.D.F. 2018). It occurs owing to inability of the cells to 
utilize the insulin secreted by the pancreatic β-cells. It is often characterized by insulin resistance 
and pancreatic β-cell dysfunctions, which leads to hyperglycemia. Chronic hyperglycemia has 
been recognized as the hallmark of T2D as it leads to generation of free radicals. Continuous 
production of these free radicals would lead to redox imbalance, with concomitant depletion of the 
399 
 
endogenous antioxidant system. Thereby leading to oxidative stress. Oxidative stress has been 
implicated as the main trigger of T2D micro and macro – vascular complications such as 
nephropathy, microangiopathy, retinopathy and death (Barar 2000; Constantino et al. 2013).  
The aim of this study was to investigate the antidiabetic effect of the hot aqueous infusion of C. 
nitida in fructose-streptozotocin (STZ) induced T2D rats. Its modulatory effect on pancreatic redox 
imbalance, and morphology as well its inhibitory activities on cholinergic, glycolytic and 
carbohydrate hydrolyzing enzymes were also investigated. The ability of the infusion to suppress 
the expressions of caspase-3 and nuclear factor erythroid 2–related factor 2 (Nrf2) were 
investigated as well. 
7.3.3 Materials and Methods 
Kindly refer to chapter 2, subsections 2.1.1, 2.1.4, 2.10.5; 2.11.2, 2.12 – 2.13 for details materials 
and methods.  
7.3.4 Results 
Induction of T2D led to significant (p<0.05) body weight loss as shown in Figure 7.3.1A. As the 
intervention period proceeded, there were significant (p<0.05) weight gain in all treatment groups, 
with rats treated with low dose of C. nitida having the highest gain. Induction of T2D also led to 
significant (p<0.05) feed and water intake (Figure 7.3.1B). Treatment with both doses of the 
infusion led to a slight decrease in fluid and food intake but these were significantly (p<0.05) 
decreased in rats treated with metformin. Additionally, the weight and relative weight of the 
pancreas were significantly (p<0.05) deceased in untreated diabetic rats (DC) as depicted in Figure 
7.3.1C. These were significantly increased in all treatment groups except the metformin-treated 
group. 
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Figure 7.3.1: (A) Body weight; (B) feed and fluid intake; and (C) weight and relative weight of 
pancreas of experimental groups. Values = mean ± SD; n = 5 (NC and NTXC) and 7 (DC, DLDC, 
DHDC, and DSM). *Statistically (p<0.05) significant to DC, #statistically significant (p<0.05) to 
NC. NC = normal rats, DC = diabetic control, DLDC = diabetic rats + C. nitida (150 g/kg bw), 
DHDC = diabetic rats + C. nitida (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), 
and NTXC = Normal rats + C. nitida (300 g/kg bw). 
Induction of T2D led to significant (p<0.05) increase in blood glucose level as depicted in Figure 
7.3.2A. As the intervention proceeded, the blood glucose level peaked for all treatments at the 4th 
week and started sliding till the end of the experiment. Treatment with low and high doses of C. 
nitida led to 40.48 and 27.38% reduction, respectively (Figure 7.3.2A). 
As shown in Figure 7.3.2B, oral administration of glucose (2 g/kg bw) led to significant (p<0.05) 
increase in blood glucose level at 30 min for all experimental animals. Except for DLDC and DSM, 
all groups peaked at this time and started declining with increasing time. The blood glucose level 
peaked at 60 min for DLDC and DSM, and started declining with increasing time. The lowest 
levels were recorded at 120 min for all groups. 
The serum insulin level was significantly (p<0.05) reduced after the induction of T2D, with 
concomitant reduction of pancreatic β-cell function as depicted in Figure 7.3.2C.  Treatment with 
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low dose of C. nitida had little or no significant effect on the serum insulin level. However, 
treatment with high dose of C. nitida and metformin led to significant (p<0.05) increased levels 
and β-cell functions (Figure 7.3.2C). 
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Figure 7.3.2: (A) Blood glucose level; (B) oral glucose tolerance; and (C) serum insulin and β-
cell function of experimental groups. Values = mean ± SD; n = 5 (NC and NTXC) and 7 (DC, 
DLDC, DHDC, and DSM). *Statistically (p<0.05) significant to DC, #statistically significant 
(p<0.05) to NC. NC = normal rats, DC = diabetic control, DLDC = diabetic rats + C. nitida (150 
g/kg bw), DHDC = diabetic rats + C. nitida (300 g/kg bw), DSM = diabetic rats + metformin (200 
g/kg bw), and NTXC = Normal rats + C. nitida (300 g/kg bw). 
There was no significant difference in the serum total cholesterol levels of all the experimental 
groups as shown in Figure 7.3.3. However, induction of T2D led to significant (p<0.05) increased 
levels of triglycerides and LDL-c with concomitant reduction in HDL-c level. These were 
significantly reversed in the treatment groups, C. nitida showing an appreciable antilipemic 
activity compared to the standard drug, metformin (Figure 7.3.3). 
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Figure 7.3.3: Serum lipid profile of experimental groups. Values = mean ± SD; n = 5 (NC and 
NTXC) and 7 (DC, DLDC, DHDC, and DSM). *Statistically (p<0.05) significant to DC, 
#statistically significant (p<0.05) to NC. NC = normal rats, DC = diabetic control, DLDC = 
diabetic rats + C. nitida (150 g/kg bw), DHDC = diabetic rats + C. nitida (300 g/kg bw), DSM = 
diabetic rats + metformin (200 g/kg bw), and NTXC = Normal rats + C. nitida (300 g/kg bw). 
As shown in Table 7.3.1, α-amylase activity was significantly (p<0.05) increased in both 
pancreatic tissues and serum after the induction of T2D. This was significantly (p<0.05) decreased 
in all treatment groups, with rats treated with low dose of C. nitida and metformin showing the 
best activities respectively. 
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Table 7.3.1: Serum enzyme activities of experimental groups 
Enzyme Activities NC DC DLDC DHDC DSM NTXC 
Serum α-amylase 25.38±3.50* 72.36±4.25# 44.89±5.56# 54.88±2.80# 41.57±9.53* 29.71±2.40* 
Pancreatic α-amylase 46.90±4.25* 89.72±4.21# 39.56±5.70* 46.97±7.18* 28.02±3.37* 52.20±9.06* 
Serum ATPase 279.18±5.60* 201.24±17.89# 271.32±17.06* 273.45±13.31* 241.92±12.42* 232.49±2.88* 
Pancreatic ATPase 144.35±21.59* 234.49±7.781# 162.11±2.48* 153.14±13.57# 103.95±14.28* 95.57±13.88*# 
Acetylcholinesterase  29.56±3.24* 44.20±3.24# 25.83±3.76* 22.58±3.65* 22.96±3.76* 20.09±4.87* 
Glycogen Phosphorylase 174.22±9.98* 209.89±17.50# 179.89±1.99* 155.09±6.31* 169.35±24.65* 167.53±10.00* 
Fructose 1,6 Biphosphatase 177.19±7.93* 247.46±9.90# 187.59±5.68* 180.97±6.93* 191.78±19.49* 184.76±8.18* 
Glucose 6 Phosphatase 153.68±3.06* 223.14±12.03# 154.69±7.97* 171.96±6.76* 176.92±23.96* 173.14±6.95* 
Values = mean ± SD; n = n = 5 (NC and NTXD) and 7 (DC, DLDC, DHDC and DSM). *Statistically (p<0.05) significant to DC, 
#Statistically significant (p<0.05) to NC. NC = normal rats, DC = diabetic control, DLDC = diabetic rats + C. nitida (150 g/kg bw), 
DHDC = diabetic rats + C. nitida (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and NTXC = Normal rats + C. nitida 
(300 g/kg bw). 
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There was significant (p<0.05) decrease in serum ATPase activity, with concomitant increased in 
pancreatic ATPase activity untreated T2D rats (DC) as depicted in Table 7.3.1. These were 
significantly (p<0.05) reversed in all the treatment groups, with metformin and high dose of C. 
nitida showing the best inhibitory activities (Table 7.3.1). 
Induction of T2D also led to significant (p<0.05) increase in pancreatic acetylcholinesterase 
activity as shown in Table 7.3.1. This was significantly (p<0.05) reduced in all treatment group, 
with high dose of C. nitida and metformin showing the best inhibitory activities (Table 7.3.1). 
The increased glycolytic enzymes activities on induction of T2D, were significantly (p<0.05) 
depleted in all treatment groups as depicted in Table 1. Rats treated with high dose of C. nitida 
(DHDC) revealed the best inhibitory activities on glycogen phosphorylase and fructose 1,6 
biphosphatase, while the low dose was best for glucose-6-phosphatase (Table 7.3.1). 
As shown in Table 7.3.2, there was a significant (p<0.05) depletion in GSH level, SOD and 
catalase activities, with concomitant increased MDA level in both serum and pancreatic tissues on 
induction of T2D, which suggests the induction of oxidative stress. The increased NO level and 
myeloperoxidase activity on induction of T2D, also portrays proinflammation on induction of 
T2D. These activities and levels were significantly (p<0.05) reversed after the treatment with C. 
nitida, with the low dose showing the better activities (Table 7.3.2). 
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Table 7.3.2: Antioxidant status of (A) serum and (B) pancreas of experimental groups 
(A) 
 GSH 
(mol/L) 
SOD  
(U/mg protein) 
Catalase  
(U/mg protein) 
MDA (mol/L) NO (µml) Myeloperoxidase  
(U/mg protein) 
NC 64.28±11.90* 86.21±8.13* 636.37±29.48* 63.09±4.57* 0.075±0.006* 100.27±9.68* 
DC 36.65±2.47# 40.23±3.32# 490.64±42.75# 71.19±4.52# 0.102±0.007# 121.08±18.63# 
DLDC 56.75±3.27* 177.20±10.36*# 643.89±26.30* 46.19±9.50* 0.020±0.005* 55.45±6.46* 
DHDC 54.39±6.77* 99.14±8.78* 598.81±15.21* 61.30±11.59* 0.019±0.003* 67.10±10.49* 
DSM 53.31±2.27* 68.97±8.78* 650.50±4.82* 50.09±9.53* 0.053±0.008* 47.44±1.53* 
NTXC 50.30±8.04* 246.65±17.95*# 664.29±24.19* 51.27±4.64* 0.041±0.009# 72.77±16.10* 
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(B) 
 GSH 
(mol/L) 
SOD  
(U/mg protein) 
Catalase  
(U/mg protein) 
MDA (mol/L) NO (µml) Myeloperoxidase  
(U/mg protein) 
NC 104.87±3.09* 659.96±57.9* 783.32±28.21* 40.96±5.79* 0.24±0.02* 20.31±5.75* 
DC 54.06±5.01# 150.86±10.6# 711.48±34.46# 71.75±3.60# 0.70±0.02# 35.35±3.61# 
DLDC 90.84±2.87* 573.28±4.06* 780.64±24.02* 48.31±3.21* 0.17±0.01* 16.55±0.65* 
DHDC 110.19±2.74* 674.57±15.67* 788.25±46.87* 57.34±7.15* 0.40±0.01* 16.11±1.80* 
DSM 51.80±6.38# 583.33±31.8* 754.29±40.8* 55.08±5.99* 0.34±0.03* 17.85±1.81* 
NTXC 67.29±6.33# 466.24±10.45* 754.81±25.91* 54.24±2.78* 0.25±0.01* 16.71±4.41* 
Values = mean ± SD; n = n = 5 (NC and NTXD) and 7 (DC, DLDC, DHDC and DSM). *Statistically (p<0.05) significant to DC, 
#statistically significant (p<0.05) to NC. NC = normal rats, DC = diabetic control, DLDC = diabetic rats + C. nitida (150 g/kg bw), 
DHDC = diabetic rats + C. nitida (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and NTXC = Normal rats + C. nitida 
(300 g/kg bw). 
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Table 7.3.3: Organ function biomarkers of experimental groups 
Enzyme Activities NC DC DLDC DHDC DSM NTXC 
ALP U/L 101.00±5.55* 1235.00±29.88# 459.75±2.83* 540.00±9.90* 582.33±10.67* 93.00±5.56* 
ALT U/L 91.00±4.24 87.50±0.71 87.5±0.58 88.00±1.41 88.00±3.20 87.33±1.53 
CK-MB U/L 625.00±15.80* 959.00±25.10# 815.3±68.59 684.3±13.65# 739.40±12.89# 484.50±15.84* 
Fructosamine mg/dL 656.00±12.6* 743.00±15.56# 700.3±68.59* 695.00±32.39# 658.50±12.02* 573.00±15.56* 
Urea mg/dL 58.00±0.71 46.00±5.67 37.00±2.31# 28.00±2.65# 31.50±6.81# 55.33±7.66 
Uric acid mg/dL 2.46±0.24 3.48±0.70 2.035±0.39 2.04±0.03 1.60±0.23*# 2.02±0.31 
Values = mean ± SD; n = n = 5 (NC and NTXD) and 7 (DC, DLDC, DHDC and DSM). *Statistically (p<0.05) significant to DC, 
#statistically significant (p<0.05) to NC. NC = normal rats, DC = diabetic control, DLDC = diabetic rats + C. nitida (150 g/kg bw), 
DHDC = diabetic rats + C. nitida (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and NTXC = Normal rats + C. nitida 
(300 g/kg bw). 
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There were significant (p<0.05) increase in the serum levels of ALP, CK-MB, fructosamine and 
uric acid after the induction of T2D as shown in Table 7.3.3. These levels were significantly 
(p<0.05) reduced in all the treatment groups, with rats treated with high dose of C. nitida (p<0.05) 
having the most reduced levels. Although induction of T2D had little or no significant effect on 
uric acid level, it was however significantly (p<0.05) reduced in all treatment groups compared to 
the diabetic control group (Table 7.3.3). 
As shown in Figure 7.3.4, induction of T2D led to depletion and inflammation of the pancreatic 
β-cells, with concomitant alteration in the acinar cell population (Figure 7.3.4B). This contrasts 
the intact pancreatic β- and acinar cells and intralobular ducts of that of the normal control (NC) 
group. The altered morphology was restored to near normal in all treatment groups as evident by 
the replenished β- and acinar cells (Figures 7.3.4C – 7.3.4E).   
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Figure 7.3.4: Morphological changes in pancreatic tissues of experimental groups. Magnification: 
10x. (A) = NC, (B) = DC, (C) = DLDC, (D) = DHDC, (E) = DSM, and (F) = NTXC. NC = normal 
rats, DC = diabetic control, DLDC = diabetic rats + C. nitida (150 g/kg bw), DHDC = diabetic rats 
+ C. nitida (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and NTXC = Normal 
rats + C. nitida (300 g/kg bw). Arrow: β-cells 
As revealed in Figure 7.3.5, induction of T2D also led to the alteration in the clusters of exocrine 
cells and acini in the pancreatic tissues, with concomitant disruption of the surface capillary 
network (Figure 7.3.5B) as compared to NC (Figure 7.3.5A). Treatment with C. nitida improved 
the capillary network, while restoring the clusters of exocrine cells and acini (Figures 7.3.5C and 
7.3.5D). Metformin-treated rats exhibited similar recovery as well (Figure 7.3.5E). 
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Figure 7.3.5: Electron microscopy of pancreatic tissues of experimental groups. Magnification = 
1000x. (A) = NC, (B) = DC, (C) = DLDC, (D) = DHDC, (E) = DSM, and (F) = NTXC. NC = 
normal rats, DC = diabetic control, DLDC = diabetic rats + C. nitida (150 g/kg bw), DHDC = 
diabetic rats + C. nitida (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and 
NTXC = Normal rats + C. nitida (300 g/kg bw). Arrow: Black = blood vessels; Red = acini 
There was an insignificant upregulation of caspase-3 expression in the pancreatic tissues of 
untreated diabetic rats (DC) as shown in Fig. 6A. Treatments with C. nitida and metformin had 
little or no significant effect on the upregulated expression (Figure 7.3.6C – 7.3.6E).  
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Figure 7.3.6: (A): Immunohistochemistry photomicrographs and (B): immunoreactivity of 
caspase3 expression in pancreatic tissues of experimental groups. Magnification = 200x; Values = 
mean ± SD; n = 5 (NC and NTXD) and 7 (DC, DLDC, DHDC and DSM). *Statistically (p<0.05) 
significant to DC, #statistically significant (p<0.05) to NC. NC = normal rats, DC = diabetic 
control, DLDC = diabetic rats + C. nitida (150 g/kg bw), DHDC = diabetic rats + C. nitida (300 
g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and NTXC = Normal rats + C. nitida 
(300 g/kg bw). Arrow: β-cells 
Similarly, induction of T2D led to upregulation of Nrf2 in the pancreatic tissues as depicted in 
Figure 7.3.7A and 7.3.7B. Treatment with C. nitida significantly (p<0.05) downregulated the 
expressions in diabetic rats, suggesting an inhibitory effect. 
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Figure 7.3.7: (A): Immunohistochemistry photomicrographs and (B): immunoreactivity of Nrf2 
expression in pancreatic tissues of experimental groups. Magnification = 200x; Values = mean ± 
SD; n = n = 5 (NC and NTXD) and 7 (DC, DLDC, DHDC and DSM). *Statistically (p<0.05) 
significant to DC, #statistically significant (p<0.05) to NC. NC = normal rats, DC = diabetic 
control, DLDC = diabetic rats + C. nitida (150 g/kg bw), DHDC = diabetic rats + C. nitida (300 
g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and NTXC = Normal rats + C. nitida 
(300 g/kg bw). Arrow: β-cells 
1H NMR analysis of C. nitida infusion revealed the presence of the alkaloids, caffeine [1H NMR 
(600 MHz, DMSO, δ, ppm) 7.98 (s, H, ArA), 3.88 (s, 3H, CH3), 3.22 (s, 3H, CH3), 3.14 (s, 3H, 
CH3)] and theobromine [
1H NMR (600 MHz, DMSO, δ, ppm) 8.75 (s, br, 1H, NH), 7.95 (s, 1H, 
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ArA), 3.84 (s, 3H, CH3)] as depicted in Figure 7.3.8. The data were compared with literature 
(Ohsaki et al. 1986). 
 
Figure 7.3.8: NMR chromatogram and identified compounds of C. nitida hot infusion 
The 3D structure of caspase-3-caffeine (highest binding affinity) complex and Nrf2-theobromine 
complex are shown in Figure 7.3.9. The active site residues are represented in CPK format; 2-D 
representations of docked complex of caspase-3-caffeine (highest binding affinity) complex and 
Nrf2-complex theobromine showing the different interactions with amino acid residues are also 
displayed in Figure 7.3.9. 
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Figure 7.3.9: 3D structure of (A) caspase-3 and caffeine (highest binding affinity) and (B) Nrf2 
and theobromine. The active site residues are represented in CPK format; 2-D representations of 
docked complex of (C) caspase-3 and caffeine (highest binding affinity) and (D) Nrf2 and 
theobromine showing the different interactions with amino acid residues. 
The Binding affinities in kcal mol -1 of compounds with caspase3 and Nrf2 are presented in Table 
7.3.4. Results revealed that Caffeine binds with caspase3 with a higher binding affinity -5.0 
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compared to Theobromine while the binding of theobromine to Nrf2 gave higher binding energy 
compared to caffeine-Nrf2 complex 
Table 7.3. 4: Binding affinities of NMR-identified compounds with caspase3 and Nrf2 
Compounds Binding affinity (kcal mol-1) 
Caspase-3 Nrf2 
Theobromine  4.8 4.9 
Caffeine  5.0 4.3 
 
7.3.5 Discussion 
The quest for affordable medicine to augment the cost of treating DM have led to a paradigm shift 
to medicinal plants with little or no side effects. This have also led to the search of the active 
phytochemical constituents that mainly influence the medicinal properties of the plants. In this 
study, the antidiabetic properties of C. nitida as well as possible underlying mechanisms were 
investigated in T2D rats. Its phytochemical constituents were also investigated. 
The reduced bodyweights of the untreated diabetic rats (Figure 7.3.1A) is consistent with previous 
studies in STZ-induced diabetes models (Gajdosik et al. 1999; Ibrahim et al. 2016). This also 
correlates with the increased food and fluid intake (Figure 7.3.1B), which depicts an occurrence 
of polyphagia and polydipsia (Ibrahim et al. 2016). Although treatment with C. nitida did not 
significantly suppress polyphagia and polydipsia, the increased weight gains in DLDC and DHDC 
groups (Figure 7.3.1A) may indicate a therapeutic effect against weight loss in T2D. 
Chronic hyperglycemia resulting from consistent hyperglycemia is amongst the major features of 
T2D (Monnier et al. 2006). Studies have attributed the hyperglycemia which is consistent to insulin 
insufficiency arising from depleted pancreatic β-cell mass and dysfunction (Donath and Halban 
2004). This is in consent with the elevated blood glucose level (Figure 7.3.2A), depleted serum 
insulin level and pancreatic β-cell function (Fig. 2C) and pancreatic weight loss (Figure 7.3.1C) 
in the untreated diabetic rats. These can be attributed to the depleted and inflamed pancreatic β-
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cells (Figure 7.3.4B), as inflammation of the β-cells have been implicated its dysfunction and 
failure, which impairs insulin secretion and utilization, and thereby leading to hyperglycemia 
(Donath et al. 2009; Newsholme et al. 2013). The ability of C. nitida to reduce blood glucose level 
(Figure 7.3.2A), with concomitant elevated pancreatic β-cell function and serum insulin level 
(Figures 7.3.2C and 7.3.2D) indicates an antidiabetic effect. This is also evident by the regenerated 
β-cells and improved morphology (Figure 7.3.4C and 7.3.4D) and increased pancreatic weight 
(Figure 7.3.1C).  The improved glucose tolerance in diabetic rats treated with C. nitida (Figure 
7.3.2B) further portrays the anti-hyperglycemic potential of the infusion. 
Activation of key enzymes involved in glycogenolytic, gluconeogenic and glycolytic pathways 
have been implicated in increased glycogenolysis, gluconeogenesis and glycolysis in T2D, 
respectively (Clore et al. 2000; Guo et al. 2012; Wu et al. 2005). Thus, the increased glycogen 
phosphorylase and fructose-1,6-biphosphatase activities in the untreated diabetic rats (Table 
7.3.1), implies the activation of glycogenolysis and gluconeogenesis respectively after the 
induction of T2D. Activation of these enzymes may contribute to the elevated blood glucose level 
(Figure 7.3.2A) as increased glycogenolysis and gluconeogenesis will lead to increase endogenous 
glucose output (EGO) in T2D and suppressed insulin functions, thereby exacerbating 
hyperglycemia (Basu et al. 2005; Gastaldelli et al. 2000). The increased glucose-6-phosphatase 
activity in the untreated diabetic rats (Table 7.3.1) indicates an activation of the glycolytic 
pathway, which has been linked to the pathogenesis of T2D owing to the generated metabolites 
for polyol, AGEs, protein kinase C, and hexosamine pathways (Luo et al. 2016; Rolo and Palmeira 
2006). The reduced activities of the enzymes in diabetic rats treated with C. nitida (Table 7.3.1), 
therefore insinuates a suppressive effect by the infusion on glycogenolysis, gluconeogenesis and 
glycolysis in T2D. This also correlates with the depleted blood glucose and elevated serum insulin 
levels (Figures 7.3.2A and 7.3.2C). 
The pancreatic α-amylase play an essential role in the elevation of postprandial glucose level as it 
involved in the breakdown of dietary carbohydrate to glucose (Adisakwattana et al. 2011; Kim et 
al. 2005). Therefore, its higher activity in the untreated diabetic rats (Table 7.3.1) may also 
contribute to their elevated blood glucose level (Figure 7.3.2A). The higher activity can be 
attributed to the distorted pancreatic acinar cells (Figure 7.3.4B) as these cells are responsible for 
the secretion of digestive enzymes from pancreas (Muniraj et al. 2015; Williams 2010). The 
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reduced activities in diabetic rats treated with C. nitida (Table 7.3.1), therefore indicates an 
inhibitory effect by the infusion which also correlates with their improved acinar cell morphology 
(Figures 7.3.4C and 7.3.4D). The inhibitory activity of C. nitida may validate previous studies 
that reported the ability of its hot infusion and phenolic extract to inhibit the activities of α-amylase 
in vitro (Erukainure et al. 2017b; Oboh et al. 2014a). This is of great advantage as inhibition of α-
amylase activities are the main mechanism of some commercial antidiabetic drugs such as miglitol 
and acarbose (Chelladurai and Chinnachamy 2018; Rahimzadeh et al. 2014) 
Decreased ATPase activity with concomitant influx of Ca2+ leading to depolarization of the 
pancreatic β-cell membrane has been reported as one of the major mechanism by which glucose 
stimulates insulin secretion (Owada et al. 1999). Thus, implying that the decreased ATPase activity 
in diabetic rats treated with C. nitida (Table 7.3.1) reflects an increased stimulation of insulin 
secretion. This is consistent with the increased serum insulin level of the groups (Figure 7.3.2C). 
Decreased serum ATPase activity has however been reported in T2D (Kiziltunç et al. 1997; 
Zadhoush et al. 2015), which corroborates with the decreased activity of the untreated diabetic rats 
(Table 7.3.1) in the present study. The increased activity in the treatment groups, thus further 
indicates an antihyperglycemic potential of C. nitida.  
Persistent hyperglycemia and insulin resistance in T2D have been implicated in the alteration of 
lipid metabolism, leading to diabetic dyslipidemia (Parhofer 2015; Vijayaraghavan 2010). It is 
often characterized by elevated levels of total cholesterol, LDL-cholesterol, triglycerides, and 
depleted level of HDL-c (Boden and Laakso 2004). This correlates with the elevated levels of 
triglycerides, LDL-c and depleted HDL-c level in the untreated diabetic rats (Figure 7.3.3), thus 
indicating an occurrence of diabetic dyslipidemia. The normal level of total cholesterol in all the 
experimental groups is in consent with previous reports that total cholesterol level may not be 
altered in dyslipidemia (Boden and Laakso 2004; Parhofer 2015; Sugden and Holness 2011). The 
reversed levels in the treatment groups therefore indicates an antilipemic activity of C. nitida. This 
corroborates previous studies which reported the ability of C. nitida methanolic extract to suppress 
hyperlipidemia in alloxan-induced diabetic rats (Dorathy et al. 2014) 
Oxidative stress and proinflammation have been recognized as the major mechanism of 
hyperglycemia-induced pancreatic injury leading to destruction of the pancreatic β-cells, which in 
turn alters insulin secretion and β-cell function. This can be attributed to the extremely low levels 
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of endogenous antioxidant enzymes the pancreas, thus making the organ highly susceptible to 
oxidative damage (Acharya and Ghaskadbi 2010; Donath 2014). This is evident in the present 
study by the depleted levels of GSH, SOD and catalase activities, and concomitant elevated levels 
of MDA, NO, and myeloperoxidase activity in both serum and pancreatic tissues of the untreated 
diabetic rats (Table 7.3.2). The depleted GSH level, SOD and catalase activities indicates an 
occurrence of oxidative stress on induction of T2D. The role of these antioxidant markers in the 
maintenance of redox balance have been reported in several studies, as they protect the cells against 
the harmful effects of free radicals particularly superoxide anion (O2
•-). SOD dismutates O2
•- to 
hydrogen peroxide (H2O2), which in turn is converted by catalase to water (H2O) and oxygen (O2). 
If not dismutated by SOD, O2
•- can react with NO to produce the potent nitric radical peroxynitrite 
(ONOO-). If the generated H2O2 from SOD dismutation is not acted on by catalase, it will be 
broken down to hydroxyl radical (•OH), a potent radical implicated in lipid peroxidation. H2O2 
can also be converted to hypochlorous acid (HOCl) in the presence of hydrochloric acid, catalyzed 
by myeloperoxidase. The high level of NO and myeloperoxidase activity indicates 
proinflammation, which also corroborates the increased acetylcholinesterase activity (Table 
7.3.1). Increased activity of pancreatic acetylcholinesterase has been implicated in inflammation 
of the tissue (Zhang et al. 2012). The high MDA level reflects an occurrence of lipid peroxidation, 
which can be attributed to the reduced catalase activity. The reversion of these levels and activities 
of these biomarkers in the treatment groups therefore indicates the antioxidative and anti-
proinflammatory protective potentials of C. nitida in T2D, which may be portrayed by the 
improved β-cell function (Figure 7.3.2C) and attenuation of inflamed β-cells (Figures 7.3.4C and 
7.3.4D). This corroborates previous studies which reported the antioxidant activities of C. nitida 
infusion (Erukainure et al. 2017b; Oboh et al. 2014a).  
Alteration in pancreatic perfusion have been reported in T2D, and has been linked to β-cell 
dysfunction (Honka et al. 2014). Pancreatic perfusion occurs via multiple arteries resulting from 
the abdominal aorta and contributes to the physiological maintenance of the islets and normal 
endocrine (Honka et al. 2014; Jansson et al. 2016). The decreased capillary network on the 
pancreatic tissue of the untreated diabetic rats (Figure 7.3.5B) may thus reflect an altered perfusion 
and may be attributed to the β-cell dysfunction (Figure 7.3.2C). An increased perfusion on 
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treatment with C. nitida is portrayed by the increased network on the pancreatic surfaces of the 
treatment groups (Figures 7.3.5C – 7.3.5F). 
The pancreatic β-cell apoptosis often arising from hyperglycemia-induced oxidative stress and 
inflammation have been implicated in the pathogenesis and progression of T2D and its 
complications (Acharya and Ghaskadbi 2010; Rojas et al. 2018; Tomita 2016). Caspases have been 
vastly studied for their orchestrating effect on apoptosis. The rather insignificant effect of C. nitida 
on the increased expression of caspase3 in diabetic rats (Figures 7.3.6C and 7.3.6D), implies that 
the antidiabetic mechanism of the infusion does not involve the caspase cascade. This however 
contrasts the molecular interaction of the identified active constituents of the infusion, caffeine 
and theobromine with caspase3 (Figures 7.3.9A and 7.3.9C, and Table 7.3.4). The molecular 
interactions may rather reflect an exacerbative effect than suppressive.  
Although exacerbated Nrf2 expression have linked with improved antioxidant status in some 
studies (David et al. 2017; Dieter 2014), its upregulation has however been reported in the onset 
of T2D (He et al. 2012; Miao et al. 2012). This reflected by the increased expression in pancreatic 
tissues of the untreated diabetic rats, thereby contradicting some reports on upregulation of Nrf2 
as possible therapeutic target in T2D (David et al. 2017; Dieter 2014). Its activation of oxidative 
stress has also been reported, which also correlates with the exacerbated pancreatic redox 
imbalance (Table 7.3.2). Downregulation of its expression in diabetic rats treated with C. nitida 
(Figure 7.3.7C and 7.3.7D) as well as the other treatment groups, depicts a suppressive effect by 
the infusion. The downregulation may also contribute to the improved pancreatic antioxidative 
status (Table 7.3.2). The down regulatory effect of the infusion is also portrayed by the molecular 
interaction of its phytochemical constituents (Figure 7.3.9B and 7.3.9D, and Table 7.3.4). 
The increased fructosamine level of the untreated diabetic rats (Table 7.3.3) portrays an activation 
of the glycation cascade, as it has been reported as an early stage glycated protein product 
oxidatively sliced to form advanced glycation end (AGE) products (Ibrahim et al. 2016; Sen et al. 
2011). It is a glycemic biomarker for diabetes (Malmström et al. 2014). The reduced level in the 
treatment groups therefore indicate a disruption in the cascade by C. nitida. 
The increased ALP, CK-MB and uric acids levels have been reported in T2D (Čaušević et al. 2010; 
Erukainure et al. 2017a; Fazel et al. 2005), which correlates with the elevated levels in the 
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untreated diabetic rats in the present study (Table 7.3.4). These elevations portray hepato-, cardio-
, and nephro-toxicities (Erukainure et al. 2018; Mortazavi et al. 2016) and can be attributed to 
leakage into the blood stream due to inflammation of the liver, heart, and kidney respectively 
(Giordano et al. 2015; Kim et al. 2008; Peppes et al. 2008). The depleted levels of these biomarkers 
in rats treated with C. nitida, portrays a protective effect of the infusion against hyperglycemia-
induced hepato-, cardio- and nephro-toxicities. This correlates with previous studies that reported 
the ability of the methanolic extract of C. nitida to suppress the elevation of serum liver and kidney 
biomarkers in diabetic rats (Adeosun et al. 2017). 
The NMR-identified phytochemical constituents of C. nitida infusion (Figure 7.3.8), caffeine and 
theobromine is in consent with previous reports on the phytochemical properties of C. nitida 
(Erukainure et al. 2017b; Lowor et al. 2010). These alkaloids have been reported for their 
biological activities. Caffeine has been recognized to exert its effects via antagonism of the 
adenosine receptors (Kerr et al. 1993). Its coadministration have been reported to improve the 
hypoglycemic activities of gliclazide and metformin (Mohiuddin et al. 2009). Theobromine has 
been reported for its antioxidant, anti-hyperlipidemic and antidiabetic activities (Martínez-Pinilla 
et al. 2015; Mubarak and Yiquen 2015; Ramos et al. 2017). Thus, the antidiabetic effect of C. 
nitida infusion can be attributed to the synergetic activities of the identified alkaloids. 
7.3.6 Conclusion 
These results indicate the therapeutic potentials of C. nitida infusion against T2D, which may be 
attributed to the synergetic effect of caffeine and theobromine. This gives credence to the folkloric 
claims and use of the plant in the treatment and management of DM and its complications. 
 
 
423 
 
7.4 Hyperglycemia-Induced Oxidative Brain Injury: Therapeutic Effects of 
Cola nitida Infusion against Redox Imbalance, Cerebellar Neuronal Insults, and 
Upregulated Nrf2 Expression in type 2 diabetes Rats 
1,2Ochuko L. Erukainure, 3,4Omamuyouvwi M. Ijomone, 1Olajumoke A. Oyebode, 3Michael 
Aschner, 1Md. Shahidul Islam* 
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Preface: This article investigated the antioxidative protective effect of Cola nitida on 
hyperglycemia-induced brain injury in a type 2 diabetes model of rats. Its antioxidative and anti-
proinflammatory effects were investigated. Its inhibitory effect on cholinergic enzyme activity and 
Nrf2 expression were investigated. Its ability to protect against neuronal damages and elemental 
dysregulation was also investigated. 
7.4.1 Abstract 
Neurodegeneration owing to persistent hyperglycemia has been associated with type 2 diabetes 
(T2D), with oxidative stress playing an influential role. In this study, the therapeutic effect of the 
hot water infusion of Cola nitida against hyperglycemia-induced neurotoxicity, cerebellar 
neurodegeneration and elemental dysregulation was investigated in fructose-streptozotocin 
induced T2D rats. A diabetic group was administered distilled water and served as a negative 
control, two other diabetic groups were treated with C. nitida infusion at 150 and 300 mg/kg body 
weight respectively, while another was administered a standard anti-diabetic drug, metformin (200 
mg/kg bodyweight). Two other groups consisting of normal rats, were administered distilled water 
(normal control) and C. nitida infusion (300 mg/kg bodyweight). After 6 weeks of treatment, their 
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brains were collected. Treatment with C. nitida led to the suppression of oxidative stress by 
significantly (p<0.05) elevating reduced glutathione (GSH) level, superoxide dismutase and 
catalase activities, with concomitant depletion of malondialdehyde level. Acetylcholinesterase and 
ATPase activities were significantly (p<0.05) inhibited in C. nitida-treated diabetic rats. 
Histological and microscopic analysis also revealed a restorative effect of C. nitida on T2D-altered 
distribution of elements, neurons and axonal nodes. Treatment with C. nitida also led to significant 
inhibition of Nrf2 expression in the cerebellar cortex. These results suggest the therapeutic effects 
of C. nitida in maintenance of the neuronal integrity and antioxidant status of the brain in T2D. 
These neuroprotective activities can be attributed to the GC-MS identified alkaloid, caffeine in the 
infusion. 
Keywords: Cola nitida; SEM-EDX; Neurodegeneration; Nrf2; and Type 2 diabetes 
7.4.2 Introduction 
Neurodegeneration have been recognized amongst the many complications of type 2 diabetes 
(T2D), with the brain being the most affected (Gejl et al. 2017; Wrighten et al. 2009). The 
susceptibility of the brain to T2D can attributed to its polyunsaturated fatty acids (PUFAs) 
constituents, which are the target of peroxidative attack in oxidative stress. Oxidative stress arises 
in T2D owing to increase production of free radicals outweighing the body’s endogenous 
antioxidant system (Maritim et al. 2003a). This increase has been attributed to chronic 
hyperglycemia arising from persistent high blood glucose level due to insulin resistance and 
pancreatic β-cell dysfunction (Maritim et al. 2003a). Insulin resistance and pancreatic β-cell 
dysfunction are the main features of T2D and distinct it from type 1 diabetes (T1D), which occurs 
owing to the inability of the pancreatic β-cell to secrete insulin (Erukainure et al. 2018).  
In spite of high blood glucose level, glucose uptake to the brain have been reported to be altered 
in T2D owing to downregulation of glucose transporters at the blood brain barrier (BBB) (Gejl et 
al. 2017; Hwang et al. 2017; Pardridge et al. 1990). This alteration can also be a major contributor 
to brain damage in T2D, as the brain is glucose-dependent for its functions. 
The cost of treating diabetes mellitus (DM) and its complications are of tremendous concern to 
health practitioners, particularly in developing countries with poor health infrastructure and very 
low gross domestic products (GDP). The search for cheaper alternatives with little or no side 
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effects have led a paradigm shift to natural medicines, with medicinal plants playing an influential 
role. Medicinal plants have been reported for their roles in the folkloric treatment of several 
ailments such as DM, malaria, tuberculosis and neurodegeneration.  
This study aims at investigating the therapeutic effect of C. nitida hot infusion on oxidative 
imbalance, ATPase and cholinergic enzyme activities in whole brain of T2D rats. The cerebellar 
cortexes were also investigated for morphological changes, neuronal and elemental distribution, 
as well as Nrf2 expression. 
7.4.3 Materials and Methods 
Kindly refer to Chapter 2, subsections 2.1.1; 2.1.4; 2.10.1; 2.12 – 2.13 for details materials and 
methods.  
7.4.4 Results 
As depicted in Fig. 1, there was a significant (p<0.05) decrease in GSH level (Figure 7.4.1A), 
SOD and catalase activities (Figures 7.4.1B and 7.4.1C), with concomitant elevation of MDA 
level (Figure 7.4.1D) on induction of T2D. These were significantly (p<0.05) reversed in the 
treatment groups, with C. nitida displaying a favourable antioxidant activity when compared to 
metformin. 
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Figure 7.4.1: Antioxidant status of experimental groups. Values = mean ± SD; n = 5 (NC and 
NTXC) and 7 (DC, DLDC, DHDC, and DSM). *Statistically (p<0.05) significant to DC, 
#statistically significant (p<0.05) to NC. NC = normal rats, DC = diabetic control, DLDC = 
diabetic rats + C. nitida (150 g/kg bw), DHDC = diabetic rats + C. nitida (300 g/kg bw), DSM = 
diabetic rats + metformin (200 g/kg bw), and NTXC = Normal rats + C. nitida (300 g/kg bw). 
Induction of T2D led to an increased myeloperoxidase activity as shown in Figure 7.4.2, depicting 
a proinflammatory effect. Treatment with both doses of C. nitida led to significant (p<0.05) 
reduction reaching levels indistinguishable from the normal controls (NC). 
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Figure 7.4.2: Myeloperoxidase activities of experimental groups. Values = mean ± SD; n = 5 (NC 
and NTXC) and 7 (DC, DLDC, DHDC, and DSM). *Statistically (p<0.05) significant to DC, 
#statistically significant (p<0.05) to NC. NC = normal rats, DC = diabetic control, DLDC = 
diabetic rats + C. nitida (150 g/kg bw), DHDC = diabetic rats + C. nitida (300 g/kg bw), DSM = 
diabetic rats + metformin (200 g/kg bw), and NTXC = Normal rats + C. nitida (300 g/kg bw). 
The ATPase activity was significantly (p<0.05) elevated on induction of T2D as shown in Figure 
7.4.3. This was significantly (p<0.05) reduced in rats treated with C. nitida to levels insignificant 
from the normal control. 
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Figure 7.4.3: ATPase activities of experimental groups. Values = mean ± SD; n = 5 (NC and 
NTXC) and 7 (DC, DLDC, DHDC, and DSM). *Statistically (p<0.05) significant to DC, 
#statistically significant (p<0.05) to NC. NC = normal rats, DC = diabetic control, DLDC = 
diabetic rats + C. nitida (150 g/kg bw), DHDC = diabetic rats + C. nitida (300 g/kg bw), DSM = 
diabetic rats + metformin (200 g/kg bw), and NTXC = Normal rats + C. nitida (300 g/kg bw). 
There was a significant (p<0.05) elevation of acetylcholinesterase activity on induction of T2D as 
depicted in Figure 7.4.4. This was significantly (p<0.05) reduced in all treatment groups to levels 
indistinguishable from the normal controls, with C. nitida-treated rats showing more inhibitory 
effect compared to metformin. 
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Figure 7.4.4: Acetylcholinesterase activities of experimental groups. Values = mean ± SD; n = 5 
(NC and NTXC) and 7 (DC, DLDC, DHDC, and DSM). *Statistically (p<0.05) significant to DC, 
#statistically significant (p<0.05) to NC. NC = normal rats, DC = diabetic control, DLDC = 
diabetic rats + C. nitida (150 g/kg bw), DHDC = diabetic rats + C. nitida (300 g/kg bw), DSM = 
diabetic rats + metformin (200 g/kg bw), and NTXC = Normal rats + C. nitida (300 g/kg bw). 
As shown in Figure 7.4.5, induction of T2D led to an altered morphology of the cerebellar cortex 
as portrayed by inflamed and distorted Purkinje and granular cell layers (Figure 7.4.5 [2]) 
indicating a neuronal insult and compromised integrity when compared to the control (Figure 
7.4.5 [1]). An intact morphology indistinguishable from the normal control (NC) were observed 
for all treatment groups, with rats treated with high dose of C. nitida showing a more intact 
morphology (Figure 7.4.5[4]). 
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Figure 7.4.5: Morphological changes in cerebellar tissues of experimental groups. Magnification: 
10x. (1) = NC, (2) = DC, (3) = DSG-LD, (4) = DSG, (5) = DSM, and (6) = PHD. NC = normal 
rats, DC = diabetic control, DLDC = diabetic rats + C. nitida (150 g/kg bw), DHDC = diabetic 
rats + C. nitida (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and NTXC = 
Normal rats + C. nitida (300 g/kg bw). Arrows: Blue = Purkinje cell layers; Red: Granule cell 
layer; White = White matter  
As shown in Figure 7.4.6, the cerebellar cortex of the normal rats consists of intact Purkinje and 
glial cells, with vast networks of dendrites and axons (Figure 7.4.6A) as revealed by SEM analysis. 
This intactness was however distorted on induction of T2D as depicted by the depleted number of 
Purkinje and glial cells, with a concomitant altered dendrites and axons network (Figure 7.4.6B). 
Treatment with low dose of C. nitida led to improved network of dendrites and axons but showed 
little or no improvement on the numbers of Purkinje and glial cells (Figure 7.4.6C). These were 
more improved in rats treated with high dose of C. nitida (Figure 7.4.6D). Administration of C. 
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nitida to normal rats increased the population of Purkinje and glial cells in the cerebral cortex, with 
discernible effect on the dendrites and axons networks (Figure 7.4.6F). 
 
Figure 7.4.6: SEM analysis of cerebellar tissues of experimental groups. Magnification = 1000x. 
(A) = NC, (B) = DC, (C) = DSG-LD, (D) = DSG, (E) = DSM, and (F) = PHD. NC = normal rats, 
DC = diabetic control, DLDC = diabetic rats + C. nitida (150 g/kg bw), DHDC = diabetic rats + 
C. nitida (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and NTXC = Normal 
rats + C. nitida (300 g/kg bw). Arrows: Black = Purkinje cells; Red = dendrite network; Blue = 
axon 
Quantitative analysis of the of EDX mapping of the cerebellar cortex revealed depleted levels of 
carbon, nitrogen, iron, and potassium with concomitantly elevated levels of oxygen, sodium, 
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aluminum and calcium as depicted in Figure 7.4.7A and 7.4.7B. Treatment with C. nitida had no 
discernible effects on the carbon and oxygen levels, but led to the reversal of the other elements to 
levels  indistinguishable from the normal controls. Treatment with metformin led to the presence 
of cobalt in cerebellar cortex of T2D rats (Figure 7.4.7A and 7.4.7B). 
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Figure 7.4.7A: EDX mapping of cerebellar tissues of experimental groups. Magnification = 
1000x. (1) = NC, (2) = DC, (3) = DLDC, (4) = DHDC, (5) = DSM, and (6) = NTXC. Legends: C 
= carbon, N = nitrogen, O = oxygen, Na = sodium, Mg = magnesium, K = potassium, Ca = calcium, 
Fe = iron, and Al = aluminum. NC = normal rats, DC = diabetic control, DLDC = diabetic rats + 
C. nitida (150 g/kg bw), DHDC = diabetic rats + C. nitida (300 g/kg bw), DSM = diabetic rats + 
metformin (200 g/kg bw), and NTXC = Normal rats + C. nitida (300 g/kg bw). 
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Figure 7.4.7B: Quantitative analysis of EDX mapping of cerebellar tissues of experimental 
groups. Legends: C = carbon, N = nitrogen, O = oxygen, Na = sodium, Co = cobalt, K = potassium, 
Ca = calcium, Fe = iron, and Al = aluminum. NC = normal rats, DC = diabetic control, DLDC = 
diabetic rats + C. nitida (150 g/kg bw), DHDC = diabetic rats + C. nitida (300 g/kg bw), DSM = 
diabetic rats + metformin (200 g/kg bw), and NTXC = Normal rats + C. nitida (300 g/kg bw). 
There was a significantly (p<0.05) exacerbated expression of Nrf2 in the cerebellar cortex on 
induction of T2D as depicted in Figure 7.4.8. The expressions were significantly (p<0.05) 
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attenuated in the cerebellar cortexes of the treatment groups to levels indistinguishable from the 
normal control. 
 
Figure 7.4.8: (A): Immunohistochemistry photomicrographs and (B): immunoreactivity of Nrf2 
expression in cerebellar cortex of experimental groups. Magnification = 200x; Values = mean ± 
SD; n = n = 5 (NC and NTXD) and 7 (DC, DLDC, DHDC and DSM). *Statistically (p<0.05) 
significant to DC, #statistically significant (p<0.05) to NC. NC = normal rats, DC = diabetic 
control, DLDC = diabetic rats + C. nitida (150 g/kg bw), DHDC = diabetic rats + C. nitida (300 
g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and NTXC = Normal rats + C. nitida 
(300 g/kg bw). 
GC-MS analysis of C. nitida hot infusion revealed the presence of caffeine only as shown in 
Figure 7.4.9, indicating the near purity of the infusion. 
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Figure 7.4.9: MS spectra of GC-MS identified compound in C. nitida hot infusion. 
7.4.5 Discussion 
Alterations in glucose homeostasis owing to suppressed glucose transportation across the BBB as 
well as the susceptibility of the brain’s PUFAs to oxidative damage have been recognized as the 
main players in the pathogenesis and progression of neurodegeneration in T2D (Gejl et al. 2017; 
Hwang et al. 2017; Kim et al. 2015; Uttara et al. 2009). These alterations and oxidative damage 
are often characterized by morphological changes, neuronal loss, and metal accumulation (Folarin 
et al. 2017; Kim et al. 2015; Wrighten et al. 2009). The neuroprotective effect of some medicinal 
plants and their constituents have been reported, with antioxidative stress being a major 
mechanism (Bhattacharya et al. 2000; Kumar 2006; Uddin et al. 2013). In the present study, the 
neuroprotective effect of caffeine-rich infusion from C. nitida on neuropathology of the brain in 
T2D.  
The brain has been reported for its low endogenous antioxidant system, which when coupled with 
its high PUFAs content, the excitotoxic and auto-oxidizable activities of neurotransmitters 
increases its susceptibility to oxidative stress (Patel 2016). In the present study, the depleted GSH 
level, SOD and catalase activities in the untreated diabetic rats (p<0.05) depicts an occurrence of 
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oxidative stress which can be attributed to hyperglycemia-induced generation of ROS. This is in 
consent with previous studies on the depleted level and activities of these antioxidants in brains of 
diabetic rats (Mastrocola et al. 2005; Moreira et al. 2003). The generation of ROS, such as O2.
- and 
.OH are toxic to neuronal cells and their production from persistent glucose oxidation have been 
reported (Maritim et al. 2003b). Glucose in its enediol form, undergoes oxidation in a transition-
metal dependent reaction to an unstable enediol radical anion. Owing to its instability, the anion is 
converted reactive ketoaldehydes and O2.
- (Maritim et al. 2003b). SOD dismutates the generated 
O2.
- to H2O2, which if not acted on by catalase will be further broken down to give .OH. Both H2O2 
and •OH can switch on the lipid peroxidation process, with PUFAs being the most susceptible 
owing to their double bonds. An initiation of lipid peroxidation due to hyperglycemia is portrayed 
in the present study by the elevated MDA level in the untreated diabetic rats (Figure 7.4.1D). H2O2 
is also involved in the proinflammatory cascade as it can be converted to hypochlorite (HOCl) in 
the presences of myeloperoxidase and hydrochloric acid (HCl) (Patel 2016). Thus, the reversed 
levels of GSH and MDA, as well as SOD, catalase and myeloperoxidase activities in rats treated 
with C. nitida (Figure 7.4.1 – 7.4.2) depicts an antioxidative and anti-proinflammatory protective 
effect of the infusion against hyperglycemia-induced oxidative brain. 
Increased ATPase activity leading to impaired facilitative transportation of glucose across the BBB 
and altered levels of ATP have been reported in neurodegenerative diseases (Falkowska et al. 
2015; Magistretti and Allaman 2015; Mochel et al. 2012; Zhang et al. 2015). The increased ATPase 
activity in brains of untreated diabetic rats (Figure 7.4.3) may thus indicate an impaired glucose 
transportation on induction of T2D and depleted ATP level. The reduced ATPase activity in brains 
of rats treated with C. nitida portrays the ability of the infusion to inhibit hyperglycemia-induced 
ATPase alteration, which may also reflect an increased facilitative glucose uptake in the brain. 
This corroborates previous reports on the suppressive effects of C. nitida on ATPase activities in 
brain tissues of STZ-induced diabetic rats (Imam-Fulani et al. 2018). 
The hydrolyzing effect of acetylcholinesterase on the neurotransmitter, acetylcholine has been 
linked with the pathogenesis and progression of neurodegenerative diseases (Kuhl et al. 1999; 
Mushtaq et al. 2014; Pavlov et al. 2009). Impaired cognition, and motor neuron dysfunction are 
amongst the neurodegenerative diseases linked to increased acetylcholinesterase activities (Hwang 
et al. 1999; Kuhad et al. 2008; Tabet 2006). The increased activity on induction of T2D (Figure 
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7.4.4) is in consent with reports on increased acetylcholinesterase activities in diabetic rat brains 
(Ghareeb and Hussen 2008; Kuhad et al. 2008), further indicating a hyperglycemia-induced brain 
injury. The reduced activities in the brains of rats treated with C. nitida portrays a neuroprotective 
potential of the infusion, which can be attributed to the caffeine constituent (Figure 7.4.9). This 
corroborates previous reports on the inhibitory effect of C. nitida and caffeine on 
acetylcholinesterase activities (Oboh et al. 2018; Salahdeen et al. 2014).  
The role of cerebellum in the facilitation of movement, motor and muscular activities is well 
documented (Imosemi 2013; Popescu et al. 2009). Purkinje cells have been recognized as the 
major neurons present in the cerebellum (Fahrion et al. 2013; Lopez et al. 2009). Morphological 
changes in the brain have been implicated in most neurodegenerative diseases, and has been linked 
to oxidative stress (Ojo et al. 2014; Sidhu and Nehru 2004). The distorted layers of Purkinje and 
granular cells in cerebellar cortexes of the untreated diabetic rats (Figure 7.4.5B) depict 
morphological alterations. This is further obvious in the depleted Purkinje and glial cells as well 
as distorted networks of dendrites and axons (Figure 7.4.6B). These morphological changes 
insinuate a compromised neuronal integrity and can be attributed to hyperglycemia-induced 
oxidative stress (Figure 7.4.1A) as Purkinje cells have been reported for their vulnerability to 
oxidative stress (Chen et al. 2003; Kern and Jones 2006; Lopez et al. 2009). These alterations 
correlate with previous reports on structural changes in the cerebellar cortexes of diabetic rats 
(Hernández-Fonseca et al. 2009; Ozdemir et al. 2016). Restoration of the layers and improved 
networks of the dendrites and axon in cerebellar cortexes of C. nitida-treated diabetic rats (Figures 
7.4.5 and 7.4.6) further portrays the neuroprotective effect of the infusion. This activity can be 
attributed to its caffeine constituent as the alleviative effect of caffeine on the loss of Purkinje 
neurons have been reported (Gonçalves et al. 2017). 
The roles of elements, particularly metals in the normal functions of the brain has been reported. 
They often act as enzyme co-factors and are involved in most redox reaction (Uttara et al. 2009). 
Alterations in their distribution have been linked with neurodegeneration, particularly cerebellar 
toxicity (Folarin et al. 2017; Kamal and Kamal 2013). The altered elemental levels (Figure 7.4.7), 
particularly elevated levels of oxygen, aluminum and sodium may portray in the cerebellar 
cortexes of the untreated diabetic rats indicates toxicity as their accumulations have been reported 
in neurodegeneration (Kamal and Kamal 2013; Wojda et al. 2008). The oxygen level may portray 
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the induced redox imbalance depicted in Figure 7.4.1, as its accumulation have been implicated 
in the generation of O2.
- (Patel 2016). Restoration of these elements to levels indistinguishable 
from the normal control in the treatment groups, further indicates the neuroprotective effect of C. 
nitida in T2D-brain injury. 
The increased expression of Nrf2 in the Purkinje and granular layers in the cerebellar cortexes of 
the untreated diabetic rats (Figure 7.4.8) correlates with reports of exacerbated expressions on the 
onset of T2D (Wrighten et al. 2009; Zucker et al. 2014). A suppressed antioxidant system have 
also been linked with Nrf2 expression (He et al. 2012; Miao et al. 2012), which also correlates 
with the induced oxidative stress in the untreated diabetic rats (Figure 7.4.1). These, however, 
contradicts some reports on the beneficial roles of increased Nrf2 expression in the recruitment of 
the endogenous antioxidants system (Dieter 2014; Ma 2013). The attenuated expression in the 
cerebellar cortex of the treatment groups, may therefore insinuates a suppressive effect of C. nitida 
on hyperglycemia-induced Nrf2 expression in diabetic cerebellum. 
7.4.6 Conclusion 
Based on these results, it can be said that the hot infusion of C. nitida confers a neuroprotective 
effect against hyperglycemia-induced oxidative brain damage in T2D. This it does by attenuating 
oxidative stress, proinflammation, Nrf2 expression and inhibiting the activities of 
acetylcholinesterase and ATPase, while concomitantly preserving the integrity of the cerebellar 
cortex.  
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CHAPTER 8 
THE ANTI-OXIDATIVE AND ANTI-DIABETIC ACTIVITIES OF 
DACRYODES EDULIS (BUSH PEAR) IN VITRO, EX VIVO, AND IN VIVO 
8.1 Dacryodes edulis 
 
Figure 8.1 
Figure 8.1.1: Dacryodes edulis. Common names: Bush pear, African plum; Butterfruit, Bush 
butter tree, Bush plum (English); Ube (Nigeria); Safou (Cameroon); and Atanga (Gabon). 
Synonyms: Canarium mansfeldianum Engl., Pachylobus albiflorus Guill, Canarium saphu Engl., 
and Canarium edule Hook F., Photo: http://tropical.theferns.info/image.php?id=Dacryodes+edulis (accessed on 
November 8, 2018 without permission). 
8.1.2 Background 
Dacryodes edulis (G. Don) H.J. Lam is an evergreen fruit tree indigenous to Africa where the fruits 
are usually utilized as foods, and other parts for medicinal purposes. It has been reported to 
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originate from central Africa and the Gulf of Guinea but found across the western coast of Africa 
ranging from Southern Nigeria to Equatorial Guinea (Rodrigues et al. 2018). It often grows to 
heights of 18-40 m (Burkill 1985; Verheij 2002). Its trunk is relatively short, with a pale gray 
rough bark. It consists of compound leaves which are glossy (Ajibesin 2011; Burkill 1985). The 
fruits vary in size and are ellipsoid drupe, with thin pink exocarps which ripens to give purple, 
blue-green, or brilliant black (Ajibesin 2011). 
8.1.3 Ethnopharmacological uses 
Different parts of the plant are used in the treatment of diabetes, malaria, hypertension, labor pain, 
retarded growth, skin diseases, tonsillitis, leprosy, oral and ear conditions, and epilepsy (Ajibesin 
2011; Conrad and Uche 2013). 
8.1.4 Biological activities 
The antidiabetic properties of the fruits have been demonstrated (Oboh et al. 2015; Okolo et al. 
2016). The antioxidant protective effects of the leaves and fruits have been reported (Agbor et al. 
2007; Conrad and Uche 2013; Oboh et al. 2015). Its antimalarial and antimicrobial properties have 
also been reported (Miguel et al. ; Zofou et al. 2013; Zofou et al. 2011). The ability of oil from the 
fruits to elevate HDL-c have been demonstrated in rats (Leudeu et al. 2006). The aqueous and 
ethanol extracts of its leaves have been reported for their ability to normalize sickled erythrocytes, 
thereby insinuating its protective effect on sickle cell disease (Mpiana et al. 2007). 
8.1.5 Phytochemistry 
The phytochemical constituents of different parts of D. edulis include: xanthone, ascorbic acid 2,6-
dihexadecanoate, isorhamnetin rhamnoside, ethylgallate, quercitrin, α-pinene, α-terpineol, 
myrcene and germacrene-D, α-cadinol, δ-cadinol and β-eudesmol, kaur-15-ene peonidin 
hexosides, isoquercitrin, petunidin, hyperin, cyanidin, sitosterol, urs-12-ene-3-ol acetate and 
sorhamnetin hexoside (Ajibesin 2011; Ella Missang et al. 2003; Erukainure et al. 2017b; Onocha 
et al. 1999). 
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8.1.6 Aim 
The aims of this study are to investigate the antioxidative, antidiabetic, and cytotoxic activities of 
the leaves of D. edulis using in vitro, ex vivo, in silico and in vivo models. 
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8.2 Dacryodes edulis Enhances Antioxidant Activities, Suppresses DNA 
Fragmentation in Oxidative Pancreatic and Hepatic Injuries; and Inhibits 
Carbohydrate Digestive Enzymes linked to Type 2 Diabetes 
1,3Ochuko L. Erukainure, 1Ramgopal Mopuri, 1Olajumoke A. Daramola, 2Neil A. Koorbanally, 
1Md. Shahidul Islam* 
3. Department of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, 
(Westville Campus), Durban 4000, South Africa  
4. School of Chemistry and Physics, University of KwaZulu-Natal, (Westville Campus), 
Durban 4000, South Africa  
5. Nutrition and Toxicology Division, Federal Institute of Industrial Research, Lagos, Nigeria 
*Corresponding author: islamd@ukzn.ac.za; Tel: +27 (0)31-260-8717; Fax: +27 (0)31-260-7942 
Preface: This article investigated the antioxidant and enzyme inhibitory activities of D. edulis 
extracts in vitro and in silico, as well as its modulatory effect on redox imbalance in oxidative 
pancreatic and hepatic injuries ex vivo. The phytochemical constituents were also investigated 
using GC-MS and FTIR. It has already been published in Biomedicine and Pharmacotherapy 
(Erukainure OL, Mopuri R, Oyebode OA, Koorbanally NA, Islam MA. (2017). Dacryodes edulis 
enhances antioxidant activities, suppresses DNA fragmentation in oxidative pancreatic and hepatic 
injuries; and inhibits carbohydrate digestive enzymes linked to type 2 diabetes. Biomed 
Pharmacoth. 96: 37–47). 
8.1 Abstract 
The leaves of Dacryodes edulis were investigated for their anti-oxidative vis-à-vis anti-diabetic 
potentials in vitro. Extracts from sequential extraction with solvents of increasing polarity (n-
hexane, ethyl acetate, ethanol and aqueous) of the leaves were subjected to in vitro antioxidant 
assays using the 2,2'-diphenyl-1-picrylhydrazyl (DPPH) scavenging and Ferric reducing 
antioxidant power (FRAP) protocols respectively. Their inhibitory effects were investigated on α-
glucosidase, pancreatic lipases, pancreatic ATPase and glucose-6-phospatase activities. Their 
antioxidant and anti-apoptotic effects on Fe2+ - induced oxidative injuries in pancreatic and hepatic 
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tissues were also investigated ex vivo. The most active extract (ethanol) was subjected to GC-MS 
and FTIR spectroscopic analysis to identify its bioactive chemical constituents. The extracts 
showed potent free radical scavenging activity and significantly (p<0.05) inhibited all studied 
enzymes, with the ethanol extract showing greater activities. Superoxide Dismutase (SOD) and 
Catalase activities were significantly (p<0.05) increased in both pancreatic and hepatic tissues with 
concomitant elevation of reduced glutathione (GSH) levels as well as reduced levels of 
malondialdehyde (MDA). The extracts significantly inhibited DNA fragmentation. These 
activities were dose – dependent. Amongst Compounds identified via GC-MS analysis of the 
ethanol extract, only Kaur-15-ene, Urs-12-ene-3-ol acetate and 2,3,23-trihydroxyolean-12-en-28-
oic acid methyl ester showed strong binding affinities when docked with α-glucosidase (PDB 
ID:3TON). These results indicate the anti-oxidative, anti-diabetic and anti-obesogenic potentials 
of D. edulis leaves. Thus, giving credence to its antidiabetic folkloric claims  
Keys: Antioxidants; Dacryodes edulis; Type 2 Diabetes; Medicinal plant 
8.2.2 Introduction 
The world has witnessed an increase in the prevalence of diabetes from 336 million individuals in 
2011 to 415 million in 2015 depicting a 13.36% rise, with more than 45% undiagnosed (Atlas 
2014). This is estimated to rise to 642 million in 2040, with Sub Saharan Africa accounting for 
5.33% compared to 3.42% in 2015 (Atlas 2014). The urban areas have been shown to witness the 
highest increase, thus implicating rural–urban drift as well as changes in dietary patterns coupled 
with less physical activity and ageing population as the main factors in Africa (Bos and Agyemang 
2013). 
Type 2 diabetes (T2D) accounts for more than 90% of all diabetes, which is a major contributor to 
global mortality and morbidity (Atlas 2014). Unlike type 1 diabetes, it occurs when the body 
cannot effectively utilize the insulin produced. It generally arises from a combination of insulin 
resistance and pancreatic β-cell dysfunction, resulting to chronic hyperglycemia. In the 
progression of T2D, hyperglycemia results to elevated reactive oxygen species (ROS) production 
which causes oxidative stress due to the imbalance in endogenous antioxidant defense system 
(Tiwari et al. 2013a). Oxidative stress has been implicated in oxidative pancreatic and hepatic 
injuries, which further aggravates T2D (Saeed et al. 2012). This is characterized by decreased SOD 
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and catalase activities leading to accumulation of superoxide (O2
. –), hydrogen peroxide (H2O2) 
and hydroxyl (.OH) which causes peroxidation of the cell membrane lipid and DNA insults 
(Oluwakemi and Olufeyisipe 2016).   
The use of medicinal plants in the treatment and management of T2D is well documented 
(Ezuruike and Prieto 2014). Their efficacy has been attributed to the presence of phytochemicals 
with reported anti-oxidative and anti-diabetic activities (Erukainure et al. 2013; Saeed et al. 2012). 
Unlike synthetic drugs, the use plant originated natural medicines is believed to be associated with 
little or no side effects and are readily affordable. However, there are rising issues concerning 
toxicity of natural products (Ifeoma and Oluwakanyinsola 2013). Amongst such plants is 
Dacryodes edulis. 
This paper aims to report the anti-oxidative potentials of the ethyl acetate, ethanol and aqueous 
extracts of D. edulis leaves on Fe2+ - induced oxidative injury and DNA fragmentation in 
pancreatic and hepatic tissues. As well as their antidiabetic effect by investigating their inhibitory 
activity on key carbohydrate and lipid digestive enzymes linked to T2D. 
8.2.3 Materials and Methods 
Kindly refer to chapter 2, subsections: 2.1.1, 2.1.3, 2.1.6, 2.3-2.4, 2.6, 2.8, 2.10.1, 2.10.4, 2.11, and 
2.13 for details materials and methods.  
8.4 Results 
The total phenolic content of the ethanol extract of D. edulis was significantly (p<0.05) higher 
than the other extracts as depicted in Figure 8.2.1. 
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Figure 8.2.1: Total phenolic contents of the D. edulis extracts. Data are presented as mean ± SEM. 
abValues with different letter above the bars for a given extract are significantly different from each 
other (p < 0.05, Tukey’s HSD-multiple range post-hoc test, IBM SPSS for Windows). 
All extracts showed significant (p<0.05) dose–dependent DPPH scavenging activity, with the 
ethanol extract showing the best activity as indicated by its low IC50 value as shown in Table 8.2.1 
and Figure 8.2.2A.  
A dose–dependent and significant (p<0.05) pattern was observed for the FRAP activity of all the 
extracts as revealed in Figure 8.2.2B. The lowest IC50 value of the ethyl acetate extract, portrays 
the best activity (Table 8.2.1). 
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Table 8.2.1: IC50 values of biological activities of D. edulis leaf extracts 
Activity Ethyl Acetate 
(µg/mL) 
Ethanol 
(µg/mL) 
Aqueous 
(µg/mL) 
Ascorbic Acid 
(µg/mL) 
Gallic Acid 
(µg/mL) 
Acarbose 
(µg/mL) 
Orlistat 
(µg/mL) 
DPPH 54.90 1.83 44.57 8.32 - - - 
FRAP 43.03 381.66 235.04 29.98    
GSH (Pancreas) 20.89 27.54 45.7 - >1000 - - 
GSH (Liver) 0.11 0.42 0.003 - 0.009 - - 
SOD (Pancreas) >1000 >1000 >1000 - 575.43 - - 
SOD (Liver) 28.84 >1000 64.66 - 85.11 - - 
Catalase (Pancreas) 8.63 5.09 23.67 - >1000 - - 
Catalase (Liver) 691.83 >1000 >1000 - 537.03 - - 
Lipid Peroxidation 
(Pancreas) 
23.71 922.99 0.22 - 2.38 - - 
Lipid Peroxidation 
(Liver) 
429..31 >1000 >1000 - >1000 - - 
Alpha glucosidase 15.05 11.03 8.29 - - 1.79 - 
Lipase 1.51 1.56 1.41 - - - 1.24 
ATPase 19.06 34.84 42.77 - 30.31 - - 
Glucose 6 Phosphate 0.66 3.59 0.05 - 1.48 - - 
DNA Fragmentation 
(Pancreas) 
6.04 2.96 4.21 - 4.40 - - 
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Figure 8.2.2: (A) DPPH scavenging and (B) Ferric reducing antioxidant power (FRAP) activities 
of D. edulis leaf extracts. Data are presented as mean ± SEM. abcValues with different letter above 
the bas for a given extract are significantly different from each other (p < 0.05, Tukey’s HSD-
multiple range post-hoc test, IBM SPSS for Windows). 
Induction of oxidative injury with FeSO4 significantly (p<0.05) decreased GSH level in pancreatic 
tissue as depicted in Figure 8.2.3A. The effect was even more pronounced in hepatic tissue 
(Figure 8.2.3B). Treatment with the extracts led to significant increase in both tissues depicting 
their therapeutic potentials, with the ethanol extract showing the best activity in both tissues. The 
increase in GSH level with increasing concentration indicates a dose–dependent effect. 
 
(A) 
 
(B) 
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Figure 8.2.3: Effect of D. edulis leaf extracts on GSH level in oxidative (A) pancreatic and (B) 
hepatic injuries. Data are presented as mean ± SEM. *Significantly different from untreated sample 
and #Significantly different from normal sample (p < 0.05, Tukey’s HSD-multiple range post-hoc 
test, IBM SPSS for Windows). 
The SOD activities were observed to be significantly (p<0.05) reduced in both tissues on induction 
of oxidative injury, with that of the pancreatic tissue more pronounced as shown in Figures 8.2.4A 
and 8.2.4B. A dose–dependent effect in the restoration of the activities to near normal was 
observed on treatment with the extracts in hepatic tissue, with the ethanol extract showing the best 
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activity in pancreatic tissues and ethyl acetate in hepatic tissues as depicted by their respective low 
IC50 values (Table 8.2.1). 
 
Figure 8.2.4: Effect of D. edulis leaf extracts on SOD activity in oxidative (A) pancreatic and (B) 
hepatic injuries. Data are presented as mean ± SD. #Significantly different from normal sample 
and *Significantly different from untreated sample (p < 0.05, Tukey’s HSD-multiple range post-
hoc test, IBM SPSS for Windows). 
Reduced catalase activities were observed in both tissues on induction of oxidative injury with 
FeSO4 as shown in Figures 8.2.5A and 8.2.5B. Treatment with the extracts led to a dose–
dependent reversion of the activities to near normal in hepatic tissue, with ethyl acetate showing 
the best activity in pancreatic tissue (Figure 8.2.5A) and aqueous in hepatic tissues (Figure 
8.2.5B) as portrayed by their low IC50 values (Table 8.2.1). 
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Figure 8.2.5: Effect of D. edulis leaf extracts on catalase activity in oxidative (A) pancreatic and 
(B) hepatic injuries. Data are presented as mean ± SD. *Significantly different from untreated 
sample and #Significantly different from normal sample (p < 0.05, Tukey’s HSD-multiple range 
post-hoc test, IBM SPSS for Windows). 
Induction of oxidative injury with FeSO4 caused a significant (p<0.05) increase in MDA levels in 
both tissues as shown in Figure 8.2.6A and 8.2.6B. This was significantly (p<0.05) reduced on 
treatment with the extracts in a dose–dependent pattern in hepatic tissue, with the ethyl acetate 
showing the best activity in pancreatic tissues (Figure 8.2.6A) and ethanol in hepatic tissues 
(Figure 8.2.6B) as revealed by their low IC50 values (Table 8.2.1).  
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Figure 8.2.6: Effect of D. edulis leaf extracts on lipid peroxidation in oxidative (A) pancreatic and 
(B) hepatic injuries. Data are presented as mean ± SD. *Significantly different from untreated 
sample and #Significantly different from normal sample (p < 0.05, Tukey’s HSD-multiple range 
post-hoc test, IBM SPSS for Windows). 
α – glucosidase was significantly (p<0.05) inhibited on incubation with the extracts as depicted in 
Figure 8.2.7A. The aqueous extract showed the best inhibitory activity respectively and compared 
favorably to Acarbose as portrayed by their low IC50 values (Table 8.2.1).  
The extracts showed significant (p<0.05) inhibitory activity on incubation with pancreatic lipase 
as shown in Figure 8.2.7B.  The aqueous extract showed the best inhibitory activity and even more 
potent than orlistat as revealed by its low IC50 value (Table 8.2.1). 
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Figure 8.2.7: (A) α-glucosidase and (B) pancreatic lipase inhibitory activities of D. edulis leaf 
extracts. Data are presented as mean ± SEM. abValues with different letter above the bars for a 
given concentration are significantly different from each other (p < 0.05, Tukey’s HSD-multiple 
range post-hoc test, IBM SPSS for Windows). 
Induction of oxidative injury led to increased ATPase activity in pancreatic tissues as depicted in 
Figure 8.2.8. A dose – dependent effect on reversion of the activity to near normal was observed 
on treatment with the extract, with the ethyl acetate showing the best activity as revealed by its 
low IC50 value (Table 8.2.1).  
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Figure 8.2.8: Effect of D. edulis leaf extracts on ATPase activity in oxidative pancreatic injury. 
Data are presented as mean ± SEM. *Significantly different from untreated sample and 
#Significantly different from normal sample (p < 0.05, Tukey’s HSD-multiple range post-hoc test, 
IBM SPSS for Windows). 
Induction of oxidative injury in hepatic tissues led to significant increase in glucose-6-phosphatase 
activity as shown in Figure 8.2.9. All extracts showed a significant (p<0.05) inhibition of the 
activity to near normal, with the aqueous showing the best activity as revealed by its low IC50 value 
(Table 8.2.1). 
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Figure 8.2.9: Effect of D. edulis leaf extracts on Glucose-6-Phosphatase activity in oxidative 
hepatic injury. Data are presented as mean ± SEM. *Significantly different from untreated sample 
and #Significantly different from normal sample (p < 0.05, Tukey’s HSD-multiple range post-hoc 
test, IBM SPSS for Windows). 
Increased DNA fragmentation was observed on induction of oxidative injury in hepatic tissue as 
depicted in Figure 8.2.10. This was significantly (p<0.05) suppressed on treatment with the 
extracts, with the ethanol showing the best activity as revealed by its low IC50 value (Table 8.2.1). 
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Figure 8.2.10: Effect of D. edulis leaf extracts on DNA fragmentation in oxidative hepatic injury. 
Data are presented as mean ± SD. *Significantly different from untreated sample and #Significantly 
different from normal sample (p < 0.05, Tukey’s HSD-multiple range post-hoc test, IBM SPSS for 
Windows). 
GC–MS analysis of the ethanol extract revealed the presence of Phytol acetate, Xanthone, 
Ascorbic acid 2,6-dihexadecanoate, Kaur-15-ene, Trans -Phytol, Octadecanoic acid, Ethyl 15-
methylheptadecanoate, 9-(4-methoxyphenyl) xanthene, 2,3,23-trihydroxyolean-12-en-28-oic acid 
methyl ester, Sitosterol and Urs-12-ene-3-ol acetate as shown in Figure 8.2.11 and Table 8.2.2.  
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Figure 8.2.11: Structures of identified compounds in the ethanol extract of D. edulis leaf 
 
 
 
471 
 
Table 8.2.2: Identified compounds of the ethanol extract of D. edulis leaf by GC-MS  
Compounds    RT (min) Molecular mass       Relative abundance (%) 
Phytol acetate    16.42   338  3.67 
Xanthone    17.01   196  0.51 
Ascorbic acid 2,6-dihexadecanoate 17.66   652  4.10 
Kaur-15-ene    18.37   272  0.28 
Trans-Phytol    19.10   296  2.03 
Octadecanoic acid   19.55   284  2.58 
Ethyl 15-methylheptadecanoate 19.83   298  0.90 
9-(4-methoxyphenyl)xanthene 22.39   288  3.25 
Urs-12-ene-3-ol acetate  24.45   468  0.63 
2,3,23-trihydroxyolean-12-en-28-oic  
acid methyl ester   25.83   502  0.69 
Sitosterol    29.77   414  1.55 
The compounds presented in the table are those which matched similar compounds in the NIST 
library software. 
FTIR spectroscopic analysis revealed the presence of aromatic C–H bending, N–H bend, C–C 
stretch (in–ring), N–O symmetric stretch, C–N stretch, C–O stretch, C=O stretch, –CO2H, O–H 
stretch, N–H stretch chemical bonds as depicted in Figure 8.2.12 and Table 8.2.3. These chemical 
bonds indicate the presence of alkyl halides; alcohols; esters; ethers; α,β–unsaturated aldehydes; 
ketones carboxylic acids; 1°, 2° amines; and amides functional groups. 
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Table 8.2.3: Quantitative analysis of FTIR spectra of ethanol extract of D. edulis leaf 
Frequency (cm-1) Assignment     Functional Group 
720.31   Aromatics               Aromatic C-H Bending 
767.39   Aromatics               Aromatic C-H Bending 
819.30   Aromatics              Aromatic C-H Bending 
1051.31  Aliphatic Amines       C–N stretch; C–O stretch 
1159.36  Alkyl Halides     C–H wag (–CH2X) 
1202.12  Aliphatic Amines    C–N stretch 
1248.86  Aromatic Amines, Alcohols, Carboxylic  N–O symmetric stretch; C–N  
Acids, Esters, Ethers    stretch; C–O stretch 
1281.59  Nitro Amines     N–O symmetric stretch 
1363.16  Alkanes      C–H rock 
1517.12  1° Amines; Aromatics         N–H bend; C–C stretch (in–ring) 
1604.60  1° Amines; Aromatics         N–H bend; C–C stretch (in–ring) 
1699.04  α,β–unsaturated aldehydes, ketones  C=O stretch 
2851.69  Carboxylic Acids    –CO2H 
2920.57  Carboxylic Acids    –CO2H 
3257.71  Phenols; 1°, 2° amines, amides O–H stretch; N–H stretch  
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Figure 8.2.12: Fourier transform infrared (FT-IR) spectroscopy of the ethanol extract of D. edulis 
leaf 
Except for octadecanoic acid, prediction of oral toxicity of the identified compounds on ProTox 
(tox.charite.de) web-based server showed they fell between toxicity classes 4 – 6 indicating their 
safety on consumption as shown in Table 8.2.4. Octadecanoic acid had the least toxicity class of 
3, implying toxic if swallowed. While phytol acetate and ascorbic acid 2,6-dihexadecanoate had 
the highest toxicity class of 6, implying their safety if swallowed.  
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Table 8.2.4: Oral Toxicity Prediction and Binding Affinity of Identified compounds of the ethanol 
extract of D. edulis leaf by GC-MS  
Compounds Predicted 
LD50 (mg/kg) 
Toxicity 
Class 
Prediction 
Accuracy (%) 
Binding 
Affinity 
(Kcal/mol) 
Phytol acetate 8000 6 72.9 16.70 
Xanthone 623 4 68.07 32.22 
Ascorbic acid 2,6-
dihexadecanoate 
25000 6 69.26 67.96 
Kaur-15-ene 5000 5 69.26 -25.90 
Trans-Phytol 5000 5 100 19.46 
Octadecanoic acid 130 3 100 38.11 
Ethyl 15-
methylheptadecanoate 
4800 5 100 21.01 
9-(4-
methoxyphenyl)xanthene 
370 4 68.07 37.82 
Urs-12-ene-3-ol acetate 4800 5 70.97 -142.73 
Sitosterol 890 4 72.90 18.27 
2,3,23-trihydroxyolean-
12-en-28-oic acid methyl 
ester 
- - - -80.49 
 
The selected conformations of the identified compounds were docked into the active site of alpha 
glucosidase using GOLD software. In the binding pocket, common H-bonding interactions were 
formed between all docked ligands and LYS356, LYS347, ALA355 and ASP969. The specific H-
bonding interaction with GLU354 was observed for some of the compounds. Among the 11 
compounds docked, only Kaur-15-ene (-25.00 Kcal/mol), Urs-12-ene-3-ol acetate (-142.73 
Kcal/mol) and 2,3,23-trihydroxyolean-12-en-28-oic acid methyl ester (-80.49 Kcal/mol) showed 
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strong binding affinities, with Urs-12-ene-3-ol acetate showing the best activity (Figure 8.2.13A 
– 8.2.13C and Table 8.2.4). The others showed weak binding affinity as indicated by their binding 
energy (Table 8.2.2). In the binding pocket, common H-bonding interactions were formed 
between all docked ligands and LYS356, LYS347, ALA355 and ASP969. The specific H-bonding 
interaction with ALA355 was only found in molecule 6. 
 
 
Figure 8.2.13: Docked conformation of (A) kaur-15-ene; (B) urs-12-ene-3-ol acetate; and (C) 
2,3,23-trihydroxyolean-12-en-28-oic acid methyl ester in the binding pocket of α-glucosidase 
(PDB ID:3TON) 
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8.2.5 Discussion 
The role of iron in the etiology and pathogenesis of T2D and its complications has been 
reported.(Andrews 1999) Alteration of optimal heath owing to iron deficiency and iron overload 
makes it the proverbial double edged sword. Its ability to exist in two ionic states: ferrous (Fe2+) 
and ferric (Fe3+) makes it a major co-factor for several enzymes involved in redox reactions 
(Andrews 1999; Rajpathak et al. 2009). This also makes it a potent pro-oxidant. Thus, high 
concentration levels may elevate T2D and its complication via increased redox imbalance 
(Rajpathak et al. 2009). In this study, oxidative injury was induced ex vivo in pancreatic and hepatic 
tissues with FeSO4 and treated with extracts of D. edulis leaves. 
 Several in vitro studies have linked high total phenolic content with increased free radical 
scavenging activities (Anahita et al. 2015; Hossain and Shah 2015; Saeed et al. 2012). This 
corresponds to the observed high total phenolic content and DPPH scavenging activity of the 
ethanol extract (Figure 8.2.2A and 8.2.2B).  
 GSH has been documented as the first line of defense in the body’s endogenous antioxidant 
system, with the highest concentration found in the liver.(Mohamed et al. 2016; Tiwari et al. 
2013a) It is regarded as a marker of oxidative stress at cellular level, thus implying the reduced 
levels observed in the untreated tissues (Figures 8.2.3A and 8.2.3B) indicates an occurrence of 
oxidative stress. Several studies have implicated a reduced GSH level in β-cell dysfunction and in 
the pathogenesis of T2D complications. (Tiwari et al. 2013) The observed reduced GSH levels in 
the tissues can be attributed to an overwhelming effect of ROS produced due to the oxidation of 
Fe2+ to Fe3+. The increased levels on treatment with the extracts therefore portrays an anti-
oxidative protective potential against Fe2+ - induced oxidative injuries, which corresponds to the 
observed FRAP activities (Figure 8.2.2B).  
Generation of superoxide (O2
. –) and hydroxyl (.OH) radicals have been recognized as major 
mechanism of iron toxicity and if not scavenged, can lead to oxidative damage (Davari et al. 2013). 
The protective role of SOD against oxidative cellular damage is well documented. It catalyzes the 
dismutation of O2
. – to H2O2, which is further converted into oxygen and water by catalase. SOD 
level in pancreatic β–cells is 50% that of hepatic tissues, while catalase have been reported to be 
extremely low making 1% that of hepatic tissues (Pi et al. 2010; Tiedge et al. 1997). Thus, making 
477 
 
the pancreatic β–cells more susceptible to oxidative damage compared to other organ tissues. The 
significantly reduced SOD and catalase activities (Figure 8.2.4A – 8.2.5B) in the untreated tissues 
further portrays an occurrence of oxidative injury on incubation with FeSO4. Increased activities 
in the treated tissues, also indicates an anti-oxidative potential.  
The role of iron on the induction of lipid peroxidation is well documented (Andrews 1999; 
Rajpathak et al. 2009). H2O2 not neutralized by catalase reacts with Fe
3+ via Fenton reaction to 
produce •OH (Aslan et al. 2000). This attacks the membrane lipid, triggering a peroxidative 
reaction which produces highly reactive aldehydes, including MDA, acrolein, 4-hydroxynonenal 
(HNE), 4-oxononenal (ONE), and isolevuglandins (IsoLGs) (Guo et al. 2012a). Increased MDA 
levels have been reported in T2D and its complications (Saddala et al. 2013). Incubation of 
pancreatic and hepatic tissues with FeSO4 led to significant increase in MDA level, signifying an 
occurrence of lipid peroxidation (Figure 8.2.6A and 8.2.5B). This also indicates a decline in the 
endogenous antioxidant system. The decreased MDA level on treatment with the extracts 
corresponds to the observed increased GSH level, SOD and catalase activities (Figure 8.2.3A – 
8.2.5B). It also portrays an anti-peroxidative effect. 
Inhibition of intestinal α – glucosidase has been demonstrated to delay and prolong carbohydrate 
digestion, thus reducing the rate of glucose absorption with concomitant attenuation of glucose-
induced insulin secretion (Bischoff ; Bischoff 1995). The dose – dependent inhibition by the 
extracts (Figure 8.2.7A) portrays their ability to delay carbohydrate digestion, thereby reducing 
the rate of glucose absorption. This therefore indicates an anti-hyperglycemic potential. The strong 
binding affinities coupled with the molecular docking of Kaur-15-ene, Urs-12-ene-3-ol acetate and 
2,3,23-trihydroxyolean-12-en-28-oic acid methyl ester with α – glucosidase (Figure 8.2.13A – 
8.2.13C and Table 8.2.3), indicates a strong inhibitory effect on the enzyme. This corroborates 
with the observed inhibitory effect of the ethanol extract on α – glucosidase (Figure 8.2.7A) and 
can be thus be attributed to a synergetic effect of these compounds.  
Pancreatic lipase plays a major function in dietary fat absorption by hydrolyzing triglycerides into 
monoglycerides and free fatty acids (Lunagariya et al. 2014). Its role in the progression of obesity 
is well documented. Thus, making it a major inhibitory target for the treatment and management 
of obesity. The dose – dependent inhibition by the extracts indicates an anti-obesogenic potential 
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(Figure 8.2.7B). This correlates with the observed α – glucosidase activity (Figure 8.2.7A), thus 
further portraying the potential of the plant in the management of T2D and its complication. 
Decrease in pancreatic ATPase activity particularly Na+K+-ATPase leading to β – cell membrane 
depolarization and Ca2+ influx has been suggested to be a major mechanism of insulin secretion 
(Costa et al. 2010; Owada et al. 1999).  Na+, K+-ATPase activity has been suggested as a possible 
mechanism by which glucose initiate insulin secretion via promotion of membrane depolarization 
(Owada et al. 1999). Thus, the increased ATPase activity in the oxidative injured pancreatic tissues 
may portray an impaired membrane depolarization reflecting a decrease in insulin secretion. The 
reduced activity on treatment with the extract may therefore indicate increased membrane 
polarization, implying an increase in insulin secretion (Figure 8.2.8). 
The role of glucose-6-phosphatase in the homeostatic regulation of blood glucose levels is well 
documented (Ghosh et al. 2004; Van Schaftingen and Gerin 2002). Its increased activity leading 
to hyperglycemia in T2D have been reported (Ghosh et al. 2004). Thus, the increased activity in 
the untreated oxidative injured hepatic tissue (Figure 8.2.9) may indicate an increased 
gluconeogenesis and glycogenolysis. The significant (p<0.05) decrease on treatment with the 
extracts further portrays an anti-hyperglycemic potential, with increased glycogenesis. 
Increased apoptosis characterized by DNA fragmentation and cellular shrinkage has been reported 
in pancreatic β – cells and hepatocytes in T2D (Donath et al. 1999). This can be attributed to 
increasing hyperglycemia and hyperlipidemia, with oxidative stress playing an influential role 
(Allameh et al. 2010). The role of Fe2+ in oxidative injury via the Fenton pathway, therefore 
implicates iron in the triggering of apoptosis. The increased DNA fragmentation on incubation of 
hepatic tissues with Fe2+ portrays an apoptotic activity (Figure 8.2.10). This corresponds to 
previous report on the induction of apoptotic cell death in isolated rat hepatocytes by iron overload 
via oxidative stress (Allameh et al. 2010). The decreased DNA fragmentation on treatment with 
the extracts indicates an anti-apoptotic activity in oxidative injured hepatic tissue. This correlates 
with the observed anti-oxidative activities of the extracts (Figure 8.2.3A – 8.2.6B).  
Owing to its consistent high activities, the ethanol extract of D. edulis leaves was subjected to GC–
MS analysis to have an idea of its likely chemical constituents (Figure 8.2.11 and Table 8.3.2). 
The antioxidant properties of the identified phytochemical constituents have been documented 
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particularly phytol and its derivatives (Santos et al. 2013), 2,3,23-trihydroxyolean-12-en-28-oic 
acid methyl ester (Abdullah et al. 2016), and Urs-12-ene-3-ol acetate (El-Kashef et al. 2015). The 
observed anti-oxidative activities of the extract can therefore be attributed to the synergetic effect 
of the identified phytochemicals. Furthermore, the identified functional groups (Figure 8.2.12 and 
Table 8.2.3) particularly the carboxylic acids and phenols corresponds to the identified compounds 
(Figure 8.2.11) and total phenol content (Figure 8.2.1). N–H bend, N–O symmetric C–C stretch 
and C=O stretches indicate an electron – deficient moiety, making it susceptible to oxidative 
reaction (Harrold 2013). Thus, a potent antioxidant and may be responsible for the antioxidative 
effect of the extracts. The presence of C–H rock of alkane indicate metabolic selectivity of the 
extract as alkanes has a large impact on the metabolism that a drug undergoes or not (Demeyer et 
al. 1994). The oxygen atom present in phenols, ether and esters makes them good hydrogen 
acceptors, which also portrays a potent antioxidative activity (Harrold 2013) and may be 
responsible for the reducing power of the extract (Figure 8.2.2B). The high concentration of 
amides and amines is of great significance. They are protonated by hydrochloric acid as the pass 
through the gut making them water soluble and prevents their absorption into the bloodstream 
from the intestinal tract (Manallack et al. 2013). 
The risk of toxicity of the use of medicinal plant is of major concern, particularly issues concerning 
standardization, characterization and preparation (Ezuruike and Prieto 2014). Studies have 
revealed that administration of plant extracts triggers different biological activities in the body, 
some of which may be toxic effects (Ezuruike and Prieto 2014; Yüce et al. 2006). The observed 
toxicity classes of the identified compounds of the ethanol extract indicates the safety of the extract 
on oral consumption (Table 8.3.4). However, further studies on their cytotoxic effect on normal 
cell lines are recommended.  
8.2.6 Conclusion 
These results suggest the anti – oxidative and anti-hyperglycemic potential of D. edulis leaves, 
with the ethanol extract showing the overall best activity. These can be attributed to the synergetic 
effect of the identified phytochemical compounds. These findings give credence to the folkloric 
claims of the use of D. edulis leaves as major ingredient in the treatment and management of T2D 
and its complications. However, in vivo studies are required to further validate its anti-
hyperglycemic activity as well as the underlying molecular mechanisms. 
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8. 3 Antidiabetic Properties of the Butanol Fraction of Dacryodes edulis L. 
Ethanol Extract: Modulatory Effects on Redox Imbalance and Nrf2 
Expression; and Inhibitory Effects on Glycolytic and Cholinergic Enzymes 
Activities in Type 2 Diabetic Rats 
1,2Ochuko L. Erukainure, 3Omamuyovwi M. Ijomone, 1,4Chika I. Chukwuma, 1Xin Xiao, 
4Motlalepula G. Matsabisa, 1Md. Shahidul Islam* 
1. Department of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, 
(Westville Campus), Durban 4000, South Africa  
2. Nutrition and Toxicology Division, Federal Institute of Industrial Research, Lagos, Nigeria 
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Africa 
*Corresponding author: islamd@ukzn.ac.za; Tel: +27 (0)31-260-8717; Fax: +27 (0)31-260-7942 
Preface: This article investigated the antidiabetic effect of the butanol fraction of D. edulis ethanol 
extract in type 2 diabetic rats. Its antioxidative, anti-proinflammatory, antilipemic and insulin 
stimulatory effects were investigated. Its inhibitory effect on glycolytic, cholinergic and 
carbohydrate digesting enzymes were investigated. Its ability to inhibit Nrf2 expression was also 
investigated in vivo. Additionally, its stimulatory effect on glucose uptake and cytotoxicity in 3T3 
adipocytes cells was investigated. 
8.3.1 Abstract 
The antidiabetic effect of the butanol fraction of Dacryodes edulis L. ethanol extract (BFDE) was 
investigated in fructose-streptozotocin induced type 2 diabetic rats.  Diabetic rats were grouped 
into 4. A group served as a negative control and was administered water only, another was 
administered metformin (200 mg/kg bodyweight), while the other 2 were administered BDFE at 
150 and 300 mg/kg bodyweight respectively. Two other groups of normal rats were administered 
water and BFDE (300 mg/kg bodyweight) respectively, with the formal serving as normal control. 
The rats were sacrificed after 6 weeks of intervention. Treatment with the fraction to significant 
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(p<0.05) reduction in blood glucose level, with concomitant increase in serum insulin secretion. It 
also caused significant (p<0.05) elevation of reduced glutathione level, superoxide dismutase, 
catalase, α-amylase, and ATPase activities, while concomitantly depleting myeloperoxidase 
activity, NO and MDA levels of the serum and pancreas. The pancreatic β-cell function and 
morphology were significantly improved in BFDE-treated rats, with restoration of the pancreatic 
capillary networks. Treatment with BFDE significantly (p<0.05) inhibited glycogen 
phosphorylase, fructose 1,6 biphosphatase, glucose 6 phosphatase, and acetylcholinesterase 
activities, with while suppressing Nrf2 expression. HPLC analysis of the fraction revealed the 
presence of gallic acid, vanillic acid, vanillin, and (-)-epicatechin. These results portray the 
antidiabetic and antioxidative properties of BFDE, which may be attributed to the synergistic effect 
of the identified phenolics. 
Keywords: Antioxidant; Dacryodes edulis; Nrf2; Phenolics; Type 2 diabetes 
8.3.2 Introduction 
The use medicinal plants in the treatment of various diseases and ailments such as diabetes mellitus 
(DM), cancers, and malaria dates to time immemorial, with their folkloric uses integrated in the 
cultural systems and practices of their indigenous flora. These plants also contribute to the 
indigenous health system of most countries in the present day, with their increasing utilizations 
attributed to the paradigm shift from synthetic drugs to plant-based natural products (Erukainure 
et al. 2018). The efficacy of folkloric claims of these plants has been validated by several studies 
and attributed the medicinal properties to their phytochemical constituents, with phenolics being 
amongst the most studied phytochemicals (Decker 1995). Amongst such plants is Dacryodes 
edulis L., belonging to the Burseraceae family. 
Diabetes mellitus is amongst the many diseases folklorically treated with D. edulis. It is 
characterized by high blood glucose level (hyperglycemia) arising from disorders in carbohydrate, 
protein, and fatty acid metabolisms. These metabolic disorders have been attributed to inability of 
the pancreatic β-cells to secrete insulin as seen in type 1 diabetes (T1D) and/or inability of the cells 
to utilize the insulin secreted by the pancreatic β-cells  as seen in type  2 diabetes (T2D) 
(Erukainure et al. 2018). T2D accounts for over 90% of all diabetes, making it the most prevalent 
(I.D.F. 2016; I.D.F. 2018). It is characterized by insulin resistance and β-cell dysfunction, leading 
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to persistent hyperglycemia and dyslipidemia (Bardini et al. 2012; Kahn 2003). Free radicals 
arising from persistent hyperglycemia will lead to oxidative stress, when its production surpasses 
the body’s endogenous antioxidant system (Maritim et al. 2003; Tiwari et al. 2013b). Oxidative 
stress has been linked with the pathogenesis, pathophysiology and progression of micro and macro 
– complications associated with T2D such retinopathy, nephropathy, and cardiopathy (Evans et al. 
2002; Giacco and Brownlee 2010). This has been evidenced by several pre-clinical and clinal 
studies using antioxidants in the treatment and management of T2D and its complications (Sabu 
and Kuttan 2002; Tiong et al. 2013). Oxidative stress has also been reported to aggravate 
pancreatic β-cell dysfunction and insulin secretion by triggering apoptosis of the pancreatic β-cell 
involving the caspase cascade (Liadis et al. 2005; Montane et al. 2014). Increased expression of 
the nuclear factor erythroid 2–related factor 2 (Nrf2) has also been implicated in the suppression 
of antioxidants and the early onset of T2D (He et al. 2012; Miao et al. 2012). 
Thus, the study aims at investigating the antidiabetic properties of the butanol fraction of D. edulis 
leaves ethanol extract in T2D rats. The inhibitory effects of the fraction on major glycolytic, 
cholinergic and carbohydrate hydrolyzing enzymes were also investigated.  Additionally, its ability 
to modulate pancreatic oxidative injury and morphology as well as suppress the expressions of 
(Nrf2) and caspase-3 were investigated. 
8.3.3 Materials and Methods 
Kindly refer to chapter 2, subsections: 2.1.1, 2.1.3, 2.1.5, 2.1.6, 2.4.1, 2.9, 2.10.1, 2.10.3, 2.11, 
2.12 – 2.13 for details materials and methods.  
8.3.4 Results 
Incubation of D. edulis fractions with α-glucosidase led to significant (p<0.05) inhibition by all 
the fractions to levels indistinguishable from the standard drug, acarbose as shown in Figure 8.3.1. 
The inhibitions were dose dependent, with the BuOH fraction showing the best activity as 
indicated by its low IC50 value of 0.13 µg/mL (Table 8.3.1). 
483 
 
 
Figure 8.3.1: α-glucosidase inhibitory activities of fractions of D. edulis ethanol extract. Values = 
mean ± SD; n = 3. abcdValues with different letter above the bars for a given concentration are 
significantly different (p < 0.05) from each other. 
Table 8.3.1: IC50 values of α-glucosidase inhibitory activities of fractions of D. edulis ethanol 
extract 
Fractions IC50 values 
Hexane 50.97 
DCM 164.92 
Ethyl acetate 4.85 
BuOH 0.13 
Aqueous 97.70 
Acarbose 62.42 
Values = mean; n = 3 
Figure 8.3.2A shows the effect of a 1.5 h treatment of extract on glucose uptake/utilization in 3T3-
L1 adipocytes, while Figure 8.3.2B shows they effect of the extract treatment on the adipocytes 
viability during the 1.5 h treatment period. Data showed that the fraction increased glucose uptake 
in adipocytes by 10, 8 and 52% at 30, 60 and 120 µg/mL, respectively, while 1 µM metformin 
484 
 
increased glucose uptake by 96% (Figure 8.3.2A). Only the 120 µg/mL extract and insulin 
significantly increased (p < 0.05) glucose uptake, although the effect of insulin was significantly 
higher (p < 0.05) than that of the extract (Figure 8.3.2A). The computed GU50 (concentration of 
extract in µg/mL causing 50% glucose uptake increase) of extract was 123.7 µg/mL. Interestingly, 
Figure 8.3.2B showed that the viability of the adipocytes after the treatment period was 87, 136 
and 166% at 30, 60 and 120 µg/mL extract concentration, respectively, which suggests that the 
extract did not markedly reduce the cells’ viability after treatment. However, the proliferative 
tendency of the fraction on the adipocytes, particularly at 120 µg/mL, may influence its glucose 
uptake activity. 
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Figure 8.3.2: Effect of BFDE on (A) Glucose uptake and (B) cell viability on 3T3-L1 adipocytes. 
Data = mean ± SD; n = 3. abcValues are significantly different from each other when comparing 
control different treatment in 3T3-L1 adipocytes (p < 0.05; Tukey’s HSD multiple range post-hoc 
test, IBM, SPSS, version 23) 
Induction of T2D led to significant (p<0.05) loss in body weight, with concomitant increase in 
food and fluid intake as depicted in Figures 8.3.3A and 8.3.3B. This also led to reduced pancreatic 
weight and relative weight (Figure 8.3.3C). Treatment with BFDE significantly (p<0.05) reversed 
these changes, with rats treated with high dose of BFDE showing reversibility higher than the 
standard antidiabetic drug, metformin. 
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Figure 8.3.3: (A) Body weight; (B) feed and fluid intake; and (C) weight and relative weight of 
pancreas of experimental groups. Values = mean ± SD; n = 5 (NC and NTXD) and 7 (DC, DLDD, 
DHDD, and DSM). *Statistically (p<0.05) significant to DC, #statistically significant (p<0.05) to 
NC. NC = normal rats, DC = diabetic control, DLDD = diabetic rats + D. edulis (150 g/kg bw), 
DHDD = diabetic rats + D. edulis (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), 
and NTXD = Normal rats + D. edulis (300 g/kg bw). 
As shown in Figure 8.3.4A, induction of T2D led to increased blood glucose level with 
concomitant reduction in serum insulin level (Figure 8.3.4C) with significantly (p<0.05) increased 
HOMA- IR and reduced HOMA-β function (Figure 8.3.4D). These were significantly (p<0.05) 
reversed in all treatment groups, with BFDE treated rats showing 33.75 and 44.067% reduction in 
blood glucose levels for low and high doses respectively (Figure 8.3.4A). OGTT analysis revealed 
an increased level of blood glucose, which peaked at 30 min for all groups except metformin 
treated (DSM) (Figure 8.3.4B). The glucose level reduced with increasing time during the test. 
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Figure 8.3.4: (A) Blood glucose level; (B) oral glucose tolerance; (C) serum insulin; and (D) 
HOMA-IR and β-cell function of experimental groups. Values = mean ± SD; n = 5 (NC and 
NTXD) and 7 (DC, DLDD, DHDD, and DSM). *Statistically (p<0.05) significant to DC, 
#statistically significant (p<0.05) to NC NC = normal rats, DC = diabetic control, DLDD = 
diabetic rats + D. edulis (150 g/kg bw), DHDD = diabetic rats + D. edulis (300 g/kg bw), DSM = 
diabetic rats + metformin (200 g/kg bw), and NTXD = Normal rats + D. edulis (300 g/kg bw). 
Induction of T2D did not cause any significant increase in TC, but treatment with BFDE led to a 
significant (p<0.05) decrease as depicted in Figure 8.3.5. However, induction of T2D significantly 
(p<0.05) increased TG and LDL-c levels, while concomitantly suppressing HDL-c level. The TG 
level of all treatment groups were significantly reduced to levels indistinguishable from the normal 
control. Treatment with BFDE had little or no effect on LDL-c level, while treatment with low 
dose of BFDE led to significant (p<0.05) increased level of HDL-c. 
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Figure 8.3.5: Serum lipid profile of experimental groups. Values = mean ± SD; n = 5 (NC and 
NTXD) and 7 (DC, DLDD, DHDD, and DSM). *Statistically (p<0.05) significant to DC, 
#statistically significant (p<0.05) to NC. NC = normal rats, DC = diabetic control, DLDD = 
diabetic rats + D. edulis (150 g/kg bw), DHDD = diabetic rats + D. edulis (300 g/kg bw), DSM = 
diabetic rats + metformin (200 g/kg bw), and NTXD = Normal rats + D. edulis (300 g/kg bw). 
There were significant (p<0.05) increases in serum and pancreatic α-amylase activities 
respectively on induction of T2D as shown in Table 8.3.2. These were significantly (p<0.05) 
reduced in all treatment groups, with rats treated with low dose of BFDE showing a better 
inhibitory activity for serum α-amylase, while the high dosed exhibited a higher pancreatic α-
amylase activity. 
As shown in Table 8.3.2, there was a significant (p<0.05) decrease in serum ATPase activity on 
induction of T2D. This was significantly (p<0.05) increased in all treatment groups, with the BFDE 
high dose – treated rats exhibiting the highest activity. 
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Table 8.3.2: Enzyme activities of experimental groups. 
Enzyme Activities NC DC DLDD DHDD DSM NTXD 
Serum α-amylase 25.38±3.50* 72.36±4.25# 31.21±3.86* 46.41±5.36# 41.57±9.53* 34.11±2.41* 
Pancreatic α-amylase 46.90±4.25* 89.72±4.21# 24.32±1.86* 8.42±1.39* 28.02±3.37* 27.29±2.45* 
Serum ATPase 279.18±5.60* 201.24±17.89# 251.38±5.97* 255.70±7.20* 241.92±12.42* 235.30±6.15* 
Pancreatic ATPase 144.35±21.59* 234.49±7.781# 133.27±15.14* 119.62±25.23* 103.95±14.28* 95.48±13.90*# 
Acetylcholinesterase  29.56±3.24* 44.20±3.24# 24.68±1.69* 26.98±1.22* 22.96±3.76* 35.97±3.16* 
Glycogen Phosphorylase 174.22±9.98* 209.89±17.50# 158.36±23.04* 133.54±3.67* 169.35±24.65* 143.32±14.14* 
Fructose 1,6 Biphosphatase 177.19±7.93* 247.46±9.90# 147.32±6.80* 135.66±7.07* 191.78±19.49* 156.31±10.57* 
Glucose 6 Phosphatase 153.68±3.06* 223.14±12.03# 138.54±9.64* 139.98±5.43* 176.92±23.96* 160.16±13.00* 
Values = mean ± SD; n = 5 (NC and NTXD) and 7 (DC, DLDD, DHDD, and DSM). *Statistically (p<0.05) significant to DC, 
#statistically significant (p<0.05) to NC. NC = normal rats, DC = diabetic control, DLDD = diabetic rats + D. edulis (150 g/kg bw), 
DHDD = diabetic rats + D. edulis (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and NTXD = Normal rats + D. edulis 
(300 g/kg bw). 
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Induction of T2D significantly (p<0.05) increased pancreatic ATPase activity as shown in Table 
8.3.2. This was significantly (p<0.05) reversed in all treatment groups to levels indistinguishable 
from the normal controls. Rats treated with high dose of BFDE exhibited a better inhibitory effect 
compared to the low dose treated. 
Pancreatic acetylcholinesterase activity was significantly (p<0.05) increased on induction of T2D 
as shown in Table 8.3.2. Treatment with both doses of BFDE led to a significant (p<0.05) 
reduction to levels indistinguishable from the normal control. This was similar for the other 
treatment groups. 
BFDE significantly (p<0.05) inhibited T2D – induced glycolytic enzyme activities as revealed by 
the decreased activities of glycogen phosphorylase, fructose 1,6 biphosphatase, and glucose 6 
phosphatase to levels indistinguishable from the normal controls (Table 8.3.2). 
Induction of T2D led to significant (p<0.05) decrease in GSH level, SOD, and catalase activities 
with concomitant increase in MDA and NO levels, and myeloperoxidase activities as depicted in 
Table 8.3.2. These were significantly (p<0.05) reversed in all treatment groups, with rats treated 
with BFDE exhibiting levels indistinguishable from the normal controls. 
As shown in Table 8.3.3, induction of T2D led to significant (p<0.05) increase in ALP, CK-MB, 
fructosamine and uric acid levels. These was significantly reduced in all treatment groups, with 
rats treated with high dose of BFDE exhibiting reduced levels indistinguishable from the normal 
control. T2D had little or no significant effect on ALT and urea levels as compared to the normal 
control. 
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Table 8.3.3: Antioxidant status of (A) serum and (B) pancreas of experimental groups 
(A) 
 GSH (mol/L) SOD  
(U/mg protein) 
Catalase  
(U/mg protein) 
MDA (mol/L) NO (µml) Myeloperoxidase  
(U/mg protein) 
NC 64.28±11.90* 86.21±8.13* 636.37±29.48* 63.09±4.57* 0.075±0.006* 100.27±9.68* 
DC 36.65±2.47# 40.23±3.32# 490.64±42.75# 71.19±4.52# 0.102±0.007# 121.08±18.63# 
DLDD 49.55±5.17* 123.08±21.34* 635.05±6.04* 52.54±2.33* 0.044±0.003* 52.14±4.77* 
DHDD 71.48±3.81* 128.83±15.83* 601.13±18.35* 51.98±2.79* 0.034±0.005* 33.85±4.26* 
DSM 53.31±2.27* 68.97±8.78* 650.50±4.82* 50.09±9.53* 0.053±0.008* 47.44±1.53* 
NTXD 41.48±2.39* 132.18±36.57* 657.31±12.12* 45.20±5.39* 0.065±0.001# 80.74±6.48* 
(B) 
 GSH (mol/L) SOD  
(U/mg protein) 
Catalase  
(U/mg protein) 
MDA (mol/L) NO (µml) Myeloperoxidase  
(U/mg protein) 
NC 104.87±3.09* 659.96±57.9* 783.32±28.21* 40.96±5.79* 0.24±0.02* 20.31±5.75* 
DC 54.06±5.01# 150.86±10.6# 711.48±34.46# 71.75±3.60# 0.70±0.02# 35.35±3.61# 
DLDD 101.48±9.92* 639.37±30.47* 789.19±12.16* 50.28±5.99* 0.16±0.04* 12.39±2.65* 
DHDD 116.97±2.61* 664.51±15.24* 785.64±19.61* 65.25±13.78* 0.10±0.02* 13.67±2.99* 
DSM 51.80±6.38# 583.33±31.8* 754.29±40.8* 55.08±5.99* 0.34±0.03* 17.85±1.81* 
NTXD 45.35±2.13# 462.64±27.8* 782.47±4.97* 47.03±4.46* 0.25±0.01* 18.62±0.49* 
Values = mean ± SD; n = 5 (NC and NTXD) and 7 (DC, DLDD, DHDD, and DSM). *Statistically (p<0.05) significant to DC, 
#statistically significant (p<0.05) to NC. NC = normal rats, DC = diabetic control, DLDD = diabetic rats + D. edulis (150 g/kg bw), 
DHDD = diabetic rats + D. edulis (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and NTXD = Normal rats + D. edulis 
(300 g/kg bw). 
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Table 8.3.4: Toxicity biomarkers of experimental groups 
Enzyme Activities NC DC DLDD DHDD DSM NTXD 
ALP U/L 101.00±5.55* 1235.00±29.88# 425.67±63.81* 364±10.80* 582.33±10.67* 123.33±28.99* 
ALT U/L 91.00±4.24 87.50±0.71 88.67±0.58 89±8.54 88.00±3.20 89.00±1.00 
CK-MB U/L 625.00±15.80* 959.00±25.10# 1104.30±159.19# 727±46.95* 739.40±12.89# 1544.25±61.97*# 
Fructosamine mg/dL 656.00±12.6* 743.00±15.56# 698.00±43.62* 605±17.68* 658.50±12.02* 558.00±30.45* 
Urea mg/dL 58.00±0.71 46.00±5.67 34.00±5.66# 28.50±4.95*# 31.50±6.81# 63.33±0.58* 
Uric acid mg/dL 2.46±0.24 3.48±0.70 2.55±0.68 2.07±0.87 1.60±0.23*# 2.75±0.38 
Values = mean ± SD; n = 5 (NC and NTXD) and 7 (DC, DLDD, DHDD, and DSM). *Statistically (p<0.05) significant to DC, 
#statistically significant (p<0.05) to NC. NC = normal rats, DC = diabetic control, DLDD = diabetic rats + D. edulis (150 g/kg bw), 
DHDD = diabetic rats + D. edulis (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and NTXD = Normal rats + D. edulis 
(300 g/kg bw). 
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Induction of T2D led to alteration of the pancreatic morphology as depicted by the 
inflamed/necrotic pancreatic β-cells (red colored) as well as the decreased number of acinar and 
normal β-cells as shown in Figure 8.3.6B. Treatment with BDFE led to restoration of the 
morphology as evident by the increased number of the β- and acinar cells as well as decreased 
number of inflamed cells  (Figure 8.3.6C and Figure 8.3.6D) when compared to the intact 
morphology of the normal rats (Figure 8.3.6A). This was same for all the treatment groups.  
 
Figure 8.3.6: Morphological changes in pancreatic tissues of experimental groups. Magnification: 
10x. (A) = NC, (B) = DC, (C) = DLDD, (D) = DHDD, (E) = DSM, and (F) = NTXD. NC = normal 
rats, DC = diabetic control, DLDD = diabetic rats + D. edulis (150 g/kg bw), DHDD = diabetic 
rats + D. edulis (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and NTXD = 
Normal rats + D. edulis (300 g/kg bw). Arrow: β-cells 
Figure 8.3.7A reveals intact clusters of acini, enriched with vast networks of capillaries in 
pancreatic tissues of normal rats. Induction of T2D led to alteration of the capillary networks, 
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leading to the conspicuousness of the acini clusters and enlargement of the cells as shown in Figure 
8.3.7B. The capillary networks were restored in all the treatment groups, with the BFDE low dose 
exhibiting much networks (Figure 8.3.7C – 8.3.7E). The acini cells were also reduced on 
treatment with BFDE. Administration of BFDE to normal rats led enlarged and conspicuous 
pancreatic acini cells, with altered capillary networks (Figure 8.3.7F). 
 
Figure 8.3.7: Electron microscopy of pancreatic tissues of experimental groups. Magnification = 
1000x. (A) = NC, (B) = DC, (C) = DLDC, (D) = DHDC, (E) = DSM, and (F) = NTXC. NC = 
normal rats, DC = diabetic control, DLDD = diabetic rats + D. edulis (150 g/kg bw), DHDD = 
diabetic rats + D. edulis (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and 
NTXD = Normal rats + D. edulis (300 g/kg bw). Arrows: Black = blood vessel; Red = acini 
As shown in Figure 8.3.8, induction of T2D had little or no effect on pancreatic caspase-3 
expression. The expressions were however increased (not significant) in BFDE treated diabetic 
groups (Figure 8.3.8C and 8.3.8D).  
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Figure 8.3.8: Immunohistochemistry photomicrographs and immunoreactivity of caspase3 
expression in pancreatic tissues of experimental groups. Magnification = 200x. NC = normal rats, 
DC = diabetic control, DLDD = diabetic rats + D. edulis (150 g/kg bw), DHDD = diabetic rats + 
D. edulis (300 g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and NTXD = Normal 
rats + D. edulis (300 g/kg bw). Arrow: β – cells  
Induction of T2D led to significant expression of Nrf2 in the pancreas as shown in Figure 8.3.9. 
Treatment with BFDE led to significant (p<0.05) inhibition of the expressions. 
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Figure 8.3.9: (A) Immunohistochemistry photomicrographs and (B) immunoreactivity of Nrf2 
expression in pancreatic tissues of experimental groups. Values = mean ± SD; n = 5 (NC and 
NTXD) and 7 (DC, DLDD, DHDD, and DSM). *Statistically (p<0.05) significant to DC, 
#statistically significant (p<0.05) to NC. Magnification = 200x. NC = normal rats, DC = diabetic 
control, DLDD = diabetic rats + D. edulis (150 g/kg bw), DHDD = diabetic rats + D. edulis (300 
g/kg bw), DSM = diabetic rats + metformin (200 g/kg bw), and NTXD = Normal rats + D. edulis 
(300 g/kg bw). Arrow: β – cells 
HPLC analysis of BFDE revealed the presence of gallic acid, vannilic acid, (-)-epicatechin, and 
vanillin as depicted in Figure 8.3.10. (-)-epicatechin had the highest peak, indicating the highest 
concentration.  
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Figure 8.3.10: HPLC chromatogram of butanol fraction of D. edulis ethanol extract 
8.3.5 Discussion 
The increasing epidemy of DM also connotes an increasing cost of its treatment, which has been 
reported to be an economic burden for most developing countries with little and/or poor health 
infrastructures. The IDF projection of 156% increase in the number people living with diabetes by 
2045 in Africa (I.D.F. 2018), raises a lot of concerns on how to tackle the rising epidemic in sub-
Saharan Africa. Several studies have suggested the use of alternative medicine in the treatment 
and management of DM, with particular interest in medicinal plants owing to their availability and 
affordability (Ekor 2014; Mohammed et al. 2014). In this study, the antidiabetic properties of the 
butanol fraction of D. edulis ethanol extract were investigated in T2D rats. 
The increased food and fluid intake as well as weight loss in untreated diabetic group (Figures 
8.3.2A and 8.3.2B), indicates an occurrence of polyphagia and polydipsia. Polyphagia and 
polydipsia as well as weight loss have been reported as key symptoms of DM (Ibrahim et al. 2016; 
Okon et al. 2012). Thus, the ability of BFDE to suppress these symptoms, may portray a beneficial 
effect in the treatment and management of T2D. 
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Hyperglycemia arising from pancreatic β-cell dysfunction, insulin insufficiency and resistance has 
been recognized as the major characteristics of T2D (Abdul-Ghani et al. 2006; Cerf 2013; Donath 
and Halban 2004). This is in consent with the elevated blood glucose level (Figure 8.3.4A), 
depleted serum insulin level (Figure 8.3.4C), decreased HOMA-β value (Figure 8.3.4D), and 
elevated HOMA-IR value (Figure 8.3.4D) of the untreated diabetic rats. The depleted serum level 
indicates an insulin insufficiency, while the decreased HOMA-β and elevated HOMA-IR values 
indicate β-cell dysfunction and insulin resistance respectively which corroborates with the elevated 
blood glucose level. This also correlates with the compromised pancreatic β-cell morphology 
(Figure 8.3.6B) and reduced weight (Figure 8.3.4C). Thereby indicating an occurrence of T2D. 
The ability of BFDE to reduce the blood glucose level, elevate serum insulin level, improve β-cell 
dysfunction, suppress insulin resistance, improving the pancreatic morphology and weight, 
demonstrates its antidiabetic potentials and affirmation of its folkloric claims. The improved 
glucose tolerance in diabetic rats treated with BFDE (Figure 8.3.4B), corroborates the antidiabetic 
potentials of the fraction. This corresponds with previous reports on the ability of antidiabetic 
medicinal plants to stimulate insulin secretion and improve the pancreatic morphology, while 
regenerating β-cells (Erukainure et al. 2015; Ibrahim et al. 2016; Islam and Choi 2007). This was 
also demonstrated in the ability of the fraction to stimulate glucose uptake in 3T3 adipocytes cells 
(Figure 8.3.2A), with high a proliferative tendency (Figure 8.3.2B). 
The increased activities of the studied glycolytic enzymes which covers for glycogen 
phosphorylase, fructose-1,6-biphosphatase and glucose-6-phosphatase in the untreated diabetic 
rats (Table 8.3.2) indicates increased glycogenolysis, gluconeogenesis and glycolysis. This 
corroborates previous reports on the elevation of these pathways in T2D (Clore et al. 2000; Guo 
et al. 2012b). Amplification of glycogenolysis and gluconeogenesis in T2D has been implicated in 
the continuous production of glucose from glycogen and non-carbohydrate, leading to increased 
blood glucose level. Increased glycolysis in T2D has been linked with the production of 
metabolites for the hexosamine, polyol, protein kinase C, and AGE pathways (Luo et al. 2016; 
Rolo and Palmeira 2006). Activation of these pathways corroborates the elevated blood glucose 
level (Figure 8.3.4A) as well as the diminished serum insulin level (Figure 8.3.4C) in the 
untreated diabetic rats. The latter has been reported for its glycogenic activity (Cersosimo et al. 
2018; Gardner et al. 1993), with insulin resistance playing an influential role (Saltiel and Kahn 
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2001). The ability of BFDE to inhibit the activities of these enzymes (Table 8.3.2) may insinuate 
parts of its antidiabetic mechanism. 
Inhibition of major dietary carbohydrate metabolizing enzymes particularly α-glucosidase and α-
amylase has been recognized as a major antihyperglycemic mechanism which is employed by 
some commercial antidiabetic drugs such as acarbose and miglitol (Chelladurai and Chinnachamy 
2018; Rahimzadeh et al. 2014). These enzymes contribute to increased postprandial blood glucose 
level by breaking down dietary carbohydrate to glucose. Thus, the increased α-amylase activities 
in the pancreas and serum of the untreated diabetic rats (Table 8.3.2) suggests an elevation of 
postprandial blood glucose level which may also be a contributor to the induced hyperglycemia 
(Fig. 4A). This is in consent with previous studies on amplified α-amylase activities in T2D  
(Aughsteen et al. 2005; Ewadh et al. 2014; Yadav et al. 2013). The distorted acinar cells (Figure 
8.3.6B) and its clusters (Figure 8.3.7B) may also contribute to the increased α-amylase activities, 
as these cells functions in the secretion of digestive enzymes in the pancreas (Muniraj et al. 2015; 
Williams 2010). The reduced α-amylase activities in diabetic rats treated with BFDE therefore 
demonstrates the antihyperglycemic activity of the fraction. This is further evidenced by their 
reduced blood glucose level (Figure 8.3.4A) and improved acinar cell morphology (Figures 
8.3.6C and 8.3.6D) and clusters (Figure 8.3.7C and 8.3.7D). This correlates with its high 
inhibitory potency on α-glucosidase activity in vitro (Figure 8.3.1 and Table 8.3.1). Previous 
studies have also reported the ability of D. edulis leaf extracts to inhibit carbohydrate digestive 
enzymes in vitro (Erukainure et al. 2017b). 
The increased pancreatic ATPase activity in the untreated diabetic rats (Table 8.3.2) may insinuate 
decreased insulin secretion as studies have linked a decreased activity coupled with depolarized β 
– cell membrane and Ca2+ influx to glucose-stimulated insulin secretion (Owada et al. 1999). This 
may also contribute to the reduced serum insulin level (Figure 8.3.4C). The decreased serum 
ATPase activity also corroborates previous studies which reported decreased activities in T2D 
(Kiziltunç et al. 1997; Zadhoush et al. 2015). The reversed activities in diabetic rats treated with 
BFDE, thus corroborates the increased serum level (Figure 8.3.4C) and further reflects the 
antidiabetic mechanism of the fraction. This correlates with previous studies on the ability of the 
D. edulis leaf extracts to inhibit pancreatic ATPase activity (Erukainure et al. 2017b). 
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Disturbances in lipid metabolism has been associated with the early stage of T2D (Erukainure et 
al. 2013). Often describes as dyslipidemia, it is characterized by elevated levels of TC, TG, LDL-
c, and depleted HDL-c level. Insulin resistance has been implicated in these metabolic changes 
which renders the lipoproteins pathogenic in T2D (Ormazabal et al. 2018). Thus, the elevated TG, 
LDL-c and depleted HDL-c levels in the untreated diabetic rats (Figure 8.3.5) depicts diabetic 
dyslipidemia. This can be attributed to hyperglycemia (Figure 8.3.4A) and insulin resistance 
(Figure 8.3.4D) on induction of T2D.  The reduced TG, LDL-c and elevated HDL-c levels in 
diabetic rats treated with BFDE suggests an antilipemic activity of the fraction. This also correlates 
with the reduced blood glucose levels (Figure 8.3.4A) and elevated serum insulin levels (Figure 
8.3.4C) in BFDE-treated diabetic rats. 
Oxidative stress and proinflammation have been implicated in hyperglycemia-induced destruction 
of the pancreatic β-cells, leading to alterations in insulin sufficiency and β-cell function (Evans et 
al. 2002; Evans et al. 2003). This has been linked to the extremely low levels of the endogenous 
antioxidant system in the pancreas, which makes it highly prone to oxidative attacks (Acharya and 
Ghaskadbi 2010; Donath 2014). The depleted GSH level, SOD and catalase activities in the 
untreated diabetic rats (Table 8.3.3) indicates oxidative stress. These antioxidants protect against 
the injurious activities of free radicals particularly superoxide anion (O2
•-). O2
•- undergoes 
dismutation to hydrogen peroxide (H2O2) in a reaction catalyzed by SOD. H2O2 is then broken 
down by catalase to water (H2O) and O2 (oxygen). NO can react with O2
•- to form the lethal nitric 
radical, peroxynitrite (ONOO-). If not converted by catalase, H2O2 can be broken down to hydroxyl 
radical (•OH) which has been recognized as a trigger for lipid peroxidation. Excess H2O2 can also 
react with hydrochloric acid (HCl) to give hypochlorous acid (HOCl), in a reaction catalyzed by 
myeloperoxidase. Thus, the elevated level of MDA, NO, and myeloperoxidase activity in the 
untreated diabetic rats (Table 8.3.2) indicates lipid peroxidation, and proinflammation. This 
corroborates with the inflamed β-cells (Figure 8.3.6B). The reversed levels and activities of these 
biomarkers in diabetic rats treated with BFDE, therefore insinuates a protective effect of the 
fraction against hyperglycemia-induced oxidative stress and proinflammation. The latter is 
corroborated by the reduced acetylcholinesterase activities in BFDE-treated diabetic rats (Table 
8.3.2), as increased pancreatic acetylcholinesterase activities have been correlated with 
inflammation of the tissue (Zhang et al. 2012). 
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Alteration in pancreatic perfusion have been reported in T2D, and has been implicated in β-cell 
dysfunction (Honka et al. 2014). Perfusion of the pancreas by multiple arteries from the abdominal 
aorta have been linked with maintenance the pancreatic islets as well as normal physiology of the 
endocrine (Honka et al. 2014; Jansson et al. 2016). Thus, the altered capillary network on the 
pancreatic suffices of the untreated diabetic rats (Figure 8.3.7B) suggests an altered perfusion. 
The increased networks in that of diabetic rats treated with BFDE insinuates an increased 
perfusion, which may also contribute to the improved β-cell function (Figure 8.3.4D). 
The detrimental effect associated with apoptosis of the pancreatic β-cells has been reported in T2D, 
with hyperglycemia-induced oxidative stress and inflammation playing key roles (Acharya and 
Ghaskadbi 2010; Kaneto et al. 1996; Rojas et al. 2018; Tomita 2016). Caspase cascade has been 
implicated in the progression of the extrinsic apoptotic pathway, with caspase-3 very effective in 
apoptosis of the β-cells (Liadis et al. 2005; Tomita 2016). In this study, induction of T2D had little 
or no effect on the expression of caspase 3 (Figure 8.3.8), thus suggesting that the induction 
mechanism may not involve caspase-3-dependent β-cell apoptosis. 
The increased pancreatic Nrf2 expression in the untreated diabetic rats (Figure 8.3.9) corroborates 
previous studies which correlated exacerbated expressions with onset T2D (He et al. 2012; Miao 
et al. 2012). This also correlates with reports on its activation of oxidative stress (Wrighten et al. 
2009; Zucker et al. 2014). Thus, insinuating its exacerbated expression may contribute to the 
pancreatic oxidative stress (Table 8.3.3). The decreased expressions in diabetic rats treated with 
BFDE (Figures 8.3.9C and 8.3.9D), further insinuates the antidiabetic properties of the fraction 
and may also be a possible antidiabetic mechanism. 
The elevated level of fructosamine in the untreated diabetic rats (Table 8.3.4) indicates an 
activation of the glycation cascade, as fructosamine is a product of an early stage glycated protein 
which undergoes oxidative cleavage to produce advanced glycation end (AGE) products (Ibrahim 
et al. 2016; Sen et al. 2011). The reduced levels in diabetic rats treated with BFDE, insinuates the 
ability of the fraction to arrest the glycation cascade. 
The elevated levels of ALP, CK-MB and uric acids in the untreated diabetic rats (Table 8.3.4), 
insinuates liver, heart and kidney toxicities (Erukainure et al. 2018; Mortazavi et al. 2016). The 
elevation of these toxicity biomarkers has been demonstrated in diabetic rats (Čaušević et al. 2010; 
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Erukainure et al. 2017a; Fazel et al. 2005). Inflammation of the liver, heart and kidney has been 
implicated in their leakage to the bloodstream (Giordano et al. 2015; Kim et al. 2008; Peppes et 
al. 2008). The reduced levels of these biomarkers in both diabetic and normal rats treated with 
BFDE as well as non-cytotoxic effect of BFDE on 3T3-adipocytes (Figure 8.3.2B), indicate the 
safety of the fraction on both diabetic and healthy tissues. This correlates with previous reports on 
the predicted safety of the D. edulis extracts if consumed orally (Erukainure et al. 2017b).  
The antidiabetic properties of BFDE can be attributed to its chemical constituents, particularly the 
identified phenolics consisting of gallic acid, vanillic acid, vanillin, and (-)-epicatechin (Figure 
8.3.10). As common with phenolics, the identified compounds have been reported as potent 
antioxidants (Makni et al. 2011; Rein et al. 2000; Rice-Evans et al. 1997) and may be responsible 
for the antioxidative activity of the fraction in diabetic rats (Table 8.3.3). Their antidiabetic 
properties which encompasses improved insulin sensitivity (Josic et al. 2010), suppressed insulin 
resistance (Cremonini et al. 2016; Latha and Daisy 2011), and glucose uptake (Prasad et al. 2010) 
have been reported. This may also contribute to the ability of the fraction to elevate serum insulin 
level (Figure 8.3.4C) and suppress insulin resistance (Figure 8.3.4D). The identified compounds 
may work synergistically to bring about the antidiabetic effect of the fraction.  
8.3.6 Conclusion 
These results insinuate the therapeutic effects of BFDE against T2D and its complications, as 
evidenced by the ability of the fraction to suppress hyperglycemia via increased insulin secretion, 
improved pancreatic β-cell function, modulation of glycolytic and carbohydrate hydrolyzing 
enzymes, attenuation of hyperlipidemia, pancreatic oxidative stress, and Nrf2 expression. These 
activities may be attributed to the synergetic effect of the identified phenolic constituents.  
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CHAPTER 9 
GENERAL DISCUSSIONS AND CONCLUSIONS 
9.1 General Discussions 
The increasing number of people living with diabetes mellitus (DM) makes it one of the fastest 
growing global epidemy. It is amongst the most common global chronic diseases, with a global 
prevalence of 425 million reported in 2017 (Cho et al. 2018; I.D.F. 2018) depicting a 2.4% increase 
in the 2015 estimate of 415 million (I.D.F. 2016; Ogurtsova et al. 2017). The International Diabetes 
Federation (IDF) projected a 48% rise in 2045 of the current figures to 629 million, with Africa 
experiencing a 156% increase (Cho et al. 2018; I.D.F. 2018). The projected rise in the number of 
diabetics in Africa can portrays a huge burden for the continent, owing to the cost of treating and 
managing of DM coupled to her poor health infrastructures. This has led to a paradigm shift from 
commercial antidiabetic drugs to the use of natural products. These natural products are majorly 
plant-based which are readily available, accessible and affordable. Often referred to as medicinal 
plants, these plants have been utilized in the treatment and management of various ailments and 
diseases such as cancer, malaria, and DM from time immemorial. Africa has been reported for the 
richness and endemicity of her indigenous flora, encompassing millions of medicinal plants 
employed in the treatment of DM and other diseases (Mohammed et al. 2014; Scott et al. 2004). 
However, there are still scientific dearth in the efficacies of some of these plants as well as their 
mechanism of actions. Although the use of medicinal plants is regarded safe, there are however 
concerns on their toxicity vis-à-vis standardization, characterization, and preparation  (Shan et al. 
2007). There have been concerns of herbal – herbal, herbal – food, and/or herbal – drug interactions 
owing to the cocktails of phytochemicals that are present in these plants (Ezuruike and Prieto 2014; 
Yüce et al. 2006). Hence, this study was carried out to investigate the antidiabetic, antioxidant and 
toxicological properties of Raffia palm (Raffia hookeri) wine, Vernonia amygdalina, 
Clerodendrum volubile, Dacryodes edulis, Cola nitida, and Phaseolus lunatus using in vitro, ex 
vivo, in silico and in vivo models. The metabolic pathways and metabolites involved were also 
investigated ex vivo and in vivo. 
The first plant to be studied is the Raffia palm (Raphia hookeri) wine which was sub divided into 
3 batches. The two of the batches were subjected to open air fermentation for 24 and 48 h 
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respectively, the other batch left unfermented. They were all concentrated at -50°C to yield 
concentrates which all showed significant (p<0.05) dose-dependent antioxidant activities in vitro. 
Their inhibitory effect on α-glucosidase, α-amylase and intestinal glucose absorption were also 
dose-dependent but increased with increasing time of fermentation. They further portrayed their 
antidiabetic potentials by stimulating glucose uptake in isolated paos muscles and yeast cells, while 
inhibiting intestinal glucose absorption and glucose diffusion ex vivo. The antioxidant activities of 
the palm wine samples were also demonstrated by their ability to protect against oxidative 
pancreatic injury ex vivo by elevating SOD and catalase activities, while depleting levels of NO, 
MDA, and myeloperoxidase activities. Their protective effect against oxidative injury also 
involved inhibition of citric acid cycle metabolites and pathways involved in SOD generation, 
while activating vitamins, lipid, steroids, inositol and its phosphates, and sulfate/sulfite metabolic 
pathways. The unfermented palm wine portrayed an antidiabetic activity by significantly (p<0.05) 
depleting blood glucose levels of T2D rats, with concomitant increased serum insulin 
concentration, while concomitantly improving pancreatic β-cell function and numbers. This 
activity can be attributed to its ability to inhibit the activities of glycogen phosphorylase, fructose-
1,6-biphosphatase, glucose-6-phosphatase, ATPase and α-amylase. It also led to down regulation 
of Nrf2 expression in the pancreatic tissue and cerebellar cortex of T2D rats, while enhancing the 
antioxidant activities of the serum, pancreas, brain and testes. It improved the morphology of the 
pancreas, cerebellar cortex and testes, while restoring the neuronal integrity and perfusion of the 
cerebellar cortex and pancreatic tissues respectively. It also led to replenishment of cholesterol and 
squalene levels, while activating pathways for plasmalogen synthesis, mitochondrial beta-
oxidation of long chain saturated fatty acids in the testicular tissues. These activities can be 
attributed to the synergetic effect of the identified phytochemicals comprising of non-calories 
sugars, phenolics, unsaturated fatty acids, and alkaloids. Considering the its availability and its 
high consumption owing to its sweetness, raffia palm wine can be explored in the development of 
nutraceuticals or food adjunct for the treatment and management of T2D and its complications. 
The second plant investigated was Phaseolus lunatus. It was subjected to aqueous extraction which 
was concentrated at -50°C to yield the aqueous extract. The extract showed significant free radical 
scavenging and ferric reducing activities in vitro, which insinuates an antioxidant potential. Its 
antioxidant activities were further affirmed by the ability of the extract to elevate the GSH level, 
SOD and catalase activities, with concomitant depletion of MDA levels in oxidative hepatic injury 
516 
 
ex vivo. The protective effect of the extract against oxidative hepatic injury was also shown to 
involve inhibition of hepatic ATPase activities and arrest of pancreatic DNA fragmentation. Its 
antidiabetic activities were demonstrated by its inhibitory effects on α-glucosidase and α-amylase 
activities as increased activities of these enzymes have been implicated in the postprandial rise in 
blood glucose level (Chukwuma and Islam 2015). Some commercial antidiabetic drugs such as 
acarbose bring about their action via inhibition of these enzymes. The antidiabetic potential was 
further demonstrated by the ability of the extract to inhibit glucose 6 phosphatase activity and 
intestinal glucose absorption, while stimulating muscle glucose uptake ex vivo. The identified 
phytochemical constituents of P. lunatus were predicted in silico to be safe as they fell between 
the toxicity classes of 5 and 6. These antioxidant and antidiabetic activities of P. lunatus can be 
attributed to the synergetic effect of the identified phytochemical and amino acids constituents. As 
a legume and the predicted toxicity class, P. lunatus can be explored in the development of 
functional foods or included in diets for the treatment and management of T2D and its 
complications. 
Vernonia amygdalina is the third plant that was studied for its antioxidant and antidiabetic 
properties. The hot infusion, ethyl acetate, ethanol and aqueous extracts displayed potent 
antioxidant activities by significantly scavenging free radicals and reducing ferric oxidation. The 
potency was further revealed by their ability to protect against oxidative injuries in the liver and 
brain as they elevated the GSH level, SOD and catalase activities, and depleted MDA level ex vivo. 
Their antidiabetic activities were demonstrated by their ability to inhibit the activities of α-
glucosidase and α-amylase, which was further ascertain by their ability to stimulate muscle glucose 
uptake. The hot infusion also arrested DNA fragmentation in oxidative hepatic injury, indicating 
an antiapoptotic potential (loannou and Chen 1996). The neuroprotective effect of the hot infusion 
against glucose-induced neurotoxicity was demonstrated by its ability to stimulate brain glucose 
uptake. This uptake also involved increasing antioxidant and anti-inflammatory activities, and 
inhibition of ATPase activities, while suppressing the oxidative activation of the pyruvate 
metabolism pathway. Histochemical analysis of the V. amygdalina leaves revealed the distribution 
of the phytochemicals, acidic lipid, mucilage and pectin, lipids, polyphenols and alkaloids in the 
mid rib, glandular trichome and epidermis. This corresponded with the identified phytochemicals 
of the hot infusion, ethyl acetate and ethanol extracts. The synergetic effects of these 
phytochemicals may be responsible for the antioxidant and antidiabetic properties of V. 
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amygdalina. This study further affirms the antidiabetic properties of this leafy vegetable. It can 
also be utilized in the development of novel drugs or nutraceuticals for treating neurodegeneration 
in T2D. 
The flowers and leaves of Clerodendrum volubile were investigated for their antioxidant, 
antidiabetic, and cytotoxic activities in vitro and ex vivo. The ethyl acetate, ethanol, aqueous 
extracts of the flowers displayed potent antioxidant activities by significantly (p<0.05) scavenging 
free radicals and reducing ferric oxidation. This was further evidenced by the ability of the extracts 
to elevate GSH level, SOD and catalase activities, as well as reduce MDA levels in oxidative 
hepatic and pancreatic injuries respectively, ex vivo. The ameliorative effect of the extracts on 
these organs was shown to involve inhibition of ATPase activity and arrest of DNA fragmentation. 
Their antidiabetic potential was revealed by their ability to inhibit the activities of α-glucosidase 
and α-amylase. Similarly, the dichloromethane (DCM) fraction of C. volubile leaves ethanol 
extract displayed potent antioxidant and antidiabetic activities in vitro. However, it was cytotoxic 
in human embryonic kidney (HEK-293) cells. Its cytotoxic mechanism involved exacerbation of 
oxidative stress and proinflammation as evidenced by the depleted GSH level, SOD and catalase 
activities, and elevated myeloperoxidase activity, NO and MDA levels. The fraction also led to 
morphological changes of the cells portraying an occurrence of apoptosis and necrosis.  In silico 
toxicological analysis of the identified phytochemicals constituents of the fraction predicted them 
as potent inhibitors of CYP1A2, CYP2C9, and CYP2C9. The predicted low maximum tolerated 
human dose by most of the compounds also portrays a toxic potential of the fraction. This study 
gives credence to the folkloric use of this plant in the tresatment and management of DM, and can 
be utilized in the development of novel antidiabetic drugs. However, the toxic effect of the leaf’s 
DCM fraction should be taken into consideration in the development of such drugs. 
The hot infusion of Cola nitida was investigated for its antioxidant and antidiabetic properties. The 
infusion displayed significant (p<0.05) antioxidant potentials as portrayed by their ability to 
scavenge free radicals and reduce ferric oxidation in vitro. This was further corroborated by their 
ability to elevate GSH level, SOD and catalase activities, while concomitantly depleting MDA 
levels in oxidative hepatic injury ex vivo. Its anti-hepatoxicity mechanisms involves modulation 
of the hepatic functional chemistry to levels indistinguishable from the normal tissues, with 
concomitant activation of catecholamine biosynthesis, phenylalanine and tyrosine metabolism, 
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tyrosine metabolism, and urea cycle pathways. The infusion also displayed an antiapoptotic 
potential by its arrest of DNA fragmentation in oxidative hepatic injury. Its antidiabetic potentials 
were displayed by its inhibition of α-glucosidase and α-amylase in vitro. This was further 
ascertained by its ability to reduce blood glucose level in T2D rats, with concomitant increase in 
serum insulin levels while improving pancreatic β-cell function and glucose tolerance. It also 
caused improvement in the pancreatic and cerebellar cortex morphologies, while restoring 
pancreatic perfusion and neuronal integrity. Its antidiabetic and neuroprotective effects were also 
corroborated by its ability to inhibit the activities of glycogen phosphorylase, fructose 1,6 
biphosphatase, glucose-6-phosphatase, ATPase α-amylase, and acetylcholinesterase. Its 
antioxidant activities were further ascertained by its ability to modulate redox imbalance in the 
serum, brain and pancreatic tissues as evidenced by the increased GSH level, SOD and catalase 
activities, and reduced MDA level. The depleted NO level and myeloperoxidase activity insinuates 
an anti-proinflammatory potential of the infusion. Suppressed expressions of Nrf2 in the pancreas 
and brains by the infusion, portrays a molecular mechanism that may contribute to its antidiabetic 
and antioxidant effect in T2D. This was further affirmed by the ability of its identified main 
phytoconstituents (caffeine and theobromine) to molecularly interact with Nrf2 in silico. In silico 
toxicity analysis of caffeine revealed it to be hepatotoxic and a substrate of P-glycoprotein. The 
Adenosine Receptor A2a was identified as its toxicity target. Its toxicity class of 3 insinuates a 
toxic potential. These results further validate the efficacy of C. nitida in the treatment and 
management of T2D and neurodegenerative complications. However, the toxicity of its main 
constituent, caffeine should be taken into consideration. 
The ethyl acetate, ethanol and aqueous extracts of Dacryodes edulis were investigated for their 
antioxidant and antidiabetic activities. The extracts displayed potent antioxidant activities as 
revealed by their significant (p<0.05) free radical scavenging and reducing power activities in 
vitro. This is further corroborated by their ability to modulate redox imbalance in oxidative 
pancreatic and hepatic injuries ex vivo. The antidiabetic potentials of the extract were demonstrated 
by their ability to α-glucosidase, ATPase and glucose 6 phosphatase activities in vitro and ex vivo. 
This was also reflected by the ability of the identified compounds to molecularly interact with α-
glucosidase. They also displayed an antiapoptotic potential by arresting DNA fragmentation in 
oxidative hepatic injury. Based on these results, the ethanol extract was further fractionated via 
liquid-liquid fractionation using gradient-based solvents to yield the hexane, DCM, ethyl acetate, 
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butanol (BuOH) and aqueous fractions. The antidiabetic potentials of these fractions were 
determined via their ability to inhibit α-glucosidase activity in vitro, with the BuOH fraction giving 
the most potent activity. To further affirm its antidiabetic potentials, the BuOH fraction was 
significantly stimulated glucose uptake in 3T3-L1 adipocytes, with little or no cytotoxic effect. 
The antidiabetic properties of the fraction were further confirmed by its ability to deplete blood 
glucose level, with concomitant increase in serum insulin concentration while improving β-cell 
function and suppressing insulin resistance. The fraction also led to improve the pancreatic 
morphology, with concomitant restoration of the pancreatic perfusion. The inhibition of glycogen 
phosphorylase, fructose 1,6 biphosphatase, glucose 6 phosphatase, ATPase α-amylase, and 
acetylcholinesterase activities by the extracts may also contribute to the observed 
antihyperglycemic activity. The ability of the fraction to attenuate dyslipidemia portrays its 
antilipemic effect as portrayed by the depleted levels of total cholesterol, LDL-cholesterol and 
triglyceride, while elevating HDL-cholesterol level. Its modulatory effect on redox imbalances in 
the serum and pancreatic tissues, portrays an antioxidant protective effect in T2D as revealed by 
the elevated GSH level, SOD and catalase activities, as well as depleted levels of MDA. The anti-
proinflammatory potential of the fraction is portrayed by its ability to deplete NO level and 
myeloperoxidase activities in the serum and pancreatic tissues. The inhibition of pancreatic Nrf2 
by the fraction may also reflect an antidiabetic (He et al. 2012; Miao et al. 2012) and antioxidant 
potential (Wrighten et al. 2009; Zucker et al. 2014). These activities can be attributed to the 
synergetic activities of the identified compounds, which are majorly phenolics. These results 
affirm the efficacy of this leaves in the treatment and management of T2D. It can be exploited in 
the development of novel affordable antidiabetic drugs. 
9.2 General Conclusions 
These results insinuate the antioxidant and antidiabetic properties of raffia palm wine, V. 
amygdalina, C. volubile, D. edulis, C. nitida, and P. lunatus as revealed by their antioxidant 
activities; ability to inhibit key carbohydrate digestive and glycogenic enzymes; reduction of blood 
glucose levels; and stimulation of insulin secretions. These activities were often better than those 
the standard commercial drugs. Of the studied plants, Raffia palm wine had the best antidiabetic 
activity, with little or no toxicity. This was followed by D. edulis and C. nitida. The DCM fraction 
of C. volubile leaves was the most toxic, while the high caffeine content of C. nitida infusion poses 
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a toxicity threat and a herbal-drug interaction. Raffia palm wine and C. nitida can further be 
utilized in the development of nutraceuticals and/or functional food for the management of 
neurodegeneration in T2D as they restored and maintained the neuronal integrity of the brain. 
Raffia palm wine can also be utilized in the treatment and management of T2D-induced male 
infertility. Metabolomic analysis of tissues treated with some of the studied plants, suggests 
suppression of the oxidative-activated glycolytic and citric acid cycle pathways. These activities 
can be attributed to the synergetic activities of the identified phytoconstituents. However, results 
from cytotoxic activities and in silico toxicology analysis suggest caution in their usage in order 
to reduce the occurrence of herbal – herbal, herbal – food, and herbal – drug interactions.  
9.3 Recommendations 
Clinical studies on the antidiabetic activities of these plants are recommended to further ascertain 
their efficacies in humans. Considering the facts that these plants are readily available and most of 
them (raffia palm wine, P. lunatus, V. amygdalina, C. nitida and C. volubile) consumed as food, 
they can be utilized in the design and development of functional foods and/or nutraceutical and 
employed in dietary therapies for treating and managing T2D and its complications. 
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